<SEC-DOCUMENT>0001615219-16-000157.txt : 20160428
<SEC-HEADER>0001615219-16-000157.hdr.sgml : 20160428
<ACCEPTANCE-DATETIME>20160428135258
ACCESSION NUMBER:		0001615219-16-000157
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20160607
FILED AS OF DATE:		20160428
DATE AS OF CHANGE:		20160428
EFFECTIVENESS DATE:		20160428

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Flex Pharma, Inc.
		CENTRAL INDEX KEY:			0001615219
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				465087339
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36812
		FILM NUMBER:		161598948

	BUSINESS ADDRESS:	
		STREET 1:		800 BOYLSTON STREET
		STREET 2:		24TH FLOOR
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02199
		BUSINESS PHONE:		617-874-1821

	MAIL ADDRESS:	
		STREET 1:		800 BOYLSTON STREET
		STREET 2:		24TH FLOOR
		CITY:			BOSTON
		STATE:			MA
		ZIP:			02199
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>flks2016proxy.htm
<DESCRIPTION>DEF 14A
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2016 Workiva -->
		<title>DEF 14A</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s3B22DECAF0E3163F2140CD6523312663"></a></div><div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:14pt;"><font style="font-family:Arial;font-size:14pt;font-weight:bold;">SCHEDULE 14A INFORMATION</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934</font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:11pt;"><font style="font-family:Arial;font-size:9pt;">Filed by the Registrant</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:Wingdings;font-size:11pt;">&#253;</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:9pt;">Filed by a Party other than the Registrant</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:Wingdings;font-size:10pt;">&#168;</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Check the appropriate box:</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">&#168;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:Arial;font-size:9pt;">Preliminary Proxy Statement</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">&#168;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:Arial;font-size:9pt;">Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))</font></div><div style="line-height:120%;text-align:justify;font-size:11pt;"><font style="font-family:Wingdings;font-size:11pt;">&#253;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:Arial;font-size:9pt;">Definitive Proxy Statement</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">&#168;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:Arial;font-size:9pt;">Definitive Additional Materials</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">&#168;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:Arial;font-size:9pt;">Soliciting Material Pursuant to &#167; 240.14a-12</font></div><div style="line-height:120%;text-align:center;font-size:14pt;"><font style="font-family:Arial;font-size:14pt;font-weight:bold;">FLEX PHARMA, INC.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div><font style="font-family:Arial;font-size:9pt;">(Name of Registrant as Specified In Its Charter)</font></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:24px;text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(Name of Person(s) Filing Proxy Statement if Other Than the Registrant)</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Payment of Filing Fee (Check the appropriate box)</font></div><div style="line-height:120%;text-align:justify;font-size:11pt;"><font style="font-family:Wingdings;font-size:11pt;">&#253;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:Arial;font-size:9pt;">No fee required.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">&#168;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:Arial;font-size:9pt;">Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.</font></div><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Title of each class of securities to which transaction applies:</font></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Aggregate number of securities to which transaction applies:</font></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (Set forth the amount on which the filing fee is calculated and state how it was determined):</font></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Proposed maximum aggregate value of transaction:</font></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Total fee paid:</font></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">&#168;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:Arial;font-size:9pt;">Fee paid previously with preliminary materials.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">&#168;</font><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;</font><font style="font-family:Arial;font-size:9pt;">Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously.  Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.</font></div><div style="line-height:120%;text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Amount Previously Paid:</font></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Form, Schedule or Registration Statement No.:</font></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Filing Party:</font></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:4px;text-align:justify;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Date Filed:</font></div><div style="line-height:120%;padding-bottom:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div></div><hr style="page-break-after:always"><div><a name="s10EC95323D87ECA3F940CD65236317D1"></a></div><div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">FLEX PHARMA, INC.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">800 Boylston Street, 24</font><font style="font-family:Arial;font-size:7pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">th</sup></font><font style="font-family:Arial;font-size:10pt;font-weight:bold;">&#160;Floor</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Boston, MA 02199</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">(617) 874-1821</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">NOTICE OF ANNUAL MEETING OF SHAREHOLDERS</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">To Be Held On June 7, 2016</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Dear Shareholder:</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">You are cordially invited to attend the Annual Meeting of Shareholders of </font><font style="font-family:Arial;font-size:10pt;font-weight:bold;">FLEX PHARMA, INC.</font><font style="font-family:Arial;font-size:10pt;">, a Delaware corporation (the &#8220;</font><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Company</font><font style="font-family:Arial;font-size:10pt;">&#8221;).  The meeting will be held on Tuesday, June 7, 2016 at 2:00 p.m. local time at Cooley LLP, 500 Boylston Street, 14th Floor, Boston, MA 02116 for the following purposes: </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">1.</font><font style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;&#160;To elect the Board&#8217;s three nominees for director to hold office until the 2019 Annual Meeting of Shareholders.  </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">2.</font><font style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;&#160;To ratify the selection by the Audit Committee of the Board of Directors of Ernst &amp; Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2016.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">3.</font><font style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;&#160;To conduct any other business properly brought before the meeting.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">These items of business are more fully described in the Proxy Statement accompanying this Notice.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The record date for the Annual Meeting is April 11, 2016. Only shareholders of record at the close of business on that date may vote at the meeting or any adjournment thereof.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:91.31707317073172%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="padding-bottom:16px;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Important Notice Regarding the Availability of Proxy Materials for the Shareholders&#8217; Meeting to Be Held on Tuesday, June 7, 2016 at 2:00 p.m. local time at Cooley LLP, 500 Boylston Street, 14th Floor, Boston, MA 02116.</font></div><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The proxy statement and annual report to shareholders </font></div><div style="padding-bottom:16px;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">are available at www.proxyvote.com.</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">By Order of the Board of Directors</font></div><div style="line-height:120%;padding-bottom:8px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:24%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">/s/ Robert Hadfield</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Robert Hadfield</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Secretary</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Boston, Massachusetts</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">April 28, 2016</font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:91.31707317073172%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">You are cordially invited to attend the meeting in person.  Whether or not you expect to attend the meeting, please complete, date, sign and return the enclosed proxy, or vote over the telephone or the internet as instructed in these materials, as promptly as possible in order to ensure your representation at the meeting. Even if you have voted by proxy, you may still vote in person if you attend the meeting.  Please note, however, that if your shares are held of record by a broker, bank or other nominee and you wish to vote at the meeting, you must obtain a proxy issued in your name from that record holder.</font></div><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div></td></tr></table></div></div><div><br></div><div><div style="line-height:100%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><a name="s6B305456E5AA5B80ADA2CD652384B528"></a></div><div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">FLEX PHARMA, INC.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">800 Boylston Street, 24</font><font style="font-family:Arial;font-size:7pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">th</sup></font><font style="font-family:Arial;font-size:10pt;font-weight:bold;">&#160;Floor</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Boston, MA 02199</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">(617) 874-1821</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">PROXY STATEMENT</font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">FOR THE 2016 ANNUAL MEETING OF SHAREHOLDERS</font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">June 7, 2016</font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">QUESTIONS AND ANSWERS ABOUT THESE PROXY MATERIALS AND VOTING</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Why am I receiving these materials?</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">We have sent you these proxy materials because the Board of Directors of Flex Pharma, Inc. (sometimes referred to as the &#8220;Company&#8221; or "Flex Pharma") is soliciting your proxy to vote at the 2016 Annual Meeting of Shareholders, including at any adjournments or postponements of the meeting. You are invited to attend the annual meeting to vote on the proposals described in this proxy statement. However, you do not need to attend the meeting to vote your shares. Instead, you may simply complete, sign and return the enclosed proxy card, or follow the instructions below to submit your proxy over the telephone or through the internet.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">We intend to mail these proxy materials on or about April 28, 2016 to all shareholders of record entitled to vote at the annual meeting.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">How do I attend the annual meeting?</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The meeting will be held on Tuesday, June 7, 2016 at 2:00 p.m. local time at Cooley LLP, 500 Boylston Street, 14th Floor, Boston, MA 02116. Directions to the annual meeting may be found at www.cooley.com/offices. Information on how to vote in person at the annual meeting is discussed below.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Who can vote at the annual meeting?</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Only shareholders of record at the close of business on April 11, 2016 will be entitled to vote at the annual meeting. On this record date, there were 17,967,891 shares of common stock outstanding and entitled to vote. </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;">Shareholder of Record: Shares Registered in Your Name</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">If on April 11, 2016 your shares were registered directly in your name with Flex Pharma&#8217;s transfer agent, Computershare Trust Company, N.A., then you are a shareholder of record. As a shareholder of record, you may vote in person at the meeting or vote by proxy. Whether or not you plan to attend the meeting, we urge you to fill out and return the enclosed proxy card or vote by proxy over the telephone or on the internet as instructed below to ensure your vote is counted. </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;">Beneficial Owner: Shares Registered in the Name of a Broker or Bank</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">If on April 11, 2016 your shares were held, not in your name, but rather in an account at a brokerage firm, bank, dealer or other similar organization, then you are the beneficial owner of shares held in "street name" and these proxy materials are being forwarded to you by that organization. The organization holding your account is considered to be the shareholder of record for purposes of voting at the annual meeting. As a beneficial owner, you have the right to direct your broker or other agent regarding how to vote the shares in your account. You are also invited to attend the annual meeting. However, since you are not the shareholder of record, you may not vote your shares in person at the meeting unless you request and obtain a valid proxy from your broker or other agent.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">What am I voting on?</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">There are two matters scheduled for a vote: </font></div><table cellpadding="0" cellspacing="0" style="padding-top:10px;padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Election of three directors; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:10px;padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Ratification of the selection by the Audit Committee of the Board of Directors of Ernst &amp; Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2016.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:100%;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">1</font><font style="font-family:Arial;font-size:10pt;">.</font></div></div><hr style="page-break-after:always"><div><a name="s6B305456E5AA5B80ADA2CD652384B528"></a></div><div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">What if another matter is properly brought before the meeting?</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Board of Directors knows of no other matters that will be presented for consideration at the Annual Meeting. If any other matters are properly brought before the meeting, it is the intention of the persons named in the accompanying proxy to vote on those matters in accordance with their best judgment.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">How do I vote?</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">You may either vote "For" all the nominees to the Board of Directors or you may "Withhold" your vote for any nominee you specify. For the approval of the appointment of Ernst &amp; Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2016, you may vote "For" or "Against" or abstain from voting.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The procedures for voting are fairly simple:</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;">Shareholder of Record: Shares Registered in Your Name</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">If you are a shareholder of record, you may vote in person at the annual meeting, vote by proxy using the enclosed proxy card, vote by proxy over the telephone, or vote by proxy through the Internet. Whether or not you plan to attend the meeting, we urge you to vote by proxy to ensure your vote is counted. You may still attend the meeting and vote in person even if you have already voted by proxy.</font></div><table cellpadding="0" cellspacing="0" style="padding-top:10px;padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">To vote in person, come to the annual meeting and we will give you a ballot when you arrive. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:10px;padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">To vote using the proxy card, simply complete, sign and date the enclosed proxy card and return it promptly in the envelope provided. If you return your signed proxy card to us before the annual meeting, we will vote your shares as you direct.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:10px;padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">To vote over the telephone, dial toll-free 1-800-690-6903 using a touch-tone phone and follow the recorded instructions. You will be asked to provide the company number and control number from the enclosed proxy card. Your telephone vote must be received by 11:59 p.m., Eastern time on June 6, 2016 to be counted. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:10px;padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">To vote through the internet, go to www.proxyvote.com to complete an electronic proxy card. You will be asked to provide the company number and control number from the enclosed proxy card. Your internet vote must be received by 11:59 p.m. Eastern time on June 6, 2016 to be counted. </font></div></td></tr></table><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;">Beneficial Owner: Shares Registered in the Name of Broker or Bank</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">If you are a beneficial owner of shares registered in the name of your broker, bank, or other agent, you should have received a voting instruction form with these proxy materials from that organization rather than from Flex Pharma. Simply complete and mail the voting instruction form to ensure that your vote is counted. Alternatively, you may vote by telephone or over the internet as instructed by your broker or bank. To vote in person at the annual meeting, you must obtain a valid proxy from your broker, bank or other agent. Follow the instructions from your broker or bank included with these proxy materials, or contact your broker or bank to request a proxy form. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:91.31707317073172%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:middle;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-left:1px solid #000000;border-right:1px solid #000000;border-top:1px solid #000000;"><div style="padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Internet proxy voting may be provided to allow you to vote your shares online, with procedures designed to ensure the authenticity and correctness of your proxy vote instructions. However, please be aware that you must bear any costs associated with your internet access, such as usage charges from internet access providers and telephone companies. </font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">How many votes do I have?</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">On each matter to be voted upon, you have one vote for each share of common stock you own as of April 11, 2016. </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">What happens if I do not vote?</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;">Shareholder of Record: Shares Registered in Your Name</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">If you are a shareholder of record and do not vote by completing your proxy card, by telephone, through the internet or in person at the annual meeting, your shares will not be voted. </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;">Beneficial Owner: Shares Registered in the Name of Broker or Bank</font></div><div><br></div><div><div style="line-height:100%;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">2</font><font style="font-family:Arial;font-size:10pt;">.</font></div></div><hr style="page-break-after:always"><div><a name="s6B305456E5AA5B80ADA2CD652384B528"></a></div><div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">If you are a beneficial owner and do not instruct your broker, bank, or other agent how to vote your shares, the question of whether your broker or nominee will still be able to vote your shares depends on whether the particular proposal is considered to be a routine matter under applicable rules. Brokers and nominees can use their discretion to vote "uninstructed" shares with respect to matters that are considered to be "routine" under applicable rules but not with respect to "non-routine" matters. Under applicable rules and interpretations, "non-routine" matters are matters that may substantially affect the rights or privileges of stockholders, such as mergers, stockholder proposals, elections of directors (even if not contested), executive compensation (including any advisory stockholder votes on executive compensation and on the frequency of stockholder votes on executive compensation), and certain corporate governance proposals, even if management-supported. Accordingly, your broker or nominee may not vote your shares on Proposal 1 without your instructions, but may vote your shares on Proposal 2 even in the absence of your instruction.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">What if I return a proxy card or otherwise vote but do not make specific choices?</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">If you return a signed and dated proxy card or otherwise vote without marking voting selections, your shares will be voted, as applicable, &#8220;For&#8221; the election of all three nominees for director and &#8220;For&#8221; the approval of Ernst &amp; Young LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2016. If any other matter is properly presented at the meeting, your proxyholder (one of the individuals named on your proxy card) will vote your shares using his or her best judgment.</font><font style="font-family:Arial;font-size:10pt;font-weight:bold;">&#32;</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Who is paying for this proxy solicitation?</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">We will pay for the entire cost of soliciting proxies. In addition to these proxy materials, our directors and employees may also solicit proxies in person, by telephone, or by other means of communication. Directors and employees will not be paid any additional compensation for soliciting proxies. We may also reimburse brokerage firms, banks and other agents for the cost of forwarding proxy materials to beneficial owners.</font><font style="font-family:Arial;font-size:10pt;font-weight:bold;">&#32;</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">What does it mean if I receive more than one set of proxy materials?</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">If you receive more than one set of proxy materials, your shares may be registered in more than one name or in different accounts. Please follow the voting instructions on the proxy cards in the proxy materials to ensure that all of your shares are voted.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Can I change my vote after submitting my proxy?</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;">Shareholder of Record: Shares Registered in Your Name</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Yes. You can revoke your proxy at any time before the final vote at the meeting. If you are the record holder of your shares, you may revoke your proxy in any one of the following ways:</font></div><table cellpadding="0" cellspacing="0" style="padding-top:10px;padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">You may submit another properly completed proxy card with a later date.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:10px;padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">You may grant a subsequent proxy by telephone or through the internet.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:10px;padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">You may send a timely written notice that you are revoking your proxy to Flex Pharma&#8217;s Secretary at 800 Boylston Street, 24th Floor, Boston, MA 02199. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:10px;padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:24px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">You may attend the annual meeting and vote in person. Simply attending the meeting will not, by itself, revoke your proxy.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Your most current proxy card or telephone or internet proxy is the one that is counted. </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;">Beneficial Owner: Shares Registered in the Name of Broker or Bank</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">If your shares are held by your broker or bank as a nominee or agent, you should follow the instructions provided by your broker or bank.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">When are shareholder proposals and director nominations due for next year&#8217;s annual meeting?</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">To be considered for inclusion in next year's proxy materials, your proposal must be submitted in writing by December 29, 2016 to Flex Pharma, Inc., Attn: General Counsel, 800 Boylston Street, 24th Floor, Boston, MA 02199.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Pursuant to our bylaws, if you wish to submit a proposal (including a director nomination) at the meeting that is not to be included in next year's proxy materials, you must do so by no later than the close of business on March 9, </font></div><div><br></div><div><div style="line-height:100%;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">3</font><font style="font-family:Arial;font-size:10pt;">.</font></div></div><hr style="page-break-after:always"><div><a name="s6B305456E5AA5B80ADA2CD652384B528"></a></div><div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">2017 nor earlier than the close of business on February 7, 2017; provided, however, that in the event that the date of the annual meeting is advanced more than thirty (30) days prior to or delayed by more than thirty (30) days after the anniversary of the preceding year's annual meeting, in order for your notice to be timely, it must be received no earlier than the close of business on the one hundred twentieth (120th) day prior to such annual meeting and not later than the close of business on the later of the ninetieth (90th) day prior to such annual meeting or the tenth (10th) day following the day on which public announcement of the date of such meeting is first made. In no event shall an adjournment or a postponement of an annual meeting for which notice has been given, or the public announcement thereof has been made, commence a new time period notice.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">How are votes counted?</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Votes will be counted by the inspector of election appointed for the meeting, who will separately count, for the proposal to elect directors, votes &#8220;For,&#8221; &#8220;Withheld&#8221; and broker non-votes and, with respect to the appointment of Ernst &amp; Young LLP, votes &#8220;For&#8221; and &#8220;Against,&#8221; abstentions and, if applicable, broker non-votes.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">What are &#8220;broker non-votes&#8221;? </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">As discussed above, when a beneficial owner of shares held in &#8220;street name&#8221; does not give instructions to the broker or nominee holding the shares as to how to vote on matters deemed by the NYSE to be &#8220;non-routine,&#8221; the broker or nominee cannot vote the shares. These unvoted shares are counted as &#8220;broker non-votes.&#8221; </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">How many votes are needed to approve each proposal?  </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">For the election of directors, the three nominees receiving the most &#8220;For&#8221; votes from the holders of shares present in person or represented by proxy and entitled to vote on the election of directors will be elected. Only votes &#8220;For&#8221; or &#8220;Withheld&#8221; will affect the outcome. </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">To be approved, Proposal No. 2, ratification of the selection of Ernst &amp; Young LLP as the Company&#8217;s independent registered public accounting firm for fiscal year ending December 31, 2016, must receive &#8220;For&#8221; votes from the holders of a majority of shares present in person or represented by proxy and entitled to vote on the matter. If you</font><font style="font-family:Arial;font-size:10pt;font-weight:bold;">&#32;</font><font style="font-family:Arial;font-size:10pt;">&#8220;Abstain&#8221; from voting, it will have the same effect as an &#8220;Against&#8221; vote. Broker non-votes will have no effect. </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">What is the quorum requirement?</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">A quorum of shareholders is necessary to hold a valid meeting. A quorum will be present if shareholders holding at least a majority of the outstanding shares entitled to vote are present at the meeting in person or represented by proxy. On the record date, there were 17,967,891 shares outstanding and entitled to vote. Thus, the holders of 8,983,946 shares must be present in person or represented by proxy at the meeting to have a quorum.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Your shares will be counted towards the quorum only if you submit a valid proxy (or one is submitted on your behalf by your broker, bank or other nominee) or if you vote in person at the meeting. Abstentions and broker non-votes will be counted towards the quorum requirement. If there is no quorum, the holders of a majority of shares present at the meeting in person or represented by proxy may adjourn the meeting to another date.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">How can I find out the results of the voting at the annual meeting?</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Preliminary voting results will be announced at the annual meeting. In addition, final voting results will be published in a current report on Form 8-K that we expect to file within four business days after the annual meeting. If final voting results are not available to us in time to file a Form&#160;8-K within four business days after the meeting, we intend to file a Form&#160;8-K to publish preliminary results and, within four business days after the final results are known to us, file an additional Form&#160;8-K to publish the final results.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">What proxy materials are available on the internet? </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The letter to shareholders</font><font style="font-family:Arial;font-size:10pt;font-weight:bold;">, </font><font style="font-family:Arial;font-size:10pt;">proxy statement, Form 10-K and annual report to shareholders are available at www.proxyvote.com. </font></div><div><br></div><div><div style="line-height:100%;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">4</font><font style="font-family:Arial;font-size:10pt;">.</font></div></div><hr style="page-break-after:always"><div><a name="sc0896aca489b4633b3a247362053a34d"></a></div><div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">PROPOSAL 1 <br> <br>ELECTION OF DIRECTORS</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">CLASSIFIED BOARD</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Flex Pharma&#8217;s Board of Directors is divided into three classes. Each class consists, as nearly as possible, of one-third of the total number of directors, and each class has a three-year term. Vacancies on the Board may be filled only by persons elected by a majority of the remaining directors. A director elected by the Board to fill a vacancy in a class, including vacancies created by an increase in the number of directors, shall serve for the remainder of the full term of that class and until the director&#8217;s successor is duly elected and qualified. </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Board of Directors presently has nine</font><font style="font-family:Arial;font-size:10pt;font-weight:bold;">&#32;</font><font style="font-family:Arial;font-size:10pt;">members. There are three directors in the class whose term of office expires in 2016. If elected at the annual meeting, each of these nominees would serve until the 2019 annual meeting and until his or her successor has been duly elected and qualified, or, if sooner, until the director&#8217;s death, resignation or removal. The Company does not have a formal policy relating to director attendance at Annual Meetings but all directors and nominees are invited to attend the Annual Meeting. </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Directors are elected by a plurality of the votes of the holders of shares present in person or represented by proxy and entitled to vote on the election of directors. Accordingly, the three nominees receiving the highest number of affirmative votes will be elected. Shares represented by executed proxies will be voted, if authority to do so is not withheld, for the election of the three nominees named below. If any nominee becomes unavailable for election as a result of an unexpected occurrence, shares that would have been voted for that nominee will instead will be voted for the election of a substitute nominee proposed by Flex Pharma. Each person nominated for election has agreed to serve if elected. The Company&#8217;s management has no reason to believe that any nominee will be unable to serve. </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The following is a brief biography of each nominee and each director whose term will continue after the Annual Meeting.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">THE BOARD OF DIRECTORS RECOMMENDS</font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">A VOTE IN FAVOR OF EACH NAMED NOMINEE.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">NOMINEES FOR ELECTION FOR A THREE-YEAR TERM EXPIRING AT THE 2019 ANNUAL MEETING</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Marc Kozin</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Marc Kozin, age 54, has served as a member of the Board of Directors since October 2014. Mr.&#160;Kozin has been a Senior Advisor to L.E.K. Consulting, a global strategy consulting firm, since July 2011. Prior to that, Mr.&#160;Kozin served as president of L.E.K.'s North American practice for 15&#160;years. Mr.&#160;Kozin currently serves as a member of the Board of Directors of UFP Technologies,&#160;Inc., Endocyte,&#160;Inc., OvaScience,&#160;Inc. and two privately-held companies, and he previously served on the Board of Directors of DYAX Corp. He also serves on the strategic advisory board for Healthcare Royalty Partners. Mr.&#160;Kozin holds a B.A., with distinction, in Economics from Duke University and an M.B.A., with distinction, from The Wharton School, University of Pennsylvania. We believe that Mr.&#160;Kozin is qualified to serve on the Board of Directors due to his nearly 30&#160;years of experience in corporate and business unit strategy consulting, merger and acquisition advisory services, and value management both domestically and internationally. </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Roderick MacKinnon</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Roderick MacKinnon, M.D., age 60, has served as a member of the Board of Directors since February 2015. Dr. MacKinnon is currently the Co-Chair of our Scientific Advisory Board and the Investigator at Howard Hughes Medical Institute and the John&#160;D. Rockefeller Jr. Professor, Laboratory of Molecular Neurobiology and Biophysics at the Rockefeller University. Dr. MacKinnon was a faculty member at Harvard Medical School before moving to Rockefeller in 1996. Dr. MacKinnon is a member of the National Academy of Sciences and is the recipient of numerous scientific awards, including the 2003 Nobel Prize in Chemistry, the 2003 Louisa Gross Horwitz Prize, the 2001 Gairdner Foundation International Award, the 2001 Perl-UNC Neuroscience Prize, the 2000 Lewis S. Rosenstiel Award for Distinguished Work in Basic Medical Science and the 1999 Albert Lasker Basic Medical Research Award. Dr. MacKinnon received his B.A. in biochemistry from Brandeis University and his M.D. from Tufts University School of Medicine. He completed his medical residency at Beth Israel Hospital, Harvard Medical School, and postdoctoral work at Brandeis. We believe that Dr.&#160;MacKinnon is qualified to serve on the Board of Directors due to his deep scientific experience and his scientific leadership of the Company.</font></div><div><br></div><div><div style="line-height:100%;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">5</font><font style="font-family:Arial;font-size:10pt;">.</font></div></div><hr style="page-break-after:always"><div><a name="sc0896aca489b4633b3a247362053a34d"></a></div><div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Michelle Stacy</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Michelle Stacy, age 60,</font><font style="font-family:Arial;font-size:10pt;font-weight:bold;">&#32;</font><font style="font-family:Arial;font-size:10pt;">has served as a member of the Board of Directors since March 2016. As the former president of Keurig, Inc. and former vice president and general manager with Gillette/P&amp;G, Ms. Stacy brings to the Board of Directors a wealth of experience leading consumer businesses and building global brands. During her five-year tenure at Keurig Inc., a division of Keurig Green Mountain, the company's revenue grew from $493 million in FY2008 to $4.3 billion for FY2013. Ms. Stacy sits on the Board of Directors of iRobot Corporation, Coravin Inc., Young Innovations Inc. and the nonprofit French Cultural Center. Ms Stacy is also a Director Advisor to The Cambridge Group (an AC Nielson Company) and is a professional speaker on leadership, innovation and growth. She received a M.S. in Management from J. L. Kellogg Graduate School of Management - Northwestern University, and a B.S. from Dartmouth College. We believe that Ms. Stacy is qualified to serve on the Board of Directors given her broad marketing, senior management and leadership roles in consumer companies.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">THE BOARD OF DIRECTORS RECOMMENDS</font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">A VOTE IN FAVOR OF EACH NAMED NOMINEE.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">DIRECTORS CONTINUING IN OFFICE UNTIL THE 2017 ANNUAL MEETING</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Robert Perez</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Robert Perez, age 51, has served as member of the Board of Directors since September 2015. Mr. Perez is currently the Managing Partner of Vineyard Sound Advisors, LLC, a biopharmaceutical consulting firm. Mr. Perez was a member of the Board of Directors of Cubist Pharmaceuticals, Inc., or Cubist, from April 2014 until its purchase by Merck &amp; Co., Inc. in January 2015. He was appointed Chief Executive Officer of Cubist on January 1, 2015 after having served in several senior positions at Cubist. Mr. Perez joined Cubist in August 2003 as Senior Vice President, Sales and Marketing, and led the launch of Cubicin (daptomycin for injection). He served as Executive Vice President and Chief Operating Officer from August 2007 to July 2012 and President and Chief Operating Officer from July 2012 to December 2014. Prior to joining Cubist, he served as Vice President of Biogen, Inc.'s CNS business unit from 2001 to 2003, where he was responsible for commercial leadership of an $800 million neurology business unit, and from 1995 to 2001 he held positions of increasing responsibility within Biogen's CNS commercial organization. From 1987 to 1995, Mr. Perez held various sales and marketing positions at Zeneca Pharmaceuticals. He currently serves on the Board of Directors of AMAG Pharmaceuticals, Inc., Zafgen, Inc, and Cidara Therapeutics, Inc., public biopharmaceutical companies. He previously served as a member of the Board of Directors of Epix Pharmaceuticals, Inc. Mr. Perez is a member of the Board of Directors of the Biomedical Science Careers Program, a member of the Board of Trustees at the Dana-Farber Cancer Institute, Inc., a member of the Board of College Bound Dorchester, and a member of the Board of Advisors of the Citizen School of Massachusetts. Mr. Perez received a B.S. from California State University, Los Angeles and an M.B.A. from the Anderson Graduate School of Management at the University of California, Los Angeles. The Board of Directors believes that Mr. Perez's twenty plus years of sales and marketing experience within the pharmaceutical and biotechnology industries has provided him with valuable commercial and operational experience, as well as leadership skills that are important to the Board of Directors. </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Stuart Randle</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Stuart Randle, age 56, has served as a member of the Board of Directors since October 2014. Mr.&#160;Randle has served as the Chief Executive Officer of Ivenix, Inc. since January 2016. Previously, Mr. Randle served as the Chief Executive Officer of GI Dynamics Inc. from 2004 through September 2014. Prior to GI Dynamics, Mr.&#160;Randle served as the President and Chief Executive Officer of ACT Medical,&#160;Inc. from 1998 to 2001. Prior to 1998, Mr.&#160;Randle was Corporate Vice President and responsible for the northeastern region of the United States for Allegiance Healthcare Corporation. Mr.&#160;Randle previously worked for Baxter Healthcare Corporation in various roles including President, New England region, General Manager of anesthesia, and various sales and marketing roles. Mr.&#160;Randle has also held various sales and engineering roles with Ingersoll-Rand Corporation. Mr.&#160;Randle is a member of the Board of Directors of Teleflex,&#160;Inc. and Beacon Roofing Supply,&#160;Inc. and previously served as a member of the Board of Directors of GI Dynamics Inc. from 2003 until November 2014. Mr.&#160;Randle earned an M.B.A. from The Kellogg Graduate School of Management at Northwestern University and a B.S. degree in Mechanical Engineering from Cornell University. We believe that Mr.&#160;Randle is qualified to serve on the Board of Directors due to his over 20&#160;years' experience in the life sciences industry in engineering, sales, marketing, senior management and leadership roles in developing companies and also divisions of major medical corporations, which enables him to provide valuable insights to the Board of Directors regarding a variety of business, management and technical issues. </font></div><div><br></div><div><div style="line-height:100%;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">6</font><font style="font-family:Arial;font-size:10pt;">.</font></div></div><hr style="page-break-after:always"><div><a name="sc0896aca489b4633b3a247362053a34d"></a></div><div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">John Sculley</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">John Sculley, age 77, has served as a member of the Board of Directors since August 2014. Between 1983 and 1993, Mr.&#160;Sculley served as the Chief Executive Officer of Apple Computer,&#160;Inc. From 1978 to 1983, Mr.&#160;Sculley served as Chief Executive Officer of Pepsi-Cola Company. Since leaving Apple, Mr.&#160;Sculley has focused on investing in early stage companies as a venture capitalist and co-founder of several companies. Mr. Sculley currently serves on the Board of Directors of Pivot Technology Solutions. Mr.&#160;Sculley earned an M.B.A. degree from the Wharton School at the University of Pennsylvania and is a graduate of Brown University. The Board of Directors believes that Mr.&#160;Sculley is qualified to serve on the Board of Directors due to his experience developing consumer brands and expertise in corporate leadership.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">DIRECTORS CONTINUING IN OFFICE UNTIL THE 2018 ANNUAL MEETING</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Jeffrey Capello</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Jeffrey Capello, age 51, has been a member of the Board of Directors since April 2015. Mr Capello is currently the founder and Chief Executive Officer of Monomoy Advisors which focuses on helping companies drive shareholder value. From July 2014 until June 2015, Mr. Capello served as the Executive Vice President and Chief Financial Officer of Ortho-Clinical Diagnostics, which was acquired by the Carlyle Group from Johnson &amp; Johnson, with responsibility for global finance and business development. Prior to his role at Ortho-Clinical Diagnostics, Mr. Capello served as Chief Financial Officer and Executive Vice President of Boston Scientific from March 2010 to December 2013. At Boston Scientific, Mr. Capello was responsible for the worldwide management of Boston Scientific's finance, information systems, business development and corporate strategy functions. Mr. Capello joined Boston Scientific in June 2008 and served as Senior Vice President and Chief Accounting Officer until March 2010. Prior to joining Boston Scientific, he was the Senior Vice President and Chief Financial Officer with responsibilities for global finance and business development at PerkinElmer, Inc. from 2006 to 2008. Previously, he served as PerkinElmer's Vice President of Finance, Corporate Controller, Treasurer and Chief Accounting Officer from 2001 to 2006. Prior to his tenure at PerkinElmer, Mr. Capello was a Partner at PricewaterhouseCoopers LLP, both in the United States and in the Netherlands. Mr. Capello is a board member of Ovascience, Inc. Previously, Mr. Capello was a member of the Board of Directors of Sirtris Pharmaceuticals, Inc., which was acquired by GlaxoSmithKline in 2008, and served as the Chair of its audit committee. Mr. Capello holds a B.S. degree in Business Administration from the University of Vermont and an M.B.A. degree from Harvard Business School. Mr. Capello is also a certified public accountant. We believe that Mr. Capello is qualified to serve on the Board of Directors due to his experience in the medical device and healthcare technology industries, his accounting background and his service on the boards of directors of other life sciences companies.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Peter Barton Hutt</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Peter Barton Hutt, L.L.B., L.L.M., age 81, has been a member of the Board of Directors since March 2014. Mr.&#160;Hutt is a senior counsel at the law firm of Covington&#160;&amp; Burling&#160;LLP and has been an attorney with that firm since 1960. He served as Chief Counsel for the U.S. Food and Drug Administration from 1971 through 1975. Mr.&#160;Hutt is a member of the National Academy of Medicine of the National Academy of Sciences and teaches a course on Food and Drug Law each winter term at Harvard Law School. He co-authored the casebook used to teach Food and Drug Law and has published numerous papers on the subject. Mr.&#160;Hutt is a member of the Board of Directors of Q Therapeutics, Xoma&#160;Ltd., BIND Therapeutics,&#160;Inc., Seres Therapeutics, Inc. Concert Pharmaceuticals&#160;Inc., and several privately-held life sciences companies. During the last five years, Mr.&#160;Hutt also served as a member of the Board of Directors of Celera Genomics, DBV Technologies, Momenta Pharmaceuticals, Inc. and Ista Pharmaceuticals,&#160;Inc. Mr.&#160;Hutt received his B.A., magna cum laude, from Yale University, his L.L.B. from Harvard University and his L.L.M. from New York University. Mr.&#160;Hutt's qualifications to sit on the Board of Directors include his 50&#160;years of experience and expertise in food and drug regulation, including his service at the U.S. Food and Drug Administration and at Covington&#160;&amp; Burling LLP, and his experience serving on other boards of directors in the biotechnology industry. </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Christoph Westphal</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Christoph Westphal, M.D., Ph.D., age 48, has served as the Chairman of the Board of Directors since co-founding the Company in February 2014. Dr.&#160;Westphal has served as our President and Chief Executive Officer since April 2014. Dr.&#160;Westphal has been a partner of Longwood Fund,&#160;LP, a venture capital investment fund, since 2010. Dr. Westphal served as the Chief Executive Officer of Verastem, Inc. from September 2011 to July 2013 and as its President from September 2011 until January 2013. Dr. Westphal has served on Verastem's board since March </font></div><div><br></div><div><div style="line-height:100%;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">7</font><font style="font-family:Arial;font-size:10pt;">.</font></div></div><hr style="page-break-after:always"><div><a name="sc0896aca489b4633b3a247362053a34d"></a></div><div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">2011, including as its Executive Chairman from July 2013 until January 2015. Dr.&#160;Westphal served on the board of OvaScience,&#160;Inc. from 2011 to 2014. Dr.&#160;Westphal served as the President of SR One, the corporate venture capital arm of GlaxoSmithKline, from 2010 until 2011. Dr.&#160;Westphal has previously been involved in founding a number of biotechnology companies. Dr.&#160;Westphal co-founded Sirtris Pharmaceuticals,&#160;Inc., which was acquired by GlaxoSmithKline&#160;plc in 2008, and served as its Chief Executive Officer from 2004 to 2010. He also co-founded Alnara Pharmaceuticals,&#160;Inc., Concert Pharmaceuticals,&#160;Inc., Acceleron Pharma,&#160;Inc., serving as its Chief Executive Officer in 2003, Alnylam Pharmaceuticals,&#160;Inc., serving as its Chief Executive Officer in 2002, and Momenta Pharmaceuticals,&#160;Inc., serving as its Chief Executive Officer in 2001. Dr.&#160;Westphal serves on the Board of Fellows of Harvard Medical School and the Board of Overseers for the Boston Symphony Orchestra, is a member of the Research Advisory Council at the Massachusetts General Hospital and is a member of the Biotechnology Industry Organization (BIO) Emerging Companies Section Governing Board. He earned his M.D. from Harvard Medical School, his Ph.D. in Genetics from Harvard University and his B.A. from Columbia University. The Board of Directors believes that Dr.&#160;Westphal's qualifications to sit on the Board of Directors include his experience as a senior executive, entrepreneur and venture capitalist and his service on the boards of directors of other life sciences companies. </font></div><div style="line-height:120%;padding-bottom:16px;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">INFORMATION REGARDING THE BOARD OF DIRECTORS AND CORPORATE GOVERNANCE</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">INDEPENDENCE OF THE BOARD OF DIRECTORS</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">As required under the Nasdaq Listing Rules, a majority of the members of a listed company's board of directors must qualify as "independent" as affirmatively determined by its board of directors. The Board of Directors consults with the Company's counsel to ensure that the Board of Directors' determinations are consistent with relevant securities and other laws and regulations regarding the definition of "independent," including those set forth in pertinent listing standards of Nasdaq, as in effect from time to time.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Consistent with these considerations, after review of all relevant identified transactions or relationships between each director, or any of his or her family members, and the Company, its senior management and its independent auditors, the Board of Directors has affirmatively determined that, with the exception of Drs. MacKinnon and Westphal, all of our directors are independent directors within the meaning of the applicable Nasdaq Listing Rules. In making this determination, the Board of Directors found that none of these directors had a material or other disqualifying relationship with the Company.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">BOARD LEADERSHIP STRUCTURE</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Board of Directors is currently chaired by the President and Chief Executive Officer of the Company, Dr. Westphal. The Board has also appointed Mr. Randle as lead independent director. </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Company believes that combining the positions of Chief Executive Officer and Board Chair helps to ensure that the Board and management act with a common purpose. In the Company&#8217;s view, separating the positions of Chief Executive Officer and Board Chair has the potential to give rise to divided leadership, which could interfere with good decision-making or weaken the Company&#8217;s ability to develop and implement strategy. Instead, the Company believes that combining the positions of Chief Executive Officer and Board Chair provides a single, clear chain of command to execute the Company&#8217;s strategic initiatives and business plans. The Company also believes that it is advantageous to have a Board Chair with an extensive knowledge of the Company (as is the case with the Company&#8217;s Chief Executive Officer) as compared to a relatively less informed independent Board Chair.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">As lead independent director, Mr. Randle presides over periodic meetings of our independent directors and performs such additional duties as the Board of Directors may otherwise determine and delegate. The Company believes that the lead independent director can help ensure the effective independent functioning of the Board in its oversight responsibilities. In addition, the Company believes that the lead independent director can serve as a conduit between the other independent directors and the Board Chair, for example, by facilitating the inclusion on meeting agendas of matters of concern to the independent directors. In light of the Chief Executive Officer&#8217;s extensive history with and knowledge of the Company, and because the Board&#8217;s lead independent director is empowered to play a significant role in the Board&#8217;s leadership and in reinforcing the independence of the Board, the Company believes that it is advantageous for the Company to combine the positions of Chief Executive Officer and Board Chair.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">ROLE OF THE BOARD IN RISK OVERSIGHT</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">One of the key functions of the Board of Directors is informed oversight of our risk management process. The Board of Directors does not have a standing risk management committee, but rather administers this oversight function </font></div><div><br></div><div><div style="line-height:100%;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">8</font><font style="font-family:Arial;font-size:10pt;">.</font></div></div><hr style="page-break-after:always"><div><a name="sc0896aca489b4633b3a247362053a34d"></a></div><div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">directly through the Board of Directors as a whole, as well as through various standing committees of the Board of Directors that address risks inherent in their respective areas of oversight. In particular, the Board of Directors is responsible for monitoring and assessing strategic risk exposure and the Audit Committee has the responsibility to consider and discuss our major financial risk exposures and the steps our management has taken to monitor and control these exposures, including guidelines and policies to govern the process by which risk assessment and management is undertaken. The Audit Committee also monitors compliance with legal and certain regulatory requirements. The Nominating and Corporate Governance Committee monitors the effectiveness of our corporate governance practices, including whether they are successful in preventing illegal or improper liability-creating conduct. The Compensation Committee assesses and monitors whether any of our compensation policies and programs has the potential to encourage excessive risk-taking.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">MEETINGS OF THE BOARD OF DIRECTORS</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Board of Directors met four times during 2015. Each director attended 75% or more of the aggregate number of meetings of the Board of Directors and of the committees on which he or she served held during the portion of the last fiscal year for which he or she was a director or committee member.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">INFORMATION REGARDING COMMITTEES OF THE BOARD OF DIRECTORS</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Board of Directors has three committees:</font><font style="font-family:Arial;font-size:10pt;font-weight:bold;">&#32;</font><font style="font-family:Arial;font-size:10pt;">an Audit Committee, a Compensation Committee and a Nominating and Corporate Governance Committee. </font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:91.22807017543859%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:49%;"></td><td style="width:17%;"></td><td style="width:17%;"></td><td style="width:17%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:8px;padding-right:2px;"><div style="padding-bottom:8px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Name</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:8px;padding-right:2px;"><div style="padding-bottom:8px;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Audit</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:8px;padding-right:2px;"><div style="padding-bottom:8px;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Compensation</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:8px;padding-right:2px;"><div style="padding-bottom:8px;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Nominating and Corporate Governance</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Jeffrey Capello</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">X*</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Peter Barton Hutt</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">X</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(6)</sup></font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">X</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">X*</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Marc Kozin</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">X</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Steve Kraus</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup></font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">X</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Roderick MacKinnon, M.D.</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(3)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Robert Perez</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(4)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">X</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(7)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Stuart Randle</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">X</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">X*</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">John Sculley</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">X</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Michelle Stacy</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(5)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Christoph Westphal, M.D., Ph.D.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">X</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(8)</sup></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:16px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Total meetings in fiscal 2015</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:16px;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">8</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:16px;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">5</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:16px;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">-</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:justify;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">*&#160;&#160;&#160;&#160;Committee Chairperson</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:94.73684210526315%;border-collapse:collapse;text-align:left;"><tr><td colspan="6"></td></tr><tr><td style="width:5%;"></td><td style="width:19%;"></td><td style="width:19%;"></td><td style="width:19%;"></td><td style="width:19%;"></td><td style="width:19%;"></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">(1)</font></div></td><td colspan="5" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Mr. Capello joined the Board of Directors and the Audit Committee on April 1, 2015.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">(2)</font></div></td><td colspan="5" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Mr. Kraus resigned from the Board of Directors and the Audit Committee on January 27, 2015.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">(3)</font></div></td><td colspan="5" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dr. MacKinnon joined the Board of Directors on February 23, 2015.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">(4)</font></div></td><td colspan="5" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Mr. Perez joined the Board of Directors on September 2, 2015.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">(5)</font></div></td><td colspan="5" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Ms. Stacy joined the Board of Directors on March 5, 2016.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">(6)</font></div></td><td colspan="5" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Mr. Hutt stepped down from the Audit Committee on April 1, 2015.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">(7)</font></div></td><td colspan="5" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Mr. Perez joined the Compensation Committee on December 22, 2015.</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">(8)</font></div></td><td colspan="5" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dr. Westphal resigned from the Nominating and Corporate Governance Committee on November 11, 2015.</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Below is a description of each committee of the Board of Directors. </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Each of the committees has authority to engage legal counsel or other experts or consultants, as it deems appropriate to carry out its responsibilities. The Board of Directors has determined that each member of each committee meets the applicable Nasdaq rules and regulations regarding "independence" and each member is free of any relationship that would impair his or her individual exercise of independent judgment with regard to the Company.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:100%;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">9</font><font style="font-family:Arial;font-size:10pt;">.</font></div></div><hr style="page-break-after:always"><div><a name="sc0896aca489b4633b3a247362053a34d"></a></div><div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Audit Committee</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Audit Committee consists of Messrs. Capello, Kozin and Randle, and is governed by an audit committee charter. The Board of Directors has determined that each of the members of the Audit Committee satisfies the Nasdaq Stock Market and SEC independence requirements. Mr. Capello serves as the chair of the Audit Committee. The functions of this committee include, among other things:</font></div><table cellpadding="0" cellspacing="0" style="padding-top:10px;padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">evaluating the performance, independence and qualifications of our independent auditors and determining whether to retain our existing independent auditors or engage new independent auditors;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:10px;padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">reviewing and approving the engagement of our independent auditors to perform audit services and any permissible non-audit services;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:10px;padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">monitoring the rotation of partners of our independent auditors on our engagement team as required by law;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:10px;padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">prior to engagement of any independent auditor, and at least annually thereafter, reviewing relationships that may reasonably be thought to bear on their independence, and assessing and otherwise taking the appropriate action to oversee the independence of our independent auditor;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:10px;padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">reviewing our annual and quarterly financial statements and reports, including the disclosures contained under the caption "Management's Discussion and Analysis of Financial Condition and Results of Operations," and discussing the statements and reports with our independent auditors and management;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:10px;padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">reviewing with our independent auditors and management significant issues that arise regarding accounting principles and financial statement presentation and matters concerning the scope, adequacy and effectiveness of our financial controls;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:10px;padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">reviewing with management and our auditors any earnings announcements and other public announcements regarding material developments;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:10px;padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">establishing procedures for the receipt, retention and treatment of complaints received by us regarding financial controls, accounting or auditing matters and other matters;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:10px;padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">preparing the report that the SEC requires in our annual proxy statement;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:10px;padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">reviewing and providing oversight of any related-person transactions in accordance with our related person transaction policy and reviewing and monitoring compliance with legal and regulatory responsibilities, including our code of business conduct and ethics;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:10px;padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">reviewing our major financial risk exposures, including the guidelines and policies to govern the process by which risk assessment and risk management is implemented;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:10px;padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">reviewing on a periodic basis our investment policy; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:10px;padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">reviewing and evaluating on an annual basis the performance of the Audit Committee, including compliance of the Audit Committee with its charter.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Board of Directors has determined that Mr. Capello qualifies as an audit committee financial expert within the meaning of SEC regulations and meets the financial sophistication requirements of the Nasdaq Listing Rules. In making this determination, the Board of Directors has considered Mr. Capello's business background and previous experience. Both our independent registered public accounting firm and management periodically meet privately with the Audit Committee.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Report of the Audit Committee of the Board of Directors</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;">The material in this report is not "soliciting material," is not deemed "filed" with the SEC and is not to be incorporated by reference in any filing of the Company under the Securities Act of 1933, as amended (the "Securities Act") or the Exchange Act, whether made before or after the date hereof and irrespective of any general incorporation language in any such filing.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Audit Committee has reviewed and discussed the audited financial statements for the fiscal year ended December 31, 2015 with management of the Company. The Audit Committee has discussed with the independent registered public accounting firm the matters required to be discussed by Auditing Standard No. 16, </font></div><div><br></div><div><div style="line-height:100%;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">10</font><font style="font-family:Arial;font-size:10pt;">.</font></div></div><hr style="page-break-after:always"><div><a name="sc0896aca489b4633b3a247362053a34d"></a></div><div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Communications with Audit Committees, as adopted by the Public Company Accounting Oversight Board (&#8220;PCAOB&#8221;). The Audit Committee has also received the written disclosures and the letter from the independent registered public accounting firm required by applicable requirements of the PCAOB regarding the independent accountants&#8217; communications with the audit committee concerning independence, and has discussed with the independent registered public accounting firm the accounting firm&#8217;s independence. Based on the foregoing, the Audit Committee has recommended to the Board of Directors that the audited financial statements be included in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December 31, 2015.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Mr. Jeff Capello <br>Mr. Marc Kozin <br>Mr. Stuart Randle</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Compensation Committee</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Compensation Committee consists of Messrs. Perez, Hutt and Randle, and is governed by a compensation committee charter. Mr. Randle serves as the chair of the Compensation Committee. The Board of Directors has determined that each of the members of the Compensation Committee is a non-employee director, as defined in Rule&#160;16b-3 promulgated under the Securities Exchange Act of 1934, as amended, or Exchange Act, is an outside director, as defined pursuant to Section&#160;162(m) of the Internal Revenue Code of 1986, as amended, or the Code, and satisfies the Nasdaq Stock Market independence requirements. The functions of this committee include, among other things:</font></div><table cellpadding="0" cellspacing="0" style="padding-top:10px;padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">reviewing, modifying and approving (or if it deems appropriate, making recommendations to the full Board of Directors regarding) our overall compensation strategy and policies;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:10px;padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">reviewing and approving the compensation and other terms of employment of our executive officers;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:10px;padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">reviewing and approving performance goals and objectives relevant to the compensation of our executive officers and assessing their performance against these goals and objectives;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:10px;padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">reviewing and approving (or if it deems it appropriate, making recommendations to the full Board of Directors regarding) the equity incentive plans, compensation plans and similar programs advisable for us, as well as modifying, amending or terminating existing plans and programs;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:10px;padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">evaluating risks associated with our compensation policies and practices and assessing whether risks arising from our compensation policies and practices for our employees are reasonably likely to have a material adverse effect on us;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:10px;padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">reviewing and approving (or if it deems it appropriate, making recommendations to the full Board of Directors regarding) the type and amount of compensation to be paid or awarded to our non-employee board members;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:10px;padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">establishing policies with respect to votes by our stockholders to approve executive compensation as required by Section&#160;14A of the Exchange Act and determining our recommendations regarding the frequency of advisory votes on executive compensation;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:10px;padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">reviewing and assessing the independence of compensation consultants, legal counsel and other advisors as required by Section&#160;10C of the Exchange Act;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:10px;padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">administering our equity incentive plans;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:10px;padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">establishing policies with respect to equity compensation arrangements;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:10px;padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">reviewing the competitiveness of our executive compensation programs and evaluating the effectiveness of our compensation policy and strategy in achieving expected benefits to us;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:10px;padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">reviewing and approving the terms of any employment agreements, severance arrangements, change in control protections and any other compensatory arrangements for our executive officers;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:10px;padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">reviewing the adequacy of its charter on a periodic basis;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:10px;padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">reviewing with management and approving our disclosures under the caption "Compensation Discussion and Analysis" in our periodic reports or proxy statements to be filed with the SEC;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:10px;padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">preparing the report that the SEC requires in our annual proxy statement; and</font></div></td></tr></table><div><br></div><div><div style="line-height:100%;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">11</font><font style="font-family:Arial;font-size:10pt;">.</font></div></div><hr style="page-break-after:always"><div><a name="sc0896aca489b4633b3a247362053a34d"></a></div><div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><table cellpadding="0" cellspacing="0" style="padding-top:10px;padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">reviewing and assessing on an annual basis the performance of the Compensation Committee.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Compensation Committee Processes and Procedures </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Typically, the Compensation Committee meets quarterly and with greater frequency if necessary, and meets regularly in executive session. The Chief Executive Officer does not participate in, and is not present during, any deliberations or determinations of the Compensation Committee regarding his compensation or his individual performance. The charter of the Compensation Committee grants the Compensation Committee full access to our books, records, facilities and personnel, as well as authority to obtain, at the Company's expense, advice and assistance from internal and external legal, accounting or other advisors and consultants and other external resources that the Compensation Committee considers necessary or appropriate in the performance of its duties. Under its charter, the Compensation Committee may form, and delegate authority to, subcommittees as it deems appropriate.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Historically, the Compensation Committee has met at one or more meetings held during the first and fourth quarters of the year to discuss and, if appropriate, make recommendations to the Board of Directors regarding, annual compensation adjustments, annual bonuses, annual equity awards, and new performance objectives. For all executives, as part of its deliberations, the Compensation Committee may review and consider, as appropriate, materials such as financial reports and projections, operational data, executive stock ownership information, company stock performance data, analyses of historical executive compensation levels and current company-wide compensation levels, compensation surveys, and recommendations of any compensation consultant, if applicable.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Generally, the Compensation Committee has designed our overall executive compensation program to achieve the following objectives:</font></div><table cellpadding="0" cellspacing="0" style="padding-top:10px;padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">attempt to attract and retain talented and experienced executives;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:10px;padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">motivate and reward executives whose knowledge, skills and performance are critical to our success;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:10px;padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">provide a competitive compensation package that aligns the interests of our executive officers and stockholders by including a significant variable component which is weighted toward performance-based rewards;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:10px;padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">ensure fairness among executive officers by recognizing the contributions each executive makes to our success; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:10px;padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">foster a shared commitment among executives by aligning their individual goals with our corporate goals and the creation of stockholder value.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Compensation Committee retained an independent compensation consultant, Pearl Meyer &amp; Partners, or Pearl Meyer, in 2015 to assist the Compensation Committee in developing our overall executive and director compensation programs for 2015, including base pay, bonus percentage, severance and equity awards. To assist in determining executive compensation in 2015, Pearl Meyer and the Compensation Committee reviewed a peer group of publicly traded companies in the biotechnology industry at a stage of development, market capitalization and size comparable to ours, which companies the Compensation Committee believed were generally comparable to our company and against which the Compensation Committee believed we competed for executive talent. In addition, with respect to Marina Hahn's compensation, Pearl Meyer and the Compensation Committee reviewed publicly traded consumer companies with a profile comparable to ours. Pearl Meyer did not provide any services to the Company other than acting as a compensation consultant to the Compensation Committee.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The specific determinations of the Compensation Committee with respect to executive compensation for fiscal 2015 are described in greater detail in the Executive Compensation section of this proxy statement.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Compensation Committee Interlocks and Insider Participation</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">We have established a Compensation Committee which has and will make decisions relating to compensation of our executive officers. The Board of Directors has appointed Messrs. Randle, Hutt and Perez to serve on the Compensation Committee. Neither of these individuals has ever been an executive officer or employee of the Company. None of our executive officers currently serves, or has served during the last completed fiscal year, on the Compensation Committee or Board of Directors of any other entity that has one or more executive officers serving as a member of the Board of Directors or Compensation Committee.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:100%;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">12</font><font style="font-family:Arial;font-size:10pt;">.</font></div></div><hr style="page-break-after:always"><div><a name="sc0896aca489b4633b3a247362053a34d"></a></div><div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Nominating and Corporate Governance Committee </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Nominating and Corporate Governance Committee consists of Messrs. Hutt and Sculley and is governed by a nominating and corporate governance committee charter. The Board of Directors has determined that each member of this committee satisfies the Nasdaq Stock Market independence requirements. Mr. Hutt serves as the chair of the Nominating and Corporate Governance Committee. The functions of this committee include, among other things:</font></div><table cellpadding="0" cellspacing="0" style="padding-top:10px;padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">identifying, reviewing and evaluating candidates to serve on the Board of Directors consistent with criteria approved by the Board of Directors;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:10px;padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">determining the minimum qualifications for service on the Board of Directors;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:10px;padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">evaluating director performance on the Board of Directors and applicable committees of the Board of Directors and determining whether continued service on the Board of Directors is appropriate;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:10px;padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">evaluating, nominating and recommending individuals for membership on the Board of Directors;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:10px;padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">evaluating nominations by stockholders of candidates for election to the Board of Directors;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:10px;padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">considering and assessing the independence of members of the Board of Directors;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:10px;padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">developing a set of corporate governance policies and principles, including a code of business conduct and ethics, periodically reviewing and assessing these policies and principles and their application and recommending to the Board of Directors any changes to such policies and principles;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:10px;padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">considering questions of possible conflicts of interest of directors as such questions arise;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:10px;padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">reviewing the adequacy of its charter on an annual basis; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:10px;padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">annually evaluating the performance of the Nominating and Corporate Governance Committee.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Board of Directors believes that candidates for director should have certain minimum qualifications, including being able to read and understand basic financial statements, being over 21 years of age and having the highest personal integrity and ethics. In considering candidates recommended by the Nominating and Corporate Governance Committee, the Board of Directors will consider such factors as the candidate possessing relevant expertise upon which to be able to offer advice and guidance to management, having sufficient time to devote to the affairs the Company, demonstrated excellence in his or her field, having the ability to exercise sound business judgment and having the commitment to rigorously represent the long-term interests of our stockholders. The Board of Directors reviews candidates for director nomination in the context of the current composition of the Board of Directors, the operating requirements of the Company and the long-term interests of our stockholders. In conducting this assessment, the Board of Directors considers diversity, age, skills, and such other factors as it deems appropriate given the current needs of the Board of Directors and the Company to maintain a balance of knowledge, experience and capability. </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Nominating and Corporate Governance Committee is responsible for identifying, reviewing, evaluating and recommending to the Board of Directors candidates to serve as directors of the Company. The Board of Directors is responsible for nominating members for election to the Board of Directors by the Company's stockholders. In 2015, the Company engaged a consultant to assist in the Company's search for additional directors for its Board of Directors. The Nominating and Corporate Governance Committee has not adopted a formal policy regarding whether it will consider any director candidates recommended by stockholders but the Board of Directors does not believe that such a policy is currently necessary because the Nominating and Corporate Governance Committee will consider candidates recommended by stockholders in the same manner as other candidates. </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">SHAREHOLDER COMMUNICATIONS WITH THE BOARD OF DIRECTORS</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Historically, the Company has not provided a formal process related to shareholder communications with the Board. Nevertheless, every effort has been made to ensure that the views of shareholders are heard by the Board or individual directors, as applicable, and that appropriate responses are provided to shareholders in a timely manner. During the upcoming year, the Company believes the Nominating and Corporate Governance Committee will consider the adoption of a formal process for shareholder communications with the Board and, if adopted, publish it promptly and post it to the Company&#8217;s website. </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:100%;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">13</font><font style="font-family:Arial;font-size:10pt;">.</font></div></div><hr style="page-break-after:always"><div><a name="sc0896aca489b4633b3a247362053a34d"></a></div><div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">CODE OF ETHICS</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">We have adopted a code of business conduct and ethics that applies to all of our employees, officers and directors, including those officers responsible for financial reporting. Our code of business conduct and ethics is available on our website at www.flex-pharma.com. We intend to disclose any amendments to the code, or any waivers of its requirements, on our website.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">CORPORATE GOVERNANCE GUIDELINES </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">In January 2015, the Board of Directors adopted the Company's Corporate Governance Guidelines to assure that the Board of Directors will have the necessary authority and practices in place to review and evaluate the Company&#8217;s business operations as needed and to make decisions that are independent of the Company&#8217;s management. The guidelines are also intended to align the interests of directors and management with those of the Company&#8217;s shareholders. The Corporate Governance Guidelines set forth the practices the Board intends to follow with respect to board composition and selection, board meetings and involvement of senior management, Chief Executive Officer performance evaluation and succession planning, and board committees and compensation. The Corporate Governance Guidelines, as well as the charters for each committee of the Board, may be viewed at wwwflex-pharma.com. </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:100%;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">14</font><font style="font-family:Arial;font-size:10pt;">.</font></div></div><hr style="page-break-after:always"><div><a name="s8d37ac7699fa4227b2f1209bd987b66b"></a></div><div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">PROPOSAL 2 <br> <br>RATIFICATION OF SELECTION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Audit Committee of the Board of Directors has selected Ernst &amp; Young LLP as the Company&#8217;s independent registered public accounting firm for the fiscal year ending December 31, 2016 and has further directed that management submit the selection of its independent registered public accounting firm for ratification by the shareholders at the annual meeting. Ernst &amp; Young LLP has audited the Company&#8217;s financial statements since its inception in 2014. Representatives of</font><font style="font-family:Arial;font-size:10pt;font-weight:bold;">&#32;</font><font style="font-family:Arial;font-size:10pt;">Ernst &amp; Young LLP are not expected to be present at the Annual Meeting. </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Neither the Company&#8217;s Bylaws nor other governing documents or law require shareholder ratification of the selection of Ernst &amp; Young LLP as the Company&#8217;s independent registered public accounting firm. However, the Audit Committee of the Board is submitting the selection of Accounting Firm to the shareholders for ratification as a matter of good corporate practice. If the shareholders fail to ratify the selection, the Audit Committee of the Board will reconsider whether or not to retain that firm. Even if the selection is ratified, the Audit Committee of the Board in its discretion may direct the appointment of different independent auditors at any time during the year if they determine that such a change would be in the best interests of the Company and its shareholders.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The affirmative vote of the holders of a majority of the shares present in person or represented by proxy and entitled to vote on the matter at the annual meeting will be required to ratify the selection of Ernst &amp; Young LLP. </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">PRINCIPAL ACCOUNTANT FEES AND SERVICES </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The following table summarizes the fees of Ernst&#160;&amp; Young LLP, our independent registered public accounting firm, incurred for the year ended December 31, 2015, and for the period from February 26, 2014 (inception) to December 31, 2014. </font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:86.15984405458089%;border-collapse:collapse;text-align:left;"><tr><td colspan="8"></td></tr><tr><td style="width:55%;"></td><td style="width:1%;"></td><td style="width:20%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:20%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Year Ended </font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">December 31, 2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Period from February 26, 2014 (Inception) to December, 31, 2014</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Audit fees</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">251,003</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">733,110</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Tax fees</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">17,000</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">All other fees</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(3)</sup></font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">1,995</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Total Fees</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">269,998</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-top:2px;padding-bottom:2px;border-top:1px solid #000000;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">733,110</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;">(1)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Audit fees consist of fees for our quarterly reviews and audit of our annual financial statements and fees related to the Company's initial public offering.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;">(2)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Tax fees are related to tax advisory services.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;">(3)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">All other fees are related to licensing fees paid to Ernst&#160;&amp; Young LLP for access to its proprietary accounting research database.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">All such accountant services and fees were pre-approved by the Audit Committee in accordance with the &#8220;Pre-Approval Policies and Procedures&#8221; described below.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">PRE-APPROVAL POLICIES AND PROCEDURES </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Audit Committee has adopted policies and procedures relating to the approval of all audit and non-audit services that are to be performed by our registered public accounting firm.&#160;This policy generally provides that we will not engage our independent registered public accounting firm to render audit or non-audit services unless the service is specifically approved in advance by the Audit Committee or the engagement is entered into pursuant to one of the pre-approval procedures described below.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">From time to time, the Audit Committee may pre-approve specified types of services that are expected to be provided to us by our independent registered public accounting firm during the next 12 months.&#160; Any such pre-approval is detailed as to the particular service or type of services to be provided and is also generally subject to a maximum dollar amount.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">THE BOARD OF DIRECTORS RECOMMENDS</font></div><div style="line-height:120%;padding-bottom:32px;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">A VOTE IN FAVOR OF PROPOSAL 2</font><font style="font-family:Arial;font-size:10pt;">.</font></div><div><br></div><div><div style="line-height:100%;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">15</font><font style="font-family:Arial;font-size:10pt;">.</font></div></div><hr style="page-break-after:always"><div><a name="s9b901ff88d734490a6e587fe3e03cc13"></a></div><div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">EXECUTIVE OFFICERS</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The following table sets forth information concerning our executive officers.</font></div><div style="line-height:120%;text-align:center;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.90243902439025%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:94.24390243902438%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:39%;"></td><td style="width:1%;"></td><td style="width:60%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Name</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Position(s)</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Christoph Westphal, M.D., Ph.D.</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">President, Chief Executive Officer and Chairman of the Board</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Robert Hadfield</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">General Counsel and Secretary</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Marina Hahn</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">President, Consumer</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Katharine Lindemann</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Chief Operating Officer</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">John McCabe</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Vice President, Finance and Treasurer</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Thomas Wessel, M.D., Ph.D.&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Chief Medical Officer</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Elizabeth Woo</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Senior Vice President, Investor Relations and Corporate Communications </font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.90243902439025%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Biographical information for Dr. Westphal is included above with the director biographies under the caption "Directors Continuing in Office Until the 2018 Annual Meeting."</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Robert Hadfield, age 38, has served as our General Counsel and Secretary since April 2014. Mr.&#160;Hadfield joined us from Cooley&#160;LLP, where he was an attorney in the firm's business department from August 2007 to August 2011 and then from April 2012 to April 2014. From August 2011 to April 2012, Mr.&#160;Hadfield served as the Corporate Counsel at Kiva Systems,&#160;Inc. prior to its acquisition by Amazon.com,&#160;Inc. Mr.&#160;Hadfield also worked as an attorney at Goulston&#160;&amp; Storrs PC and began his career as a financial analyst in the health care investment banking group of SG Cowen Securities Corporation. Mr.&#160;Hadfield holds a B.S. degree in Finance from Providence College and a J.D. from the Georgetown University Law Center.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Marina Hahn, age 58, has served as our President, Consumer since September 2014. Ms.&#160;Hahn joined us from Quirky&#160;Inc., where she served as Chief Strategy Officer/Chief Marketing Officer from September 2012 to December 2013. From 2003 to 2012, Ms.&#160;Hahn served as Chief Marketing Officer of Spirits Marque One&#160;LLC, makers of SVEDKA vodka and a division of Constellation Brands. From 1998 to 2001, Ms.&#160;Hahn served as Executive Vice President of J. Walter Thompson Company. Previously, Ms.&#160;Hahn was employed in various capacities by the William Morris Agency,&#160;Inc., Sony Electronics,&#160;Inc., Pepsi-Cola Company and DDB Needham Worldwide,&#160;Inc. From May 2000 until November 2014, Ms.&#160;Hahn served on the Board of Directors of The Hain Celestial Group,&#160;Inc. Ms.&#160;Hahn holds a B.A. degree in French Literature and Political Science from Wellesley College.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Katharine Lindemann, age 54, has served as our Chief Operating Officer since August 2015. Prior to joining us, Ms. Lindemann served as the Chief Operating Officer at DAVIDsTea Inc. from May 2012 until September 2014. Prior to DAVIDsTea Inc., Ms. Lindemann served as Principal of KGL Consulting from May 2011 to May 2012, and as Senior Vice President, Store Operations at Savers, Inc. (Value Village) from May 2009 to May 2011. In addition, Ms. Lindemann spent 19 years at Starbucks Corporation in a variety of roles, most recently as the Senior Vice President, Starbucks Foodservice. Ms. Lindemann currently serves on the Board of Directors of Cambia Health Solutions. Ms. Lindemann holds a B.S. degree from Santa Clara University.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">John McCabe, age 46, has served as our Vice President, Finance since May 2014. Mr.&#160;McCabe joined us from ARIAD Pharmaceuticals,&#160;Inc. where he was Vice President and Chief Accounting Officer from May 2013 to May 2014. Previously, Mr.&#160;McCabe served as Vice President and Corporate Controller at Charles River Associates from June 2009 to May 2013. Previously, Mr.&#160;McCabe was the Director, Strategic Business Unit Controller at Biogen&#160;Inc. from 2007 until 2009. Mr.&#160;McCabe has also held positions at Performance Technologies,&#160;Inc., IP.com&#160;Inc. and Arthur Andersen&#160;LLP. Mr.&#160;McCabe earned an M.B.A. from the University of Massachusetts at Amherst and B.S. degrees in Accounting and Management Information Systems from Babson College.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Thomas Wessel, M.D., Ph.D., age 60, has served as our Chief Medical Officer since December 2014. Prior to joining us, Dr.&#160;Wessel was an independent consultant to several biotechnology and large pharmaceutical companies, including Concert Pharmaceuticals,&#160;Inc., Alkermes&#160;plc, Sanofi&#160;SA and Novartis AG. Previously, Dr.&#160;Wessel was the Chief Medical Officer of Acorda Therapeutics,&#160;Inc. from November 2008 until September 2011. Between March 2002 and October 2008, Dr.&#160;Wessel was employed in various leadership positions at </font></div><div><br></div><div><div style="line-height:100%;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">16</font><font style="font-family:Arial;font-size:10pt;">.</font></div></div><hr style="page-break-after:always"><div><a name="s9b901ff88d734490a6e587fe3e03cc13"></a></div><div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Sepracor,&#160;Inc., including Senior Vice President of Clinical Research. Before joining Sepracor, Dr.&#160;Wessel worked on several CNS projects at Janssen Pharmaceuticals in Europe and the U.S. Before working in the pharmaceutical industry, Dr.&#160;Wessel held several academic and research positions. Dr.&#160;Wessel received his M.D. from the University of Munich School of Medicine and completed his Ph.D. in experimental neurobiology at the Max-Planck-Institute for Psychiatry in Martinsried, Germany. He completed his residency in neurology at New York Hospital and Memorial Sloan-Kettering Cancer Center (Cornell University Medical Center).</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Elizabeth Woo, age 49, served as our Vice President, Investors Relations and Corporate Communications from October 2014 until March 2015, when she became Senior Vice President, Investor Relations and Corporate Communications. Ms.&#160;Woo previously served an investor relations consultant to Cubist Pharmaceuticals,&#160;Inc. from August 2013 to December 2013 and as an investor relations consultant to Ironwood Pharmaceuticals,&#160;Inc. from February 2011 to June 2012. Ms.&#160;Woo also served as Vice President, Investor Relations at Biogen Idec&#160;Inc. from 1998 to 2010. Ms.&#160;Woo earned an M.B.A. from The Kellogg Graduate School of Management, and graduated summa cum laude and Phi Beta Kappa with bachelor degrees in Biochemistry and History from the University of California, Berkeley.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">&#160;</font></div><div><br></div><div><div style="line-height:100%;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">17</font><font style="font-family:Arial;font-size:10pt;">.</font></div></div><hr style="page-break-after:always"><div><a name="s9b901ff88d734490a6e587fe3e03cc13"></a></div><div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">SECURITY OWNERSHIP OF</font><font style="font-family:Arial;font-size:10pt;">&#32;</font><font style="font-family:Arial;font-size:10pt;font-weight:bold;">CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The following table sets forth information regarding beneficial ownership of our common stock as of April 11, 2016 by:</font></div><table cellpadding="0" cellspacing="0" style="padding-top:10px;padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">each person, or group of affiliated persons, known by us to beneficially own more than 5% of our common stock;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:10px;padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">each of our directors;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:10px;padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">each of our named executive officers; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:10px;padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">all of our current executive officers and directors as a group.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Information with respect to beneficial ownership has been furnished by each director, officer or beneficial owner of more than 5% of our common stock. We have determined beneficial ownership in accordance with the rules of the SEC. These rules generally attribute beneficial ownership of securities to persons who possess sole or shared voting power or investment power with respect to those securities. In addition, the rules include shares of common stock issuable pursuant to the exercise of stock options or warrants that are either immediately exercisable or exercisable on or before June 10, 2016, which is 60&#160;days after April 11, 2016. These shares are deemed to be outstanding and beneficially owned by the person holding those options or warrants for the purpose of computing the percentage ownership of that person, but they are not treated as outstanding for the purpose of computing the percentage ownership of any other person. Unless otherwise indicated, the persons or entities identified in this table have sole voting and investment power with respect to all shares shown as beneficially owned by them, subject to applicable community property laws.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Percentage of beneficial ownership is based on 17,967,891 shares of common stock outstanding as of April 11, 2016. Except as otherwise noted below, the address for each person or entity listed in the table is c/o Flex Pharma,&#160;Inc., 800 Boylston Street, 24th Floor, Boston, MA 02199. </font></div><div style="line-height:120%;text-align:center;padding-left:0px;text-indent:0px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.90243902439025%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:90.53658536585367%;border-collapse:collapse;text-align:left;"><tr><td colspan="6"></td></tr><tr><td style="width:70%;"></td><td style="width:14%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:13%;"></td><td style="width:1%;"></td></tr><tr><td rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;text-decoration:underline;">&#160;Name of beneficial owner</font></div></td><td colspan="2" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Number of shares beneficially owned</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" rowspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-weight:bold;">Percentage of shares beneficially owned</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfe4ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">5% or greater stockholders</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#bfe4ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfe4ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#bfe4ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Longwood Funds</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">2,960,518</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">16.48</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfe4ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Directors and executive officers</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#bfe4ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfe4ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#bfe4ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Jeffrey Capello</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(2)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">16,943</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">*</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfe4ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Peter Barton Hutt</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(3)</sup></font></div></td><td style="vertical-align:bottom;background-color:#bfe4ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">39,812</font></div></td><td style="vertical-align:bottom;background-color:#bfe4ff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfe4ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfe4ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">*</font></div></td><td style="vertical-align:bottom;background-color:#bfe4ff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Marc Kozin</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(4)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">27,530</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">*</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfe4ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Roderick MacKinnon, M.D.</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(5)</sup></font></div></td><td style="vertical-align:bottom;background-color:#bfe4ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">463,014</font></div></td><td style="vertical-align:bottom;background-color:#bfe4ff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfe4ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfe4ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">2.57</font></div></td><td style="vertical-align:bottom;background-color:#bfe4ff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Robert Perez</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(6)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">5,000</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">*</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfe4ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Stuart Randle</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(7)</sup></font></div></td><td style="vertical-align:bottom;background-color:#bfe4ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">23,030</font></div></td><td style="vertical-align:bottom;background-color:#bfe4ff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfe4ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfe4ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">*</font></div></td><td style="vertical-align:bottom;background-color:#bfe4ff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">John Sculley</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(8)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">81,421</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">*</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfe4ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Michelle Stacy</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(9)</sup></font></div></td><td style="vertical-align:bottom;background-color:#bfe4ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">4,251</font></div></td><td style="vertical-align:bottom;background-color:#bfe4ff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfe4ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfe4ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">*</font></div></td><td style="vertical-align:bottom;background-color:#bfe4ff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Christoph Westphal, M.D., Ph.D.</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(10)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">3,925,248</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">21.85</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfe4ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Marina Hahn</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(11)</sup></font></div></td><td style="vertical-align:bottom;background-color:#bfe4ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">202,616</font></div></td><td style="vertical-align:bottom;background-color:#bfe4ff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfe4ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfe4ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">1.12</font></div></td><td style="vertical-align:bottom;background-color:#bfe4ff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">%</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Thomas Wessel, M.D., Ph.D.</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(12)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">164,604</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">*</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#bfe4ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#160;&#160;All directors and executive officers as a group (total of 15 persons)</font><font style="font-family:Arial;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(13)</sup></font></div></td><td style="vertical-align:bottom;background-color:#bfe4ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">8,049,535</font></div></td><td style="vertical-align:bottom;background-color:#bfe4ff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#bfe4ff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#bfe4ff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">43.35</font></div></td><td style="vertical-align:bottom;background-color:#bfe4ff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">%</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.90243902439025%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;padding-top:10px;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">* Represents beneficial ownership of less than one percent.</font></div><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;">(1)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Includes 2,697,264 shares of common stock held by Longwood Fund&#160;II, L.P and 263,254 shares of common stock held by Longwood Fund III, L.P. Longwood Fund&#160;II GP, LLC (the "Fund II General Partner") is the general partner of Longwood Fund&#160;II, L.P. and exercises voting and investment power with respect to securities owned directly by Longwood Fund&#160;II, L.P. Longwood Fund&#160;III GP, LLC (the "Fund III General Partner") is the general partner of Longwood Fund&#160;III, L.P. and exercises voting and investment power with respect to securities owned directly by Longwood Fund&#160;III, L.P. Richard Aldrich, Michelle Dipp, M.D., Ph.D. and Christoph Westphal, M.D., </font></div></td></tr></table><div><br></div><div><div style="line-height:100%;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">18</font><font style="font-family:Arial;font-size:10pt;">.</font></div></div><hr style="page-break-after:always"><div><a name="s9b901ff88d734490a6e587fe3e03cc13"></a></div><div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-left:48px;padding-bottom:8px;padding-top:8px;text-align:left;"><font style="font-family:Arial;font-size:8pt;">Ph.D. are the managers of the Fund II General Partner and Fund III General Partner and share voting and dispositive power with respect to the securities held by Longwood Fund&#160;II, L.P and Longwood Fund III, L.P. (collectively, the "Longwood Funds"), each of whom disclaims beneficial ownership of the shares held by the Longwood Funds except to the extent of his or her pecuniary interest therein. The address for the Longwood Funds is 800 Boylston Street, Suite&#160;1555, Boston, MA 02199.</font></div><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;">(2)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Represents shares of common stock issuable upon the exercise of options exercisable within 60&#160;days of April 11, 2016.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;">(3)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Includes 11,675&#160;shares of common stock and 28,137 shares of common stock issuable upon the exercise of options exercisable within 60&#160;days of April 11, 2016.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;">(4)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Includes 4,500 shares of common stock and 23,030 shares of common stock issuable upon the exercise of options exercisable within 60&#160;days of April 11, 2016.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;">(5)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Includes 431,277 shares of common stock and 31,737 shares of common stock issuable upon the exercise of options exercisable within 60&#160;days of April 11, 2016.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;">(6)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Represents shares of common stock issuable upon the exercise of options exercisable within 60&#160;days of April 11, 2016.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;">(7)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Represents shares of common stock issuable upon the exercise of options exercisable within 60&#160;days of April 11, 2016.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;">(8)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Includes 54,402&#160;shares of common stock held by John and Diane Sculley, Tenants in the Entirety and 27,019 shares of common stock issuable upon the exercise of options exercisable within 60&#160;days of April 11, 2016.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;">(9)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Includes 2,585 shares of common stock and 1,666 shares of common stock issuable upon the exercise of options exercisable within 60&#160;days of April 11, 2016.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;">(10)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Represents shares of common stock held by Christoph Westphal, M.D., Ph.D. This number does not include 2,697,264 shares of common stock held by Longwood Fund&#160;II, L.P. and 263,254 shares held by Longwood Fund&#160;III, L.P. The ultimate general partner of Longwood Fund&#160;II, L.P. is the Fund II General Partner and the ultimate general partner of Longwood Fund&#160;III, L.P. is the Fund III General Partner. Voting and investment power with respect to the shares held by the Longwood Funds are vested in Richard Aldrich, Michelle Dipp, M.D., Ph.D. and Christoph Westphal, M.D., Ph.D., the managers of the Fund II General Partner and the Fund III General Partner, each of whom disclaims beneficial ownership of the shares held by the Longwood Funds except to the extent of any pecuniary interest therein.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;">(11)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Represents shares of common stock issuable upon the exercise of options exercisable within 60&#160;days of April 11, 2016.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;">(12)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Includes 57,064 shares of common stock and 107,540 shares of common stock issuable upon the exercise of options exercisable within 60&#160;days of April 11, 2016.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;">(13)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Includes (a)&#160;4,486,751 shares held by all current executive officers and directors as a group, (b)&#160;602,266 shares that all current executive officers and directors as a group have the right to acquire from us within 60&#160;days of April 11, 2016 pursuant to the exercise of stock options, and (c)&#160;shares of common stock held by the Longwood Funds, which are deemed to be beneficially owned by Dr.&#160;Westphal.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">SECTION 16(A) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Section 16(a) of the Securities Exchange Act of 1934, as amended, or the Exchange Act, requires our directors and executive officers, and persons who own more than ten percent of a registered class of our equity securities, to file with the SEC initial reports of ownership and reports of changes in ownership of common stock and other equity securities of the Company. Officers, directors and greater than ten percent stockholders are required by SEC regulation to furnish us with copies of all Section 16(a) forms they file.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">To the best of our knowledge, based solely on a review of the copies of such reports furnished to us and written representations that no other reports were required, during the fiscal year ended December 31, 2015, all of our officers, directors and greater than ten percent beneficial owners complied with all Section 16(a) filing requirements applicable to them, except for Marina Hahn, Katharine Lindemann and Robert Perez, each of whom filed one Form 4 five business days after the applicable deadline.</font></div><div><br></div><div><div style="line-height:100%;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">19</font><font style="font-family:Arial;font-size:10pt;">.</font></div></div><hr style="page-break-after:always"><div><a name="sB834574731846208C792CD6523F6ECC7"></a></div><div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">EXECUTIVE AND DIRECTOR COMPENSATION</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Our named executive officers for the period ending December&#160;31, 2015, which consist of our principal executive officer and the two other most highly compensated executive officers who were serving as executive officers as of December 31, 2015, are:</font></div><table cellpadding="0" cellspacing="0" style="padding-top:10px;padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Christoph Westphal, M.D., Ph.D., our President, Chief Executive Officer and Chairman of the Board;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:10px;padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Marina Hahn, our President, Consumer; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:10px;padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Thomas Wessel, M.D., Ph.D., our Chief Medical Officer.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Summary Compensation Table</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The following table provides information regarding the compensation provided during the year ending December 31, 2015 and during the period from February&#160;26, 2014 (inception) to December 31, 2014 to our named executive officers:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="30"></td></tr><tr><td style="width:16%;"></td><td style="width:1%;"></td><td style="width:5%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:6%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:3%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Name and Principal </font></div><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Position</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Year</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Salary</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">($)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Bonus</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">($)</font><font style="font-family:Arial;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Option</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Awards</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">($)</font><font style="font-family:Arial;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(2)</sup></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Stock</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Awards</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">($)</font><font style="font-family:Arial;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(3)</sup></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Non-Equity</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Incentive Plan</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Compensation</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">($)</font><font style="font-family:Arial;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(4)</sup></font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">All Other</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Compensation</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">($)</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Total</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">($)</font></div></td></tr><tr><td rowspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Christoph Westphal, M.D., Ph.D.,</font></div><div style="text-align:left;padding-left:12px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-style:italic;">President, Chief Executive Officer, Chairman of the Board</font><font style="font-family:Arial;font-size:9pt;font-style:italic;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(5)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2015</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">459,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">218,025</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">19,832</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(8)</sup>&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">696,857</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2014</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">337,500</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">375,804</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">172,603</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">885,907</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td rowspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">Marina Hahn</font><font style="font-family:Arial;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(6)</sup></font></div><div style="text-align:left;padding-left:12px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-style:italic;">President, Consumer</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2015</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">340,500</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,096,170</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">154,470</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">10,602</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(9)</sup>&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,601,742</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2014</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">76,154</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">100,000</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">703,379</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">34,027</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:middle;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">913,560</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td rowspan="2" style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-style:italic;">Thomas Wessel, M.D., Ph.D.</font></div><div style="text-align:left;padding-left:12px;text-indent:-12px;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;font-style:italic;">&#160;&#160;&#160;Chief Medical Officer</font><font style="font-family:Arial;font-size:9pt;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(7)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2015</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">395,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,158,266</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">150,100</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">10,432</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(10)</sup>&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">1,713,798</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">2014</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">4,558</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">55,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">$</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">59,558</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;">(1)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Amounts shown represent a $100,000 signing bonus paid to Ms.&#160;Hahn and a $55,000 signing bonus paid to Mr. Wessel under the terms of their offer letters.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;">(2)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">In accordance with SEC rules, this column reflects the aggregate grant date fair value of the option awards granted during the respective fiscal years computed in accordance with ASC 718. Assumptions used in the calculation of these amounts are included in Note 11 to our consolidated financial statements included in our Annual Report on Form 10-K filed with the SEC.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;">(3)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">In accordance with SEC rules, this column reflects the aggregate grant date fair value of the restricted common stock awards granted during the respective fiscal years. Discussion of restricted common stock is included in Note 10 to our consolidated financial statements included in our Annual Report on Form 10-K filed with the SEC.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;">(4)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Amounts shown represent annual performance&#8209;based bonuses for 2014 and 2015. For more information see &#8220;Annual Performance&#8209;Based Bonus Opportunity&#8221; below.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;">(5)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dr.&#160;Westphal joined us as our President and Chief Executive Officer on April 9, 2014 at an annual salary of $450,000. Amounts shown for the period beginning on February&#160;26, 2014 (inception) and ending on December 31, 2014 represent the compensation earned by Dr.&#160;Westphal from his April&#160;9, 2014 start date through December 31, 2014.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;">(6)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Ms. Hahn joined us as our President, Consumer on September&#160;30, 2014 at an annual salary of $300,000.  Amounts shown for the period beginning on February&#160;26, 2014 (inception) and ending on December 31, 2014 represent the compensation earned by Ms. Hahn from her September&#160;30, 2014 start date through December&#160;31, 2014.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;">(7)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dr. Wessel joined us as our Chief Medical Officer on December 29, 2014 at an annual salary of $395,000. Amounts shown for the period beginning on February&#160;26, 2014 (inception) and ending on December 31, 2014 represent the compensation earned by Dr. Wessel from his December 29, 2014 start date through December 31, 2014.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;">(8)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Amounts consist of: (i) $700 for long-term disability premiums and a $582 related tax gross up, (ii) $7,950 of matching contributions defined in our 401(k) plan and (iii) $10,600 for reimbursement of monthly telecommunications charges. For more information regarding these benefits, see below under "Perquisites, Health, Welfare and Retirement Benefits."</font></div></td></tr></table><div><br></div><div><div style="line-height:100%;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">20.</font></div><div style="line-height:100%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><a name="sB834574731846208C792CD6523F6ECC7"></a></div><div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;">(9)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Amounts consist of: (i) $700 for long-term disability premiums and a $752 related tax gross up, (ii) $7,950 of matching contributions defined in our 401(k) plan and (iii) $1,200 paid as an allowance for cell phone costs. For more information regarding these benefits, see below under "Perquisites, Health, Welfare and Retirement Benefits."</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;">(10)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Amounts consist of: (i) $700 for long-term disability premiums and a $582 related tax gross up, (ii) $7,950 of matching contributions defined in our 401(k) plan and (iii) $1,200 paid as an allowance for cell phone costs. For more information regarding these benefits, see below under "Perquisites, Health, Welfare and Retirement Benefits."</font></div></td></tr></table><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Annual Base Salary</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Base salaries are intended to provide a fixed level of compensation for our executive officers that is commensurate with their responsibilities and competitive market conditions. When considered in combination with other elements of our executive compensation, we believe our base salaries are sufficient to attract and retain an effective management team.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The compensation of our named executive officers is generally determined and approved by the Board of Directors or the Compensation Committee. The Compensation Committee approved the following 2015 base salaries for our named executive officers, which became effective on January 1, 2015:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:87%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;text-decoration:underline;">Name</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">2015 Base Salary</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Christoph Westphal, M.D., Ph.D.&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">459,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Marina Hahn</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">306,000</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Thomas Wessel, M.D., Ph.D.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">395,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">In July 2015, we entered into an amendment to Ms. Hahn's offer letter increasing her base salary to $375,000. In December 2015, following the recommendation of the Compensation Committee, the Board of Directors approved a 3% increase to the base salaries of eligible employees, including our named executive officers. This salary increase became effective on January&#160;1, 2016.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Annual Performance-Based Bonus Opportunity</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">In addition to base salaries, our named executive officers are eligible to receive annual performance-based cash bonuses, which are designed to provide appropriate incentives to our executives to achieve defined annual corporate goals and to reward our executives for individual achievement towards these goals. The annual performance-based bonus that each executive officer is eligible to receive is set out in the individual's offer letter and will be based on the individual's target bonus, as a percentage of base salary, or target bonus percentage, and the extent to which we achieve the corporate goals and the executive achieves his or her personal goals, if any, established for each year. The actual performance-based bonus paid to each executive, if any, is calculated by multiplying the executive's annual base salary, target bonus percentage, and the percentage attainment of the corporate goals and personal goals, if any, established for such year with respect to the executive and is prorated for the duration of employment for that year. There is no minimum bonus percentage or amount established for the named executive officers and, as a result, the bonus amounts vary from year to year based on corporate and individual performance as well as the Compensation Committee's evaluation of other factors it deems relevant in determining annual bonuses.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The corporate goals are determined by the Compensation Committee, reviewed by the Board of Directors and comprised of our most important annual corporate goals and various business accomplishments, which vary from time to time depending on our overall strategic objectives. At the end of the year or the beginning of the following year, the Compensation Committee reviews our performance against each corporate goal and approves the extent to which we achieved each such goal. The Compensation Committee may award a bonus in an amount above or below the amount that would otherwise be associated with the degree of goal achievement, based on factors the Compensation Committee determines are material to our corporate performance and provide appropriate incentives to our executives, including events or circumstances that arise after the original corporate goals are set.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">For 2015, each of our named executive officer's bonuses were entirely dependent upon our achievement of our corporate goals. Our corporate objectives for 2015 were related to identifying an initial drug product candidate, initiating and completing certain clinical studies, developing our first consumer product, establishing marketing plans and commercialization plans for our consumer product launch and ensuring our financial stability. Each named </font></div><div><br></div><div><div style="line-height:100%;padding-bottom:8px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div><div style="line-height:100%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">21.</font></div><div style="line-height:100%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><a name="sB834574731846208C792CD6523F6ECC7"></a></div><div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">executive officer was eligible to receive up to 150% of their target bonus. The Compensation Committee concluded that 95% of our 2015 corporate objectives had been achieved and, in January 2016, we paid each of our named executive officers 95% of their target bonus. In determining that we had achieved 95% of the 2015 corporate goals for purposes of the 2015 annual performance-based bonuses, the Compensation Committee considered the substantial progress made by our research and development group identifying a lead drug product candidate and completing certain clinical studies, the efforts of our consumer group preparing for the launch of our consumer product, and the success of our capital-raising and financial discipline efforts during 2015.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Each named executive officer's 2015 target bonus percentage and actual bonus amount paid are set forth below:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:95.51656920077973%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"></td></tr><tr><td style="width:73%;"></td><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;text-decoration:underline;">Name</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Target bonus<br>(% of base<br>salary)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">2015</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Bonus Amount</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Christoph Westphal, M.D., Ph.D.&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">50</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">218,025</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Marina Hahn</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">50</font></div></td><td style="vertical-align:bottom;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">154,470</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Thomas Wessel, M.D., Ph.D.</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">40</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-right:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">%</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">150,100</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:95.51656920077973%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Equity-Based Incentive Awards</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Our equity-based incentive awards are designed to align our longer-term interests and the longer-term interests of our shareholders with those of our employees and consultants, including our named executive officers. The Board of Directors, following the recommendation of the Compensation Committee, is responsible for approving equity grants. We have generally granted stock options to our named executive officers and employees as incentive compensation because we believe in using equity compensation to reward our named executive officers and other employees for stock price appreciation; however, we entered into a restricted stock purchase agreement and a restricted stock award agreement with Dr.&#160;Westphal in connection with and shortly after our formation. Vesting of equity awards is generally tied to continuous service with us and serves as an additional retention measure. We anticipate awarding to our executives an initial equity grant upon commencement of employment. Additional grants may occur periodically in order to specifically incent executives with respect to achieving certain corporate goals or to reward executives for exceptional performance.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">During 2015, we did not grant Dr. Westphal any equity-based incentive awards. </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">On November 11, 2015, the Board of Directors granted Ms. Hahn an option to purchase 150,000 shares of common stock at an exercise price of $11.05 per share. Vesting of the shares subject to this option are based on performance criteria for which the SEC has afforded confidential treatment under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. For additional information, see the section below titled &#8220;-&#160;Potential Payments Upon Termination or Change of Control.&#8221;</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">On January 7, 2015, in connection with the commencement of Dr. Wessel's employment, the Board of Directors granted Dr. Wessel an option to purchase 163,136 shares of common stock at an exercise price of $10.79 per share. Dr. Wessel's options are subject to a four year vesting schedule subject to his continued service and also include an early exercise provision pursuant to which Dr. Wessel may exercise a portion of his options in advance of their vesting. For additional information, see the section below titled "- Potential Payments Upon Termination or Change of Control." </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Agreements with our Executive Officers</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Below are written descriptions of our offer letters with our named executive officers.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Christoph Westphal, M.D., Ph.D.</font><font style="font-family:Arial;font-size:10pt;font-style:italic;">&#160;</font><font style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;We entered into an Executive Employment Agreement with Dr.&#160;Westphal in May 2015, which replaced Dr. Westphal's offer letter. Pursuant to his employment agreement, Dr. Westphal will receive an annual base salary of $459,000, subject to increase by the Board of Directors, and is eligible for an annual bonus that targets 50% of his annualized base salary based upon an assessment of Dr. Westphal's performance and the attainment of targeted goals established by the Board of Directors. The assessment of Dr. Westphal's performance and the achievement of goals will be determined in the sole discretion of the Board of Directors. In the event that he is terminated without cause or resigns for good reason, Dr. Westphal is entitled to certain additional severance and change of control benefits pursuant to his restricted stock agreements and his </font></div><div><br></div><div><div style="line-height:100%;padding-bottom:8px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div><div style="line-height:100%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">22.</font></div><div style="line-height:100%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><a name="sB834574731846208C792CD6523F6ECC7"></a></div><div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">employment agreement, the terms of which are described below under "&#8212; Potential Payments Upon Termination or Change of Control."</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Marina Hahn.</font><font style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;&#160;We entered into an offer letter with Ms.&#160;Hahn in September 2014, which was amended in May 2015 and further amended in July 2015. The offer letter provides for an annual base salary of $375,000, subject to increase by the Board of Directors, and that Ms.&#160;Hahn is eligible for an annual bonus based on company and individual performance. The target amount of Ms.&#160;Hahn's annual performance bonus equals 50% of her annual base salary and will be based on parameters determined by the Board of Directors after consultation with Ms.&#160;Hahn. Pursuant to the July 2015 amendment, Ms.&#160;Hahn was granted an option to purchase 150,000 shares of our common stock on November 11, 2015, which vests based on performance criteria for which the SEC has afforded confidential treatment under Rule 24b-2 of the Securities Exchange Act of 1934, as amended.  Under Ms. Hahn's offer letter, if Ms. Hahn is terminated without cause or resigns for good reason, Ms. Hahn will be entitled to severance benefits and payments upon a change of control, the terms of which are described below under "&#8212; Potential Payments Upon Termination or Change of Control."</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Thomas Wessel, M.D., Ph.D.</font><font style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;&#160;We entered into an offer letter with Dr. Wessel in December 2014, which was amended in May 2015. The offer letter provides for an annual base salary of $395,000, subject to increase by the Board of Directors, and that Dr. Wessel is eligible for an annual bonus based on company and individual performance. The target amount of Dr. Wessel's annual performance bonus equals 40% of his annual base salary and will be based on parameters determined by the Board of Directors. Pursuant to his offer letter, Dr. Wessel was granted an option to purchase 163,136 shares of our common stock, which vests over a four year period, with 25% vesting on December 29, 2015 and the remaining shares vesting ratably each month thereafter. Under Dr. Wessel's offer letter, if Dr. Wessel is terminated without cause or resigns for good reason, Dr. Wessel will be entitled to severance benefits and payments upon a change of control, the terms of which are described below under "&#8212; Potential Payments Upon Termination or Change of Control."</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Restrictive Covenant Agreements.</font><font style="font-family:Arial;font-size:10pt;">&#32;&#32;In connection with entering into offer letters with the Company, each of our named executive officers entered into an Employee Non&#8209;Solicitation, Non&#8209;Competition, Confidential Information and Inventions Assignment Agreement with us, or the Restrictive Covenant Agreement, each of which became effective upon signing. Under the Restrictive Covenant Agreement, the named executive officer generally is subject to: (1)&#160;a perpetual covenant not to disclose or use any of our or third&#8209;party confidential information (except under limited circumstances); (2)&#160;an invention disclosure and assignment provision pursuant to which he or she agrees to assign to us (and will cooperate with us to enforce) all his or her rights, title, and interest in and to any and all inventions (and intellectual property rights with respect thereto) made, conceived, reduced to practice or learned by him or her, either alone or with others, during his or her employment with us; (3)&#160;a non&#8209;competition provision pursuant to which he or she has agreed not to compete with the Company during employment and for 12&#160;months thereafter; (4)&#160;a non&#8209;solicitation provision pursuant to which he or she has agreed not to solicit any of our employees, independent contractors or consultants to terminate his, her or its relationship with us during employment and for 12&#160;months thereafter; and (5)&#160;a covenant to return all company property to us upon any termination employment or upon our request. In addition, each named executive officer has agreed to indemnify us and certain other parties, for all verdicts, judgments, settlements and other losses incurred by us in the event we are the subject of any legal action resulting from the breach of any of the named executive officer&#8217;s obligations under the Restrictive Covenant Agreement, as well as any reasonable attorneys&#8217; fees and costs if the plaintiff is the prevailing party in any such action.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Potential Payments Upon Termination or Change of Control</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Regardless of the manner in which a named executive officer&#8217;s service terminates, the named executive officer is entitled to receive amounts earned during his or her term of service, including salary and unused vacation pay. </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Under his employment agreement, in the event that he is terminated without cause or resigns for good reason prior to a change in control (each as defined in his employment agreement), Dr. Westphal will be entitled to severance in the form of salary continuation for twelve months at his then-current base salary. In the event that he is terminated without cause or resigns for good reason during the period beginning 30 days prior to and ending twelve (12) months following a change in control, Dr. Westphal will be entitled to severance in the form of salary continuation for twelve months at his then-current base salary and the target bonus payment for the year in which the termination occurs. </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Under Dr.&#160;Westphal's restricted stock purchase agreements, we may only exercise our repurchase rights with respect to unvested shares of common stock if Dr.&#160;Westphal's employment is terminated by us for cause or Dr.&#160;Westphal terminates his employment for any reason (each as defined in his restricted stock purchase agreements), in each case, </font></div><div><br></div><div><div style="line-height:100%;padding-bottom:8px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div><div style="line-height:100%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">23.</font></div><div style="line-height:100%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><a name="sB834574731846208C792CD6523F6ECC7"></a></div><div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">within 90&#160;days of such termination. In addition, Dr.&#160;Westphal's shares shall vest with respect to all of the shares held by Dr.&#160;Westphal in the event he is terminated by us without cause or due to his death or disability, or upon the occurrence of a corporate transaction (as defined in his restricted stock purchase agreements). </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Under Ms. Hahn's offer letter, if Ms. Hahn is terminated without cause or resigns for good reason (each as defined in her offer letter), Ms. Hahn will be entitled to severance in the form of salary continuation for nine months at her then-current base salary and we will pay, for up to nine months, that portion of the COBRA premiums that we paid prior to such termination. Additionally, if during the period beginning 30&#160;days prior to and ending 12&#160;months following a change of control (as defined in her offer letter), we terminate Ms.&#160;Hahn's employment other than for cause or Ms.&#160;Hahn terminates her employment for good reason, then 100% of the shares of common stock subject to Ms.&#160;Hahn's stock options shall automatically vest except for any options that were forfeited prior to the change of control. </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Under Dr. Wessel's offer letter, if Dr. Wessel is terminated without cause or resigns for good reason (each as defined in his offer letter), Dr. Wessel will be entitled to severance in the form of salary continuation for nine months at his then-current base salary and we will pay, for up to nine months, that portion of the COBRA premiums that we paid prior to such termination. Additionally, upon a change of control (as defined in his offer letter), 50% of the shares of common stock subject to Dr. Wessel's stock options shall automatically vest.  Further, if during the period beginning 30&#160;days prior to and ending 12&#160;months following a change of control, we terminate Dr. Wessel's employment other than for cause or Dr. Wessel terminates his employment for good reason, then 100% of the shares of common stock subject to Dr. Wessel's options shall automatically vest. </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Outstanding Equity Awards at December 31, 2015</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The following table sets forth certain information regarding outstanding equity awards granted to our named executive officers that remain outstanding as of December 31, 2015.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="18"></td></tr><tr><td style="width:9%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:7%;"></td><td style="width:1%;"></td><td style="width:8%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:10%;"></td><td style="width:1%;"></td><td style="width:9%;"></td><td style="width:1%;"></td><td style="width:9%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;font-weight:bold;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="7" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;font-weight:bold;">Option Awards</font><font style="font-family:Arial;font-size:7pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;font-weight:bold;">Stock Awards</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;font-weight:bold;">Equity Incentive</font></div><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;font-weight:bold;">Plan Awards</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;text-decoration:underline;">Name</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;font-weight:bold;">Grant Date</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;font-weight:bold;">Number of</font></div><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;font-weight:bold;">Securities</font></div><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;font-weight:bold;">Underlying</font></div><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;font-weight:bold;">Unexercised</font></div><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;font-weight:bold;">Options (#)</font></div><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;font-weight:bold;">Exercisable</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;font-weight:bold;">Number of</font></div><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;font-weight:bold;">Securities</font></div><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;font-weight:bold;">Underlying</font></div><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;font-weight:bold;">Unexercised</font></div><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;font-weight:bold;">Options (#)</font></div><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;font-weight:bold;">Unexercisable</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;font-weight:bold;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;font-weight:bold;">Option</font></div><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;font-weight:bold;">Exercise</font></div><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;font-weight:bold;">Price Per</font></div><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;font-weight:bold;">Share</font><font style="font-family:Arial;font-size:7pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(2)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;font-weight:bold;">Option</font></div><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;font-weight:bold;">Expiration</font></div><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;font-weight:bold;">Date</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;font-weight:bold;">Number of</font></div><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;font-weight:bold;">shares or</font></div><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;font-weight:bold;">units of</font></div><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;font-weight:bold;">stock</font></div><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;font-weight:bold;">that have not</font></div><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;font-weight:bold;">vested (#)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;font-weight:bold;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;font-weight:bold;">Market value</font></div><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;font-weight:bold;">of shares</font></div><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;font-weight:bold;">or units</font></div><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;font-weight:bold;">of stock</font></div><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;font-weight:bold;">that have not</font></div><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;font-weight:bold;">vested ($)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;font-weight:bold;">Number of</font></div><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;font-weight:bold;">unearned</font></div><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;font-weight:bold;">shares that</font></div><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;font-weight:bold;">have not</font></div><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;font-weight:bold;">vested (#)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;font-weight:bold;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;font-weight:bold;">Market value</font></div><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;font-weight:bold;">of unearned</font></div><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;font-weight:bold;">shares that</font></div><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;font-weight:bold;">have not</font></div><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;font-weight:bold;">vested ($)</font></div></td></tr><tr><td rowspan="2" style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Christoph Westphal, M.D., Ph.D.</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">3/5/2014</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">1,331,879</font><font style="font-family:Arial;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(3)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">16,581,894</font><font style="font-family:Arial;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(4)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">4/9/2014</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">253,697</font><font style="font-family:Arial;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(3)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">3,158,528</font><font style="font-family:Arial;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(4)</sup></font></div></td></tr><tr><td rowspan="2" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Marina Hahn</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">10/15/2014</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">179,497</font><font style="font-family:Arial;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(5)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">69,358</font><font style="font-family:Arial;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(5)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">$4.28</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">10/15/2024</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">11/11/2015</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">-</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">150,000</font><font style="font-family:Arial;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(6)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">$11.05</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">11/11/2025</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Thomas Wessel, M.D., Ph.D.</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">1/7/2015</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">98,274</font><font style="font-family:Arial;font-size:7pt;background-color:#cceeff;"><sup style="vertical-align:top;line-height:120%;background-color:#cceeff; font-size:5pt">(7)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">27,798</font><font style="font-family:Arial;font-size:7pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(7)</sup></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">$10.79</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">1/7/2025</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">&#160;</font></div></td><td style="vertical-align:middle;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:7pt;"><font style="font-family:Arial;font-size:7pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;">(1)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">All of the option awards listed in the table above were granted under the 2014 Plan or the 2015 Plan, the terms of which are described below under "&#8212;&#160;Equity Benefit Plans." Except as otherwise indicated, each option award becomes exercisable as it becomes vested and all vesting is subject to the executive's continuous service with us through the vesting dates.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;">(2)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">All of the option awards listed in the table above were granted with a per share exercise price equal to the fair market value of one share of our common stock on the date of grant, as determined in good faith by the Board of Directors.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;">(3)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">The shares vest at the rate of 1/4</font><font style="font-family:Arial;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">th</sup></font><font style="font-family:Arial;font-size:8pt;">&#160;of the total number of shares on the date of issuance, with 1/48</font><font style="font-family:Arial;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">th</sup></font><font style="font-family:Arial;font-size:8pt;">&#160;of the shares vesting monthly over four years measured from February&#160;26, 2014, and subject to vesting acceleration as described above under "&#8212;&#160;Potential Payments Upon Termination or Change of Control."</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;">(4)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Computed based on the fair market value of a share of our common stock as of December&#160;31, 2015, which was $12.45.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;">(5)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">The option vests at the rate of 1/4</font><font style="font-family:Arial;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">th</sup></font><font style="font-family:Arial;font-size:8pt;">&#32;of the total number of shares subject to the option one year after September&#160;30, 2014, with 1/48</font><font style="font-family:Arial;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">th</sup></font><font style="font-family:Arial;font-size:8pt;">&#32;of the shares vesting monthly thereafter over the next three years. The option is subject to vesting acceleration as described above under &#8220;-&#160;Potential Payments Upon Termination or Change of Control.&#8221; Notwithstanding the vesting schedule of Ms. Hahn&#8217;s option, Ms. Hahn&#8217;s Stock Option Grant Notice provides that 156,378 shares were exercisable as of the date of grant and an additional 23,119 shares are exercisable on January&#160;1 of each year beginning in 2015 and ending in 2018.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;">(6)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">The option vests based on performance criteria for which the SEC has afforded confidential treatment under Rule 24b-2 of the Securities Exchange Act of 1934, as amended. </font></div></td></tr></table><div><br></div><div><div style="line-height:100%;padding-bottom:8px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div><div style="line-height:100%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">24.</font></div><div style="line-height:100%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><a name="sB834574731846208C792CD6523F6ECC7"></a></div><div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;">(7)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">The option vests at the rate of 1/4</font><font style="font-family:Arial;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">th</sup></font><font style="font-family:Arial;font-size:8pt;">&#160;of the total number of shares subject to the option one year after December 29, 2014, with 1/48</font><font style="font-family:Arial;font-size:8pt;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">th</sup></font><font style="font-family:Arial;font-size:8pt;">&#160;of the shares vesting monthly thereafter over the next three years. Notwithstanding the vesting schedule of Dr. Wessel's option, Dr. Wessel's Stock Option Grant Notice provides that 135,338 shares were exercisable as of the date of grant and an additional 9,266 shares are exercisable on January&#160;1 of each year beginning in 2016 and ending in 2018.  On January 15, 2015, Dr. Wessel exercised 37,064 options. </font></div></td></tr></table><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Perquisites, Health, Welfare and Retirement Benefits</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Our named executive officers are eligible to participate in our employee benefit plans, including our medical and dental insurance plans, in each case on the same basis as all of our other employees. We provide a 401(k) plan to our employees, including our named executive officers, as discussed in the section below entitled "&#8212;&#160;401(k) Plan." </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">We generally do not provide perquisites or personal benefits to our named executive officers, except in certain limited circumstances. We do, however, pay the premiums for group term life insurance and long-term disability benefits (and, with respect to life insurance and long-term disability benefits, we provide a tax gross up relating to such payment) for all of our employees, including our named executive officers.  We also reimburse our employees, including our named executive officers, for approximately 90% of their health and dental premiums, pay each of our employees, other than Dr. Westphal, a $100 monthly allowance for cell phone costs, and, with respect to Dr. Westphal, reimburse his monthly telecommunications charges. </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">401(k) Plan</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">We maintain a tax-qualified retirement plan that provides eligible U.S. employees with an opportunity to save for retirement on a tax advantaged basis. Eligible employees are able to defer eligible compensation up to certain Code limits, which are updated annually. In January 2015, we began making matching contributions equal to 100% of the first 3% of the eligible compensation that an employee contributes to the 401(k) Plan, up to the maximum amount allowed by the Code. Pre-tax contributions by employees and any employer contributions that we make to the 401(k) Plan and the income earned on those contributions are generally not taxable to employees until withdrawn. Employee contributions are allocated to each participant's individual account and are then invested in selected investment alternatives according to the participants' directions. Employees are immediately and fully vested in their own contributions. The 401(k) plan is intended to be qualified under Section&#160;401(a) of the Code, with the related trust intended to be tax exempt under Section&#160;501(a) of the Code. As a tax-qualified retirement plan, contributions to the 401(k) plan are deductible by us when made, and contributions and earnings on those amounts are not taxable to the employees until withdrawn or distributed from the 401(k) plan.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Non-qualified Deferred Compensation</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">None of our named executive officers participate in or have account balances in non-qualified defined contribution plans or other non-qualified deferred compensation plans maintained by us. The Board of Directors may elect to provide our officers and other employees with non-qualified defined contribution or other non-qualified deferred compensation benefits in the future if it determines that doing so is in our best interests.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Equity Benefit Plans</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">2015 Equity Incentive Plan</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Board of Directors adopted the 2015 Equity Incentive Plan, or 2015 Plan, in January 2015, and our stockholders approved the 2015 plan in January&#160;2015. The 2015 plan became effective as of January 28, 2015, the date of the final prospectus for our initial public offering. </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Awards.</font><font style="font-family:Arial;font-size:10pt;">&#32;&#32;The 2015 plan provides for the grant of incentive stock options, or ISOs, non&#8209;statutory stock options, or NSOs, stock appreciation rights, restricted stock awards, restricted stock unit awards, performance based stock awards, and other forms of equity compensation, collectively stock awards. Additionally, the 2015 plan provides for the grant of performance cash awards. ISOs may be granted only to employees of us and our affiliates. All other awards may be granted to employees, including officers, and to non&#8209;employee directors and consultants of us and our affiliates.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Share Reserve.</font><font style="font-family:Arial;font-size:10pt;">&#32;&#32;The aggregate number of shares of our common stock that may be issued pursuant to stock awards under the 2015 plan is the sum of (i)&#160;1,711,965, plus (iii)&#160;any shares subject to outstanding stock options or other stock awards that would have otherwise returned to our 2014 plan (such as upon the expiration or termination of a stock award prior to vesting). Additionally, the number of shares of our common stock reserved for issuance under our 2015 plan will automatically increase on January&#160;1 of each year, through and including January&#160;1, 2025, by 4% of the total number of shares of our capital stock outstanding on December&#160;31 of the preceding calendar </font></div><div><br></div><div><div style="line-height:100%;padding-bottom:8px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div><div style="line-height:100%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">25.</font></div><div style="line-height:100%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><a name="sB834574731846208C792CD6523F6ECC7"></a></div><div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">year, or a lesser number of shares determined by the Board of Directors. The maximum number of shares that may be issued upon the exercise of ISOs under our 2015 plan is 5,919,390 shares.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">No person may be granted stock awards covering more than 934,033 shares of our common stock under our 2015 plan during any calendar year pursuant to stock options, stock appreciation rights and other stock awards whose value is determined by reference to an increase over an exercise or strike price of at least 100% of the fair market value on the date the stock award is granted. Additionally, no person may be granted in a calendar year a performance stock award covering more than 350,262 shares or a performance cash award having a maximum value in excess of $3,000,000. Such limitations are designed to help assure that any deductions to which we would otherwise be entitled with respect to such awards will not be subject to the $1,000,000 limitation on the income tax deductibility of compensation paid to any covered executive officer imposed by Section&#160;162(m) of the Code.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">In addition, the maximum number of shares subject to awards granted during a single fiscal year to any non-employee director, taken together with any cash fees paid to such non-employee director during the fiscal year, shall not exceed $350,000 in total value (calculating the value of any such awards based on the grant date fair value of such awards for financial reporting purposes and excluding, for this purpose, the value of any dividend equivalent payments paid pursuant to any award granted in a previous fiscal year).</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">If a stock award granted under the 2015 plan expires or otherwise terminates without being exercised in full, or is settled in cash, the shares of our common stock not acquired pursuant to the stock award again will become available for subsequent issuance under the 2015 plan. In addition, the following types of shares under the 2015 plan may become available for the grant of new stock awards under the 2015 plan: (1)&#160;shares that are forfeited to or repurchased by us prior to becoming fully vested; (2)&#160;shares withheld to satisfy income or employment withholding taxes; or (3)&#160;shares used to pay the exercise or purchase price of a stock award. Shares issued under the 2015 plan may be previously unissued shares or reacquired shares bought by us on the open market. As of March 4, 2016, stock awards covering a total of 1,331,799 shares of our common stock have been issued under the 2015 plan.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Administration.</font><font style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;&#160;The Board of Directors, or a duly authorized committee thereof, has the authority to administer the 2015 plan. The Board of Directors may also delegate to one or more of our officers the authority to (1)&#160;designate employees who are not officers (other than himself or herself) to be recipients of certain stock awards, and (2)&#160;determine the number of shares of common stock to be subject to such stock awards. Subject to the terms of the 2015 plan, the Board of Directors or the authorized committee, referred to herein as the plan administrator, determines recipients, dates of grant, the numbers and types of stock awards to be granted and the terms and conditions of the stock awards, including the period of their exercisability and vesting schedule applicable to a stock award. Subject to the limitations set forth below, the plan administrator will also determine the exercise price, strike price or purchase price of awards granted and the types of consideration to be paid for the award.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The plan administrator has the authority to modify outstanding awards under our 2015 plan. Subject to the terms of our 2015 plan, the plan administrator has the authority to reduce the exercise, purchase or strike price of any outstanding stock award, cancel any outstanding stock award in exchange for new stock awards, cash or other consideration, or take any other action that is treated as a repricing under generally accepted accounting principles, with the consent of any adversely affected participant.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Stock Options.</font><font style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;&#160;Incentive and non-statutory stock options are granted pursuant to stock option agreements adopted by the plan administrator. The plan administrator determines the exercise price for a stock option, within the terms and conditions of the 2015 plan, provided that the exercise price of a stock option generally cannot be less than 100% of the fair market value of our common stock on the date of grant. Options granted under the 2015 plan vest at the rate specified by the plan administrator.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The plan administrator determines the term of stock options granted under the 2015 plan, up to a maximum of 10&#160;years. Unless the terms of an option holder's stock option agreement provide otherwise, if an option holder's service relationship with us, or any of our affiliates, ceases for any reason other than disability, death or cause, the option holder may generally exercise any vested options for a period of three months following the cessation of service. The option term may be extended in the event that the issuance of shares of our common stock upon the exercise of the option or the same of such shares following such a termination of service is prohibited by applicable securities laws or our insider trading policy. If an optionholder's service relationship with us or any of our affiliates ceases due to disability or death, or an optionholder dies within a certain period following cessation of service, the optionholder or a beneficiary may generally exercise any vested options for a period of 12&#160;months in the event of disability and 18&#160;months in the event of death. In the event of a termination for cause, options generally terminate </font></div><div><br></div><div><div style="line-height:100%;padding-bottom:8px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div><div style="line-height:100%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">26.</font></div><div style="line-height:100%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><a name="sB834574731846208C792CD6523F6ECC7"></a></div><div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">immediately upon the termination of the individual for cause. In no event may an option be exercised beyond the expiration of its term.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Acceptable consideration for the purchase of common stock issued upon the exercise of a stock option will be determined by the plan administrator and may include (1)&#160;cash, check, bank draft or money order, (2)&#160;a broker-assisted cashless exercise, (3)&#160;the tender of shares of our common stock previously owned by the optionholder, (4)&#160;a net exercise of the option if it is an NSO, and (5)&#160;other legal consideration approved by the plan administrator.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Unless the plan administrator provides otherwise, options generally are not transferable except by will, the laws of descent and distribution, or pursuant to a domestic relations order. An optionholder may designate a beneficiary, however, who may exercise the option following the optionholder's death.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Restricted Stock Awards.</font><font style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;&#160;Restricted stock awards are granted pursuant to restricted stock award agreements or restricted stock purchase agreements adopted by the plan administrator. Restricted stock awards may be granted in consideration for (1)&#160;cash, check, bank draft or money order, (2)&#160;services rendered to us or our affiliates, or (3)&#160;any other form of legal consideration. Common stock acquired under a restricted stock award may, but need not, be subject to a share repurchase option in our favor in accordance with a vesting schedule to be determined by the plan administrator. Rights to acquire shares under a restricted stock award may be transferred only upon such terms and conditions as set by the plan administrator. Except as otherwise provided in the applicable award agreement, restricted stock awards that have not vested will be forfeited upon the participant's cessation of continuous service for any reason.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Tax Limitations On Incentive Stock Options.</font><font style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;&#160;The aggregate fair market value, determined at the time of grant, of our common stock with respect to ISOs that are exercisable for the first time by an optionholder during any calendar year under all of our stock plans may not exceed $100,000. Options or portions thereof that exceed such limit will generally be treated as NSOs. No ISO may be granted to any person who, at the time of the grant, owns or is deemed to own stock possessing more than 10% of our total combined voting power or that of any of our affiliates unless (1)&#160;the option exercise price is at least 110% of the fair market value of the stock subject to the option on the date of grant, and (2)&#160;the term of the ISO does not exceed five years from the date of grant.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Restricted Stock Unit Awards.</font><font style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;&#160;Restricted stock unit awards are granted pursuant to restricted stock unit award agreements adopted by the plan administrator. Restricted stock unit awards may be granted in consideration for any form of legal consideration. A restricted stock unit award may be settled by cash, delivery of stock, a combination of cash and stock as deemed appropriate by the plan administrator, or in any other form of consideration set forth in the restricted stock unit award agreement. Additionally, dividend equivalents may be credited in respect of shares covered by a restricted stock unit award. Except as otherwise provided in the applicable award agreement, restricted stock awards that have not vested will be forfeited upon the participant's cessation of continuous service for any reason.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Stock Appreciation Rights.</font><font style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;&#160;Stock appreciation rights are granted pursuant to stock appreciation grant agreements adopted by the plan administrator. The plan administrator determines the strike price for a stock appreciation right, which generally cannot be less than 100% of the fair market value of our common stock on the date of grant. Upon the exercise of a stock appreciation right, we will pay the participant an amount equal to the product of (1)&#160;the excess of the per share fair market value of our common stock on the date of exercise over the strike price, multiplied by (2)&#160;the number of shares of common stock with respect to which the stock appreciation right is exercised. A stock appreciation right granted under the 2015 plan vests at the rate specified in the stock appreciation right agreement as determined by the plan administrator.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The plan administrator determines the term of stock appreciation rights granted under the 2015 plan, up to a maximum of ten years. Unless the terms of a participant's stock appreciation right agreement provides otherwise, if a participant's service relationship with us or any of our affiliates ceases for any reason other than cause, disability or death, the participant may generally exercise any vested stock appreciation right for a period of three months following the cessation of service. The stock appreciation right term may be further extended in the event that exercise of the stock appreciation right following such a termination of service is prohibited by applicable securities laws. If a participant's service relationship with us, or any of our affiliates, ceases due to disability or death, or a participant dies within a certain period following cessation of service, the participant or a beneficiary may generally exercise any vested stock appreciation right for a period of 12&#160;months in the event of disability and 18&#160;months in the event of death. In the event of a termination for cause, stock appreciation rights generally terminate immediately upon the occurrence of the event giving rise to the termination of the individual for cause. In no event may a stock appreciation right be exercised beyond the expiration of its term.</font></div><div><br></div><div><div style="line-height:100%;padding-bottom:8px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div><div style="line-height:100%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">27.</font></div><div style="line-height:100%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><a name="sB834574731846208C792CD6523F6ECC7"></a></div><div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Performance Awards.</font><font style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;&#160;The 2015 plan permits the grant of performance-based stock and cash awards that may qualify as performance-based compensation that is not subject to the $1,000,000 limitation on the income tax deductibility of compensation paid to a covered executive officer imposed by Section&#160;162(m) of the Code. To help assure that the compensation attributable to performance-based awards will so qualify, the Compensation Committee can structure such awards so that stock or cash will be issued or paid pursuant to such award only after the achievement of certain pre-established performance goals during a designated performance period.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The performance goals that may be selected include one or more of the following: (1)&#160;earnings (including earnings per share and net earnings); (2)&#160;earnings before interest, taxes and depreciation; (3)&#160;earnings before interest, taxes, depreciation and amortization; (4)&#160;earnings before interest, taxes, depreciation, amortization and legal settlements; (5)&#160;earnings before interest, taxes, depreciation, amortization, legal settlements and other income (expense); (6)&#160;earnings before interest, taxes, depreciation, amortization, legal settlements, other income (expense) and stock-based compensation; (7)&#160;earnings before interest, taxes, depreciation, amortization, legal settlements, other income (expense), stock-based compensation and changes in deferred revenue; (8)&#160;total stockholder return; (9)&#160;return on equity or average stockholder's equity; (10)&#160;return on assets, investment or capital employed; (11)&#160;stock price; (12)&#160;margin (including gross margin); (13)&#160;income (before or after taxes); (14)&#160;operating income; (15)&#160;operating income after taxes; (16)&#160;pre-tax profit; (17)&#160;operating cash flow; (18)&#160;sales or revenue targets; (19)&#160;increases in revenue or product revenue; (20)&#160;expenses and cost reduction goals; (21)&#160;improvement in or attainment of working capital levels; (22)&#160;economic value added (or an equivalent metric); (23)&#160;market share; (24)&#160;cash flow; (25)&#160;cash flow per share; (26)&#160;share price performance; (27)&#160;debt reduction; (28)&#160;implementation or completion of projects or processes (including, without limitation, clinical trial initiation, clinical trial enrollment, clinical trial results, new and supplemental indications for existing products, regulatory filing submissions, regulatory filing acceptances, regulatory or advisory committee interactions, regulatory approvals and product supply); (29)&#160;user satisfaction; (30)&#160;stockholders' equity; (31)&#160;capital expenditures; (32)&#160;debt levels; (33)&#160;operating profit or net operating profit; (34)&#160;workforce diversity; (35)&#160;growth of net income or operating income; (36)&#160;billings; (37)&#160;bookings; (38)&#160;the number of users, including but not limited to unique users; (39)&#160;employee retention; (40)&#160;initiation of phases of clinical trials and/or studies by specific dates; (41)&#160;patient enrollment rates; (42)&#160;budget management; (43)&#160;submission to, or approval by, a regulatory body (including, but not limited to the FDA of an applicable filing or a drug product candidate); (44)&#160;regulatory milestones; (45)&#160;progress of internal research or clinical programs; (46)&#160;progress of partnered programs; (47)&#160;partner satisfaction; (48)&#160;timely completion of clinical trials; (49)&#160;submission of INDs and NDAs and other regulatory achievements; (50)&#160;research progress, including the development of programs; (51)&#160;strategic partnerships or transactions (including in-licensing and out-licensing of intellectual property, and (52)&#160;to the extent that an award is not intended to comply with Section&#160;162(m) of the Code, other measures of performance selected by the Board of Directors.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The performance goals may be based on a company-wide basis, with respect to one or more business units, divisions, affiliates, or business segments, and in either absolute terms or relative to the performance of one or more comparable companies or the performance of one or more relevant indices. Unless specified otherwise (i)&#160;in the award agreement at the time the award is granted or (ii)&#160;in such other document setting forth the performance goals at the time the goals are established, we will appropriately make adjustments in the method of calculating the attainment of performance goals as follows: (1)&#160;to exclude restructuring and/or other nonrecurring charges; (2)&#160;to exclude exchange rate effects; (3)&#160;to exclude the effects of changes to generally accepted accounting principles; (4)&#160;to exclude the effects of any statutory adjustments to corporate tax rates; (5)&#160;to exclude the effects of any "extraordinary items" as determined under generally accepted accounting principles; (6)&#160;to exclude the dilutive effects of acquisitions or joint ventures; (7)&#160;to assume that any business divested by us achieved performance objectives at targeted levels during the balance of a performance period following such divestiture; (8)&#160;to exclude the effect of any change in the outstanding shares of our common stock by reason of any stock dividend or split, stock repurchase, reorganization, recapitalization, merger, consolidation, spin-off, combination or exchange of shares or other similar corporate change, or any distributions to common stockholders other than regular cash dividends; (9)&#160;to exclude the effects of stock based compensation and the award of bonuses under our bonus plans; (10)&#160;to exclude costs incurred in connection with potential acquisitions or divestitures that are required to be expensed under generally accepted accounting principles; (11)&#160;to exclude the goodwill and intangible asset impairment charges that are required to be recorded under generally accepted accounting principles; (12)&#160;to exclude the effect of any other unusual, non-recurring gain or loss or other extraordinary item; and (13)&#160;to exclude the effects of the timing of acceptance for review and/or approval of submissions to the FDA or any other regulatory body. In addition, we retain the discretion to reduce or eliminate the compensation or economic benefit due upon attainment of the goals. The performance goals may differ from participant to participant and from award to award.</font></div><div><br></div><div><div style="line-height:100%;padding-bottom:8px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div><div style="line-height:100%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">28.</font></div><div style="line-height:100%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><a name="sB834574731846208C792CD6523F6ECC7"></a></div><div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Other Stock Awards.</font><font style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;&#160;The plan administrator may grant other awards based in whole or in part by reference to our common stock. The plan administrator will set the number of shares under the stock award and all other terms and conditions of such awards.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Changes to Capital Structure.</font><font style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;&#160;In the event that there is a specified type of change in our capital structure, such as a stock split or recapitalization, appropriate adjustments will be made to (a)&#160;the class and maximum number of shares reserved for issuance under the 2015 plan, (b)&#160;the class and maximum number of shares by which the share reserve may increase automatically each year, (c)&#160;the class and maximum number of shares that may be issued upon the exercise of ISOs, (d)&#160;the class and maximum number of shares subject to stock awards that can be granted in a calendar year (as established under the 2015 plan pursuant to Section&#160;162(m) of the Code) and (e)&#160;the class and number of shares and exercise price, strike price, or purchase price, if applicable, of all outstanding stock awards.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Corporate Transactions.</font><font style="font-family:Arial;font-size:10pt;font-style:italic;">&#160;</font><font style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;In the event of certain specified significant corporate transactions, the plan administrator has the discretion to take any of the following actions with respect to stock awards:</font></div><table cellpadding="0" cellspacing="0" style="padding-top:10px;padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">arrange for the assumption, continuation or substitution of a stock award by a surviving or acquiring entity or parent company;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:10px;padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">arrange for the assignment of any reacquisition or repurchase rights held by us to the surviving or acquiring entity or parent company;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:10px;padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">accelerate the vesting of the stock award and provide for its termination prior to the effective time of the corporate transaction;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:10px;padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">arrange for the lapse of any reacquisition or repurchase right held by us;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:10px;padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">cancel or arrange for the cancellation of the stock award in exchange for such cash consideration, if any, as the Board of Directors may deem appropriate; or</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:10px;padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">make a payment equal to the excess of (a)&#160;the value of the property the participant would have received upon exercise of the stock award over (b)&#160;the exercise price otherwise payable in connection with the stock award.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Our plan administrator is not obligated to treat all stock awards, even those that are of the same type, in the same manner.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Under the 2015 plan, a corporate transaction is generally the consummation of (i)&#160;a sale or other disposition of all or substantially all of our consolidated assets, (ii)&#160;a sale or other disposition of at least 90% of our outstanding voting securities, (iii)&#160;a merger, consolidation or similar transaction following which we are not the surviving corporation, or (iv)&#160;a merger, consolidation or similar transaction following which we are the surviving corporation but the shares of our common stock outstanding immediately prior to such transaction are converted or exchanged into other property by virtue of the transaction.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Change of Control.</font><font style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;&#160;The plan administrator may provide, in an individual award agreement or in any other written agreement between a participant and us that the stock award will be subject to additional acceleration of vesting and exercisability in the event of a change of control. Under the 2015 plan, a change of control is generally (i)&#160;the acquisition by a person or entity of more than 50% of our combined voting power other than by merger, consolidation or similar transaction; (ii)&#160;a consummated merger, consolidation or similar transaction immediately after which our stockholders cease to own more than 50% of the combined voting power of the surviving entity; (iii)&#160;a consummated sale, lease or exclusive license or other disposition of all or substantially of our consolidated assets; (iv)&#160;our complete liquidation or dissolution (or the approval by our stockholders or the Board of Directors of our complete liquidation or dissolution); or (v)&#160;members of the incumbent board cease for any reason to constitute at least a majority of the members of the board.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Amendment and Termination.</font><font style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;&#160;The Board of Directors has the authority to amend, suspend, or terminate our 2015 plan, provided that such action does not materially impair the existing rights of any participant without such participant's written consent. No ISOs may be granted after the tenth anniversary of the date the Board of Directors adopted our 2015 plan.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">2014 Equity Incentive Plan </font></div><div><br></div><div><div style="line-height:100%;padding-bottom:8px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div><div style="line-height:100%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">29.</font></div><div style="line-height:100%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><a name="sB834574731846208C792CD6523F6ECC7"></a></div><div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Board of Directors and our stockholders approved our 2014 Equity Incentive Plan, or the 2014 Plan, which became effective in March 2014. Through December 31, 2015, there were outstanding stock awards covering a total of 1,037,318 shares that were granted under our 2014 plan.  No additional awards will be granted under the 2014 Plan, and all awards granted under the 2014 Plan that are repurchased, forfeited, expire, are cancelled or otherwise not issued will become available for grant under the 2015 plan in accordance with its terms.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Stock Awards.</font><font style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;&#160;The 2014 Plan provides for the grant of stock awards, which include ISOs, NSOs, restricted stock awards, restricted stock unit awards and stock appreciation rights. ISOs may be granted only to employees of us and our affiliates. All other awards may be granted to employees, including officers, and to non-employee directors and consultants of us and our affiliates.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Share Reserve.</font><font style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;&#160;The aggregate number of shares of our common stock originally reserved for issuance pursuant to stock awards under the 2014 Plan was 116,754&#160;shares. In April 2014, the Board of Directors approved an increase in the 2014 Plan reserve by 1,334,333&#160;shares and in September 2014 the Board of Directors approved an increase in the 2014 Plan reserve by 619,113&#160;shares. The maximum number of shares that may be issued pursuant to stock awards under our 2014 Plan was 2,070,200&#160;shares.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">If a stock award granted under the 2014 Plan expires or otherwise terminates without being exercised in full, or is settled in cash, the shares of our common stock not acquired pursuant to the stock award again will become available for subsequent issuance under the 2014 Plan. In addition, the following types of shares under the 2014 Plan may become available for the grant of new stock awards under the 2014 Plan: (1)&#160;shares that are forfeited to or repurchased by us prior to becoming fully vested; (2)&#160;shares withheld to satisfy income or employment withholding taxes; or (3)&#160;shares used to pay the exercise or purchase price of a stock award. Shares issued under the 2014 Plan may be previously unissued shares or reacquired shares bought by us on the open market.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Administration.</font><font style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;&#160;The Board of Directors, or a duly authorized committee thereof, has the authority to administer the 2014 Plan. The Board of Directors may also delegate to one or more of our officers the authority to (1)&#160;designate officers and employees to be recipients of certain stock awards; provided, however, that an officer may not grant a stock award to himself, and (2)&#160;determine the number of shares of common stock to be subject to such stock awards. Subject to the terms of the 2014 Plan, the Board of Directors or the authorized committee, referred to herein as the plan administrator, determines recipients, dates of grant, the numbers and types of stock awards to be granted, and the terms and conditions of the stock awards, including the period of their exercisability and vesting schedule applicable to a stock award. Subject to the limitations set forth below, the plan administrator will also determine the exercise price, strike price or purchase price of awards granted, and the types of consideration to be paid for the award.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The plan administrator has the authority to modify outstanding awards under our 2014 Plan. Subject to the terms of our 2014 Plan, the plan administrator has the authority to reduce the exercise or strike price of any outstanding stock award, cancel any outstanding stock award in exchange for new stock awards, cash or other consideration, or take any other action that is treated as a repricing under generally accepted accounting principles, with the consent of any adversely affected participant.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Stock Options.</font><font style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;&#160;ISOs and NSOs are granted pursuant to stock option agreements adopted by the plan administrator. The plan administrator determines the exercise price for a stock option, within the terms and conditions of the 2014 Plan, provided that the exercise price of a stock option generally cannot be less than 100% of the fair market value of our common stock on the date of grant. Options granted under the 2014 Plan vest at the rate specified by the plan administrator.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The plan administrator determines the term of stock options granted under the 2014 Plan, up to a maximum of 10&#160;years. Unless the terms of an option holder's stock option agreement provide otherwise, if an option holder's service relationship with us or any of our affiliates ceases for any reason other than disability, death or cause, the option holder may generally exercise any vested options for a period of three months following the cessation of service. The option term may be extended in the event that exercise of the option following such a termination of service is prohibited by applicable securities laws or our insider trading policy. If an optionholder's service relationship with us or any of our affiliates ceases due to disability or death, or an optionholder dies within a certain period following cessation of service, the optionholder or a beneficiary may generally exercise any vested options for a period of 12&#160;months in the event of disability and 18&#160;months in the event of death. In the event of a termination for cause, options generally terminate immediately upon the termination of the individual for cause. In no event may an option be exercised beyond the expiration of its term.</font></div><div><br></div><div><div style="line-height:100%;padding-bottom:8px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div><div style="line-height:100%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">30.</font></div><div style="line-height:100%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><a name="sB834574731846208C792CD6523F6ECC7"></a></div><div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Acceptable consideration for the purchase of common stock issued upon the exercise of a stock option will be determined by the plan administrator and may include (1)&#160;cash, check, bank draft or money order, (2)&#160;a broker-assisted cashless exercise, (3)&#160;the tender of shares of our common stock previously owned by the optionholder, (4)&#160;a net exercise of the option if it is an NSO, and (5)&#160;other legal consideration approved by the plan administrator.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Unless the plan administrator provides otherwise, options generally are not transferable except by will, the laws of descent and distribution, or pursuant to a domestic relations order. An optionholder may designate a beneficiary, however, who may exercise the option following the optionholder's death.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Restricted Stock Awards.</font><font style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;&#160;Restricted stock awards are granted pursuant to restricted stock award agreements adopted by the plan administrator. Restricted stock awards may be granted in consideration for (1)&#160;past or future services rendered to us or our affiliates, or (2)&#160;any other form of legal consideration. Common stock acquired under a restricted stock award may, but need not, be subject to a share repurchase option in our favor in accordance with a vesting schedule to be determined by the plan administrator. Rights to acquire shares under a restricted stock award may be transferred only upon such terms and conditions as set by the plan administrator. Except as otherwise provided in the applicable award agreement, restricted stock awards that have not vested will be forfeited upon the participant's cessation of continuous service for any reason.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Tax Limitations On Incentive Stock Options.</font><font style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;&#160;The aggregate fair market value, determined at the time of grant, of our common stock with respect to ISOs that are exercisable for the first time by an optionholder during any calendar year under all of our stock plans may not exceed $100,000. Options, or portions thereof, that exceed such limit will generally be treated as NSOs. No ISO may be granted to any person who, at the time of the grant, owns or is deemed to own stock possessing more than 10% of our total combined voting power or that of any of our affiliates unless (1)&#160;the option exercise price is at least 110% of the fair market value of the stock subject to the option on the date of grant and (2)&#160;the option is not exercisable after the expiration of five years from the date of grant.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Changes to Capital Structure.</font><font style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;&#160;In the event that there is a specified type of change in our capital structure, such as a stock split or recapitalization, appropriate adjustments will be made to (a)&#160;the class and maximum number of shares reserved for issuance under the 2014 Plan, (b)&#160;the class and maximum number of shares that may be issued upon the exercise of ISOs, and (c)&#160;the class and number of shares and exercise price, strike price, or purchase price, if applicable, of all outstanding stock awards.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Corporate Transactions.</font><font style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;&#160;In the event of certain specified significant corporate transactions, the plan administrator has the discretion to take any of the following actions with respect to stock awards:</font></div><table cellpadding="0" cellspacing="0" style="padding-top:10px;padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">arrange for the assumption, continuation or substitution of a stock award by a surviving or acquiring entity or parent company;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:10px;padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">arrange for the assignment of any reacquisition or repurchase rights held by us to the surviving or acquiring entity or parent company;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:10px;padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">accelerate the vesting of the stock award and provide for its termination prior to the effective time of the corporate transaction;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:10px;padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">arrange for the lapse of any reacquisition or repurchase right held by us;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:10px;padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">cancel or arrange for the cancellation of the stock award to the extent not vested or exercised prior to the effective time of the corporate transaction; or</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:10px;padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">make a payment equal to the excess of (1)&#160;the value of the property the participant would have received upon exercise of the stock award over (2)&#160;the exercise price otherwise payable in connection with the stock award.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Our plan administrator is not obligated to treat all stock awards, even those that are of the same type, in the same manner.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Under the 2014 Plan, a corporate transaction is generally the consummation of (1)&#160;a sale or other disposition of all or substantially all of our consolidated assets, (2)&#160;a sale or other disposition of at least 50% of our outstanding securities, (3)&#160;a merger, consolidation or similar transaction following which we are not the surviving corporation, or (4)&#160;a merger, consolidation or similar transaction following which we are the surviving corporation but the shares of our common stock outstanding immediately prior to such transaction are converted or exchanged into other property by virtue of the transaction.</font></div><div><br></div><div><div style="line-height:100%;padding-bottom:8px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div><div style="line-height:100%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">31.</font></div><div style="line-height:100%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><a name="sB834574731846208C792CD6523F6ECC7"></a></div><div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Change in Control.</font><font style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;&#160;The plan administrator may provide, in an individual award agreement or in any other written agreement between a participant and us that the stock award will be subject to additional acceleration of vesting and exercisability in the event of a change in control. Under the 2014 Plan, a change in control is generally (1)&#160;the acquisition by a person or entity of more than 50% of our combined voting power other than by merger, consolidation or similar transaction; (2)&#160;a consummated merger, consolidation or similar transaction immediately after which our stockholders cease to own more than 50% of the combined voting power of the surviving entity; (3)&#160;a complete dissolution or liquidation; or (4)&#160;a consummated sale, lease or exclusive license or other disposition of all or substantially of our consolidated assets.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Amendment and Termination.</font><font style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;&#160;The 2014 Plan will terminate on March&#160;21, 2024. However, the Board of Directors has the authority to amend, suspend, or terminate our 2014 Plan, provided that such action does not materially impair the existing rights of any participant without such participant's written consent.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">2015 Employee Stock Purchase Plan</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Board of Directors adopted the 2015 Employee Stock Purchase Plan, or the ESPP, in January 2015 and our stockholders approved the ESPP in January 2015. The ESPP became effective as of January 28, 2015, the date of the final prospectus for our initial public offering. The purpose of the ESPP is to retain the services of new employees and secure the services of new and existing employees while providing incentives for such individuals to exert maximum efforts toward our success and that of our affiliates.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Share Reserve.</font><font style="font-family:Arial;font-size:10pt;">&#32;&#32;The ESPP authorizes the issuance of 354,569&#160;shares of our common stock pursuant to purchase rights granted to our employees or to employees of any of our designated affiliates. The number of shares of our common stock reserved for issuance will automatically increase on January&#160;1 of each calendar year through January&#160;1, 2025 by the least of (a)&#160;1% of the total number of shares of our common stock outstanding on December&#160;31 of the preceding calendar year, (b)&#160;233,508&#160;shares, or (c)&#160;a number determined by the Board of Directors that is less than (a) and (b). The ESPP is intended to qualify as an &#8220;employee stock purchase plan&#8221; within the meaning of Section&#160;423 of the Code. As of the date hereof, no shares of our common stock have been purchased under the ESPP.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Administration.</font><font style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;&#160;The Board of Directors has delegated its authority to administer the ESPP to the Compensation Committee. The ESPP is implemented through a series of offerings of purchase rights to eligible employees. Under the ESPP, we may specify offerings with durations of not more than 27&#160;months, and may specify shorter purchase periods within each offering. Each offering will have one or more purchase dates on which shares of our common stock will be purchased for employees participating in the offering. An offering may be terminated under certain circumstances.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Payroll Deductions.</font><font style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;&#160;Generally, all regular employees, including executive officers, employed by us or by any of our designated affiliates, may participate in the ESPP and may contribute, normally through payroll deductions, up to 15% of their earnings for the purchase of our common stock under the ESPP. Unless otherwise determined by the Board of Directors, common stock will be purchased for accounts of employees participating in the ESPP at a price per share equal to the lower of (a)&#160;85% of the fair market value of a share of our common stock on the first date of an offering or (b)&#160;85% of the fair market value of a share of our common stock on the date of purchase.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Limitations.</font><font style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;&#160;Employees may have to satisfy one or more of the following service requirements before participating in the ESPP, as determined by the Board of Directors: (a)&#160;customarily employed for more than 20&#160;hours per week, (b)&#160;customarily employed for more than five months per calendar year or (c)&#160;continuous employment with us or one of our affiliates for a period of time (not to exceed two years). No employee may purchase shares under the ESPP at a rate in excess of $25,000 worth of our common stock based on the fair market value per share of our common stock at the beginning of an offering for each year such a purchase right is outstanding. Finally, no employee will be eligible for the grant of any purchase rights under the ESPP if immediately after such rights are granted, such employee has voting power over 5% or more of our outstanding capital stock measured by vote or value pursuant to Section&#160;424(d) of the Code.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Changes to Capital Structure.</font><font style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;&#160;In the event that there occurs a change in our capital structure through such actions as a stock split, merger, consolidation, reorganization, recapitalization, reincorporation, stock dividend, dividend in property other than cash, large non-recurring cash dividend, liquidating dividend, combination of shares, exchange of shares, change in corporate structure or similar transaction, the Board of Directors will make appropriate adjustments to (a)&#160;the number of shares reserved under the ESPP, (b)&#160;the maximum number of shares by which the share reserve may increase automatically each year and (c)&#160;the number of shares and purchase price of all outstanding purchase rights.</font></div><div><br></div><div><div style="line-height:100%;padding-bottom:8px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div><div style="line-height:100%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">32.</font></div><div style="line-height:100%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><a name="sB834574731846208C792CD6523F6ECC7"></a></div><div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Corporate Transactions.</font><font style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;&#160;In the event of certain significant corporate transactions, including: (i)&#160;a sale of all our assets, (ii)&#160;the sale or disposition of 90% of our outstanding securities, (iii)&#160;the consummation of a merger or consolidation where we do not survive the transaction, and (iv)&#160;the consummation of a merger or consolidation where we do survive the transaction but the shares of our common stock outstanding immediately prior to such transaction are converted or exchanged into other property by virtue of the transaction, any then-outstanding rights to purchase our stock under the ESPP may be assumed, continued or substituted for by any surviving or acquiring entity (or its parent company). If the surviving or acquiring entity (or its parent company) elects not to assume, continue or substitute for such purchase rights, then the participants' accumulated payroll contributions will be used to purchase shares of our common stock within 10 business days prior to such corporate transaction, and such purchase rights will terminate immediately.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-style:italic;font-weight:bold;">Plan Amendments, Termination.</font><font style="font-family:Arial;font-size:10pt;">&#160;&#160;&#160;&#160;The Board of Directors has the authority to amend or terminate our ESPP, provided that except in certain circumstances any such amendment or termination may not materially impair any outstanding purchase rights without the holder's consent. We will obtain stockholder approval of any amendment to our ESPP as required by applicable law or listing requirements.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Director Compensation </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Historically, we have not paid cash or equity compensation to directors who are also our employees for service on the Board of Directors, nor have we paid cash or equity compensation to our non-employee directors who are associated with our principal stockholders for service on the Board of Directors. We have reimbursed and will continue to reimburse all of our non-employee directors for their travel, lodging and other reasonable expenses incurred in attending meetings of the Board of Directors and committees of the Board of Directors.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The following table sets forth in summary form information concerning the compensation that we paid or awarded during fiscal year ended December 31, 2015 to each of our non-employee directors:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="16"></td></tr><tr><td style="width:41%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:3%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td><td style="width:3%;"></td><td style="width:1%;"></td><td style="width:11%;"></td><td style="width:1%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;text-decoration:underline;">Name</font><font style="font-family:Arial;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(1)</sup></font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Fees Earned or Paid in Cash</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Option</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Awards</font><font style="font-family:Arial;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(4)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">All Other Compensation</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Total</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Jeffrey Capello</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">41,250</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">335,000</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(5)</sup>&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">376,250</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Peter Barton Hutt</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">49,729</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">108,800</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(6)</sup>&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">158,529</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Stephen Kraus</font><font style="font-family:Arial;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(2)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Marc Kozin</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">48,250</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">108,800</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(7)</sup>&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">157,050</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Roderick MacKinnon, M.D.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">34,111</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">108,800</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(8)</sup>&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">107,500</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(12)</sup>&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">250,411</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Robert Perez</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">13,288</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">141,658</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(9)</sup>&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">154,946</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Stuart Randle</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">87,808</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">108,800</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(10)</sup>&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">196,608</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">John Sculley</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">43,238</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">108,800</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(11)</sup>&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">152,038</font></div></td><td style="vertical-align:bottom;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Michelle Stacy</font><font style="font-family:Arial;font-size:8pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:5pt">(3)</sup></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#8212;</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:99.80506822612085%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:5px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;">(1)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Dr.&#160;Westphal was an employee director during 2015 and his compensation is fully reflected in the "&#8212;&#160;Summary Compensation Table" above. Dr.&#160;Westphal did not receive any compensation in 2015 for services provided as a member of the Board of Directors.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;">(2)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Mr. Kraus resigned from the Board of Directors on January 27, 2015.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;">(3)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Ms. Stacy joined the Board of Directors in March 2015. Because Ms. Stacy was not a member of the Board of Directors during 2015, Ms. Stacy did not receive any compensation related to her board membership.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;">(4)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">In accordance with SEC rules, this column reflects the aggregate grant date fair value of the option awards granted during the respective fiscal year computed in accordance with ASC 718. Assumptions used in the calculation of these amounts are included in Note&#160;11 to our consolidated financial statements included in our Annual Report on Form 10-K filed with the SEC.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;">(5)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Represents the grant date fair value associated with an option to purchase 30,000 shares of our common stock at an exercise price of $17.43 per share.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;">(6)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Represents the grant date fair value associated with an option to purchase 10,000 shares of our common stock at an exercise price of $17.43 per share.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;">(7)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Represents the grant date fair value associated with an option to purchase 10,000 shares of our common stock at an exercise price of $17.43 per share.</font></div></td></tr></table><div><br></div><div><div style="line-height:100%;padding-bottom:8px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div><div style="line-height:100%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">33.</font></div><div style="line-height:100%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><a name="sB834574731846208C792CD6523F6ECC7"></a></div><div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;">(8)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Represents the grant date fair value associated with an option to purchase 10,000 shares of our common stock at an exercise price of $17.43 per share.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;">(9)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Represents the grant date fair value associated with an option to purchase 20,000 shares of our common stock at an exercise price of $11.05 per share.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;">(10)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Represents the grant date fair value associated with an option to purchase 10,000 shares of our common stock at an exercise price of $17.43 per share.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;">(11)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Represents the grant date fair value associated with an option to purchase 10,000 shares of our common stock at an exercise price of $17.43 per share.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:24px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:8pt;padding-left:0px;"><font style="font-family:Arial;font-size:8pt;">(12)</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;">Represents $90,000 of fees paid to Dr. MacKinnon during 2015 for his services as co-chair of our scientific advisory board pursuant to a scientific advisory board agreement, as well as $17,500 for payment of travel and entertainment expenses.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Effective on January 28, 2015, the Board of Directors adopted a new compensation policy that became applicable to all of our non-employee directors. The policy was subsequently revised by the Board of Directors, upon the recommendation of the Compensation Committee, on June 29, 2015. The compensation policy, as revised, provides that each such non-employee director will receive the following compensation for service on the Board of Directors:</font></div><table cellpadding="0" cellspacing="0" style="padding-top:10px;padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">an annual cash retainer of $40,000;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:10px;padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">an additional cash retainer of $50,000 for our lead independent director;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:10px;padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">an additional annual cash retainer of $7,500 for service as a member of the Audit Committee or $15,000 for service as chair of the Audit Committee;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:10px;padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">an additional annual cash retainer of $5,000 for service as a member of the Compensation Committee or $10,000 for service as chair of the Compensation Committee; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:10px;padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">an additional annual cash retainer of $3,500 for service as a member of the Nominating and Corporate Governance Committee or $7,500 for service as chair of the Nominating and Corporate Governance Committee; </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:10px;padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">upon first joining the Board of Directors, an initial grant of an option to purchase 20,000 shares of our common stock vesting monthly over a period of three years measured from the date of such grant (or such other date as the Board of Directors shall otherwise determine); and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:10px;padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">for each non-employee director whose term continues on the date of our annual meeting each year, an annual grant of an option to purchase 10,000 shares of our common stock vesting in monthly installments over one year following the grant date.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The options will be granted under our 2015 plan, the terms of which are described in more detail above under &#8220;-Equity Benefit Plans&#160;- 2015 Equity Incentive Plan.&#8221;</font></div><div style="line-height:120%;text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;"><br></font></div><div><br></div><div><div style="line-height:100%;padding-bottom:8px;text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"><br></font></div><div style="line-height:100%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">34.</font></div><div style="line-height:100%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><a name="s170636D46507DCCB9DBACD6524218E4D"></a></div><div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">TRANSACTIONS WITH RELATED PERSONS</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">RELATED-PERSON TRANSACTIONS POLICY AND PROCEDURES </font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">We have adopted a written related-person transactions policy that sets forth our policies and procedures regarding the identification, review, consideration and oversight of "related-person transactions." For purposes of our policy only, a "related-person transaction" is a transaction, arrangement or relationship (or any series of similar transactions, arrangements or relationships) in which we and any "related person" are participants involving an amount that exceeds $120,000.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Transactions involving compensation for services provided to us as an employee, consultant or director are not considered related-person transactions under this policy. A related person is any executive officer, director or a holder of more than 5% of our common stock, including any of their immediate family members and any entity owned or controlled by such persons.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Under the policy, where a transaction has been identified as a related-person transaction, management must present information regarding the proposed related-person transaction to the Audit Committee (or, where review by the Audit Committee would be inappropriate, to another independent body of the Board of Directors of directors) for review. The presentation must include a description of, among other things, the material facts, the direct and indirect interests of the related persons, the benefits of the transaction to us and whether any alternative transactions are available. To identify related-person transactions in advance, we rely on information supplied by our executive officers, directors and certain significant stockholders. In considering related-person transactions, the Audit Committee or other independent body of the Board of Directors takes into account the relevant available facts and circumstances including, but not limited to:</font></div><table cellpadding="0" cellspacing="0" style="padding-top:10px;padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">the risks, costs and benefits to us;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:10px;padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">the impact on a director's independence in the event the related person is a director, immediate family member of a director or an entity with which a director is affiliated;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:10px;padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">the terms of the transaction;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:10px;padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">the availability of other sources for comparable services or products; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:10px;padding-bottom:10px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:72px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:48px;"><font style="font-family:Arial;font-size:10pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">the terms available to or from, as the case may be, unrelated third-parties or to or from our employees generally.</font></div></td></tr></table><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">In the event a director has an interest in the proposed transaction, the director must recuse himself or herself from the deliberations and approval.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">CERTAIN RELATED-PERSON TRANSACTIONS</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The following includes a summary of transactions since January 1, 2015, to which we have been a party, in which the amount involved in the transaction exceeded $120,000, and in which any of our directors, executive officers or, to our knowledge, beneficial owners of more than 5% of our capital stock or any member of the immediate family of any of the foregoing persons had or will have a direct or indirect material interest, other than equity and other compensation, termination, change in control and other arrangements, which are described under "Executive and Director Compensation."</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Initial Public Offering</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">In February 2015, we completed our initial public offering pursuant to which we issued and sold an aggregate of 5,491,191 shares of our common stock at a price to the public of $16.00 per share. The following table sets forth the number of shares of common stock purchased in our initial public offering by Longwood Fund II,&#160;L.P., a holder of more than 5% of our common stock:</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:87.5243664717349%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:65%;"></td><td style="width:3%;"></td><td style="width:15%;"></td><td style="width:3%;"></td><td style="width:14%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Name</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Shares of</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Common</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Stock</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Purchase</font></div><div style="text-align:center;font-size:8pt;"><font style="font-family:Arial;font-size:8pt;font-weight:bold;">Price</font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#c2eaff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Longwood Fund II,&#160;L.P.</font><font style="font-family:Arial;font-size:10pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:6pt">(1)</sup></font></div></td><td style="vertical-align:bottom;background-color:#c2eaff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#c2eaff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">312,500</font></div></td><td style="vertical-align:bottom;background-color:#c2eaff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;background-color:#c2eaff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">$5,000,000</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:100%;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">35.</font></div><div style="line-height:100%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:100%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><a name="s170636D46507DCCB9DBACD6524218E4D"></a></div><div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">(1) Additional detail regarding Longwood Fund II,&#160;L.P. and its equity holdings is provided above under "Security Ownership of Certain Beneficial Owners and Management."  Christoph Westphal, M.D., Ph.D., our Chief Executive Officer and Chairman, is a manager of Longwood Fund&#160;II GP, LLC, which is the general partner of Longwood Fund&#160;II, L.P.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Indemnification of Officers and Directors</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">We have entered into, and intend to continue to enter into, separate indemnification agreements with our directors and executive officers, in addition to the indemnification provided for in our amended and restated bylaws. These agreements, among other things, require us to indemnify our directors and executive officers for certain expenses, including attorneys' fees, judgments, fines and settlement amounts incurred by a director or executive officer in any action or proceeding arising out of their services as one of our directors or executive officers or any other company or enterprise to which the person provides services at our request. We believe that these bylaw provisions and indemnification agreements are necessary to attract and retain qualified persons as directors and officers.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The limitation of liability and indemnification provisions in our amended and restated certificate of incorporation and amended and restated bylaws may discourage stockholders from bringing a lawsuit against directors for breach of their fiduciary duties. They may also reduce the likelihood of derivative litigation against directors and officers, even though an action, if successful, might benefit us and our stockholders. A stockholder's investment may be harmed to the extent we pay the costs of settlement and damage awards against directors and officers pursuant to these indemnification provisions.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Employment Arrangements</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">We have entered into employment arrangements with our executive officers, as more fully described in "Executive and Director Compensation&#160;&#8212; Agreements with our Executive Officers," and "&#8212; Potential Payments Upon Termination or Change of Control."</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Stock and Stock Options Granted to Executive Officers and Directors</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">We have issued stock and granted stock options to our executive officers and directors, as more fully described in "Executive and Director Compensation."</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">License Agreement</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">On May&#160;1, 2014, we entered into a license agreement with ECLDS,&#160;LLC for the license of a portion of our office space that we sublease at 800 Boylston Street, 24th&#160;Floor, Boston, Massachusetts. ECLDS,&#160;LLC is owned by Christoph Westphal, M.D., Ph.D., our President, Chief Executive Officer and Chairman. The license agreement provided that ECLDS,&#160;LLC will license 2,647 square feet of office space from us for $7,721 per month. Under the license agreement, ECLDS,&#160;LLC pays us the same price per square foot that we pay our sublessor for the space. The term of the license is from May&#160;1, 2014 to August&#160;30, 2017 and may be terminated by either party with 90&#160;days written notice. In September 2014, January 2015, May 2015, September 2015 and October 2015, we amended the license agreement to reduce the amount of space ECLDS,&#160;LLC licenses from us and reduce the amount ECLDS,&#160;LLC pays to us. Effective October 2015, the amount ECLDS, LLC pays us was reduced to $4,540 per month. In October 2015, the license agreement was assigned by ECLDS, LLC to a third party that is not owned by Dr. Westphal but with which Dr. Westphal has a business relationship.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:100%;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">36.</font></div><div style="line-height:100%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:100%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><a name="s170636D46507DCCB9DBACD6524218E4D"></a></div><div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">HOUSEHOLDING OF PROXY MATERIALS</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The SEC has adopted rules that permit companies and intermediaries (e.g., brokers) to satisfy the delivery requirements for Annual Meeting materials with respect to two or more shareholders sharing the same address by delivering a single set of Annual Meeting materials addressed to those shareholders.  This process, which is commonly referred to as &#8220;householding,&#8221; potentially means extra convenience for shareholders and cost savings for companies.</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">This year, a number of brokers with account holders who are Flex Pharma shareholders will be &#8220;householding&#8221; the Company&#8217;s proxy materials.  A single set of Annual Meeting materials will be delivered to multiple shareholders sharing an address unless contrary instructions have been received from the affected shareholders.  Once you have received notice from your broker that they will be &#8220;householding&#8221; communications to your address, &#8220;householding&#8221; will continue until you are notified otherwise or until you revoke your consent.  If, at any time, you no longer wish to participate in &#8220;householding&#8221; and would prefer to receive a separate set of Annual Meeting materials, please notify your broker or Flex Pharma.  Direct your written request to Flex Pharma, Inc., Robert Hadfield, General Counsel, 800 Boylston Street, 24th Floor, Boston, MA  02199 or contact Robert Hadfield at (617) 874-1821.  Shareholders who currently receive multiple copies of the Annual Meeting materials at their addresses and would like to request &#8220;householding&#8221; of their communications should contact their brokers.</font></div><div><br></div><div><div style="line-height:100%;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">37.</font></div><div style="line-height:100%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:100%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><a name="s170636D46507DCCB9DBACD6524218E4D"></a></div><div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">OTHER MATTERS</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">The Board of Directors knows of no other matters that will be presented for consideration at the Annual Meeting.  If any other matters are properly brought before the meeting, it is the intention of the persons named in the accompanying proxy to vote on such matters in accordance with their best judgment.</font></div><div style="line-height:120%;padding-bottom:16px;text-align:justify;padding-left:336px;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">By Order of the Board of Directors</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;padding-left:336px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:24.561403508771928%;border-collapse:collapse;text-align:left;"><tr><td colspan="1"></td></tr><tr><td style="width:100%;"></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">/s/ Robert Hadfield</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Robert Hadfield</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Secretary</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:24px;text-align:justify;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">April 28, 2016</font></div><div style="line-height:120%;padding-bottom:16px;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">A copy of the Company&#8217;s Annual Report to the Securities and Exchange Commission on Form 10-K for the fiscal year ended December 31, 2015 is available without charge upon written request to: Corporate Secretary, Flex Pharma, Inc., 800 Boylston Street, 24th Floor, Boston, MA 02199.</font></div><div><br></div><div><div style="line-height:100%;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">38.</font></div><div style="line-height:100%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:100%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><a name="s170636D46507DCCB9DBACD6524218E4D"></a></div><div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:16px;text-align:center;"><img src="flexpharmapcpage1.jpg" style="height:884px;width:684px;"></div><div><br></div><div><div style="line-height:100%;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">39.</font></div><div style="line-height:100%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:100%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><a name="s170636D46507DCCB9DBACD6524218E4D"></a></div><div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-bottom:16px;text-align:center;"><img src="flexpharmapcpage2.jpg" style="height:885px;width:684px;"></div><div><br></div><div><div style="line-height:100%;text-align:center;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">40.</font></div><div style="line-height:100%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:100%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>flexpharmapcpage1.jpg
<TEXT>
begin 644 flexpharmapcpage1.jpg
M_]C_X  02D9)1@ ! @$ R #(  #_[@ .061O8F4 9       _]L 0P ," @;
M"ALB$1<D*B0<&R D*R@H("0I)24Q+R4I+BHK*SDK*BXO-#4U-30O.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[_\  "P@(F :D 0 1 /_$ !\   $% 0$! 0$!
M       ! @,$!08'" D*"__$ +40  (! P,"! ,%!00$   !?0$" P $$042
M(3%!!A-180<B<10R@9&A""-"L<$54M'P)#-B<H()"A87&!D:)28G*"DJ-#4V
M-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@X2%AH>(B8J2
MDY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>XN;K"P\3%QL?(R<K2T]35UM?8V=KA
MXN/DY>;GZ.GJ\?+S]/7V]_CY^O_:  @!    /P#U6BBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBN?\ "7BO^WO.C=/*
MEMY-CINWX[ [@ .H8<9Z9[BJ3?$.-);I60^19 !I <DN2%"!" <EMPSG;QDD
M YK/A^*P1A)<6TL5LY 28@D'=RI(V@8*Y;Y68\< ]:L>*?B#-H,CI]D=XH]O
M[W<RH=P'?RR.IQUZ_E52+XGS>3)=26;I&D:NK,S!6W.B@!C&!R'W#KD#\0R'
MXFW<RATT^4JP!!!<@@\@@B+D&NXU:^_L^&2YQN\J-WQG&=JDXS@XSCTK@HOB
MQ<2Q_:%L9#%@G>'8IA<Y.[RL8&#GTK=O_'JP00:A'&SVTS8DD)*F(;@N2H5B
M<'(XXR, G<,V+SQBHN8;&V43M* SE'XC0[2')P000<@9!/']Y<O\:^*_^$8A
M6YV>9ND"8W;>JL<YPW]WTJE-\0X[;4#I,B$<HJR YRSJI4%<< [L9R><9P,D
M,U+QZ]M<7%C%;M*]O&CC8QW/N,8("A"1@29[]/?C'3XL7#R&W%C(95&2@=BX
M'')7RL@<C\Q5B[^)\T4QM8[-WD6.-V56;<N]%8@J(R1M+;3[^F<5;7X@S1VT
M][/:/%Y'EX61F7?YC;3@F,8V\'H>O:L\?%>:-1<2V,JP':3)N8KM8C!!,:@Y
MSQR >.>:TM;^)L.DSPQ,I,,\22>:">%<L =FW)' )YS@]"1@Z=[XK^S7\6E;
M,^=&7W[L8P'.-N.?N>HZ^U<_<?$^;SIK:"S>7R)&0F-F/1B 2!&<9P>]6'\?
M7:Q+*+"4LSNI3Y\@*$(;_5=&W$#C^$\GM7T'XGS:RZ+'9OY;2*C2*S,JY(R2
M1'C@')Y'%>@4R:985+N0%4$DDX  Y))/0"JCZY;I&+@RQB)C@.74(3SP&S@G
M@_D:+W7+>P;9-+&C$9 =U4XZ9P2..*F?48DD%N742L,A"P#D<\A<Y(X/Y&H8
MM<MY9/LZRQF7)&P.I?*YR-N<Y&#GTIZ:M#)OVR(?)SYF'4[,9SNY^7&#UQT/
MI3XM1BEC^T*ZF+!.\,"F%SD[LXP,'/I4,&N6]PRHDL;-("5"NI+ 9!( /(&T
M]/0^E$^N6]NS(\L:M& 6#.H*@X )!/ .X=?4>M%[KEO8-LFEC1B,@.ZJ<=,X
M)''%37.HQ6K*DCJK2'"!F"ECP, $\GD=/457NO$-M:,8I9HD<8RKR(K#(R,@
MG/2K%[J,5@N^9U12< NP49ZXR2.>*A37+=XS<"6,Q*<%PZE >."V< \C\Q1<
MZY;VJJ\DL:K(,H6=5##@Y!)Y'(Z>HK*\7>-8O#T"W( D,I&Q5<#<",EL\_*!
MW /)4=\UJOKEND8N#+&(F. Y=0A// ;.">#^1JQ:W:7:B6)E=#G#(0RG!P<$
M<=:BOM6AT_'GR)'NSCS'5<XQG&2,XR*ENKM+13+*RH@QEG(51DX&2>.M16^K
M0W*-/'(C1IG<RNI48&3E@<# Y/M42^(;9RJB:(F3[@$B9;)*\<\\@CCN,=:E
MM]6AN7:".1&D3.Y5=2PP<'*@Y&#P?>K=%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%>9>*+UO!NH->1X$5W!(2&Y0RHI(^5,');;DG^^_(R2
M,F_\*R'1A=8)FDE%Q*6^9RI#*#D D@*P<[CQER2.E:WC7Q]:Z[9M:6Q9YIS&
M @1MP.]6P>,$\8^4MDD8R.:U?&UDUAHQMWP6BBMU)'3*O&#C...*K^)?^0"O
M_7O:_P XZXS3KF,1(#JLL9V+E!'.0G ^4$-C"]....*]=\6?\>=S_P!>\W_H
M#5XE8S(+0J;^1&V2?Z.$E*'EL+N#;,/WXQSSWKUOPW9QZWID<$D0BCEB(V*.
MG) <;@>3]]2<G)!RQY//_!>R5X9;ULM*7$66YPD:*0 >H'(!&<85>.*L?&O_
M (\X_P#KX7_T"2L?5/#ZZ_JM]:G&XVRE">S@0E3G!P.QP,[20.M'PXU.34]4
MFGF!67[,%<'@[HS$C$C P25SC''3M6QHW_(>NO\ KW7^4%<OXJD5-6N"]RUJ
M-B?.BNQ/R1_+A"#@]?3BK%S*DFG7NR\>[_X]\^8LB[/WO;S"<[O;TY[5F:KH
M\^F6]M/<S2RV,Z1[D20J5RNY5"L64A0,CC!VX^7@UT&O:/!?ZI:68P8'LBJ[
M2&^79-M()W9(X*GGD UF^&)I1JMM:7 Q):1R0D]F"+*58#:O&U@!Z@!N]9YE
M2.\O-]X]I_I#X\M9&W_._7RR,;??UX[UZ;\/)%>W8I<M=#S3\[JZD?*ORX<D
MX'7TYK'^"G_'G)_U\-_Z!'74>*+F[MX@UA&LDN\ AR -N#D\LG.<=_PJ71C-
M>VX%]&JRN&#H,,F"2 .K @KC/)Z_A7DL>ESZAGPZ-S?9'N7Z)'D!?W!^;G#.
MQS_LN#G !6Q;6<GC=+J^?<S16L4<>8@29%"R.%VXY+*PXYQ(. ,*60ZQ->LO
MB-MQ6U>VC8XC'RE"+CY>Y+N-IXX?MCY7VUG)I,%MXA?<9&NGDEQ$ WES?*3G
M@8(4[> ,R?*1P31FEN=(B+G<7U> DX"-ND:;L ,@&)^@'WGXY'R^@7=W;V%G
M/HT; S6UE)N 0K_RSY;IMRQ8$\DY//>O,I/LWV"V^S?\A#[0V=F[S.IQT_[9
M[<=\[>=]=K;:5%J6NW*SHKJD*L XRN=D2Y(/!X8]<^O4"N?O/LWG:I]O_P!=
M\WD>9NW?>;9M_P#(>/\ 8_V-U:U[Y?\ 8,7VW?NY\KKNW9?RNO&W9Z\;/N\[
M:=X9\/Q:_:WEK)G[>929B^,"0,Y0J5!4+G<&VC/+#[I6J^DZK_PFLMC9N&9+
M:,R3Y;<&9/E4L&&&R0I/WCB0C(P35+4]/DL9I?#<1817-S"Z8CR!&P)<Y)W$
M*0O.?^6;9*\@W;ZUM+359(;\8MH[55A$A<J L:C"GKTWX_V^GSXKG9X6.CH[
M@\7K",L.B&,E@I/\)<'..-P.>171>,-GVZU^S_9_LWDOY?G8^Q[LR;_N_+GI
MG'.[;GM5[P/JL7AY;FXN)H_)DG4 0+,85<[RRK^[ Q@#[N1@+D_=S7UG[-_;
M$W]I?ZG[/^[\S=M^XN=N/^!XQ_']WY\5#XQ\GR-,QYOV'<-_F[\[?DQNQWV[
M]NWC&?+^7%167E_:=4^Q_P#'K]CE^YGR]VT?AUW[>V,[?EK*U/2HH=&M[E44
M2R7!W/CYB!YHQGJ!A1P.,C.,\UU4VE1:7K=I# BH@MVX48R=LPR3U)P!DG)/
M<UZ711111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M1111111111111111111111111111111111111111111111111152^TF'4,>?
M&DFW./,16QG&<9!QG JQ#"L*A$ "J   ,  <  #H!5>WTF&V=IXXT61\[F5%
M#')R<L!DY/)]ZENK1+M3%*JNAQE7 93@Y&0>.M-ETZ*6/[.R*8L ;"H*87&!
MMQC P,>E4?\ A$[/_GWA_P"_*?\ Q-:<T*S*4< JP(((R"#P00>H-9G_  B=
MG_S[P_\ ?E/_ (FM:J]EIT5@NR%%12<D(H49Z9P .>*+W3HK]=DR*Z@Y =0P
MSTS@@\\T)IT22&X"*)6&"X4!R.."V,D<#\A0FG1)(;@(HE88+A0'(XX+8R1P
M/R%":=$DAN BB5A@N% <CC@MC)' _(57NO#UM=L9988G<XRSQHS' P,DC/2B
M/P];1*T2PQ!),;E$:!6VG(R,8.#TSTJQ+IT4L?V=D4Q8 V%04PN,#;C&!@8]
M*A@T.WMV5TBC5HP0I5%!4')(! X!W'IZGUJ9].B>07!13*HP'*@N!SP&QD#D
M_F:J3>&+29B[P1%F)))B0DD\DDD<DU;LM.BL%V0HJ*3DA%"C/3. !SQ19:=%
M8+LA144G)"*%&>F< #GBK%%5TTZ))#<!%$K#!<* Y''!;&2.!^0HLM.BL%V0
MHJ*3DA%"C/3. !SQ4*:';I&;<11B)CDH$4(3QR5Q@G@?D*FETZ*6/[.R*8L
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M************YKP1=O<_:_,9FV7TZKN).%&W"C/0#L.E9D_B=M'GU*>0L\<
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MN7U7C/J*RIOB!.?M!AM&=+2259',JHN(^XRN2< DJ =HQR=U6+[QVWF0V]K
M99+B 3 -*D7RMT W9RW!) Z 9&1G&?=^)+FZN]/*Q21K*)=\;OLR<;7#*<9$
M8&]21\P(P :NIX\DE-QLMF,=HTX>0R +^Z4E<97)+$8( .P$$DYK0N?%?D0V
MESLS]LD@3&[[OG+G.<<X^@S[52O/'4@ED2VMI)XK=PDLB'!#9PRJA&7*]\$>
M^%PQS(]:G^T:HL@<1Q0Y7;-RFV,[=G!VF0?/D#Y2,$$UH+XP:WCM;:WB>>XF
MMTDVM( 0FW[SRE<$D\9P,GT)4$E^(JK;QW:PN6:X$$D7(D1\$L "/F(QP.,Y
M .TY EM/&SH\L-Y;M"\-NT^%D27**2#R, '/0=^<XXR>'/&,^K-'OM62*=6*
MRI(LJ949PVT#9W'/.[Y<=<;NL:BUA'O2-I7)"JB#JQZ9;HJ^K'@#WP#S5E\0
MFD:XAFA"2VT#R[5F24'R\AE+(/E;..,$]20.,EIX_ED,$DEJR073QHLAD4G=
M(./DP#MR#AN,K\P'(%1>(O&TCK=16T,C1P)(CSHVW9)M(^53@D(<;F!^49;&
M,$]!H=U(;&&8 R2_9D8 M@NWE@X+'NQ[GZFN$\)^(9K&!M6NC/(TQV1)YH=)
M7=VX6(+^[*[,=Q@G:.BUU%MXW8">.X@:*XMX6E\LN&5T49R) ,=>#P<=LD,!
MH>%]?DUM//>%HHV5"A9@2V0=WR@ @ CY2?O A@!TJ+7_ !2UA*EE;PM/<.I?
M8&"*J#(W%R"!DC 'Z@E0<?5?$[:C#9SQ%HF:_ACE3=AE(+!XVQCCCH0,C!('
M2K&H^/V@>4PV[RP6K;9I0P7:0?G"J1EMHZ\C'4X7#&[K/BXVTD=K:1&XFE3S
M %<*@CYPYD(*X)X'KZC*AL6[\27-U=Z>5BDC642[XW?9DXVN&4XR(P-ZDCY@
M1@ UI6/C=KF293 RP6LDRRS%P541 D$#&6)QRHSM!!R<U%IWC]IWB,UN\4%T
MVV&4L&W$GY R@97<.G)SU&5RPBF^($Y^T&&T9TM))5D<RJBXC[C*Y)P"2H!V
MC')W58A\2QO=B8F18CIPG.7^0*7SDQ 'YP/X@QXX [U+H/B^;5)$#6LB03!S
M'*2&X7D%E ^0,.F2<G&W(.:TO$OB!="B\YE9V9@D:("6=VSM48!QG'7\@3@'
MFM/\32M?N;I7@2&Q9GC9MZ960'S%V\-\IQD#.05[5>TGQT]W)$);=HH+DL(9
M7=?F/50RX&TN!\O)W'&W<.1CV^L.N[S'E.=:,2[92N%[*<ALQCNG /J*Z"+Q
MLHLY;^5-CV[.CQ[BV)%;:$WA<'<2O(! S[&J]_XVFC<V\%JTLT42O.H< 1EE
M#! VT[V]EZ_PYY =J'CP1BU:WB:;[:KE K ,"H!VGJ.IPYS\F"><8JWH_BO[
M2L_VE/(DM,&1-WF84IO#;E&#D9X&3Q[UH:!J;:I!'=.GEF5=VW<&P#]TY '4
M8/3C.#S7-?\ "R?^7KR'^P^9L^T9_#=Y>-VW=QG/M][Y*HVLMUJVJRQOYJ0V
MSQ\1SJJ!<%E+)CYQ+CD=5!P3P,>AT4444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M44444444444444444444444444444444444444445QEO:7OAV2?R(5N8KB=Y
M1B41.I?&0V\$$=ACT).,@ MM%O(UO+TI$;B[$>(6RT85%V[&;(#,5)!Z+N&<
M[3Q2T#PQ<NUU&T7V6VN867R_,651(XV[U"@;0!U7([ < !:7AKP&]O+$);2-
M&@<,UQY[N'V'@K$'&&;@Y;Y1R2O1:ZWQ[I<FJV4MM NZ1]F!D#.)%)Y) Z ]
MZBM-/GEOUOY(]B&Q"-\RMMD,F\IP<G [XP:Y_4?!$][;W$>U=_\ :$EPB.?E
MD4C 4E6!7<">X/8[<Y&EX)\,?V?*]T;9;;*; OFM,YR0Q;=NV!>  ,%L@G('
M!T]9TN2YO;.Y1<QP?:-YR!C?& O!.3D^@/O6?8Z!/%;:A"5^>YFNFC&Y?F$B
M80YS@9/KC'?%1:)HMS8W=M*T?[M=/CAD;>OR,OS'C)+<@#CCG.>*YRR^&KP-
M]D>UCD^?BZ:9PNSKDPJX8MC(P"HSC)(!8]QHVER6U[>7+KB.?[/L.0<[(R&X
M!R,'U ]JY_\ X1:Y_L7^S=G^D?W-R_\ /??][.W[O/7]:E\=>$'U"XCOEA6Y
M01^6T1D,3#!9@X?<!U."#GZ'.5KW'A.>SM8!;P*)$O4G,*2'@*I^4R2,<MP
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M*TS1",R$DAT5LL%//RC)'?)PN[?:)<Z1/#>V<:S".V%NT6[R_E4[@RL[-QD
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MSM+J<V"29G#,NW8XY3.X9*XXP>_TKC_^$IO_ +-_;^]/L_F?\>VT?ZO=Y?\
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M*T<]FJB.51Z*%;*9P0P'(S[9(R#4D^'OG6T]O),S3W;(9)F7^XP90$W   #
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M=PUO)*H$GR"57VX"G:Q ! &,^G3&6W;NGV8LHUA#,VT8W2,7<^I+'J3^0Z
M8%<OJ7@!IVF$%P\4-UN,D84,"Y!RP8G(!.-RC[PRN0,!7S>")8VAFMK@Q2PV
MRP,WE*X95P0=K'Y3GKR>PXYS";*W\&6DR7<C217$LA.02[>8GW"0>6(4_,2H
M)/:KWP[T(Z-91QN-LCY=QSG+= 0V,$*%!&.H/U)K?A*2^N1J$%PT,BPB,;4#
M#[Y8E@3A@03\N.#AL\8J'_A7T?V3[%YC^;YGF^=N._SO^>G7\,9Z=]WS58A\
M+S2131W-RTLDT31AMH1%5@1GRE.TMD\L><8 P,Y;?^#/M$-O''*T<]FJB.51
MZ*%;*9P0P'(S[9(R#4D^'OG6T]O),S3W;(9)F7^XP90$W   # &>_H HU?$O
MAK^V/+ECD:*>!B8Y%&<9QN!7(#!@.1_3(-C0]*DL%8S3--*YRS-\J\< +&#M
M48ZXY8Y)/0"OK7AYM0GMKM)-AM6<XV!MP?:&7)(QD C.#UR.145MX4\B&[MM
M^?MDD[YV_=\Y<8QGG'U&?:JESX(8""2WG:*XMX5B\P(&5T48P8R<=>1R<>Y"
MD;NCZ<UA'L>1I7)+,[GJQZX7HJ^BC@#WR3BZUX-DN9GN[2X:W>9-LN%WAL !
M2 6&U@.,CD=L'))J/@^5Y8[JVN6BEC@$+,Z+,64'<"=V/F)Y)[^W.:7_  KE
MHX?(CN&#B\^T+(Z!VR%P <L QSR6[G^&NUKBO^%;?\NOGO\ 8?,W_9\?CM\S
M.[;NYQCW^]\]:LOA3S'O9-__ !_1JF-OW-L9CSU^;.<]O3WK5TFQ_L^&.VSN
M\J-$SC&=J@9QDXSCUKFM2\ -.TP@N'BANMQDC"A@7(.6#$Y )QN4?>&5R!@*
M^;P1+&T,UM<&*6&V6!F\I7#*N"#M8_*<]>3V''.:_P#PKEHX?(CN&#B\^T+(
MZ!VR%P <L QSR6[G^&M#5/"4DD[7UG<-;R2J!)\@E5]N IVL0 0!C/ITQEMV
M[I]F+*-80S-M&-TC%W/J2QZD_D.@ &!7+ZCX :=Y1#</%!=-NFB"AMQ)^<JQ
M.5W#KP<]#E<*-6T\,+:7*W<9PD=J(%CP3@*^X'<3GIQC'OFMNBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBL^]UM+2>&S8-ON?,VD ;1Y:[CGG/3I@'\*ET_4/MF_P"1T\N1D_>+
MMW;<?,O)RISP>]6Z**S[W6TM)X;-@V^Y\S:0!M'EKN.><].F ?PK0K/_ +;3
M[3_9^&\SR?-S@;=N_9C.<YS[8QWK0HK/O=;2TGALV#;[GS-I &T>6NXYYSTZ
M8!_"C5];32O*\P,?/F2)=H!PSYP3DCCCGJ?:M"BBBBBBBBBBBBBBBBBBL_\
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MV+XY(PIVC &*Y?78S>6YUB./9F3*W$\Y-Q(?,PNQ(]J(4"G(QPH^7[N:[O\
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M XR.X&#CH]0U"/3HVN)F"QH,DG_/)/0 <D\#FL33/&\=[,MH\,\+R!BGGQ;
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MR2[ BIM:1F<XV!=V"P.<@'(P?2J6I_$2VT^5H")'$142R1INCC+'&&;/!'?
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M=!XJTF:?^U-D;MYOV+9A&.[;C=MP.<=\=.]=-KUH\M_8RJK%(_M.Y@"57=&
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M!R>AK:TCXCOK]U'!9PL8.?->4$%<@D<IN"].,_>/R_+]ZHOB/_Q^:;_U\?\
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MMG#E_P!Y]HX5]J';&#\R;3O_ -GD;3SS6%#\397@&H&T86P(#OYJ\?/M^52
M7'(YX&[*]B:U=:\926TSVEI;M</"FZ7#; N0"H!*G<Q'.!R>V3D"[:>)?M-R
MMEY;+OM1/ESAAE]NPIC@COSUXQWK*N_B%]F1I?)9ME\;;:C98X&=X&WDGLOK
M_%1-XVN8I4L_LC&X>'S-BS*0O[QEPSXV@;5SN]2%QDYHU'Q^T#RF&W>6"U;;
M-*&"[2#\X52,MM'7D8ZG"X8W=9\7&VDCM;2(W$TJ>8 KA4$?.',A!7!/ ]?4
M94-7^'NIOJ*7,LA?_C\F"K+G<BX4A,$G;MSTZ YK-E\27-C?7L<,4EP$$#!
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M[2P6\\7E&ZA9U^<L=R\F,C8I!"$$DX&<J,D9JUH^N_VI)/&J_N[>01A]WWF
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M(S@ *"P7 !S73?#^[>6V,$S,\MM-+%(S$MN96)R&/)&& &<'CI7133+"I=R
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MS)*-ZMM_=B-#P>=V,\9QG!]:9JO@^;5'U%.$6Z%MY;$@@F)<D$ Y R,9([Y
M-5_!WA!K:=+A[1+8Q*<MYSRL[,NWY0'(0#)SNW'D <Y8=!XUT:74HD:WV^;;
MS),BO]UC'GY2<C&<_P!"1G(S[[3[WQ/:W%M<QI;[]GE+N\QLJ0QW,IQ@D #
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M0+*EP(0NZ15.4CP&P3]U3D,#M)R-IQDTS4/#7]C:4L3R*);/]\CX^42*Q<
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MJD>P+EC*$$C,,<CD;5 !4#D,2:E%G=VNH6"WDJRDBX(*H$(/E?.O  *CC:<
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M_N?PXW?+BG^*+F.ZO+B)S;PB)(MTMPOG2GY"X\J)R4QSAE R<[N6( K^#_\
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M7GIUYID6AV\0PL48&PI@(H^1B24Z?=)))'0GFIH=.BA8.B*&5 @(4 A!R$!
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MXYA5)8W\L2*)DV[D)QN4@D$9QSWSQGG'/Z%XNFEBLIIG=WF6[+)'$C&3R=Q
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M%DB:&X$LD>]8_*_>$!V7&W=D'"EN>-HSG/%6%\>6WV9[]]R+&[(R.NV3>O\
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MO[ 6TSO<S7+HRI^ZVR*.=^>N,D* 23A>&/!JUF4AM5:VN!*EF@2XM03+&X4
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MN) D2X&>>0S%L8 4>I) '/-:-\3&D@NKF94?[+Y>#!O57\W@#$@####DXZ=
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M&1-:).#/N&W<W5MI.1C P.=QSG -17_C"\=KB>UBC-M9.5D\QB)',?,NW!P
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MY"VAE"E#)_I00_+YA0,> >=H4MCIQ\];J:_=W5]-8PI%Y5NT)9W+!MKJ&90
M3ECD[3@*-I#9R*RM!UY[/3;=X%AB\QI!NFD*0)AW/.]S(Q;!P 3SDD@#!Q]5
M\8/XATZ]23RR83;X>$.$8/(O&V0!L@J<GOV'&3T&O>+[N&[>PMQ I1$*"X+J
MTI8=$(*KG)V@$\D'GKM[*TD:5%>1=CE067(;:2.5R.#@\9[U-11111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111117
MG]SX'NT:Z2!K<)=M*3(R-YX$HR8\X("DC!ZX!+ ;L ;&A^%Y;"XAN'*E8K!(
M" 3G>K DC('R\=>OM5*;P+++%,HD5)3?/=0L/F4'C8&!7ZYQG'!^;H;6B:!=
MI>'4;MXFW6YCVQ!@%.\, -PR1@9))SDD8P :V] N)KB!)+D*LIW9"!@N-QVD
M!OF&5P<-@C." >!CP^$"M[)=/Y;6TB.1&4&5DE$:R'I@AU3DYYW$8Y).5'X
MG&GRV+O&US,8_FP0H6+8J+N"Y("IQQU)]V/1:KHCW=W:WBE=EMYVX$G<?,0*
M,<8Z]<D?C7+V7PXELV^S#[.UMOR)7A5[H+UV_,A0G/&6SP<@<!1U&E:(]I=W
M5XQ79<^3M )W#RT*G/&.O3!/X4>#-$?1+2.SE*EX]^2A)7YG9AC(!Z'TKC=+
MTF\U(7T%O)&L,U[.DF]2749&YDQP2RG!#8Q@;2"21U4OA=DFLGC(\JR213N/
MSD-&$7&!@GCGI[55U;P[>07$MYI\D8-RBB19@>&0;4=2JGD#/!XSU#9 4L/!
M+:<]B(V#1V0GWEN&8S+U  (QN)X)X&.2:KWG@J::TO+,,F^ZNFE0DMM"ET;!
M^7(.%/0$>]0ZW'</JP-HR+(MB#B4$HP\X@J2O(Z[@1W '0FB7P+<16\:QR(]
MR+P74C296,O@Y "+G&<>F>3\O $VO^"I9;I[ZW%O)YRJ'2[3>H* *K*54D9
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M59@RO&R@@E60<D]<DGKMQMSNFUOP_>S1I;1O%-%Y CD2Z5OF9<?O=R9?<?\
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MXQ79<^3M )W#RT*G/&.O3!/X5R__  KZXCM[2,>0\MH9LI,&:%A*2<],Y7C
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MT  .25(#8;/S$K\W\0+;#Q?-IEMJ$19I&LI2L<DC!GQ(YC7)*\E2-W.<YV\
M"G>%-4ET^\MK5I994O;-)&\Z3?M<JSY7(R!A2,9[Y).!78>--9;1K.:ZC^^J
M@+TX+L$#<@@X)SC'.,5QO@&]::XBW7-P&: ,8;H967<#EHV+?=! (XW$ \D;
ML8D/BRY$(UUY9"_VT1F$/B IY>XJ$(.#VSR>_+<UN^*]4EU"\N;5998DLK-Y
M%\F39N<*KY; R1A@,9[9!&35XZA=>(-/M[I91#'@M<N"PE*Q-ABA1#@G:S$
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MM<L&!$BNNUNHW?,0%7JK*IYVM/TJ)H-5NRBF437JAR,L $/ ST^\<XQG.#G
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M\*ETLMYCW!L(Q)4JIQN&T,"?O;3R:N^*H8AJ6GO(%Y,XRP')"@QC)[AS\O\
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MXAE,<C"/*)AMH9B#]UCG'\1P?EZ9M:KXZ@T^5;8+)*\D0D00*)-X)(PN#R<
MMZ;1US@5%J?Q$MM/E: B1Q$5$LD:;HXRQQAFSP1WP#SP,L"!H'Q5 DCPL2/+
M@$^[AD:+NZE2V0/0@$]5!'-,T[Q7'>O%%L=#<0^;&9 H##/W00QRV,-M&<*<
MG!XJWI^MI?R301AO]'959L#86(R5# G)7HPX(-9FO>.H-'D-N5DED5"[B%0^
MQ1CYFR1@<Y]AR< C,NH^,8;18RBR3-,@=4@0N^P]'*G&%Y YP<G '!Q5?XB6
MT4 O'$BKY_DL&3#HX!)W+GH ,G&3VQG(#[KQY%;+$6CF\V?=M@$>9P%)!8IG
M@?+QSR.1T.#P+K[:VD\Q;>@NI5C.T+^[ 4H,8!Z'OSZU#<^+5TN2]DE9WCMO
ML_R"-!M\T8^5MP+9)R=V-O09JQIGCF'4)EM@DJ>:&,3R1E4D"C.5.<D%?F&0
M..N"0"_Q[JDFE64MS VV1-F#@'&9%!X((Z$]J9IGCF'4)EM@DJ>:&,3R1E4D
M"C.5.<D%?F&0..N"0#7NOB/!;DMY<S0!@#.D68.NTD/GD \9 .2/ESQF;4/'
MD5G/)9".:26+;E88]Y(90VX8/09 .<<D8SR0Z?QY;1V\5Z-S"X.(XU7,K-G:
M5"YZJ>#SCT)RN:_A'Q,VMW-V,MY47D;$= K(2K>8IXSD,"#DGD<<5JKXEBWW
M$3;E^QJK2,1\N&0OD8))P!SQ],U77QE \,%VNXI=2I&F ,AF)'S D< J02,^
MV1S7->&_B<HMHY+I97()$LR1?ND)<@!B,#(4J?E!ZCJ>*Z#7O'4&CR&W*R2R
M*A=Q"H?8HQ\S9(P.<^PY. 1E^K>-X--$#$.XNE)C\M-Q. I48.#EMP"C'4\X
M'-6/#_B>/6S(BI)')"5#I,FQQN&5.,G@\XYSQTP1FQ;ZVD\\ECAEDB5&^8 !
ME;^)><D \,<8!XK*G^(%O%'Y^'.9FBC55#-*5(!:, X9<G[V1SQU(!%^(%NU
MM)?8<>0P62,J!*I+;0"I..OOZCJ"!JWNMI:3PV;!M]SYFT@#:/+7<<\YZ=,
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M1H9!E)%*L,D9##!&1STKFO\ A5NG?\\?_(DO_P 7740PK"H1  J@  #  '
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M$BW$MJ('C,5T)3R'+ML7(VD#:"#]X/@]ASD4V]\?6-D[PR3*'B^\,,><@8!
M()!/(&2.<C@X=J?CFSTMVAFE"O&5#+M<GYUW#@*<C'4C(' ."16MI^H1ZC&M
MQ"P:-QD$?YX(Z$'D'@\UDZQXYL]'D^SSRA9  2 KMC/3.U3@]\'G&#T(I^I>
M-+/32%EE49C608#,"K':""H(;)[#)QSC S5O3=?@U*(W<4BF(;LL?E V]<[L
M%<#GG''/0UA0>/XM1N;:VM'5XYC,),A@Z^6@9< [< ^I!!P0.0:Z74-0CTZ-
MKB9@L:#))_SR3T ')/ YKG]'\:IK%Y]FMV5X/LQDW ,'#B385(.,#'."N>AS
M@BK%KX^L;N46J3*9&8J!AMI/H&(VG/;!YXQG(JOX0\:IKBW#LRA8)6P0&4>5
MU1V+=SAL],8Y K0T/Q=:ZXS);2!V09(PRG'3.& R/7'3(SU%7;C5([:2.V=L
M23[]@P3G8,MR!@8'J1[4R;6H893;.X$BQ&4@Y " [2Q8C: #[Y[]*JZ'XNM=
M<9DMI [(,D893CIG# 9'KCID9ZBG?\)3;?9O[2W_ .C_ -_:W][9]W&[[W'3
M]*;<>+K6VF^QO(!-OC39AL[I!E>W(/<]!D9(R*M:KK4.DJKW#A%=P@)SC<V2
M,D#@<'DX [FJNG>+K748I+F&0-'""7.&!4 ;L[2 V, XXYP0.0:9;^-+.Y22
M9)5*0*C.V&  <97J.2>FT9.?E(W<46?C.TO8I+J*3='#]\A'+*/4KMW8]\8X
M//!Q8NO$EO;$!G!S$TOR@O\ NU&2Y*@X7T)^\>%R>*?<Z_!:P"_=L0%5;=M8
M\/C:< 9YR.WUJ[-,L*EW("J"22<  <DDGH!65H?BZUUQF2VD#L@R1AE..F<,
M!D>N.F1GJ*KVOCZQNY1:I,ID9BH&&VD^@8C:<]L'GC&<BK%OXNM;F;[&D@,V
M^1-F&SNC&6[< =CT.#@G!K'U'XB0,\4-I(DCM=11."&^ZY8%E/ ."/O#<O(]
M176S3+"I=R J@DDG  ')))Z 5B:/XYL]8D^SP2AI""0"KKG'7&Y1D]\#G&3T
M!J!?B1I[%5\]?WG3*N!R2O)*X7D?Q8XYZ$&K^K>*K72'2&XD5'D^Z#GIG&20
M"%&>[8'!YX.(O!FMOK=I'>2A0\F_(0$+\KLHQDD]!ZT^W\76MS-]C20&;?(F
MS#9W1C+=N .QZ'!P3@TS3?&EGJ<IM(95:0;N & .WKAB &]>"<CD<#-97A_X
MB0WT=S<S,JQV\V 51_\ 5L0(F(Y)+'.<#CN!72W&J1VTD=L[8DGW[!@G.P9;
MD# P/4CVK'3XAV#J9!,"%3><(YPN\1\C;D'<1QUP0<8YJQIOC2SU.4VD,JM(
M-W # ';UPQ #>O!.1R.!FI=?U1M/\G:R+YMQ'&?,#G(;.0NP'#''!;Y?4U0\
M%^+QXC\_!7]U,0NU6&8S_JV.[N<'/3IT%6KO7_LERT,C((H[4S,-KF0;7P6R
M!MVX[?>SVQ45IX^L;N1;:.92\F-HPP!+#(&XC&>V,YS\N-W%'CGQ*?#MJURF
MWS"RJ@<$J23D@[2/X0QZCI^!I7GC^*RN521U6U>T697(;>2\FU0!U(*\XVY'
M)/ -:]OXJM;B!K]9%,"9W-R,$=B",YZ8&,G(P#D9?H?B2WUU6>V<.$.&X*D9
MZ<, <'L<8.#Z&C6/$EOHQ47#A-X<KD'G8,MR >>>!U)X&3Q4NCZU#K$?GV[A
MTR1D9&".H((!!^HZ8/0BJ6F^-+/4Y3:0RJT@W< , =O7#$ -Z\$Y'(X&:BNO
M'UC:2FU>91(K!2,-M!]"P&T8[Y/'.<8-1:'XO&IWMS897$&W9A6#''RRY)X^
M5R .F>V1S4MKX^L;N46J3*9&8J!AMI/H&(VG/;!YXQG(J74_&EGIDAMII560
M+N(PQP,$\D @$@<+G)R, Y&7ZCXNM=.BCN9I L<P!0X8E@1NSM +8P1GCC(!
MY(K0T_4(]1C6XA8-&XR"/\\$="#R#P>:S]8\76NCMY5Q($;8'P0QRI;:,8!R
M<]AS@$XP":L?V_!Y'V_S%\C;NW]L=.G7.>-N,YXQGBLR'QS;:C%,]K*K/#$S
M_.K@# /S$;0Q4'KM!(^I%2S>+H-.MX;F[D5?.12"H<AB5#$JN"^WGN.,@'DT
M>$O$#:VL[G:5BN9(T*="B[2K9R<DYZC@]A4VN>+K70V5+F0(SC(&&8XZ9PH.
M!Z9ZX..AIVI^*K73 C32*JRJS(>2K!0&)!4$=",?WL@+DU7L_'-G>J'CE!#2
MK$/E<'>^=HP5R <'!(V\'G@UIW&J1VTD=L[8DGW[!@G.P9;D# P/4CVK/TWQ
MI9ZG*;2&56D&[@!@#MZX8@!O7@G(Y' S5?2/%0DCNKBY*I':W,L>1D?*FW!/
M)RQSCCJ< #-6].\76NHQ27,,@:.$$N<,"H W9VD!L8!QQS@@<@TS3/&EGJ<@
MMH95:0KN PPR, \$@ D \KG(P<@8.#4O&EGIDHM)I560[>"&(&[IE@"%]>2,
M#D\'-:MW=+:(TTAPD:EF."<!1DG YZ55.OP*(6,BC[3CRL\%LC<, \],=<<D
M#J0"R?Q);VYF#N!]E"F7((V[QE><<D]@,G/'7BC0_$EOKJL]LX<(<-P5(STX
M8 X/8XP<'T-:=%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%>60.+ R:G@?Z-J\X=CGY8I0L<AV@\GE<8!.>V
M,U-H<#"?3;B10LET]],X!R"94RI')P-FWCMWYS7+ZKJOVRS>.25UE1C_ *+#
M#Y,,0\WYM^% 89QMR<JY .22:](\/0J=3U!R!N M@#CD QY(SZ' S]!Z5Q_@
M=%T-;34IB##<"2(M)M_<N'?858@L%<;@P&%!)9CT ]2M]4CN9)+9&S)!LWC!
M&-XRO)&#D>A/O7&^/;V'3[A9_-DM[KR&$<NPO PW?ZM@ V2,YX7Y<ACDA15?
M3;O[9-I,WE+#N6[.Q%VJ/DZ@8& WWA['J>IYF]OXK+2GTB2-ENXI,N/+^Z?,
M!$I<<8*D(&SDY 'RD&N^\/0J=3U!R!N M@#CD QY(SZ' S]!Z4[X6_\ (.@_
M[:?^C7KBM>U7S#>VTLKQ,))MEM;P["^%XE>0+\RLN6<$\@;@<;16[X6A5[VU
M) )72(B"1G!W 9'H<$CZ$BJLFGR:A8:G#"I9S?RD*.IVO&QP.YP#QU/0<U+!
MK]MK.H6#VBD*B3*3Y>P#$61%GN4SR!E1N&"<UM_$JW+P13%#)'!<QR2J &_=
MJ&W?*>HYY'IR> 2,%=9CU2_N+JT3S =-DQNC.V5E<#[I +@X"'N=I4< 5A0:
MFM^UB?/DFD6YM@R+'Y5O$.R;0H4OG(5AU4$8  SJM"VI6>J6<(+S"]=]@'.W
MS%/'J?W;<#GCIR,S>#)/[3NH9X[AIO)B96"VJP*B%?EC=E8 C=]U5#C*DC R
MU=EXOT9M4@(BXGB998CQQ)'RO!('/*_-P,Y(XKAQ9S>(]/O=16,^;>/'M12#
M\ENR@8[EN&![L1\JC(!T-/U2#Q%?VDUBAV6L4GF-L"! Z%8X\^JG. ,CDE21
MNQS4WB&*+1CI1W?:4)#IL8;,7&[+$@ #H.N=Q QUQW?AZ%3J>H.0-P%L <<@
M&/)&?0X&?H/2H?B>RI%;%T+J+V'*!=Q88?*A3U)Z8[]*Q;J\CUN:]U&U4F!=
M.EC:3;M#28W=\$D+@$D<8';;FQK-D%TNQE$>^*!K:6554'Y A,AVG .2V6^I
M)XR:(-:M[V[N-75=UG'9F.1R@59'+!MH#XW$KA<'V'0KFQX&B_LR?R;A"LMQ
M%O@+.S[8@<_909 "&CZE5SD<MC JC;Z7)#>Q:'M_T:WF-TC @,$&=B<DD@2$
MJ2<LV<C:!74?$/3Y-0L)H85+.0A"CJ=KJQP.YP#QU/0<UFVGBFTU=)?L4.^2
M.S;K#\H&#MMSCDY/\ RI ."<5QD&IK?M8GSY)I%N;8,BQ^5;Q#LFT*%+YR%8
M=5!&  ,]7H.GFZM]42-099;F[0= 3\ORKDXXRQQDX&3[U@_VS!<QZ=9QHRS6
MUU LF8]NQ@<.I..LC M@<G:2V",5W?CZ=H+&9T178*/E=!(N-PRQ4Y!VCYN0
M0,9/ KBM'OEOM1LY5N);DGS]SNACB!$1^5$P-I P7QG.5/4X#$A5/#I( !8Y
M) QD_:0,GU. !] !6Q=7\6AZA=/=QL1>1QB'$?F>8%0(\0QGEC@;3@' W8!7
M.K\+?^0=!_VT_P#1KUFZ#IYNK?5$C4&66YNT'0$_+\JY..,L<9.!D^]<YX64
MWCVEN)W,MM("8%M%C:(*<2[I=R_*>C<DL2,H6XJQ>2B>QU6W3)D2]=R "<*9
M4^;IT^1B?0#)P*V)?$T&NZC8FV+,B?:<N495),7W1N )( !/' 8>M8Z0JGAT
MD  L<D@8R?M(&3ZG  ^@ KJ]<A6'4-.1  JBZ  &  (@  !T IWC[_ES_P"P
MA;_^S5%\/KI6>^A!^=;Z9B,'HYPISTY*G\OI6?XL_P"/RY_[ \W_ *&U,OH5
MBLM*"@ ?:;,X QRRDD_4DDGU/-;'Q2_Y!T__ &S_ /1J57MY8[_5H[A<,ITX
M.A(_O2\,,C()5B.QP2*Y75K-[BUN70$B'5Y9'PJOA%7!;8Q 8#(R#QCK@9(Z
M#P)F\NI;U;AKA6B"NXMQ!&6# J#R"SJN>=IPI W#@&7QW>1V5Y83S*6C0W!.
M%WXPB_/CT3[Q(Y &1R*J:-;G6!J=U;(1%=IMB) 3>RQNK$ XX+G.3C))SR&
MS;2_BU5=/T^WC;[1:S1M*#'M,8B.)22<8W-SQU/WL-@%FN:Q#ID\J6^YF>Y_
M?6=Q&724DC#Q_*VTL3N&3\W!QA55MN.\$5[JD2J'E:")EC*E@^R'!! Z@EE&
M.ISQ7*0:FM^UB?/DFD6YM@R+'Y5O$.R;0H4OG(5AU4$8  SIWE_%I*:E8W$;
M>?<2321CR]V]&!*,&&1B,@N2<;><?,"!7U'?I[V-\9#!&;"*,3>2LX#A2Q7:
M>5)4\$#)Y XW8Z#PQH5R]L/LMTT:&61@7MD 96V[2D98[$R&91A<[L[0,$PZ
MGJ4>B:G'->$OLL%#2B/.&\P@R$+G:&Y7CH6"]#64DKV%B;I$$44^H^8C/"K^
M5$^-LH3D*1C ]C\O535>VN%N9KN1)99@VESGS)05#'=\VQ2!MC!R .Q# 9 S
M6G:WD>B366HW2D0-IT4:R;=P63&[MD@E<@$#G)[;L;7PP97BN2B%%-[-A"NT
MJ,)A2HZ$=,=NE<[XGSINH7$DLWV:.YC0*[6RW"R*J*KISDCGJ,8(P6_AS=LM
M--O+I,$NYMHNB/.4!QA0R97<^TKQ@9RN!T(P+%QHG]MW&JV><&1;3:<X&Y8]
MRYX/&0,\9QG'-,TVWG\2K=:@Z%)&M&MHT(*9;:3+D-GCS3M4[N "&&16%X64
MWCVEN)W,MM("8%M%C:(*<2[I=R_*>C<DL2,H6XJQ=VY>">8H9(X-9DDE4 -^
M[4?-\IZCGD>G)X!(MW5Y'K<U[J-JI,"Z=+&TFW:&DQN[X)(7 )(XP.VW->SO
MXM633;&WC;S[>2&20>7MV(H!=BQP,2$AP1G=QGYB <_483:S7EE-*T)N)G98
MA:K.9E=B8]KYSG/ &0%;H0V['J^G6A^SI!-ESY2J_F $M\H#;AE@2>_+#W/6
MO,H+"22.>$R-OTB$[#)&"=PF:99%W$D QQ(H!R #Q\OWGZUICWEB=3"L?.O?
MM#%HU:185WJF58X=57! SMVM_=RU;?@3-Y=2WJW#7"M$%=Q;B",L&!4'D%G5
M<\[3A2!N' />T44444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M4444444444444444444444444445#':K&S2@?,^,DDDX48 YZ <G XR2<9))
MFHKC'\ S70%O<7<DMJ'W&-E =@"2JM*#N89Z_3@*0".SHHHHHHHHHHK,\0:=
M-J,7E6\Q@8GEP@<[<$$#)&#R#N!R,<58TK3$TN)+6(82-0!TR<=2< #)/)..
M22:MT45DZ_H7]K^3\VWR+B.7[N<[,_+U&,YZ\X]*UJ***P?#_AM]/DDNKB4S
MSR!5WE%3:B]%51G )Y.#@G!QG).]1111111111111111111111163J.A?;+F
MWO=V/LWF_+MSN\U0O7(QC&>AS[5K44445R6I>"[B]:2/[9(+:9R6C*!FPV-R
M+(3E5[  8 X(/.>GM+5;1%AC&$C4*HR3@*, 9//2IJR?["_TS^TMW_+OY6S;
M_M[]V[/X8Q^-:U%%%%%%%%%5-6L?[0ADML[?-C=,XSC<I&<9&<9]:-)L?[/A
MCML[O*C1,XQG:H&<9.,X]:MT444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444445YEIFI7MBM_-:K%Y4-W<N[
M3%B3C!*JJ8Y 7J3@[@!T-;NM>,98H89XO)B\Z$2EKF3Y<;03&JI^\=AG.0N,
M8'); I:+\09KQ8)G6,QO=M;N8P_)908G0,1A>?FW9..0,G T-7\;-ITMT=H:
M&RBBW#H[23'Y #DC9@_,2,@] :K^&/&LMW.MI=&W)FC+(;9]^&7EHV 9L''.
M<A>" 6)XU?&6ORZ*D+P(LCRW$<>UCC(8-P#D $D  G('<5F)XLNK(W%K=I&)
MX;9YXVBW&)E48P0QW AN.V>>F 6B'C"\@M4NY8HR]T84MT1C]^13\SDG 4X#
M* <@':Q!RP)O%E[9"XM9DB%S#!YZ,NXPM&I <$$[PPY Z9/7 &6U;SQ0SM9)
M;@9O3N_>#I&J;W^Z>'P1MZC.<USN@>)9+:RL[>SB03W33!%);RE$<C%V.YBY
MXYQGUQT"FQX9U*2TN-2N;M0KQ) SB,[@?+B;E<XX8#(!Y&<'D&F:)\0Y;B6'
MS_LXBNF*JL4F^:,M_JPX!.=W3@#!.6V_=)X@\1W>I1W@MXD-K LL3EVQ*S!2
M'9<$@!,@X/+#H<G"]5X3_P"/.V_Z]X?_ $!:Y7_A/KOR_P"UO)3^S_,VXS_I
M&W.S?][;][^'KVZ?/6JFOW=U?36,*1>5;M"6=RP;:ZAF4 $Y8Y.TX"C:0V<B
MK?C+7Y=%2%X$61Y;B./:QQD,&X!R "2  3D#N*Q]8\7W6G-%8M]G6Y9#)))(
M[);A=S*H&2'+' SZ>A&2N/KOB&;7H+*:,1"1;Y$<$LRB9?N89<@QD$DX)X(
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MF17<'<HP,;6X!)R57H-PRW5:'9-86\-N^"T42*2.F54 XSCCBN-_X0&[\O\
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M&;S9(AM<BW/0'/REL<D=^@VY4Z?@FS:RO;^%W:0K]F&]\;B/+;;G'4@8!/\
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M#1L0K)(>2F=P*[@.?4$=W7D6IR:9'YY;/]H>?<;2&D3#F9Q&VXLL8"_*22<
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MTD\\LV]9"F58;2H 0MPHP,*H.< T>(O$@\.RRG<K3O;VJ1B1@NYO,G!9B-H
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MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBN?T;2Y+:]O+EUQ'/]GV'(.=D9#<
MY&#Z@>U4K.VN= FN5B@,T,[M,A61%82.!N1MY7"Y'! .!C[Q)QK^&=(;2H!'
M*5:5F=Y&50H9W8LQX SC. <#@#@= _Q+HXUBVEM#C,B$+DD ,.4)(YP& /\
M0]*Q_#/AZ:6VF%^?](O-PE*A P79Y:C*94X49'8%CQG.:4-E?SV8TAXA&V!"
M9PZ-'Y2C!8*27+,HV[<#D[MR]!J^*=%>Z6U2W0;8+N!R!M4*B9!P"1P..!SZ
M"F^.M/GNT@>VC\QX+J*4KN5,A W=CCK@=^O2I=+UF]N9%CGL_*C.<O\ :(WQ
M@$CY0,G)P/QS5TZP1=BPVC!@,F[>,\.%V[.H'.0QX/('0XTZY_1M+DMKV\N7
M7$<_V?8<@YV1D-P#D8/J![52UGP_+J3/;%2()[M'D.5P8HX(_E^\&!:1, KR
M,$GC&:E[X%CT26"^TZ$F2.7#KOSF-U97/[QQ\P_AP1R>01TT+[PJVI6CV[92
M59YY8F#8VN99'C;*YX(89[@'LP&'V-I-JKPS7L"JR0SHZL4==SF( K@MPRAA
MSR!E3D$%F>&M.N-"E:QV!K/+-$ZD Q[B6,;!FW,,]&&3TSP<)L>(;5KNVGAC
M&7DAD51D#)9" ,GCK7*:U'J'B-5M&MEMQYB-YQF21DV'.Y0F"&[ CU(X!R)I
M([W2KVZN8+;SH[CR<'SHX\>7'@\')ZD]ATIVHP7E_P"3J0MPES:RN!"TR,'C
MD4*YW  !O3)XP20W JW)HLFO3/-<H8X1 \4:-Y;29E \R7<I8*<?*!EN,GC.
M#4A.I6-JMA'"OG($C68.ODA H DVL=^Y1P1MQD;AD?*=67PXMY-+]H421O;0
MQ[G"[CM>1G^[C!Y1L@ 9P1RO&+:VFJ6$!LH]I:V*F*3";)HU&/*92=R-C'S=
M\8+#[[6[RVN=<FMF: VXMW61I&D1FX!#PJ$))5\C))4$ Y7@ ];7%/<W]HDM
MK'9+(C27!5GGCVL)9'89C/)&&Y&1D>E5)/#MYI L&B3[2]FLX?\ >*@_> !0
M"YSA0<#CHHX&<#5FN[W5X;BVEM?*WV\H4^?&^6*X5<#&,YZDX&*JZ3J>HZ?#
M';?8=WE1HF?M40SM4#.,'&<>M6+.VN= FN5B@,T,[M,A61%82.!N1MY7"Y'!
M .!C[Q)QF:GX#FDBMESNG\Z3[0\81 5NLB=L,.2!A5.,XZ+T U;/PV]MJ3W6
MU3;M&[K\J#;-)Y:/C^++*F2V,<D=2<]77%>7>_VE]M^S?NO+\C=YT?W?-W>;
MCKTYVXS[UOR:7]IFG\Q<Q36\49YQG#3;QP<CAQSQUX/%9O@#0IM%BFBN"2S7
M,C!R02ZD* YP6P6P3@G/K6EXGADE@/D)YDBR0N$W!=WERHY&X\#A36!+;WVO
M3V[RP+;);R>89/-61R.AC&S! <<-G@CZ8:'2S?Z(]PD=IYJ374LJM]HC3AR,
M<')Z#/;KTK0O&O9'M;]8,,GFI-")(RVV0K@ASA3C8&X(.<+TR1E:UX6N=1@O
MI@F);QH-D19=P6!@,EL[<L 3@$@=,D]-NTUZ_E=4DL=B%@&;[3&VT$\M@#)P
M.<=ZZ6N*TJSO=#@DTR&+(5F%O-YD>T+(Q.YPW.4W9.$(;& ,<G7TO03IC6T:
M &."VEC+ !<LS0G.W/5MK$]>>IR>:OAO2IM F>R1"UDQ+Q/Y@)C)'S1E6(.W
M()7 .,\DDDKL>(;5KNVGAC&7DAD51D#)9" ,GCK7*:U'J'B-5M&MEMQYB-YQ
MF21DV'.Y0F"&[ CU(X!R)I([W2KVZN8+;SH[CR<'SHX\>7'@\')ZD]ATIUUI
MD_BIXHKZ PP1&1G3S$<.VT+'\R,KJ1N<GC' !SGBO/X"339U^QQ,(+B&6&XP
MX)57QM=?,;.<]?O# X7/6Q"=2L;5;".%?.0)&LP=?)"!0!)M8[]RC@C;C(W#
M(^4ZLOAQ;R:7[0HDC>VACW.%W':\C/\ =Q@\HV0 ,X(Y7B+PA!=:<IL+E0T<
M( BF4J R# "E,[@P''3!P><C<V[=R-$C/&N]PI*KD+N('"Y/ R>,]JY7P+;W
M=H\Z7,'EI/-+,&\U'P7*_)A>>F3NXZ=*?K/A>34;&6V&5F$MQ)'AO[\LA R&
M PZ.5.3@!N1QBK&FZ 2+19XU(ALWC<-M8!F$*X[YR%<$C(QD9P>6>&M.N-"E
M:QV!K/+-$ZD Q[B6,;!FW,,]&&3TSP<)H>++26^MVM8,AIBJ%@%.U&($C$,1
MD;,C ^;)&/4<YK?PX@LD%SI\/^DPR1N@,C%6*N"0=[8QCG@@\<'L=."^U"SD
MEWPF>)QOBVM%&Z$_\L7RV,+TWC=Z_-G"VO!VCR:7"RRX4R2O((U.5B#G(B!'
M&%]@!DG'J6^+]+DU#[-Y2[O*O(9&Y PJ[MQY(SC/0<^U;&HV2W\3V[Y"RHRD
MCKA@0<9SSS7'PV5_/9C2'B$;8$)G#HT?E*,%@I)<LRC;MP.3NW+T$NJV5SIU
M\MY:6XEB%H(0HD2(+B0M@ ]@ . ,<]>*;X@CO?$-E/;/;>5(?*V#SHWW8D!;
MD8 P!W/.>*T+37K^5U22QV(6 9OM,;;03RV ,G YQWK/TJSO=#@DTR&+(5F%
MO-YD>T+(Q.YPW.4W9.$(;& ,<EC^!FMKBS,6?*BB$<Q78H/DL)HSM.3EY1EL
M9/N,DDT_PI<V3WGDE8R0HM9-B852[RO'M&2%W-M)(]"!P 'ZK#>^((([22W\
MF0LK--YD96)D8$.@5F<D@$#[I7.-Q&375:A<20;/*C\S=(JM\X7:ISN?GKC^
MZ.35NBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBF"%0Q< ;B "<<D#) SZ#)Q]3ZT^BBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBL?Q7,L, =R JSVQ))P !<1DDD] *RM F7Q7(=0<A
MH8)66",'*Y7_ );,.N\Y^4,!L'(!)#5P/A;^Q?LR?;?^/CYM_P#K_P"\=OW/
ME^[CI_.N@\:_8O[27^T?]5]C&/\ 6?>\UL?ZOGIGV_2KQBTZ73W2TQ]E:Y@$
MF3(HYEAWY,A! VXY!P/KFJD.EV=M=VZZ0X$V_,HC=Y(S#@E]S?.H.5 49'S,
M#_=(](KS36? 5E;7MG;)%B.?[1O&^0YV1@KR6R,'T(]ZT-8M(= N].BB5A%'
M]KPJ!Y&^9 3@#<QY/OCZ"GK)'K&J.A5O+?3F1@Z21$@RX/#A6Q@]1^!R*9\-
M= @M'NIHUP\=U-"IW,<1J4(7!..O?K[UGRZ;9QR.VI++'<F9@+G]ZD9+,QB9
M'#.B[$"X#?=Q@YVFO0-)3RX8UW^9B-!YF<[\*/GSDYW=>IZ]37.^,;&TO;B!
M+\J(A%.1OD,8W;H<<AEYP3QFN4N+A=&CO9]+<_9%B12,N5$SR",F-CSE4YR&
M/+*>1@#;\0^'HO"47]K6VX30NAD9G9FF5F"NK$DJ"Q.XG;P1D <8J:O#I<U[
M.E^"9VEC" "8DJ88@H CX)+9]_TJ)?",=UI\ES=1MYD$4X@,ID658TWM&'7(
M7<#G&!C;M'2NB\!^%K;3X8;V)-LLMO'N;<QSN56;@D@9(SP*RO"/A:VL]1N_
M+3'V;R/*^9CM\V)M_4G.<]\X[8J73-!A\627,]Z&D\JZDBC7S'"(L849"AA@
MMU;L2. *S;DW&K6L=JKEKFTOY(TD(!+M;Q2R(2#P"<!>2?[Q)YK2T#65UK48
M[M.!)IN<<\$3X9<D#."",XYQD<5W=>*>%O[%^S)]M_X^/FW_ .O_ +QV_<^7
M[N.G\ZZO0?"]OXA,YN59TMKAH(D\R0(B0JJC W9RP W$DY(SQS5*YU"*YM8X
M-38O%:W\D+N=V7\N*78Q"?,#DJ.I)QDDY-7?"EI!%=I+I:N+62%_-9Q*(F*M
MA-A?K(#G.> N<<YKN-0T^/48VMYE#1N,$'_/!'4$<@\CFN"EOKNY0>'6+?:&
M9U>9TW VP!Q+QQEP=@Y;D$,RL0:L6OAR#5KJ?3Y5/V:R2!8XE=U3+JSER W+
M\D;L\@G.3S1:3-:^?I9)9+6[LC&2>B2S1LL?.20F, DDD>@ %:7B+_D(Z?\
M]O7_ **%<+;6FF7-H/LJRMJ"0HW[@3EQ(-N6_N@!NI';[O.*]?M-^Q?-V^9M
M&[9G;NQ\V,\XSTSSBN%\8_V=]L/]I_\ /O%Y?^M_OS;O]7^'7\.]96JVC6FF
MWT2*Z6HFC\E9@ZR %XR_#_\ +//W._WMW-:OA;^Q?M*?8O\ CX^;9_K_ .Z=
MWW_E^[GK_.K'A[0;?Q;#_:=VA>2X+@!G/R(LA"HNW;@#;U #$ELG#$4RXTHW
M]U%HUU(\L45F9&^8H96,@0;]I&0N 5_BSR6;G.;KD46B--I+Y^Q,EM-M)8^6
MOVE$E4')<AN6X(P<X&3FG:1:6GVFWGT97_UC+,V)O)\O;EE9G_BZ% .-V-W\
M-:=GX%@U%9;I-T5TT]SB:-W#*1/(H. P&,#!'&1GD'FL_P"T_P#"206EU>12
M30,CJZPAB1*'""5A&RDJ55C@*=N2.=PKH/!$-JH=["8O P3$19CY9!?) <[E
M#GG!')!()!&.HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MK,\1:>=0B\D*&!E@+*<8*K,C/D'@C:#QWZ5CWFD3Z/=_;K*-7CN,"XB!5&)&
M2)5+$#//(R,GDY+%ERO"TNHZ#;)9?8M_E[OF^TQ+G<Q;ISZXZU;U".]@O$U*
M*V\S=9K&R>=&NUBY=AN/7'3(&#ZUH">[U:,I-;>25FMF'[Y)-P697<\8QM"Y
M]^W-=+17/ZSI<ES>V=RBYC@^T;SD#&^,!>"<G)] ?>C6=+DN;VSN47,<'VC>
M<@8WQ@+P3DY/H#[U%=Z?/%?M?QQ[T%B47YE7=()-X3DY&1WQ@54\"V]W:/.E
MS!Y:3S2S!O-1\%ROR87GID[N.G2GP7.H6L<MM<0"Z(.$=6BC21&ZAU8_*0#C
MA2#T_P!IM?PKI+Z1:Q6LK[WC7!;G'4D 9YPH.T=. .!T$T]JS7,<P'R+#,I.
M1U=X2HQUY"G\OI4/BK1/[;M9;/.#(ORG.!N4AESP>,@9XSC..:R)HKS7TAMK
MB$0J'5YRS1R(XC8,(U4,QPY )SC: 1E^]^?PZNI+=V]P#Y=Q*I!!P<"*(!AC
MH0Z'KZ<@@\TK6WO+FPFLKF/]^L,D:N'5EERA56R6R">^['7/&2%V_#UJUI;0
M0R##QPQJPR#@J@!&1QUKFO#4=['>S7,]MY<=UY>3YT;;/*C(' Y;<<=ACWJQ
M9VUSH$URL4!FAG=ID*R(K"1P-R-O*X7(X(!P,?>).+&E^'I+%+97*O(MQ)+,
MZ@*"TD<P+8XSRZJ.,X X &!7TSPO)8:G)>+DP20-C+9VN\@9E +$X)W/P N6
M(KK:Y_P%I<FE645M.NV1-^1D'&9&(Y!(Z$=ZI6=M<Z!-<K% 9H9W:9"LB*PD
M<#<C;RN%R." <#'WB3BQI?AZ2Q2V5RKR+<22S.H"@M)',"V.,\NJCC. . !@
M,MM*FT6\9[="]K=G=(/,&8Y,G+A6(^5LC<!D\<8 53U%<_\ V7)_:7VW;^Z^
MQ^7NR/O>;NQC.>G.<8]ZKRV4^E7LEW#$98;I$\S:Z!T>(%5(#E 5(/3).<G(
MP :D_A^ZDM;B4;1>W$J2@?+\OE,C1Q;\88J$P"1MW$YX)8VTLI]7NK>\EB,"
MVJ2$AG1RSRKM*C83\JXSN."<@;1R17OO#,KVEJ\0Q>V4<90%\*2%421D@X(8
M#'49_O!2<]1I\[W$:O(AC<CYD+*V#W&Y201Z'TZ@'@49-+^TS3^8N8IK>*,\
MXSAIMXX.1PXYXZ\'BN2O] O#8SZ.(RZH5\B3S$.Y!*K!6W$$,J\= N!@8P-V
M]::]?RNJ26.Q"P#-]IC;:">6P!DX'..]4=-MKSPU ]C! )@A8P.)$ P[L<2;
MBAW+G)VC#9QD8)I\NDW>GS6^H*/M$OD^3<#<B'!;?N3(C7ALCGJ-HQG+!YT6
M>]>2]E0!WEMA&AV%TBAG5VRX.,MRY4$XP!DG $NIZ5-IUV-2M$,@F&RXC\P+
MD #9(H8A=R@8Y/(X &6:JBR:E")+."!4W2SE)Y)5*@22.X;RP&;.&P.O."1C
M(J:'2;KPX+>*T FMD39+%\J/N)+-,K.W4D_<+8'0=<K8T73YYKN7498_(5HQ
M'Y>Y69RK9$K;#M!"_*!EB.1G&,]+1111111111117G_BGQ?J6GW+P6UMYD2[
M=K>3*V<J"?F5@#@DCBLK_A/M9_Y\_P#R7G_^*H_X3[6?^?/_ ,EY_P#XJK6D
M^-]6N9HXI;7;&\B!F\B884L QR6P,#N>*] U:X>VADEB&Z1(W*K@G+!25&!R
M<GL.:\U_X3[6?^?/_P EY_\ XJC_ (3[6?\ GS_\EY__ (JC_A/M9_Y\_P#R
M7G_^*KM?!6KW.JPM+>1^5()" NQTRH52#AR3U)YZ<5E>-?$]_I4RQ6<'FQF,
M$MY4CX8LP(RA Z <=>:Y_P#X3[6?^?/_ ,EY_P#XJC_A/M9_Y\__ "7G_P#B
MJ/\ A/M9_P"?/_R7G_\ BJ]5KRK_ (3[6?\ GS_\EY__ (JC_A/M9_Y\_P#R
M7G_^*H_X3[6?^?/_ ,EY_P#XJN@\%>)[_59FBO(/*C$9(;RI$RP90!ER1T)X
MZ\5J^-=7N=*A66SC\V0R %=COA2K$G"$'J!STYKBO^$^UG_GS_\ )>?_ .*H
M_P"$^UG_ )\__)>?_P"*H_X3[6?^?/\ \EY__BJ]*TFX>YACEE&V1XT++@C#
M%06&#R,'L>:\_P!6\;ZM;32116NZ-)'"MY$QRH8A3D-@Y'<<55_X3[6?^?/_
M ,EY_P#XJC_A/M9_Y\__ "7G_P#BJU?"WB_4M0N4@N;;RXFW;F\F5<84D?,S
M$#) '-=5XIU";3[9Y[9/,E7;M7:S9RP!^52"< D\5P'_  GVL_\ /G_Y+S__
M !5'_"?:S_SY_P#DO/\ _%4?\)]K/_/G_P"2\_\ \57:^"M7N=5A:6\C\J02
M$!=CIE0JD'#DGJ3STXK*\:^)[_2IEBLX/-C,8);RI'PQ9@1E"!T XZ\US_\
MPGVL_P#/G_Y+S_\ Q5'_  GVL_\ /G_Y+S__ !56M)\;ZM<S1Q2VNV-Y$#-Y
M$PPI8!CDM@8'<\5Z!JUP]M#)+$-TB1N57!.6"DJ,#DY/8<UYK_PGVL_\^?\
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M^$^UG_GS_P#)>?\ ^*KU6O*O^$^UG_GS_P#)>?\ ^*H_X3[6?^?/_P EY_\
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M6S9L_=NF<[MWWR<XP.G3-'CK7[S2/*^Q0^;OW[_W;OC&W;]PC&<GKUQ7*_\
M"?:S_P ^?_DO/_\ %4?\)]K/_/G_ .2\_P#\51_PGVL_\^?_ )+S_P#Q5>E:
M3</<PQRRC;(\:%EP1ABH+#!Y&#V/->?ZMXWU:VFDBBM=T:2.%;R)CE0Q"G(;
M!R.XXJK_ ,)]K/\ SY_^2\__ ,51_P )]K/_ #Y_^2\__P 570>"O$]_JLS1
M7D'E1B,D-Y4B98,H RY(Z$\=>*U?&NKW.E0K+9Q^;(9 "NQWPI5B3A"#U YZ
M<UQ7_"?:S_SY_P#DO/\ _%4?\)]K/_/G_P"2\_\ \51_PGVL_P#/G_Y+S_\
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MCX8LP(RA Z <=>:Y_P#X3[6?^?/_ ,EY_P#XJC_A/M9_Y\__ "7G_P#BJ/\
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M_P#XJC_A/M9_Y\__ "7G_P#BJU?"WB_4M0N4@N;;RXFW;F\F5<84D?,S$#)
M'-=5XIU";3[9Y[9/,E7;M7:S9RP!^52"< D\5P'_  GVL_\ /G_Y+S__ !5'
M_"?:S_SY_P#DO/\ _%4?\)]K/_/G_P"2\_\ \57:^"M7N=5A:6\C\J02$!=C
MIE0JD'#DGJ3STXKG_%/B_4M/N7@MK;S(EV[6\F5LY4$_,K '!)'%97_"?:S_
M ,^?_DO/_P#%4?\ "?:S_P ^?_DO/_\ %5:TGQOJUS-'%+:[8WD0,WD3#"E@
M&.2V!@=SQ7H&K7#VT,DL0W2)&Y5<$Y8*2HP.3D]AS7FO_"?:S_SY_P#DO/\
M_%4?\)]K/_/G_P"2\_\ \51_PGVL_P#/G_Y+S_\ Q5=KX*U>YU6%I;R/RI!(
M0%V.F5"J0<.2>I//3BLKQKXGO]*F6*S@\V,Q@EO*D?#%F!&4('0#CKS7/_\
M"?:S_P ^?_DO/_\ %4?\)]K/_/G_ .2\_P#\51_PGVL_\^?_ )+S_P#Q5>E:
MM</;0R2Q#=(D;E5P3E@I*C Y.3V'->:_\)]K/_/G_P"2\_\ \51_PGVL_P#/
MG_Y+S_\ Q5'_  GVL_\ /G_Y+S__ !5=5X%U^\U?S?ML/E;-FS]VZ9SNW??)
MSC Z=,T>.M?O-(\K[%#YN_?O_=N^,;=OW",9R>O7%<K_ ,)]K/\ SY_^2\__
M ,51_P )]K/_ #Y_^2\__P 51_PGVL_\^?\ Y+S_ /Q5>JUY5_PGVL_\^?\
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MEX+:V\R)=NUO)E;.5!/S*P!P21Q65_PGVL_\^?\ Y+S_ /Q5'_"?:S_SY_\
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M1111111111111111116?K>OP:(@FN6V(6"@[6;D@G&%!/0&L3_A:6G?\]O\
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M.]@K9GC7<R[6X!V\YQ@_>'0]ZQ/^%I:=_P ]O_(<O_Q%:O\ PE-M]F_M+?\
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MKR_0_$[:/I5S:N0L]J[Q !MK RDX(89!96WGY>R=OO5IZA(?#&AK"W^LECV
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M-8DGB!M6?3$ER)[>Y,<@;[V5>(!B"2V2.I.,L&XXKH+/3HK_ %RZ29%=1 I
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MDWG@^*YEEN \BFYB,<JJPV,-I0,0RG# '@C&,=.6S0A^':PJ$2[NPJ@  3X
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MZ="06V_A>*%6!+,\DJ2/(Q!D9HW#H"0 -HV@!0  O3!.:EO/#\5U<17YR)8
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MCKD<6EW2+!:1+'N97#2,(U"[?E8@[C\PRN%P#R0 WI$,*PJ$0 *H   P !P
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M./U_0_X4?VG'Z_H?\*/[3C]?T/\ A1_:<?K^A_PH_M./U_0_X4?VG'Z_H?\
M"C^TX_7]#_A1_:<?K^A_PH_M./U_0_X4?VG'Z_H?\*/[3C]?T/\ A1_:<?K^
MA_PH_M./U_0_X4?VG'Z_H?\ "C^TX_7]#_A1_:<?K^A_PH_M./U_0_X4?VG'
MZ_H?\*/[3C]?T/\ A1_:<?K^A_PH_M./U_0_X4?VG'Z_H?\ "C^TX_7]#_A1
M_:<?K^A_PH_M./U_0_X4?VG'Z_H?\*/[3C]?T/\ A1_:<?K^A_PH_M./U_0_
MX4?VG'Z_H?\ "C^TX_7]#_A1_:<?K^A_PH_M./U_0_X4?VG'Z_H?\*/[3C]?
MT/\ A1_:<?K^A_PH_M./U_0_X4?VG'Z_H?\ "C^TX_7]#_A1_:<?K^A_PH_M
M./U_0_X4?VG'Z_H?\*/[3C]?T/\ A1_:<?K^A_PH_M./U_0_X4?VG'Z_H?\
M"C^TX_7]#_A1_:<?K^A_PH_M./U_0_X4?VG'Z_H?\*/[3C]?T/\ A1_:<?K^
MA_PH_M./U_0_X4?VG'Z_H?\ "C^TX_7]#_A1_:<?K^A_PH_M./U_0_X4?VG'
MZ_H?\*/[3C]?T/\ A1_:<?K^A_PH_M./U_0_X4?VG'Z_H?\ "C^TX_7]#_A1
M_:<?K^A_PH_M./U_0_X4?VG'Z_H?\*/[3C]?T/\ A1_:<?K^A_PH_M./U_0_
MX4?VG'Z_H?\ "C^TX_7]#_A1_:<?K^A_PH_M./U_0_X4?VG'Z_H?\*/[3C]?
MT/\ A1_:<?K^A_PH_M./U_0_X4?VG'Z_H?\ "C^TX_7]#_A1_:<?K^A_PH_M
M./U_0_X4?VG'Z_H?\*/[3C]?T/\ A1_:<?K^A_PH_M./U_0_X4?VG'Z_H?\
M"C^TX_7]#_A1_:<?K^A_PH_M./U_0_X4?VG'Z_H?\*/[3C]?T/\ A1_:<?K^
MA_PH_M./U_0_X4?VG'Z_H?\ "C^TX_7]#_A1_:<?K^A_PH_M./U_0_X4?VG'
MZ_H?\*/[3C]?T/\ A1_:<?K^A_PH_M./U_0_X4?VG'Z_H?\ "C^TX_7]#_A1
M_:<?K^A_PH_M./U_0_X4?VG'Z_H?\*/[3C]?T/\ A1_:<?K^A_PH_M./U_0_
MX4?VG'Z_H?\ "C^TX_7]#_A1_:<?K^A_PH_M./U_0_X4?VG'Z_H?\*/[3C]?
MT/\ A1_:<?K^A_PH_M./U_0_X4?VG'Z_H?\ "C^TX_7]#_A1_:<?K^A_PH_M
M./U_0_X4?VG'Z_H?\*/[3C]?T/\ A1_:<?K^A_PH_M./U_0_X4?VG'Z_H?\
M"C^TX_7]#_A1_:<?K^A_PH_M./U_0_X4?VG'Z_H?\*/[3C]?T/\ A1_:<?K^
MA_PH_M./U_0_X4?VG'Z_H?\ "C^TX_7]#_A1_:<?K^A_PH_M./U_0_X4?VG'
MZ_H?\*/[3C]?T/\ A1_:<?K^A_PH_M./U_0_X4?VG'Z_H?\ "C^TX_7]#_A1
M_:<?K^A_PH_M./U_0_X4?VG'Z_H?\*/[3C]?T/\ A1_:<?K^A_PH_M./U_0_
MX4?VG'Z_H?\ "C^TX_7]#_A1_:<?K^A_PH_M./U_0_X4?VG'Z_H?\*/[3C]?
MT/\ A1_:<?K^A_PH_M./U_0_X4?VG'Z_H?\ "C^TX_7]#_A1_:<?K^A_PH_M
M./U_0_X4?VG'Z_H?\*/[3C]?T/\ A1_:<?K^A_PH_M./U_0_X4?VG'Z_H?\
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M]B_[7Z?_ %Z/[%_VOT_^O1_8O^U^G_UZ/[%_VOT_^O1_8O\ M?I_]>C^Q?\
M:_3_ .O1_8O^U^G_ ->C^Q?]K]/_ *]']B_[7Z?_ %Z/[%_VOT_^O1_8O^U^
MG_UZ/[%_VOT_^O1_8O\ M?I_]>C^Q?\ :_3_ .O1_8O^U^G_ ->C^Q?]K]/_
M *]']B_[7Z?_ %Z/[%_VOT_^O1_8O^U^G_UZ/[%_VOT_^O1_8O\ M?I_]>C^
MQ?\ :_3_ .O1_8O^U^G_ ->C^Q?]K]/_ *]']B_[7Z?_ %Z/[%_VOT_^O1_8
MO^U^G_UZ/[%_VOT_^O1_8O\ M?I_]>C^Q?\ :_3_ .O1_8O^U^G_ ->C^Q?]
MK]/_ *]']B_[7Z?_ %Z/[%_VOT_^O1_8O^U^G_UZ/[%_VOT_^O1_8O\ M?I_
M]>C^Q?\ :_3_ .O1_8O^U^G_ ->C^Q?]K]/_ *]']B_[7Z?_ %Z/[%_VOT_^
MO1_8O^U^G_UZ/[%_VOT_^O1_8O\ M?I_]>C^Q?\ :_3_ .O1_8O^U^G_ ->C
M^Q?]K]/_ *]']B_[7Z?_ %Z/[%_VOT_^O1_8O^U^G_UZ/[%_VOT_^O1_8O\
MM?I_]>C^Q?\ :_3_ .O1_8O^U^G_ ->C^Q?]K]/_ *]']B_[7Z?_ %Z/[%_V
MOT_^O1_8O^U^G_UZ/[%_VOT_^O1_8O\ M?I_]>C^Q?\ :_3_ .O1_8O^U^G_
M ->C^Q?]K]/_ *]']B_[7Z?_ %Z/[%_VOT_^O1_8O^U^G_UZ/[%_VOT_^O1_
M8O\ M?I_]>C^Q?\ :_3_ .O1_8O^U^G_ ->C^Q?]K]/_ *]']B_[7Z?_ %Z/
M[%_VOT_^O1_8O^U^G_UZ/[%_VOT_^O1_8O\ M?I_]>C^Q?\ :_3_ .O1_8O^
MU^G_ ->C^Q?]K]/_ *]']B_[7Z?_ %Z/[%_VOT_^O1_8O^U^G_UZ/[%_VOT_
M^O1_8O\ M?I_]>C^Q?\ :_3_ .O1_8O^U^G_ ->C^Q?]K]/_ *]']B_[7Z?_
M %Z/[%_VOT_^O1_8O^U^G_UZ/[%_VOT_^O1_8O\ M?I_]>C^Q?\ :_3_ .O1
M_8O^U^G_ ->C^Q?]K]/_ *]']B_[7Z?_ %Z/[%_VOT_^O1_8O^U^G_UZ/[%_
MVOT_^O1_8O\ M?I_]>C^Q?\ :_3_ .O1_8O^U^G_ ->C^Q?]K]/_ *]']B_[
M7Z?_ %Z/[%_VOT_^O1_8O^U^G_UZ/[%_VOT_^O1_8O\ M?I_]>C^Q?\ :_3_
M .O1_8O^U^G_ ->C^Q?]K]/_ *]']B_[7Z?_ %Z/[%_VOT_^O1_8O^U^G_UZ
M/[%_VOT_^O1_8O\ M?I_]>C^Q?\ :_3_ .O1_8O^U^G_ ->C^Q?]K]/_ *]'
M]B_[7Z?_ %Z/[%_VOT_^O1_8O^U^G_UZ/[%_VOT_^O1_8O\ M?I_]>C^Q?\
M:_3_ .O1_8O^U^G_ ->C^Q?]K]/_ *]']B_[7Z?_ %Z/[%_VOT_^O1_8O^U^
MG_UZ/[%_VOT_^O1_8O\ M?I_]>C^Q?\ :_3_ .O1_8O^U^G_ ->C^Q?]K]/_
M *]']B_[7Z?_ %Z/[%_VOT_^O1_8O^U^G_UZ/[%_VOT_^O1_8O\ M?I_]>C^
MQ?\ :_3_ .O1_8O^U^G_ ->C^Q?]K]/_ *]']B_[7Z?_ %Z/[%_VOT_^O1_8
MO^U^G_UZ/[%_VOT_^O1_8O\ M?I_]>C^Q?\ :_3_ .O1_8O^U^G_ ->C^Q?]
MK]/_ *]']B_[7Z?_ %Z/[%_VOT_^O1_8O^U^G_UZ/[%_VOT_^O1_8O\ M?I_
M]>C^Q?\ :_3_ .O1_8O^U^G_ ->C^Q?]K]/_ *]']B_[7Z?_ %Z/[%_VOT_^
MO1_8O^U^G_UZ/[%_VOT_^O1_8O\ M?I_]>C^Q?\ :_3_ .O1_8O^U^G_ ->C
M^Q?]K]/_ *]']B_[7Z?_ %Z/[%_VOT_^O1_8O^U^G_UZ/[%_VOT_^O1_8O\
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M<].G-9^OZ^^D/"/+5HYYHXMWF$,&<GG;L(( ']X$GC'>MB:985+N0%4$DDX
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M,SM(@4,'"^7U^]U)!P0 .N>-B]U&*P7?,ZHI. 78*,]<9)'/%2PS+,H=""K
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M?:F;<%8!$3;MQN3R]P7:I;;Z]A\4O^0=/_VS_P#1J5U=%<E\1(A*MHASAK^
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M0\=):3R6:P7$KP[=QAB#J-ZAA_%GIZ@=#4]WXOCL[=+R2.5?-<(L1C_?%B2
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MC$#<V!M) "]1S\U: OKG3%N)!'((([9GC^T2)(1(FXE<J[NRL"#EGXP0, @
MT^W>2*UOFNF2281%Q(5*2^8%;RQ&<(K'&%* -C.=Q)-8]^9]6%[J*7$L7V*1
MTCC1OW?^C@,Q8<!MY]>G0[@ *S_%_B:<L+N&1X@=/@F"*V5W/<(.01@\-@G
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M/,1)-L<GE_=W#&>G'!&.HP<FK^H>'4NY5O%9XYU7;OC89*\G85<,A&3GE<Y
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M H)QA22X<9/3('RFMWQ!X8CULQNSR1R0EBCPOL<;AAAG!X/&>,\=<$YJ'P+
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MS_B=9O#;OJ$4\T;Q*@"QR%8SF0 DJ.2<-USV%=+K>D?VJ@B\R6+# [H'V,<
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MS9M)UUV+"Y@4$D@!>!GL,PDX'N2?4UH:/XJN([O^RK](UE="\;PEBC#'W=K
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MC/\ IY_\@_\ VRC_ (49_P!//_D'_P"V4?\ "C/^GG_R#_\ ;*/^%&?]//\
MY!_^V4?\*,_Z>?\ R#_]LH_X49_T\_\ D'_[91_PHS_IY_\ (/\ ]LH_X49_
MT\_^0?\ [91_PHS_ *>?_(/_ -LH_P"%&?\ 3S_Y!_\ ME'_  HS_IY_\@__
M &RC_A1G_3S_ .0?_ME'_"C/^GG_ ,@__;*/^%&?]//_ )!_^V4?\*,_Z>?_
M "#_ /;*/^%&?]//_D'_ .V4?\*,_P"GG_R#_P#;*/\ A1G_ $\_^0?_ +91
M_P *,_Z>?_(/_P!LH_X49_T\_P#D'_[91_PHS_IY_P#(/_VRC_A1G_3S_P"0
M?_ME'_"C/^GG_P @_P#VRC_A1G_3S_Y!_P#ME'_"C/\ IY_\@_\ VRC_ (49
M_P!//_D'_P"V4?\ "C/^GG_R#_\ ;*/^%&?]//\ Y!_^V4?\*,_Z>?\ R#_]
MLKH/!7PW_P"$8F:Y\[S-T93'E[>K*<YW-_=]*[6BBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBO/_C7_P ><?\ U\+_ .@25E? S_EZ_P"V/_M2O5:***H:
MQ]P?[P_D:-'^X?\ >/\ (5?HHHHHHHHHHHK"U/\ UC?A_(5L6OW%_P!T?RJ6
MBBBN4T3QN-:O#:P#-O\ 9S('9&4LP<*2N<949(^Z#N!YP*ZNBBBL3P_<7-]'
M%=2O%LEC5RJ0NK#>N0 QE8<$_P!WGV[2WMU-;3Q+N0Q32%-NQ@XQ$[YW[\'E
M/[@X/MFKU[J,5@N^9U12< NP49ZXR2.>*L57BU&*6/[0KJ8L$[PP*87.3NSC
M P<^E9_A_P 1Q:L"%DC:0/+\J,"=B2,BMC)."NTYZ'.1P15B;5D\Y+5)(O,W
M?.C./,V[&8;5!SG.T\C&W)]*L7NHQ6"[YG5%)P"[!1GKC)(YXJ6698AEB ,@
M9)QRQ  ^I) 'J>*9:W:7:B6)E=#G#(0RG!P<$<=:FJNFHQ/(;<.IE49*!@7
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M1D\#/.&3>)H(HTGRQ$LGEH-C*S299=F&"[3E2/FV@'J0*?INO+>2-;,K1S(
M2DFW<5/1P59E9<\$@G!X..,Z=%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%4-8^X/]X?R-&C_ '#_ +Q_D*OT44444444445A
M:G_K&_#^0K8M?N+_ +H_E4M%%%%%%%9GB>%IK2X1 2S02@ #))*$  #J37G]
M]X6G233;J-&VXM!,JJ1M:+&'<#G(4E<D?*!@GD"KU^)])%[IR6\LOVV1WCD1
M?W?^D *P8\A=A]>O4[00:S_&/AJ:+,$2/((]-@B#)&Q#,EPF0,9YP-V,D@<]
M*[#P1:/;?:_,5EWWT[+N!&5.W##/4'L>E9GA[3I8M%:W9&$OD7(V%2'RQDP-
MN,Y.1CUHU#3I7M-,0(Q:*>S+@*<J%0ABPQP!WST[U%+H0TXW2213S&XG=XUB
M>1(W$H7*MY;[4"DD,T@&5Y&[&!:O/#@M;B&Z99!"EH(2MN\A*%&4KS&RRNIR
M1PIZ!F ZK7N]&66Q9?L;E)IC(R>:6N%!'^N_>9/FX _=@G.<$G+"IO!NE3:?
M<,L<DSV/D@+]H#*RNI "A7"M@+DY50O.WDK7:T4444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444450UC[@_P!X?R-&C_</^\?Y"K]%
M%%%%%%%%%%86I_ZQOP_D*V+7[B_[H_E4M%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%4-8^X/]X?R-
M&C_</^\?Y"K]%%%%%%%%%%%86I_ZQOP_D*V+7[B_[H_E4M%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%4-8^X/]X?R-&C_ '#_ +Q_D*OT44444444445A:G_K&_#^0K8M?N+_ +H_
ME4M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%4-8^X/]X?R-&C_</^\?Y"K]%%%%%%%%%%%86I_P"L
M;\/Y"MBU^XO^Z/Y5+115'7+UK"WFN$P6BB=@#TRJDC.,<<5GWMDNDA;F//F-
M+"KLW)D$LBQG?C&2-V4QC9C:N$)0FK)(;FV9B!&)V"J.<YMYB68D<$= !QC)
M))(";U%9/BS_ (\[G_KWF_\ 0&K%6ZGN+BVCE/\ Q[S.CG"_/(8)B'P/N_NP
MKX&1^]VYRAK:N]8>VW3&/_1XL[W9BKX7[S+'MY4>I8$@$HK#;O-1U66"9+:*
M-7\R-V#&38 490V[Y&(&'&"-Q)X*@9833:J;9$9XV\UVVB-"I)8!B<,2JXVJ
M6!8J<=0&.VI;&Z>7*2IL=<9P2R$'."KE5STP00"#VVE6:W7*17?GW-QIZ-M>
M28.Q!PPC2&V#8QR"^=JD8Q\S!MR@'5:;[$19V<2910Q4GRHU5RV/NHW+$-P%
MQP2Q!V[A=7DN4#019?S"CI,XC*;03EBHDZX7;C.0RM]WFC3=3FN_-#1H#'PI
M65F1F&=R[C&I&T@!B P!)'WE90:%,96GWHJ2"8!]CF16/E1$,"RICY2HQ@=,
M]ZKQ>)'/[QHB(O/,.X.I;=YQA#;>/D)QDYW \;"OSG>HHHHHHHHHHHHHHHHH
MHHHJCKEZUA;S7"8+11.P!Z9521G&..*S[VR720MS'GS&EA5V;DR"618SOQC)
M&[*8QLQM7"$H8M<TM;>.6[X:Z)_<OC#*S82&-2<D*6QN!.QBSE@%8@='163X
ML_X\[G_KWF_] :J%C]F\Z/\ L[RL;F\[[/LV[-C8W;/ESOV[<_-C=M^7?5H>
M(6VBZ,?^C/M(<.-X5B,2,A "QX^8G<6"X+*/F"V)]4D9V2",2"(@29?8<E0V
MU05(9MI!^8HO(&[[VW/T+4&AM+2&)0\KVT9 9MB[41-S%L-@#<!P"22.,;F6
MW=:\T-O-<! 9+8-O0O@950Y <*<@H0RG'.0&"G(6U974TK8EB"*1E2) Y'LP
MP,-S_"77@_-TW55N&-VJ2QJ#Y4QC=9&8[0\08%"B@%LJ>K8P1GUEGU9R[101
MF3RB Y+*@!VAMBYY+[64C(5.<&0$$57UFZ4-:S$[4\YF)<%,#[-.<D-@K@=<
MXQWK0L;I[G+LFQ#C9DG>1SDLA4;/4#).#\P5LK53Q9_QYW/_ %[S?^@-6*MU
M/<7%M'*?^/>9T<X7YY#!,0^!]W]V%? R/WNW.4-;5WK#VVZ8Q_Z/%G>[,5?"
M_>98]O*CU+ D E%8;=\UYJ;(_P!GA3?(%#'+!$4,2%+-@GYMK ;5;D?-M!!J
MCXAO5:V6=\H!/;%O,^7;MN(]V>V!@\@E2.02"#4VCPKJ.W47 )D :+<,F-&4
M8 ]&;)+D<\["65%-&EW#27$JRQJDHBA)*2-("I:7:/F1,$$-VYSUXJ&\\2/;
M&=O*+16I^=@Z[B/+63*J<9(W?,"R\8*EB2HMZEJDD$J6T48=I$D;+/L4>64'
M)VL<'?V!.<#&"65B:^)8UD5&WR2/&J.0#O0N&!92P &QB2">!P&;"F:QU-I7
M-O,FR15#<,&1@202C84G;P&RJ[21U!!-'2O$CW8@>2(HMT!L(=7P?+,A##C
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M)D U]6EDCNX?*0.Q@N!AFV*/G@.2V&..,<*QR1P!DBPFOB6-9%1M\DCQJCD
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MKIKZ>EM(JLYM[?RF3Y%<AA'R,MLR#&,C=C!)#$@!M73_ #&#/+QO;*IP2BX
M"DC@G(+'J 6*@L "<?P;9-$KNV,(?(CQ_P \[5W1"W^V26W$<$8P!S71T444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444450UC[@_WA_(T:/\ </\ O'^0J_111111
M111116%J?^L;\/Y"MBU^XO\ NC^52T444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M44444444445#=6JW2F-QE3CN0<@Y!!&""",@C!! (((I\,*PJ$0 *H   P !
MP  .@%/HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHJAK'W!_O#^1HT?[A_WC_(
M5?HHHHHHHHHHHK"U/_6-^'\A6Q:_<7_='\JEHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHJAK'W!_O
M#^1HT?[A_P!X_P A5^BBBBBBBBBBBL+4_P#6-^'\A6Q:_<7_ '1_*I:*****
M************************************************************
M************************************************************
M************************************************************
M***********H:Q]P?[P_D:-'^X?]X_R%7Z***********PM3_P!8WX?R%;%K
M]Q?]T?RJ6BBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBJ&L?<'^\/Y&C1_N'_>/\A5^BBBBBBBBBBBL
M+4_]8WX?R%;%K]Q?]T?RJ6BBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBJ&L?<'^\/Y&C1_N'_>/\A5
M^BBBBBBBBBBBL+4_]8WX?R%;%K]Q?]T?RJ6BBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBJ&L?<'^\/
MY&C1_N'_ 'C_ "%7Z***********PM3_ -8WX?R%;%K]Q?\ ='\JEHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHJAK'W!_O#^1HT?[A_WC_(5?HHHHHHHHHHHK"U/_ %C?A_(5L6OW
M%_W1_*I:**AN[C[,C2X9MBD[4&6.!G '<GL/6N:L/B$E[+]E6WN0X9 VZ$ )
MOZ%_F)48YR1TYK;TC6TU7S?+##R)GB;< ,LF,D8)XYXZ'VK0HJOJ-ZMA$]P^
M2L2,Q ZX4$G&<<\5S^E_$*"^DCA9)8?/&8VG0(C],!6W').1CL>!G) /4444
M5GZOK::5Y7F!CY\R1+M .&?."<D<<<]3[5H445DZ'XA76AYL2/Y1W;9&V!6V
MMMX&\N,D'&Y1P.<5K5R6E_$RVOVC0I+&)SB-I(\([;@NT%2V3D\]AW(KHM0U
M#['L^1W\R14_=KNV[L_,W(PHQR>U6Z***HWFL1VDL5JV?,N"X0 ?W%+,2>P'
M ]<D<8R1>HHHHHHHHHHHHHHHK/TC6TU7S?+##R)GB;< ,LF,D8)XYXZ'VK0H
MHHHHHHHJCK6L1Z/"]W-G9&,G R3D@  >I) [#U('-7J**YK4/'26D\EFL%Q*
M\.W<88@ZC>H8?Q9Z>H'0U/=^+X[.W2\DCE7S7"+$8_WQ8D@+MSU."1SR.G)
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MTV,1(S8)VY('"Y]6. /<]#7CNA:[;:,]I>B3=.6D%WS-EA*<ACN7#;.K =6
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M[M5NT:&09212K#)&0PP1D<]*S[7PZD,HNG9Y'12L?FL&$8/7;P#DC +,6<@
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M39O $#10VZ-+']EW;'BDVR?/]_G!'S'DX ]!@9%5]2^&L%\TA\V=$G<N\:2
M1EC@EMI4\DC//?I@  7=:\%0ZO.+R1G#B%XL*5"[75U)Y4G.'..<=./6Q/X7
MBFBM[<EMMH\3(01DF(87=QR#WQCVQ6Q15#6/N#_>'\C1H_W#_O'^0J_11111
M1111116%J?\ K&_#^0K8M?N+_NC^52T44444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444450UC[@_P!X?R-&
MC_</^\?Y"K]%%%%%%%%%%%86I_ZQOP_D*V+7[B_[H_E4M%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%4-8^X/]X?R-&C_</^\?Y"K]%%%%%%%%%%%86I_ZQOP_D*V+7[B_[H_E4M%%
M%<EIOC_[8T<K0LEK<.(XI6922YR IC4DJ"589R1P"< Y'6T44R8L%)0 M@X!
M. 3V!(!P/?!^AK'L-5N;IWC,40$4@1R)W)Y1'R!Y(SPXZD<\=.:VZ****J1W
MV^9[;'W(XWSGKYC2#&,=MGKSGVYENY&B1GC7>X4E5R%W$#A<G@9/&>U35F:/
MJ4NHJLY15AD0,A$A9\-@KN38 #@\X9L'@9ZUIT54DOMDR6V/OQR/G/3RVC&,
M8[[_ %XQ[\%[??9GBCQGSI"F<XQB-Y,].?N8[=<]L5;HHHHIDQ8*2@!;!P"<
M GL"0#@>^#]#5+2-1>[\Q)45'ADV$(Y=3E$<$$JAZ/CIVK0HJIJ=]]A028SF
M2),9Q_K)%CST/3=GWQCCK5NH;:1I 2Z[3N88R#P&(5LC^\ &QVS@\BIJ**J:
MG??84$F,YDB3&<?ZR18\]#TW9]\8XZU;HHJI>WWV9XH\9\Z0IG.,8C>3/3G[
MF.W7/;%&IWWV%!)C.9(DQG'^LD6//0]-V??&..M6Z**S/$6N+HD)N64MM(^5
M?O$9RQ [E4#-CT4Y(&2-.BJDE]LF2VQ]^.1\YZ>6T8QC'??Z\8]^)6D8.$"Y
M0JQ+9'!!7:N.IW DY[;?<5%)?;)DML??CD?.>GEM&,8QWW^O&/?BW5?4+U;&
M-IFR0HZ+RQ/0*!QEF. H[D@54MM8/F+;SJ(Y) S1C>&W!<;AQC#KD%E&1@Y5
MF ;;IT445##(SEPR[0K84Y!W#:IW8[<DK@^F>AJ*ROOM+RQXQY,@3.<YS&DF
M>G'W\=^F>^*)+[9,EMC[\<CYST\MHQC&.^_UXQ[\6Z****J:I??84\S&2615
M&< M(X1<G!P,L,G!(&2 3P7V3RNN9E56SP$<N,>N2B<^V/Q]+%5-,OOMR&3&
M,22IC.?]7(T>>@Z[<^V<<]:+*^^TO+'C'DR!,YSG,:29Z<??QWZ9[XJW116)
MH^OO=K%)-&J+<J#&4D,G)0R;6RB8.T$C&1P02#M#;=%%%5)+[9,EMC[\<CYS
MT\MHQC&.^_UXQ[\6Z*KZC>K81/</DK$C,0.N%!)QG'/%,L9)GSYZ(G3'ER-)
MGKG.8TQV]<^W>W6);>(6.Z66/;"))$\Q7#!1$[1EG!"E02,Y7> ,ERH&:U;F
M1HP"B[CN48R!P6 9LG^Z"6QWQ@<FIJ***J1WV^9[;'W(XWSGKYC2#&,=MGKS
MGVYMT444445F:/J4NHJLY15AD0,A$A9\-@KN38 #@\X9L'@9ZUIUCG5+B:26
M.&*,K"X4EYF0DF-'Z")^/GQU[5L44454LK[[2\L>,>3($SG.<QI)GIQ]_'?I
MGOBK=4=4U(V6Q54N\K[$ ( SM9\L3T4!3D@,?12>*?I>H#4$\T*R_,ZE7QN!
M1RC [2PZJ>A-6)BP4E "V#@$X!/8$@' ]\'Z&LHZ\SPQR(@,TK^6(R^ '4D2
MJ7VGA-CG.,-M^7.1G8HHHHHJI>WWV9XH\9\Z0IG.,8C>3/3G[F.W7/;%&K7W
M]GPR7.-WE1N^,XSM4G&<'&<>E6ZP=.\02S1Q7,T:I%.(]I24NP,N-@93&G!)
M"Y!;!(XVY8;U%%%%5([[?,]MC[D<;YSU\QI!C&.VSUYS[<DE]LF2VQ]^.1\Y
MZ>6T8QC'??Z\8]^+=%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%<?K/
MBFYEO?[+L%B+I'OD:;?M7.,#Y<'H1TW9W#I@U2ATG748,;F!@""05X..QQ"#
M@^Q!]#6KX7\52WL\NFW:*ES  3Y9)1U)^\,@X !7J<G/08('4444445@^-?$
MP\.6S7( +DA4!S@L?7'8 $]LXQD$BL*XLM<O-L@EMX<J,HH)P>O)9).>QPV.
M./4MG\27_A81-J/E2PN^PR1E@ZDG.XC: 0%S@*O..2#U[VBBBBBBO/[7Q'J/
MBCSFT_R8X$DV)))N+G&"2 0PY&#\R# ; R02);>RURSW2&6WFPIPC C)Z\%4
MCY[#+8YY]1T'A#Q.OB2 72C:=S*RY)VD=LX7.00>!WQU%;=%%%4-8^X/]X?R
M-&C_ '#_ +Q_D*OT44444444445A:G_K&_#^0K8M?N+_ +H_E4M%%%<9 \GB
MRY6; %C:2DH3R9I4RH=2#]Q3T(.&Z'.2$[.BBBLG1O\ 6W7_ %\+_P"D\%4K
M/1X]722:7/G&6X02J=LJ!)7C4(XY4!0.!P>2P.YLZNAWK7]O#</@-+$C$#IE
ME!.,YXYJEXNM5N85##I<6V""0P)G120PP5."1D$'GK5AK&#1XI9(P(4"$L8U
M "[027" %=P'?:2< '( %8]O"UE/ T<*PI-(RN2X:5\12/\ O H92=RY#^8S
M=>1O<58M]#MS?2N8H]PB@<'8N0YDG)?./O' R>O ]*E\:Z=%=6D[R(K-'!,4
M+*&*G83D$C@\#IZ"MBZM$NU,4JJZ'&5<!E.#D9!XZUSOA_0(I=/1(U6-Y[:+
M+J@#;]@*R'&"65CN!SD'D$'FK&E7W]M2I/C AA!9<[@LLOWD/ Q)$%*GC=B0
M@A0?FZ"N<U+0[>ZO8S)%&Q>"<L616R5: *3D<D D#T!P*L>([5;M[6)QE6N#
MD9."/L\QP<=0>A!X(R"""16;<,UC#=1PDA8[F)0"[*J1LD!D ;DQH%9CE1^[
M&2N,"K6BVK6=QY0CB@0Q,3'"[$,=R@. 8HURHR&*Y/S)NXV5T=<YKMBTTWF!
M!. D8,7F['C^=OWJ _+O()PQ*,-A"OR<1:G*U^;9$"SPS1.V)V\M'8",H3B-
M@6VEV"%0."V 4&-#PR&59$;: DI"HC,PC 5?DRR(<9RRC& C+M^3;3M&_P!;
M=?\ 7PO_ *3P5SNEI,4@NF2))9'C$DWF.922P$B./)P"<% C-M1]JKAE0#:B
ML$U26?SP6\J550%F 4>3&^Y0" '#.Q#CYQG 8# J#7[:'4[:&9@LH,EKM>1%
M+%9)H@3C:,;Q]X  'IC'%;7]DP^7]E\M/*_N;%V==WW<8Z\].O-85K*=.T^X
M>'"&(WI3 &%V2R[<#&,#'3&*L:AI<>D[+F!=CB:)6VDCS!*ZQ'S.<R$!RP9B
M2&YSRP.9JM@C)J-U@B6(L4<,P9"MK$<J01M)_BQC<,!L@ 5V=8_BN(2P!#G#
M3VP."5/-Q'T(((/N#D=JA73HK.X6UC15AF@F+QJH",5:)0=N,9P[ \?,,!L[
M5Q5TZ9KQH+)R6:V+F4L=Q)A_=Q%P>AER)DSG[F1N^\.HKG_$>DPW<UJTL:.3
M,5)=%8E1!,P4Y'3/..F>>M2^);51;K"!M3SK50$)3 \^,8!7!7 Z8QCM5*>%
MM-:[CM 5VVD;QH@RH<^?]V/E025&0!ACR0233-,MVMYH71(8EEW%FBF>0S#8
M2 6,2AVR0X9F+D!R,@O75U@ZQ<LUQ$B1M)Y ,C",H&!<-''GS&0%2#)D D@J
MO0=:&EN1'8PL"K03M$RMC</+MYE!(!(!90'P"1AA@L,$RW,S1_:MI(W7MLA(
M.#MD6U1L$<@E6(R,$=00<&K$.E1:?>1"%%0-;W&50;5R'@YVCC/J<9( !) &
M'?V=%:WT;QHJM)!<%RJA2Q\R Y) Y/)Z^IJ+4M#M[J]C,D4;%X)RQ9%;)5H
MI.1R0"0/0' KHZR?$W$(;LLUNS'L%2>-F8^@4 DGH "3Q5Z6_2*1("3OD#%0
M%8\)C<20" !D=2,D@#FN7%JHL!JH&+D6ZSF0$J[LJ"0JQ&"T;$8*?="X"A=J
MX9/8)/=-N!/F7H1AN;!06(<H0#C:S*"PZ/M4-D  4M1)N+:"=RQ==+GD#;CG
M>$@(8G/)!^8$YPP##Y@".ET2U4&YMB,QK-MVL2PPT$3,#NSG<6);.=Q))R23
M1X<M$M'NHHE5$%P,*@"J,V\). ..M5_#^AV]O/<.D4:M'. I5%!4&WB) ('
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M;9S,H;=N9L-([*&<DLRHS%5)W'D '!(Z$U:N;5;H!'&0&5NI'*,'4\>A /\
M/BB:U68H[#)C;<O)X)5DS[\,1SZ^M'R7B?PO'(OLRLK#\000?H15?2[&*W7S
M(26$@!WM(TI(ZK\[LQ*\D@9QR2.IR1:-%%)YX!W9) W,4!;.Y@A.Q6.3E@ 3
MELGYCENIZ##J>?-#<KM.R1X]R\_*VQEW#DX!R!DXZG+M4L8KA?,F)41@G>LC
M1$#JWSHRD+P"1G' )Z#$5C';7T02%EDB1U.4??\ .C"0$L"26W88Y)))RV<G
M.A%,LHRI!&2,@YY4D$?4$$'T/%5(M%ACD\\(-^203D[2V=Q4$D(6S\VT#<>6
MR:O54OM+2^P7W KG#([QL <9&Y"IP<#(S@D D9 P9BTF/)*QQIU9VP,L>I9C
MR6)Y).23DDDT:48O*06Y5HE4*A1MRX7Y<!LG.,8Z_6K=9D_AV*9VE/F!I""V
MR>:,$A0H.U'49PH'3M5M+!$9'P2T:%%)9F.UMI.22<D[!R<GCKR<NN;5;H!'
M&0&5NI'*,'4\>A /\^*%M55S,!\[*JDY/1"Q48Z<%C^?TJO%HL,<GGA!OR2"
M<G:6SN*@DA"V?FV@;CRV33;G08;EQ,P;=N5L+(ZJ60@JS(K!6(VCD@G  Z 5
MH57O;!+U=C@\'(*LR,#TR&4A@<$C@C()!X)%,L=*BT_(A14#8RJ#:N1GG:.,
M^IQD@ $D 8L&90P0D;B"0,\D# )QZ#(S]1ZU$(HTE+\"61 .O)6,GMGH#)R0
M/XAGM4-[H\=XV]MP;&,QR21$@<@$QLN0,G&<XR<8R<ON-*BN$6%D78F-H QM
M(&%*D8*D#H5P1V(J*+0((HY+=5^2?/F#<Q+%E",22<Y(')SDG+$[B35IK56<
M3$?.JLH.3T<J6&.G)4?E]:Y6*RCU24Q!$,L$R.\BNKHI20.=D>]FC:0KAQM7
MG<2TA4;^PJIJ&EIJ 42;OD;<I1W1@<%<AD*GHQ'7O42:%$J/"=[)*I5A)++)
MP000"[DC(/;'Z"BUT..U82*921G[\\SKR,<J[D'\1[]:M6EJMHBPQC"1J%49
M)P%& ,GGI3TF5R0""5." <X. <'T."#]"#5>^TN._P >8N=N>Y&0<94X(W*V
M!N4Y5L#(.!3XM/CCC^SA1Y>"-IY7!SE<'/R\X"] .   !3+'2X[')C7YFQN8
MDL[8SC<[$LV,X&2<#@<5;K)U?3+:^813G#RJRA1*T;.H!)4A&4N ">#D#)Z9
M.;UQ%'&WVI\ QHXW$X 5MK-GG&/D!R>F/K3#I<90P;?D9F8C)SN9RY8'.0=Q
MW @@J<%<8%/LK!+)=B \G)+,SL3TR68EB< #DG   X %6*KW.HQ6K*DCJK2'
M"!F"ECP, $\GD=/44ZZNTM%,LK*B#&6<A5&3@9)XZU-3(IEE&5((R1D'/*D@
MCZ@@@^AXIEO=I<[O+96V,5;:0<,.JG'0CN.M344444444444444444444444
M444444445YTMVFCZY-+<LL:3VZ[&<@*>(QR>@YC;KCI[C/7_ /"66?\ S\0_
M]_D_^*KDO"LRZEK%W>0D/"(E3>#QNQ&./4?NVY'''7D9]#HHHHHKA/C):M-8
MAU&1',C-R. 0R9]^6 X]?2NCA\8V4JAQ<188 C,BJ>?4$@@^Q&1WKC/BGJT.
MLPPV5M(DLLEPNU8W5OX67D@X'+ <D?H<>ET444445YI\+-6AT:&:RN9$BECN
M&W+(ZK_"J\$G!Y4C@G]1GLYO&-E$I<W$6%!)Q(K'CT ))/L!D]JYSX-VK0V)
M=A@23.R\CD *F?;E2.?3TKNZ***H:Q]P?[P_D:-'^X?]X_R%7Z**********
M*PM3_P!8WX?R%;%K]Q?]T?RJ6BBBBBBBBL?2Y91<2Q3&-F6*%@\<9C)#-*-I
MR[Y VY'(^\>*J7VN7%O]IF58S%:$_*=P=P(4D(W<A2-QP=K;ONX3&XZ%W=RS
M2FU@*JR(KLTBEQARRJH563GY"221C  #;B5Q[+6?[-M@TA1'ENKE-SM^Z5C-
M,Q)8[20 IQ]TL<#Y<Y&GH.NKJ#/"'CE:((2\)^0A]V!C<VUAM.1N/&&S\VU:
MFFZY</##>SK&(YA""L>XMF8J%?+8&-S %,' RPD8C::]YXU2 R2^;"$A9U:%
MF'GMY9*L1\X )(.Q=IW #++O^35U.\F$T=M!L'F1RL6D#-CRVC PH*YSO(QD
M>N>-K11:Z\\:$*JRRS21 ;BZ*T9D#,3A21B,D# ).%RN2PSWU-]*FN)K@H2L
M-J RYC0[Y9E4MN+; "WS'+X4;AR=HNZ+XA6ZE^RF6*9BC.&M^  I52K+O?!^
M8%3GYOF&!MRT46N7 'VAEC,7VDP[1N#X^T&$2;N1D<93'/WMX^X#4HKAKV/R
MWC4&"?;NB9L#=!N!Q*N23@@\8'!!SD='6?X@O'L;>6XBV[XHV<;P64[!N((!
M4\@8Z\=>>A=9"X#9F,94C("!@5/]W))WC_:PG3[OS?+A6?C5)S'+YL)29D58
M58>>OF$*I/SD$@D;UVC:"<,VSY]62^FG=UMPA$#!6$A8%F9%?AE#;0H8')5B
MQRN% #$L;J;4K:&XC9$DDCC=MR,Z_,F2  Z$<GCD\>O6FZ=J+"Q2Z2,%OLRN
M(XQ@$^6&"*!G [ <_C3M$U1K[)W12(<_/ P95/&8SR22 00P W#.43C=2\/Q
M7"SW!=XRHG&X+$RDG[/%@@F5MHZ<$-G!Y&>#4?%"Q2O")8(C"0"L[89R55\
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MEPPRRS1ZE/=;IHE4Q1NZ[23YC^6Q1L'A4(*G;DL'& 3'R1+K%Y);C<K1Q1J
M6EFY3DX"@!TY]22 .  Q)VRZ-JBZI$)UQ@EA\IW+E&*$AN,J2#M.!D8.!TJO
MX:_U3?\ 7Q=?^E$E:U8\VN-;+<%U!>W/RJ/E,@908P <G+,3&",[G4X&?E%?
M5/$'V-Q:M-#%((U=GF&%;<67")YBGJI)RQVC:/FW96U9ZNVI0+- %+.S+G<&
MC4HS*SY!!=<J=N,%LKG8"2L6CZY_:/F0))%))&JGS(OFC^?=MRH<D$%3E=W(
MP0PW84\/WES?1Q74OE;)8U8J@<,NY<@AB2&R?X=HQG[[;?FVZYS4?%"Q2O")
M8(C"0"L[89R55\ [AL7# ;\/SGY?E^:Q<ZV\\=M);!?]+88\T'Y5:%Y,X4\D
M;1QG!Y7(SN FNO$DOF*IDAF2(;6(5FD$>QN02@)D&X?.5&<%^\4*S)>1"<HW
M^CW&&C5D_C@R"I9^G'.[G.,#&6L+++'=K'(8V5XIF0K&5=0KQ#;N+MD'<,X"
MY*@X[47-[</<-;P^7MCBC<E]V27:0;..@.S[W.W^X^?E9%K;WZ0"$*DES#YN
M7!=54!"1@%2QS( .5&,MG@*UC1=0ENS,LRJK12A0$8L,&.-_O$+D_/\ W1Z<
MXR=.N2EA5;*:Z 'FP/?/&^/F5A-*>#Z' W#HPX8$$BK6H^*%BE>$2P1&$@%9
MVPSDJKX!W#8N& WX?G/R_+\UO^W&NUA%NHW7,1D4R<!4&S)(7.YAYB_+D \_
M.O&77FKMIL#33A0R,JYW!8V+LJJ^2247+#=G)7#8W@ ME-XO\M)@LL,\D=O+
M*K0_='E@?*Z^8Y')&"&^8;AA=N6MVNNS&802J@'G&(E&8G<8/M (R!PH^3U<
MG=A -I99BX,]T83&%$ZDAPQ+'[/#\N01L'^UA^OW?E^9MSXO238$EB@\R&.7
M=<XY63.U0HD3)X.X[L+P &W966?Q"\]LEY;A"3,B$,2R-F;R6VNO;/*OM.5Y
MV9.!JV*S)D3E&Z8:-63UR"I9^G'.[G.,#&6MUS_B&R*)+Y:.[7&,N-I\H(%"
ML!D.=AS(BH&)?.-I8&CQ@GVVSED1_P!U]GE;Y#]_Y"4^<'[O<@?>X!.W<K=!
M1169J$,5FLUU*"^] I4@'<JY"Q*O )9F. <EF;&<;0*6CV[K*L$YWO;VMN<D
MDCS'\U)'R>22$ R>0"<8W-F73(VQ<6T3;%BF"IP&V*8HG(4'C@LVW.57@;2J
MA:S8Y&LK%A'N/^ENG#?.5>]*, [,#N*DC<6!!.=P/-788/*FA,T21,,I&T#[
M@0J.?);,:$+C+J!E<IDD$*&Z"BBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBLS7/
M#=OKJJER@<(<KR5(SUY4@X/<9P<#T%8__"K=._YX_P#D27_XNMW1]%AT>/R+
M= B9)P,G)/4DDDD_4] !T J]111113)H5F4HX!5@001D$'@@@]0:Y?\ X5;I
MW_/'_P B2_\ Q=7='\#6>CR?:((@L@! )9VQGKC<QP>V1SC(Z$UO4444445@
MZQX&L]8D^T3Q!I" "0SKG'3.UAD]LGG&!T JE_PJW3O^>/\ Y$E_^+KJ(85A
M4(@ 50  !@ #@  = *?1115#6/N#_>'\C1H_W#_O'^0J_111111111116%J?
M^L;\/Y"MBU^XO^Z/Y5+111111115&*R9+B2X.-KQ1*!WRC2D_A\XQ^/XTKS1
M'FBO(@5S=;MF2<#,"1<\<<J>F>/?BK%W:2PRFZ@"LSHJ,LC%!A"S*P95?GYR
M""#G((*[2&J6^ARQ0JI93/'/)*K#(0EY'8C!W$!D<H?O;=V1N(!K0TV"52TD
MQ +D?(K%T7 QPS $DXR<!5'9<[F?"\.6<U[:6T4FP1+';N&4MO/E['1=A&%P
M0-S;FR <*N[Y-!M+FC+01%5ADDWAPS"1"Q#L NTALOELLV!OVE&1=K79;)GN
M([@8VI%*I'?+M$1^'R'/X?A2CT1XT7!7S(KB:5,D[#YCR_*3C(RDA&0#M;G#
M 8:)M$FO6FDF*(TD<(3RRS[&A>1U8E@N_#,K= #]T@@9;0L89F<S3;5^4*$C
M=I%X).XEE3!YQ@*./O%OE"5/[$?R?(RN[[5YO4XV_:O/QTZ[>/3/?'-6-2M)
M?-2ZA"LR)(A5V*#$A1MVX*_(\O&,<YSD8P;MIOV+YNWS-HW;,[=V/FQGG&>F
M><57URR:_MYK=,!I8G4$],LI SC/'-7JQ++2YK?9;@JL,+91E9MY49"Q%"NW
M 4[2Q9R0N[ <AD9*6MI)S"\:ABKRF8-^[Q&J[@ORAT94QG<H5@YW-@HMOPQ"
MT-I;HX(98(@01@@A ""#T(I^DZ>UI;1VI;#QPHA9,'!5 N1N&.O(R/J.U5[#
M2Y5G-U)Y:DH581 _O#E=LC$XY 4A4^;8"<2'-'V2XM97:$1E)I4=B[,&4!8X
MV4*%(8[4R"67D\C Y+S3ID>0P;=MP!OW.ZE6"[#(-@RQ*A1M#1XV A@6)%BZ
MT]I6MSNSY$A9BV S#RI(\_* ,DN"> .N.PIVJV37*JT>!)$X=">F1D,IZX#(
M67.#MW;@"0*KC2WO8YH[@X^T*5*1L65 5V$JS*#DCD_*%'&%SN9XFL[FYEA>
M7R@D$C,2A<L^8I$! ( 3EL[<OU^_\OS;=8.K&5;N$PA2P@N,AR5!&^#C< VT
M]\[6SC&!G<'RZ$\\;@LJRRS1RD[2Z*T9C*J!E21B, G().6PN0HETRSF$TES
M/L'F1Q*%C+-CRVD)RQ"YSO!S@>F.-S4M-T.X$,-G.T8C@$.3'N+.8BK*/FP$
M 90"?GWC) C/ U=0LFN'@<8Q%*6.?0Q2)Q[Y<>G&:-<LFO[>:W3 :6)U!/3+
M*0,XSQS1JEDUQLD3'F0OO4-]TG:R%21D@%6/(S@X.& VDT^"7<TTQ 9PH"(Q
M9%"YY!(7+-NY.U> JX^7<UZN<O?#\KK/#'Y>VX#[W;/FL&R/+) Z+N(1SNV+
MA?*;&3H7=I+#*;J *S.BHRR,4&$+,K!E5^?G(((.<@@KM(:)M*E@V3HPDFC$
MH/F$JK"9E=@" Y4*5&S[V%&PYR&#GTE[F-ED?]X\B2#&61&C*,B@'!*@H-WW
M2Q+$;-V%([6:\=)+A400L641NTA+%&3DLB8 #'@ DD@Y 4AJ4NAW 'V=6C,7
MVD3;CN#X^T"8Q[>1D<X?//W=@^^-6*R9+B2X.-KQ1*!WRC2D_A\XQ^/XTDT1
MULXK3*^9"MOW.TM R-C.,@,4QG!(!S@]*T-/:9@QN BG=\HC9G&W ZLRKDYS
MT &,=\FF:?9-;O.YQB64,,>@BC3GWRA]>,52_L1_)\C*[OM7F]3C;]J\_'3K
MMX],]\<TR4M;23F%XU#%7E,P;]WB-5W!?E#HRIC.Y0K!SN;!1;?AB%H;2W1P
M0RP1 @C!!" $$'H16G5'2+)K)"C8),LS<>DDKN/3G##/O1+9,]Q'<#&U(I5(
M[Y=HB/P^0Y_#\"*R9+B2X.-KQ1*!WRC2D_A\XQ^/XTM2T1[J5I5*X;[)C).?
MW$[2MV[@\>_7 YJ[I%DUDA1L$F69N/225W'ISAAGWJ;4;);^)[=\A94921UP
MP(.,YYYK/DM+B^VQ3B,1JZ,6C9BS&-@Z_(R@("R@GYGP,J,D[Q:ELF>XCN!C
M:D4JD=\NT1'X?(<_A^%ZJFK6/]H0R6V=OFQNF<9QN4C.,C.,^M,T][AV8SK&
MJX7:(W9SGG<261..F !ZY/3%*ST1X8K.(E<VNW?@G!Q \7''/+#KCCWXH;2Y
MHRT$1589)-X<,PD0L0[ +M(;+Y;+-@;]I1D7:VW5'5=/:\53&P22-PR,5W '
ME6RN5R&1F7KQG(P0#55M&;4%E-R2IFB,6R.1BBJ<@D;@ SG/WB@P,*!P2Q):
M7%]MBG$8C5T8M&S%F,;!U^1E 0%E!/S/@949)WC/NO"\LJ.@*Y>*_4<GK=2A
MT[= !\WH>F:L3-,EY*8 C?Z/;Y61F3^.?!#!7Z<\;><YR,89TGA]HEC9=LCQ
M/(^V7Y8R\K^87'#E&5B=APQ"DKR6W@ET.66"ZA9E,MR'^895,M"L8.WYBH&T
M9&Y_[V>=JZ$MDSW$=P,;4BE4COEVB(_#Y#G\/PRK.V6\O&G1@T*I'(-O*F:1
M&3?O!ZB$*-O3#JV,D$]'5'7+)K^WFMTP&EB=03TRRD#.,\<T_5+'[<GEYP0R
M,IQD!HW#KD9&1E1D9!(R 0>14CM9KQTDN%1!"Q91&[2$L49.2R)@ ,> "22#
MD!2&L:19-9(4;!)EF;CTDE=QZ<X89]ZO451T.R:PMX;=\%HHD4D=,JH!QG''
M%5="M+BQ6.U<1^3#$$#*S%V*[55MI4!00"2,MR0 >"2R^TB6ZD0DIMCD#K(5
MS,!N!:(8"@!@-I?/*?*R,<N=NJ.KV37J!%P")86Y](Y4<^O.%./>KU4=(LFL
MD*-@DRS-QZ22NX].<,,^]4H](E:=)W*?N<CS O[V52K (V H4*3N(&Y68!@(
M\8H;2YHP]K&5$4K2,9-S"5/-8NX50N"<L=K;EVY&5;;\\NH:8[RK=1!&<+M'
MFY(CZYD3 SD@X=<KO 4;UV\V-'LFLH_+?!8O(Q(Z$O(SD@'H#NZ<[>FYL;B:
M19-9(4;!)EF;CTDE=QZ<X89]ZO5SE[;+?WD?EL"@0M,%^;)@D'DJ2#\A60N1
MC[Q1E((!QH7MI+'+]J@"LS)L=78H" =R-N"O@KEA@#YM^2?E J*[T-IX$@9A
M(8R"1+S&^ 1L8'<2O/RD[F5@KL7(.Z73;*5)7N)MNZ1(U 3. $+G;SU(W_?X
MW?W$Q\TNAV36%O#;O@M%$BDCIE5 .,XXXJ]6/>:=,CR&#;MN -^YW4JP789!
ML&6)4*-H:/&P$,"Q(L76GM*UN=V?(D+,6P&8>5)'GY0!DEP3P!UQV%5Y-#:7
MSP6 \V>.5".<&)8=NX<9&^/D \KT()X+:TN)KA;J81JJ12(%1F<Y=HVW;BJ<
M?)C&!C&<MNPMJ6R9[B.X&-J12J1WR[1$?A\AS^'X$5DR7$EP<;7BB4#OE&E)
M_#YQC\?QRH+!M-6U0%3/% 8@K%EC?Y8]X#A3AAL#+P25#?+U9+'AI7#7+2%6
M+7'WD4JAVQ1(< LW0J5/S'Y@1P1@;=<_;Z/,Z/9RA! \DS,RNQ=EED=]FTHH
M7(;#,&8XR%P2&6Q>:=,CR&#;MN -^YW4JP789!L&6)4*-H:/&P$,"Q(EN["1
M6CN(B'EB1DQ(=H8/L+$LBG:V4!R%(ZC:,@JR327NHG21\22,'!&62-EVF/:#
MC(0H&.<!VW$@!MHKWNF7&HQ3K(51I8'C5%=G3+ X<L47!YQ\JCC.XO\ *$?_
M &(_G>?E=OVKS>ISM^R^1CIUW<^F.^>*%L;F"69HC$$GD5@7#EEVQ1H<J"H;
M<5QC<NW[V6SM FCOIGEFU"MLA6)EE<IN6/\ U;;E1^5RW 4!MY)/R@5+<:2[
MP);[]S))"Q9L\B.5)"/XCT7"Y))XW,3ECK45F3P7$+L82K+*03YK-^[(4+E5
M .Y>,[,I\V[YOF^5EWHG^AMI\1_Y=S$I<_[&Q22!^>!^%:U4=#O6O[>&X? :
M6)&('3+*"<9SQS5ZL2\M[DS^<J1/&B@1AYG0JQSO? B89((4<D@ X(WL*L3V
MDJL+J,+YQ15=&8[& R0-^TD%2S$';\P)#+RI2QI]C]D#$G<\C;G;& 6P%X&3
M@ * !R< 9+-EC230V:W>V9@&:6616'.UFF:6-L'&2I*D@\$C'(IT=C-<NDEP
M4 A8E1&&RS;&3>2Q^4$.?D 8@X/F,,BM!=^\YV^7M7;C.[=EMV>V,;<=\YSV
MJ:BBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBJ&
ML?<'^\/Y&C1_N'_>/\A5^BBBBBBBBBBBL+4_]8WX?R%;%K]Q?]T?RJ6BBBBB
MBBBBBBBBF0PK"H1  J@  #  '   Z 4^BBBBBBBBBBJ]SIT5TRO(BLT9RA90
MQ4\'()'!X'3T%6**********885+!R!N (!QR <$C/H<#/T'I3Z*********
M*********KW.G173*\B*S1G*%E#%3P<@D<'@=/058HHHHHHHHHHHHHHHHHHH
MI@A4,7 &X@ G') R0,^@R<?4^M/HHID4*Q#"@ 9)P!CEB23]222?4\T^BBBB
MBBBBBBBBBBBBBBBF)"J$D  L<D@8R< 9/J< #Z "GT4444444445#=6B7:F*
M55=#C*N RG!R,@\=:?#"L*A$ "J   ,  <  #H!3Z*******************
M************************************************************
MH:Q]P?[P_D:-'^X?]X_R%7Z***********PM3_UC?A_(5L6OW%_W1_*I:***
M************************************************************
M************************************************************
M************************************************************
M*************H:Q]P?[P_D:-'^X?]X_R%7Z***********PM3_UC?A_(5L6
MOW%_W1_*I:**AN[I;1&FD.$C4LQP3@*,DX'/2J7_  DEN8XK@.#'<.J1D G+
M/G"\#@\$'.,$8.#5?4O&EGIDHM)I560[>"&(&[IE@"%]>2,#D\'-&M^,[31'
M$-S)L<J& V.W!)&<JI'4&HO^$]LO)^V^;^Z\SR]VR3[VW=C&W/3G.,>]6M"\
M4VVO;OLS[_+V[OE9<;LX^\!Z'I6M152^U1+' ?<2V<*B/(Q QD[4#' R,G&
M2 3DC,MK=I=J)8F5T.<,A#*<'!P1QUJ:BH8;I9BZ*<F-MK<'@E5?'OPP/'KZ
MU-114-I=+=HLT9RDBAE.",AAD'!YZ46UTMT"Z'(#,O0CE&*,.?0@C^7%3444
M5#;72W0+H<@,R]".48HPY]""/Y<5-114,-TLQ=%.3&VUN#P2JOCWX8'CU]:F
MHHHHHHHHHHHHHHHHHHHHHJC>:Q'9,L<FX%RH!$<C)EVVJ"X4J"3QR1U'J*O4
M44444445"MTK.80?G558C!Z.6"G/3DJ?R^E3451LM8CO6VQ[CQD,8Y A'JKE
M0C YR-I.1R,CFKU%%%%0VUTMT"Z'(#,O0CE&*,.?0@C^7%$-TLQ=%.3&VUN#
MP2JOCWX8'CU]:FHHHHHJ&YNEM0'<X!95Z$\NP11QZD@?SXJ:H8;I9BZ*<F-M
MK<'@E5?'OPP/'KZU-11111111111114*W2LYA!^=55B,'HY8*<].2I_+Z4+=
M*SF$'YU56(P>CE@ISTY*G\OI4U%%%%%%%%0VUTMT"Z'(#,O0CE&*,.?0@C^7
M%35"UTJN(2?G968#!Z(5#'/3@L/S^M$UTL)1&.#(VU>#R0K/CVX4GGT]:FHH
MHHHJC%K$<LGD+N)R1D1R&/*YR/,V[,@@@_-PWR]>*O444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M50UC[@_WA_(T:/\ </\ O'^0J_111111111116%J?^L;\/Y"MBU^XO\ NC^5
M2T45D^+/^/.Y_P"O>;_T!J\MTV9M/6STV0DEKNSN(B3U253N '(4(^1U!8DL
M *Z6UA6YM-6>0!F\^Z&6&3B) 8QD]D_A_N]L5-XKF:;0P[DEF@MB23DDEHR2
M2>I-7?B5(T26KQKO<7T)5<A=Q ?"Y/ R>,]JVM"U&YO-WVFW\C;MV_O5EW9S
MG[H&,8'7KGVJW;V\D<DDCR;HWV;$V ;,##?,.6W'GGIT%6ZR=1MY;9VN[=5D
M=HU5HW?9D1EV7:VU@#ER"",'(.Y=IW4EO%MX#) &C9KN,.DAW,K27""08W.%
M#!MPVG&&#+US5C4-9:Q>Y<_,D%JDH7@9.9]W.">0@'?'IUS;M;>>)@TDBN&S
MN&S8JX'!0?,?9@S-G.Y2H&UL*ZEFM/MUW$X'DN6"% RL5MHB=QR&Q@#;M*X.
M2V\?*.MK/U>Z:+RX4.UIY-F[ )4!'D) /!.$P,\ D$A@-IJ+YT<ALGE8^9&7
MCD54$HV,HD#94QG[Z[<(.-P/(#%G@JV:&T@9I&<-!"0&" +\@X&U5..?XBQX
M'/7-"QEFLHS<*X*F]D3RR@V[9+QD)SD-ORQ(.=N.-F?FJQ?:TSS21!Y8_(95
M CMWF5B45\N5C;CY@-JLC8!.[YEVRWUY/<BT=&:!KAL.A56(#0O(1\RY#*5P
M#P,_>5A\M;%E \"[7<R<\,RJ&QZ': I.<\A5XP""02;%<E:/+8V\U\)#MAEN
MW$6U=C!)I2P)(+[CSA@0!\N4;!W;L%TS7,D)/R+#"P&!U=Y@QSUY"C\OK68F
MI3R6=M."<RI$976,R. T9)947JQ? 'RL%SDJ5!K0T>Y.H0;UD#JX.R5,;B,<
M,5*[0X.01C&1G:N=BLT*1]T\4CM)Y4P56<(&P8HGP=BJ.K'M6;%?W")]J,@(
M^UF+84&W8;HP@Y&&W@=#G;@8*%LN7WVM,\TD0>6/R&50([=YE8E%?+E8VX^8
M#:K(V 3N^9=MJ]U&9X(9U5H_,VF4!&DDC5D).$ R6#87[K 9W,A -,CU.6:U
M^T6[++DKL<*6RFY0S-&NT[U7=E5Y++P%)V"QX?OOM:L5D\U%8J&9=DH8$AD=
M-J %3TX4D$97C<^M7+ZWKK:>9)C*2T(8^1$GF)M R/,94+(SCD,2JKQPX1BU
MWQ'?O9[6W-'!M<R2)&9'4KM*@##A01N+,R, !CY20:T]/F::-78JQ(SNC.48
M=F'LPP<9.,XW-C)K^(;IK2VGFC.'CAD93@'!5"0<'CK65:ZE/'.(9'5E%P8C
MA-N<VWV@MU/0X51V7.XNQ#!FMZZVGF28RDM"&/D1)YB;0,CS&5"R,XY#$JJ\
M<.$8ML7%TUO/&A/[N977D#B1?G4#'/S(')SD?(,8)^8T.Z:\C^T,<B5F9. !
MY9.(R._S( QSR"Q' PHT*Y?3+^X2W@OII _FBW!0($7$Q1=V>3O!?)((0@8"
M*3N%BUBN+J6X G8+#, @\N,CF*.3:WRY906P I5L9RY)!6U=2/>3-:H[1".-
M'+($+$R,Z@?.K  ;"3P221@J 0U"75+AS';AD68731.WEDQD>0\RX4ON^[LS
M\PPP(R5ZNO-9DTH2Q,3(8Q 5=ERW^D2-%RD8&XH5)PH4L,+P1N,NBZBSR^1F
M61"C-OF@:(J05&W/EQJP8'(P,C:<D@C:W0HKBX7S7G8[)I4VF./:RQRNGS84
M'=@<%2JCY<J<-NM>)?\ 5+_U\6O_ *41U-JETUHT4@/[LR!'R!C$@PA]<^9M
M7CC#$D<!E-+NFNVED)_=B0HF ,8C&'/KGS-R\\84$#DLVA6)I,T]\D=[O7;*
MJ-Y6W"A' ;[WS,9%SUX1@,;%)W!Y>74))5CD,8MW" !58,3&DF6W#.WYP-JE
M3P3OY&W'U'Q#.$65&56CM[MY %RK26KHI R<A2V[W*'^%L,MV36Y;**<N0[P
MSQQA@A_Y:B$YV*22%,IPH.XJ I8MEC+HNHL\OD9ED0HS;YH&B*D%1MSY<:L&
M!R,#(VG)((V[U<_-:O<WDH21HP+>WR45"Q.^?'+A@!US\N2<8( (-+_A)&NV
M\AFDC,8;<UO"TI8K++%T\N4(O[HM@@D[@ WRG=M6$TFIP!F+1.2PW!-K?*Y
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ML<?>ZYVK&U>VR'D:0'&"ZH&!YSR@4$=,?+D'.200!A:-?W 2SFED#_:PH<%
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M5"KEB/ODG+-D],# &A6)>>'FF62!)-L,N\E-@8[I"2X+9SY;$DD##Y)VR*,
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M5]ISNXN('5) I4[T+JRD@C(#(25.=IS@!GX^;(L:?9+8QK N2$&!G_ZV !Z
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M4444444444444444444444444444444444444444444450UC[@_WA_(T:/\
M</\ O'^0J_111111111116%J?^L;\/Y"MBU^XO\ NC^52T44444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M450UC[@_WA_(T:/]P_[Q_D*OT44444444445A:G_ *QOP_D*V+7[B_[H_E4M
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%4-8^X/\ >'\C1H_W#_O'^0J_111111111116%J?^L;\/
MY"MBU^XO^Z/Y5+1111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M1111111111111111111111111111115#6/N#_>'\C1H_W#_O'^0J_1111111
M11116%J?^L;\/Y"MBU^XO^Z/Y5+111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M11111111111111111111111111111111111111111115#6/N#_>'\C1H_P!P
M_P"\?Y"K]%%%%%%%%%%%86I_ZQOP_D*V+7[B_P"Z/Y5+1111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M5#6/N#_>'\C1H_W#_O'^0J_111111111116%J?\ K&_#^0K8M?N+_NC^52T4
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M4444444444444450UC[@_P!X?R-&C_</^\?Y"K]%%%%%%%%%%%86I_ZQOP_D
M*V+7[B_[H_E4M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%4-8^X/]X?R-&C_</^\?Y"K]%%%%%%%%
M%%%86I_ZQOP_D*V+7[B_[H_E4M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%4-8^X/]X?R-&C_ '#_
M +Q_D*OT44444444445A:G_K&_#^0K8M?N+_ +H_E4M%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%4
M-8^X/]X?R-&C_</^\?Y"K]%%%%%%%%%%%86I_P"L;\/Y"MBU^XO^Z/Y5+111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M11111111111115#6/N#_ 'A_(T:/]P_[Q_D*OT44444444445A:G_K&_#^0K
M8M?N+_NC^52T444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M44444444444444444444444444450UC[@_WA_(T:/]P_[Q_D*OT444444444
M45A:G_K&_#^0K8M?N+_NC^52T44444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444450UC[@_WA_(T:/\ </\
MO'^0J_111111115?4;U;")[A\E8D9B!UPH).,XYXJOJ>L"Q9(0CR22[MJQ@9
MP@&YB695 &0.3R2 ,T[3=66^+( 5DB(#QL5WKN&Y<[2PP1R""1VZ@@4-3_UC
M?A_(5L6OW%_W1_*I:*******************************************
M************************************************************
M************************************************************
M*********************************H:Q]P?[P_D:-'^X?]X_R%7Z****
M****J:M8_P!H0R6V=OFQNF<9QN4C.,C.,^M5+73)O.6YGD1MD;H!'$R??9"2
M29'_ +@[#K5N.QV3/<Y^_'&F,=/+:0YSGOO].,>_&;J?^L;\/Y"MBU^XO^Z/
MY5+111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M11111111111111111115#6/N#_>'\C1H_P!P_P"\?Y"K]%%%%%%%%9GB>9H;
M2X="0RP2D$'!!"$@@CH15(>%?[-W2V+,DAWDK([R1.S8Y<,Q.>/O*0WKN'RF
M+PYJW]I7,[,C1R)#;I(C=58/.2,]&!!!5AP00?86-3_UC?A_(5L6OW%_W1_*
MI:**********************************************************
M************************************************************
M************************************************************
M******************H:Q]P?[P_D:-'^X?\ >/\ (5?HHHHHHHHHHJ&-7#,6
M*E#C: I##CG+;B&R>F N/?K61J?^L;\/Y"MBU^XO^Z/Y5+11111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M115#6/N#_>'\C1H_W#_O'^0J_111111115?44D>)UA(64HP0GH&(.TG@\ ^Q
M^E<II^BZI<1J\EX8W(^9#;0M@]QN5B"/0^G4 \#=T+3KFSW?:;CS]VW;^Z6+
M;C.?NDYSD=>F/>H-3_UC?A_(5L6OW%_W1_*I:***********************
M************************************************************
M************************************************************
M*****************************************************H:Q]P?[
MP_D:-'^X?]X_R%7Z**********AC9RS!@H08VD,2QXYRNT!<'I@MGVZ5D:G_
M *QOP_D*V+7[B_[H_E4M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%4-8^X/\ >'\C1H_W#_O'^0J_
M111111115'7)9(K>9X<^:L3E,#<=P4[<#!R<]L<UBV_@NQU$1W66F90 LQN)
M7;Y#U#*^ 0V3\N #G %6/#EZL\LT<$C2V\:Q;26,BAVWEU$IR7XV$Y9MN<<#
M@/U/_6-^'\A6Q:_<7_='\JEHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHJAK'W!_O#^1HT?[A_WC_(
M5?HHHHHHHHHK,F\,6DS%W@B+,223$A))Y))(Y)JW:HT1,855B0*$VGL!R"NT
M!0.@P3D>G2LK4_\ 6-^'\A6Q:_<7_='\JEHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHJAK'W!_O#^
M1HT?[A_WC_(5?HHHHHHHHJOJ+R)$[0@-*$8H#T+ ':#R."?<?6N4T^\UB]C6
M8+:KN&=LBW"./4%3T(_(]02,&MW0OMGS?;?)_AV>1O\ ?=G?^&,>]0:G_K&_
M#^0K8M?N+_NC^52T44444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444444444444444444444444444444444
M444444444444444444444444444444450UC[@_WA_(T:/]P_[Q_D*OT44444
M4457U&]6PB>X?)6)&8@=<*"3C..>*PG\6R63I!<V[+).H,2PN)2Q!&]#D(%*
M AB2=F,G=QSJZ7<3W!9YHUB3C8N_?)P6R6V_*,C:0%+8YR?2EJ?^L;\/Y"MB
MU^XO^Z/Y5+11111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111111111111111111111111111111111111111
M111111111111111111111111115#6/N#_>'\C1H_W#_O'^0J_111111115?4
M;);^)[=\A94921UPP(.,YYYK,F\./,4=KF8F-MR\6_!*LF?]3SPQ'/KZUH6-
MD]MG?*\F<8\P1C&,]/+1.OOGIQCFLW4_]8WX?R%;%K]Q?]T?RJ6BBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBBB
MBBBBBBBJ&L?<'^\/Y&C1_N'_ 'C_ "%7Z***********PM3_ -8WX?R%;%K]
MQ?\ ='\JEHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHJAK'W!_O#^1HT?[A_WC_(5?HHHHHHHHHHHK
M"U/_ %C?A_(5L6OW%_W1_*I:************************************
M************************************************************
M************************************************************
M****************************************H:Q]P?[P_D:-'^X?]X_R
M%7Z***********PM3_UC?A_(5L6OW%_W1_*I:***P=.\02S1Q7,T:I%.(]I2
M4NP,N-@93&G!)"Y!;!(XVY86[G4I;>:.(HOE2N5#B0[\B-I.4V8Q\A'W_0^U
M:=%%%%%%%0K(Q<H5P@52&R.22VY<=1M !SWW>QJ:BBBBBBBBJFDWW]H0QW.-
MOFQH^,YQN4'&<#.,^E5XM2E%P+61%"NDC(RR%B1&R+RI1<$[P>"W0CWK3HHH
MHHHHHHHHHHHHHHJII]]]LWL!A4D9%.?O;,!CC (PX9??;D<$5;JI]NQ-]F(Q
MF/>IS][:V'&,<;<IU/.[C[IJW1111111152XOO*DC@ RTF\GG&U4'+=.?F9%
MQU^;/0&K=5-4OOL$;3D95,%N<87(WMT.=JY; Y.,#DU;HJIIE]]N0R8QB25,
M9S_JY&CST'7;GVSCGK5NBBBBBBBL_7]3;2X)+I$\PQ+NV[@N0/O')!Z#)Z<X
MP.:=K.I'3HC,%+ME5500-S.P11D\ %F&3V'//2GV5]]I>6/&/)D"9SG.8TDS
MTX^_COTSWQ5NBBBBH;F1HP"B[CN48R!P6 9LG^Z"6QWQ@<FIJ**A:1@X0+E"
MK$MD<$%=JXZG<"3GMM]Q4U%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%4-8^X/]X?R-&C_</^\?Y"K]%%%%%%%%5]1>1(G:$!I0C%
M >A8 [0>1P3[CZURFGWFL7L:S!;5=PSMD6X1QZ@J>A'Y'J"1@UNZ%]L^;[;Y
M/\.SR-_ONSO_  QCWJ#4_P#6-^'\A6Q:_<7_ '1_*I:***Y?POILMU:VWG.I
MB6*!E1(RK9159-SEVR%(!X"Y('\.5.EK/^MM?^OAO_2>>J&L0/>7)@,44T8A
M1E6=RJ[M[AV"^7(&(&P$GE 1C&\Y(9]]K&LVZ0R2,HCC;)< N1$S2B,G8B_/
MOVEBA5\DE6E\/*]M-+;,B1(L<+K'$Q9 7:4,1E$VYV#*@8SEOO,U5-"@^PO&
MKC_6* MPDOF"X.QC^\W#=G:N]3E@H^19 "5:E=)-*LUR4B$L<LJK/)(XEC <
MB,E1"VU A5B-P1D)=^'8GN*S]>@,\)0/L):/!WF/)WK\F]>5W_<R,D;N 3P:
MGAS$)>#R_)9<$Q*P:( E@LB$ 8#[3E<+@@DH"2S,TG3HK"[F2%%13!;DA%"C
M.^<9P .>*RM5L$OK.ZNY 3*!> .&96VQO(BIE2/D 493[I/S,"Q).KJVGQWU
MW#'*H9?(N#M;E3\\'5>C#O@@C.#U (L>&2?)()9MLUPH+L6;"SR*H+,23@ #
MDT>*)W@MV:/@[HP3N* *9%$A+@$H A.7'*C+#D52T6U:SN/*$<4"&)B8X78A
MCN4!P#%&N5&0Q7)^9-W&RJJ6<0G_ +/P/LBOPFT%#,R-*T1&?N!#YJ@J0'Z.
MNU4JUJ-LNH2NJ1"9XR!NE?RTB.U6VQLJLZOAE?<J]_\ 6915$5E,VKK:).2R
MS6C2N =H9AY(^8+C*G>V4/R'/*G QJVUC!*LEI@/&C@&-U#(ORJX0 C[HR&
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MRB-VD)8HR<ED3  8\ $DD'("D-8TBR:R0HV"3+,W'I)*[CTYPPS[T:A>M;O
M@QB64J<^@BD?CWR@]>,U>JIJEC]OC:'.-V.V0<$':PR-RMC#+D;E)&1G-4M/
MTV594FD$:K'$Z(D1.$#&/C)4;@=@QA4V?=P^=PJ-HMPL<=DGE^3 \!#EFWLD
M,B,%*A<!L+][<0Q'W5W?)8_L1_.\_*[?M7F]3G;]E\C'3KNY],=\\5=T.R:P
MMX;=\%HHD4D=,JH!QG''%4H]$=;2"SRN^'[+N.3M_<O&S8XSR%..!VSBKL5D
MR7$EP<;7BB4#OE&E)_#YQC\?Q(K)DN)+@XVO%$H'?*-*3^'SC'X_C2UW2)=0
M!B4IM?E7=<O"P& Z  9/<$LK(V3E@0HMZO9O/Y<L6TO#)O"N2JME'C(+ ,1P
M^?NG.,<9R(;FSFOH5278)!-&Y"%B@6.=7 !(!)V+CH 6]!TT+NW^THT667>I
M&Y#AAD8R#V(['UK'M-'E1H05B2*!V(6$%>2CKOQC !WG,>.#\WFMC:9M0M+B
M*5[BV$;-)$B8E9E"F,R%6^56W ^9R/EQCJ<\2W=I+#*;J *S.BHRR,4&$+,K
M!E5^?G(((.<@@KM(:O)HCR(V2OF2W$,KX)V#RWB^4'&3A(P,D#<W.%!PNW5'
M3[UKAYT.,12A1CT,4;\^^7/IQBKU9EW:2PRFZ@"LSHJ,LC%!A"S*P95?GYR"
M"#G((*[2&KQZ(^])V*[_ +099 "=HS;M"%7C)P-N2<9^9L+D*-NBN?\ ['F\
MG^S,)]G\ORO,WMYGE[=O^KV;=VWC=OQGY]N/DJ[J5I+YJ74(5F1)$*NQ08D*
M-NW!7Y'EXQCG.<C&"2V4MQ]F>3;OB?=)MSMR89$.W/.-S\9QQ[U%+H;3"X4L
M 9I5DC8<[62.((Q' )5X]V.A& >I%6+&&9G,TVU?E"A(W:1>"3N)94P><8"C
MC[Q;Y0CM(LFLD*-@DRS-QZ22NX].<,,^]7JHZY9-?V\UNF TL3J">F64@9QG
MCFKU4=/LFMWG<XQ+*&&/011IS[Y0^O&*RFT6X6..R3R_)@> ARS;V2&1&"E0
MN V%^]N(8C[J[ODNW5C,DS7,!0^9&B$2!AMV,Y#@@_-C>?DPN?[Z]ZNGZ/-I
M:1F((\BV\,3J[LB_N@<,K!&/5FR"O((.5VD-L6%LUL@1V+MEB6/JS%B "3A1
MG"C)PH R<9JI9Z4T<,ENS%3(]P=T9PP$LCN"#CA@&'T/K52TT>5&A!6)(H'8
MA805Y*.N_&, '><QXX/S>:V-IT-/LFMWG<XQ+*&&/011IS[Y0^O&*S_%9,B+
M'"X6Y$L7ED ,R^8Q1FV'[P\OS#R,8#'C;D;%I:K:(L,8PD:A5&2<!1@#)YZ5
M7T.]:_MX;A\!I8D8@=,LH)QG/'-7JYRS-P)[H0B,J9U!+E@5/V>'YL '>/\
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M\Q& NW7):X$T]KBYS&8R4>X5PR2X5 $,<@(Y!4>6,?ZS<!(K?=U;R94O8 2
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M'I4.L:>%>%K<QI-&DBPB2,F+E5RHVE=K848P<[-^%8 XJP74=S%:/& (?M+
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M5E4O'G:Q ++N&#@]1D=<=:+JT2[4Q2JKH<95P&4X.1D'CK0;1"IBVKL;=N7
MVG>26R.AW$G/KDYIL6G111_9U11%@C8% 3#9R-N,8.3GUJ4PJ6#D#< 0#CD
MX)&?0X&?H/2@0J&+@#<0 3CD@9(&?09./J?6GU#=6B7:F*55=#C*N RG!R,@
M\=:?#"L*A$ "J   ,  <  #H!5>QTF'3\^1&D>[&?+15SC.,X SC)JP85+!R
M!N (!QR <$C/H<#/T'I41EC24)P)9$)Z<E8R.^.@,G )_B..].^R)L\C:OE[
M=NW V[<8V[>F,<8Z8JOH\,"1*]JJK%( XV($!W 8;  Y(QU&:O54_LF'S/M7
MEIYO]_8N_IM^]C/3CKTXJP(5#%P!N( )QR0,D#/H,G'U/K3%M$0*H50(_N
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M"@@@ MN((!VHFX;-L0J&+@#<0 3CD@9(&?09./J?6B&%85"( %4   8  X
M'0"JFN637]O-;I@-+$Z@GIEE(&<9XYJ:VTZ*U9GC15:0Y<JH4L>3DD#D\GKZ
MFA-.B20W 11*PP7"@.1QP6QDC@?D*+B6.T_?/@%C&F[')W-M1<@9QN?CL,D\
M<TZZM$NU,4JJZ'&5<!E.#D9!XZT^:%9E*. 58$$$9!!X((/4&HK+3HK!=D**
MBDY(10HSTS@ <\4Y;1$"J%4"/[@ &%P"O'IP2..QQTJO>0P;P954O,#$"4!+
M#:SE"<'Y<*3@\?C5N:%9E*. 58$$$9!!X((/4&GU"8/+4K%M4G<1\N5W,222
M 5SDG)Y!//.3FLJPNTLW='W&::0,XBCD>-&*(BKO52!A54DL5)SOPJL -@PJ
M6#D#< 0#CD X)&?0X&?H/2JFJ:Q'I:[Y=P7!)*QR. %Y))16VCZX[^AI]\L<
M6+F1-S19VD1F1UW8!VA0S<]\#IUXIEI)#J@2Z50Q0N%9D*NI!*. & 93D$'I
MTJV(5#%P!N( )QR0,D#/H,G'U/K0\*N02 2IR"1G!P1D>AP2/H2*?3'A5R"0
M"5.02,X.",CT."1]"10D*H20 "QR2!C)P!D^IP /H *KV.DPZ?GR(TCW8SY:
M*N<9QG &<9-6#"I8.0-P! ..0#@D9]#@9^@]*BN=.BNF5Y$5FC.4+*&*G@Y!
M(X/ Z>@HETZ*6/[.R*8L ;"H*87&!MQC P,>E.^R)L\C:OE[=NW V[<8V[>F
M,<8Z8HM+I;M%FC.4D4,IP1D,,@X//2C[(F_S]J^9MV[L#=MSG;NZXSSCIFIJ
MAGM$G^^JME67Y@#\K8W+SV.!D=#@9IZ0JA)  +')(&,G &3ZG  ^@ J*#3HH
M&+HBJQ+$E5 )+X+'('5MHSZX&>@IWV1-_G[5\S;MW8&[;G.W=UQGG'3-17VD
MPZACSXTDVYQYB*V,XSC(.,X%6Z**********************************
M************************************************************
M********H:Q]P?[P_D:-'^X?]X_R%7Z********J:M8_VA#);9V^;&Z9QG&Y
M2,XR,XSZU2BUBX Q):R;@2/W<D+(<$X(+21M@CGE0>V*-%MIWDDO+D*C2I$H
MC1B^T)N;YGP 6+.>@P !@GK46I_ZQOP_D*V+7[B_[H_E4M%%%<YH.JRW$@BE
M<>=L#2PM&8]G4;HR02ZAAM8[G4D[E91A6MZ@9+>X@82-LEE*F,B/9@0R-P=F
M_.Y ?O'OVIUU-)=3-;1OY?E1H^=H;<79P%(/\(V'< 0S9&&3!W4/[2G^R>9O
M7SOM7E[MGRX^U^5]S/3;QC=G'\6?FJ_IDTD<TEI(_F*D<3JQ4!_WC2 AMN%.
M-G&%7C@Y/)UJ*R?$O^J7_KXM?_2B.M"ZA,RE%9D)Q\R;2PY[;U8>W(/YUC^"
MK9H;2!FD9PT$) 8( OR#@;54XY_B+'@<]<[U<OK>NMIYDF,I+0ACY$2>8FT#
M(\QE0LC..0Q*JO'#A&+=16?J]X\'EQ1;0\TFP,X+*N$>0DJ"I/"8^\,9SSC!
MKW4\VF1G+"3+Q*CN &S+((_F5 JD*6R-NW</E."-["/+ITL<3R&6.8LH+JHD
M#A2XY0(NS:C?P[@V.2#\M?0HKBX7S7G8[)I4VF./:RQRNGS84'=@<%2JCY<J
M<-NEN&GNKE[=)?+C6&%CA%9\N\HRK-D#[@!W*W'3:>:B@U234"EN&\MF^T;G
M0 G_ $:41':KA@-Y.>=VT97DD.(M2U">UANHC)^]MX?-2154$J5;;N#!E+;H
MV#84*005"DX77LK.6!MTDID##D%%4 _[.T A>O#%ST^;@[L6376MG5C*9&:5
M(WCC3= A=PFWS53Y73()WM\W/R)O7;+J6GO->QE9I$W03D!1$=N&@! W1MP>
MISDY'! R#MWMLUPNU)&C.<Y0(3]/G5QC\,\=:R;;6)!907)P994MP21QNF*)
MN(&,@%LX&,XP".HF1Y=.ECB>0RQS%E!=5$@<*7'*!%V;4;^'<&QR0?ESXK^X
M1/M1D!'VLQ;"@V[#=&$'(PV\#H<[<#!0MESU%9FI3O)*EHC%/,21RZA2P$90
M;0&!7)+CD@\ @#)#+E:C?W%N&MQ(/-CEM2K[ 0T<\@B =3U;(8MLV9^4J5R5
M&[8VKVV0\C2 XP75 P/.>4"@CICY<@YR2" +=8,1N+V6=5E")%*H0",$Y\F-
M\,2>4)8Y "OZ2 <5%-K)NXH9C(8!-$KJL0$L[%@"5"F-\J@.254DYR=@4[FS
MZQ+=VJ7,3>7)]H2/)3Y3_I'D'*/\P!^]MR&7INX).O;6,D2LC3,^X?*S+&'4
M\@G*J$(Z$ IP<Y+ @#-\(V3Q(SM*[CSKD;6$87(N'^;Y44Y.,GG')P ,8KZC
M?W$0O+E) !:$E$* J<01R,&/#$9)VX*D$DDL,*+&L:N5F-KNEC"QH^Z"$S,2
M[.H!_=R!0-A/(RQ(P0%(9EYJ4\UJDZ$Q2^?&GS1D!@9Q%DQO\P5@=VW(8<#?
MW.Q8VKVV0\C2 XP75 P/.>4"@CICY<@YR2" ,?0=5EN)!%*X\[8&EA:,Q[.H
MW1D@EU##:QW.I)W*RC"M5NI9K3[==Q.!Y+E@A0,K%;:(G<<AL8 V[2N#DMO'
MRC5\5&2&WDN(I&C:&*1@%$9#%5R,[T;CCMCJ?;#M=N)8V@C@95:28J2Z;UP(
MI7P0&4]5'1A^(R"_39WCE>T=B_EI&X=@H8B0N-I"@+D%#R ." 1D%FTZ*Q+A
MI[JY>W27RXUAA8X16?+O*,JS9 ^X =RMQTVGFKNCWK7D>]\;E>1#C@$Q2-&6
M .< [<XR<9QDXR<BQU(Z;IMO,!D^3;*/E+8,FQ,[5Y;&[.T<MC ()S4^BZBS
MR^1F61"C-OF@:(J05&W/EQJP8'(P,C:<D@C;5DUUK9U8RF1FE2-XXTW0(7<)
MM\U4^5TR"=[?-S\B;UVV->U1[*3YY/)@VIM?RBZF0L5*NW(2,97.=A;/RR#!
MIVM:LT#16[%HS*CLS0(T[#9L!50(VX)?[S)C Q@%@5MZ#?-=JV\-\C[5:2-H
MF<;5(8HRK@\E3@ $J2  =HTZYRWU67[1Y,CA9"\@6%HRB-&K<,LA!W2!"&(5
MB,94HIRZV]?,EOLGCD91YL"E (RA#S*C9RA;)#=F';WRZZFDNIFMHW\ORHT?
M.T-N+LX"D'^$;#N (9LC#)@[J']I3_9/,WKYWVKR]VSY<?:_*^YGIMXQNSC^
M+/S5?TR:2.:2TD?S%2.)U8J _P"\:0$-MPIQLXPJ\<')Y.M6/J!DM[B!A(VR
M64J8R(]F!#(W!V;\[D!^\>_:C5'EEN(K:.0QJ\4S,556;Y&B"X+ @'YCU!&"
M1C.&6QH5X]W%OEV[Q)*A* JI\N5T! )8C(7/4UH5SGA_3WCGN&,TC!9P"&$6
M&S;Q<G;&#D9_A(' R#SE]]JDD45](K?-;[_+.!\N+:.0=N?F8GG/ITXJUXL_
MX\[G_KWF_P#0&K6K)\-?ZIO^OBZ_]*)*UJQ+::>_W7$;JH2215CV_*WENT9W
MOR?FVY4J%V9^82 8+R\NH22K'(8Q;N$ "JP8F-),MN&=OS@;5*G@G?R-M*74
M)[M;8I)Y;O-)%+M564F-)0Y7<"1AHCL)/0@NK?=J[JCRZ;:3R>87>.*1D=E4
M,,(2,X 4D'T4#& 02"2"6:QDB$KB3SW*$! BJ1&[AEY9L$(0P9FR2"I4#::0
MU"<6XU;S/E,:RM$54H(\!V"D!6\P+T+,59L_*H(VSRI-<W4L"S,D:Q0N J1E
M@6:12 S(WRG9D@@G/1E (-C5KAK=$#RK'GAG4#>S8X2.-@X)8YX^=L#:H).Y
M8M(O6U6.2(.ZM%)L$FP)(1M1P2DB8!PVT_+@\LH4$ ,\%6S0VD#-(SAH(2 P
M0!?D' VJIQS_ !%CP.>N:&G>(WNA%<J96,QCS%]G<1*LA R)?+'* Y+%RK8;
M"KN7;UM9FI3O)*EHC%/,21RZA2P$90;0&!7)+CD@\ @#)#+FZEJ$]K#=1&3]
M[;P^:DBJH)4JVW<&#*6W1L&PH4@@J%)PNO96<L#;I)3(&'(**H!_V=H!"]>&
M+GI\W!W7J***************************************************
M*****************************************************H:Q]P?[
MP_D:-'^X?]X_R%7Z********S_$-TUI;3S1G#QPR,IP#@JA(.#QUKG-3T&W0
M6TBR223;T\LFYE9W1RJRLN'!QL;>2F , GY,@[>BJUG++9%V=4"2(9&W,%E+
MCR]QY8*4)!))PP7^')BU/_6-^'\A6Q:_<7_='\JEHHHK)CT5MZ.\K,D#%HUP
M-V2C)\[G)? 8A2-I_OEV^:K=[8_:7BDSCR9"^,9SF-X\=>/OY[],=\UF:U,M
MG+YIE$!=%5I) I1@I8A06("R+N)7.00Q^63:=C=+TAIK98G+ _:#+EU 8@7)
MF4E0%P6&,C VD\J",5JQV.R9[G/WXXTQCIY;2'.<]]_IQCWXEAC9"Y9MP9LJ
M, ;1M4;<]^06R?7'05-69KFFRZ@JI&ZH%=&.Z,ODQNKKC#I@97GKD'C%:$(8
M* Y!; R0, GN0"3@>V3]35?2;'^SX8[;.[RHT3.,9VJ!G&3C./6K=8EYX>:9
M9($DVPR[R4V!CND)+@MG/EL220,/DG;(HP!MU4U"Q^UA2#M>-MR-C(#8*\C(
MR"&((X."<%6PPJ#0O/#M.VZ63R\NB[ OE,7CVJ2_W6);YBV23G*X4/@TV61U
MEN'5_*)*".,Q@,5*ECEW).TD#D#DD@G:5L:98_84,><YDE?.,?ZR1I,=3TW8
M]\9XZ5E30RR7DIA=4(M[?(=-ZD%Y^P9#D8X^;&"<@G!%HZ%Y 1H&VRQ^9AW7
M>&\U@\FY04^\P#?*5P0,87*EL^@M=13)*X,MQ$8RZIM4+A@H";CP-Y/+$DD\
M@;0NQ6(OAYE"0B3]Q"T92/8.D;!@K-G+;=HV$;<8'F>;SFWJ.G/,Z7$+JLB*
MZ_.A==KE2> R'.4&#G&,\'((M6D;1(J2-O<* S8"[B!RV!P,GG':J4&AJEM'
M9,Q/E)$ PX.Z+:5< Y&0R@X.1V((SD@TV61UEN'5_*)*".,Q@,5*ECEW).TD
M#D#DD@G:59_87[KR-W_+QYN=O_3QY^W&?^ Y_'':M:J.H:>TS+-$P25 P!9=
MZ[7QN4KE<@[0>"""!SC<K57T%IP6E<&5G@)94VKM@D$BH%W' Z\EB<L3G 51
ML45SEG:S2SW1BE"*9U# QAR/]'AY4Y&&Y_B#KP/EZ[KIT+[/M^S-Y6(TB/R[
M_P!VF=N-QX9<G:QW#D[U?C -"Q"+?=TF60MMY)$XF.1G&6(Y(P,DE5 PHUJR
M;32I;1P$D7R/,D<IY>7)D+,07WXP';(P@.  2>22ZT+SX[J+=C[7NYV_=W0K
M%Z\_=SVZX]ZFOM.=W%Q ZI(%*G>A=64D$9 9"2ISM.< ,_'S9#'T-?)2U5B!
M&\3 GG_5R+)C P #MP  %4<*H  K3K)CT5MZ.\K,D#%HUP-V2C)\[G)? 8A2
M-I_OEV^:BZT+SX[J+=C[7NYV_=W0K%Z\_=SVZX]ZMZM8_P!H0R6V=OFQNF<9
MQN4C.,C.,^M9_B.-I'M0C;6^T'!P&&1;S'D'J#T."#C."#@B[I^GM"S32L'E
M<*"578NU,[5"Y; &XGDDDD\XVJII$LDB$RYW>;,!D8^42N$XP.-@&#W'/.<U
M>KGYH99+R4PNJ$6]OD.F]2"\_8,AR,<?-C!.03@C8L+);)!$N3RQ)/4L[%F8
MXP,EB3P !G  &!52'0U6U6P9B0D2)O7Y6!10 XZ[6! 93S@@'M3['3GC<W$S
MJTA4+^[0QKM!)&06<DY)Y)( ^Z%RY:HOAYE"0B3]Q"T92/8.D;!@K-G+;=HV
M$;<8'F>;SF[>V4DK;XI"A(VMD;QCU4$X5QGAL$?WU?"[:YT+R8X8X&VO;*%1
MG7=E0NPJP4H2",' *C<JM_#BK>FV/V-2I.69F9B!M7<QR<+DA1GMR3U8LQ9C
M;K)N=%:X8*96\D2+)MP"VY'#@;VS^[R,[<;@> X3""WJ=C]N01YQB2)\XS_J
MY%DQU'7;CVSGGI69K4RV<OFF40%T56DD"E&"EB%!8@+(NXE<Y!#'Y9-IV-TO
M2&FMEB<L#]H,N74!B!<F925 7!88R,#:3RH(Q6K'8[)GN<_?CC3&.GEM(<YS
MWW^G&/?BW52]L?M+Q29QY,A?&,YS&\>.O'W\]^F.^:)+'?,ESG[D<B8QU\QH
MSG.>VSTYS[<FF6/V%#'G.9)7SC'^LD:3'4]-V/?&>.E6ZJ65C]F>63.?.D#X
MQC&(TCQUY^YGMUQVS69JOAM[L3I'*46Z!W@HKX/EB,%3Q@$*-P.[(^Z4/-:>
MK6/]H0R6V=OFQNF<9QN4C.,C.,^M6ZJ:98_84,><YDE?.,?ZR1I,=3TW8]\9
MXZ5;K'FT%G#0!P+:4N739ESYA)<"3=PK$G.5+#+;67Y=LL^FRQNTMNZIYI!<
M21F0%@H4,,.A!V@ \D< @ [BPNAK'Y(5C^YE>0D\EF=9 Q., $M(6X&.P &,
M,\6?\>=S_P!>\W_H#4^#2Y&=7GD$@B),>$V')4KN8AB&;:2/E"+R3M^[MK_V
M ^S['YB_9=NS9Y9\S9C&SS-^,8^7.S=M_BW_ #UH1V.R9[G/WXXTQCIY;2'.
M<]]_IQCWX9J&GM,RS1,$E0, 67>NU\;E*Y7(.T'@@@@<XW*QI>FFQWY8N9'W
M%F #'Y57G;A<@+CY548QD$Y9J^D:5+I^V(R*T$4>Q$$>UL#:%+.7.2 ,<*H)
M)..@#8-!:-E0N/)B<O&H3#J><+OW?<7<0%55^3"$E=P;8JCJ&GM,RS1,$E0,
M 67>NU\;E*Y7(.T'@@@@<XW*U6?06NHIDE<&6XB,9=4VJ%PP4!-QX&\GEB22
M>0-H78HHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
MHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHJAK'W!_O#
M^1HT?[A_WC_(5?HHHHHHHHJOJ-ZMA$]P^2L2,Q ZX4$G&<<\5S]AJ$=C*TUQ
M:BU+E_WQ$14C*GYY$)V,Q/1C@D8#$\5M17*M<21!0&6*)B_<AFE 7IT7:2.?
MXCP.]#4_]8WX?R%;%K]Q?]T?RJ6BBBL?3O$\=\J2A)%CE"X>1-B[GP53DYR<
MC# &,DA5<L0#+-KRQL?E8Q(2'E&WRU(X(/S;L*>&8*54YW$;7VFH:W]CE6V$
M<CNZ,R[ N#M(##+,NTC<#EL*>@)8A:J>)-4=+*6>-) WE2=-JNA"MECEAPI'
M5"V>"FX8-:UE<M<+N>-HSG&'*$_7Y&<8_'/'2L_3?$\=]Y9V2(+@ QETP&^4
MN1P3M( /WMH;&4+#FI9M>6-C\K&)"0\HV^6I'!!^;=A3PS!2JG.XC:^TU#6_
ML<JVPCD=W1F78%P=I 899EVD;@<MA3T!+$+4LNKI!%]ID#(,@$%&+ABP0+M4
M,2=QP-N0>JD@@T^QU 7>5*LCKC<CXW '.#\I8$''!!(R",[E8#'\+Z^)H;:.
M42!I8D"NZDB1A'N?GD@\$Y<+OZIN'-7;V_VSQ0LDJ@R':ZE/+8^4[;6&_?C&
M3RH^90>G6;4=:6Q=(2KL\BN5$:%L["HP3T7)<<MA1_$P[V+*]6[7<,@J<,K<
M,K#DJ0,\\@\$@@AE)4@DU&]6PB>X?)6)&8@=<*"3C..>*KV>M+<OY)5T<J64
M2(1N0$#<#R!RP^5L.,_,HID.O+(P^5A$Y 24[?+8G@ ?-NPQX5BH5CC:3N3=
M%/XGCAD:WV2%E<(-J9#.8Q(J@YQDJ2<G"KM)<J"I:P^MH422,-(9E#1J@ 9E
MP#N^<J  ",EB!DA?O$ V+*]6[7<,@J<,K<,K#DJ0,\\@\$@@AE)4@FQ16#/J
MCV]W)&J22?N("%3;@?/,&;+LJ G"CKN.. 0IQH)K$;F/&2)BP4XQ\R@DH0?F
M#85L@C@J0V&P#-!>K.[Q+G]T5#'MN*AMOKD*5)XQ\P )((%BLR'7ED8?*PB<
M@)*=OEL3P /FW88\*Q4*QQM)W)NMI>J\K6XSN1$8GMARX'X_(<_A^&)K6N,]
MO#<PI(1,]LP*E%(#2QG:<NO+@[>,CKN('-6-<U!H[=9RKQGSH,KP7QYZ C$9
M?.X=@3D'&,\5;M=;27>'#1-$H9UE &U6W8;<"4((4\JQ P0<$$4R#75=UB=)
M(_-)$9=>'PI8_=)*':,XD"-VQD$"(>(]SR1"&4^2^UR%4@#:&##Y\L"ISM0,
MXZ%02H+O$M_]CA<E)2GER;GA*!D 7EAO=3D#D8!Y'TS;U"^-H%*QO(6;&(]N
M1P3DEV4 <8R3U('4U7LM<$YD$B-%Y(!8R&/:,@G[R.X! &2"00"IZ$&GVNL"
M9@C(\>_.PR  /@9X 8D''.UPK8S\ORMMS/$^O&.WN/*60A(I1YL>-JN%(QPV
M_*M@%E4JISN(VMMZ.J][>K:+N.26.%5>69CR% ..>">2  "S$*"1#I^JK>,T
M15DD0*61QR V=IW*61@=I^ZQQT.""*Q=-G?4KB0RQSKY<JA?WRJB 1(^UDCF
MPQ+$G[KY# $X&%?KMX\MPEKY4S1^7(W[F1(RQ4Q $,)8VPNX@@D9)! ;&1=U
M^Z_LZW8;96C$3[GB==Z*J_>W2.&+8Y!&XY&3SUNWVI+9X!#,[YVHBEF.,?@!
MD@%F(4$C<PS3$UB,QF9LKL.&5A\ZMQ\FT9RQR-H7.[(*;@RDEEJGVAO+=&CD
MQD+)MR5Z%@49E(!.#SD9&0 RYJV'B/[;@B&4+O9&8JN%96*$$!R2,C[R!D&>
M6&&V[%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%4-8^X/]X?R-&C_ '#_ +Q_D*OT4444
M44454U:Q_M"&2VSM\V-TSC.-RD9QD9QGUK'O?'.GAOLTDT;>8,$#YT(;Y<,P
M!0#UW$8')XI_A;14LB\T,WFP2*BQ#(8(L9<[!("=P!<@9Y4 +DXI^I_ZQOP_
MD*V+7[B_[H_E4M%%%<?HTYU"SM;54<.JVK$LA"!8FCD)W_=.X+\H4ELL-P7#
M;3Q#:R7B3PR"9I&60((BRPJA!"N2FTOQC>C>8^X-Y<90\[MQ"QNXG .T03@G
M' )> @9]3@X^A]*?XAM6N[:>&,9>2&15&0,ED( R>.M.T_5EOF9460!0IS)$
M\8.[/ WA22,<\8Y'/ID:=:.D.G*58&/9O!!RN+61>?3D@<]SCK5&YT0#S;5E
ME9Y)790)+A8'25M[!MCB- -S*<Y8[=^QBP1N@N(6-W$X!VB"<$XX!+P$#/J<
M''T/I5C5(?.C9=F_H=N[:>"#E6XPPQE3D?,!\R_>&?X<WJ70>:8.#&UQGS,L
M6WK\V)-J_*%\P;NO++MJKIUHZ0Z<I5@8]F\$'*XM9%Y].2!SW..M:6K0L\EL
M0"0L[$D#.!Y$PR?09('U(%5-6O!9W<+E68>1< [%+D?/!SM7+$9X^4$\Y(P"
M1;T6%LS3D$">4.H88;:(XXQD'H3L)P>0"-P#94'B>%IK2X1 2S02@ #))*$
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M_NC^52T445@ZMIT5_=PI,BNH@N" ZAAG? ,X(//-6/\ A$[/_GWA_P"_*?\
MQ-'_  B=G_S[P_\ ?E/_ (FC_A$[/_GWA_[\I_\ $T?\(G9_\^\/_?E/_B:/
M^$3L_P#GWA_[\I_\31_PB=G_ ,^\/_?E/_B:/^$3L_\ GWA_[\I_\31_PB=G
M_P ^\/\ WY3_ .)H_P"$3L_^?>'_ +\I_P#$T?\ ")V?_/O#_P!^4_\ B:/^
M$3L_^?>'_ORG_P 31_PB=G_S[P_]^4_^)H_X1.S_ .?>'_ORG_Q-'_")V?\
MS[P_]^4_^)H_X1.S_P"?>'_ORG_Q-'_")V?_ #[P_P#?E/\ XFC_ (1.S_Y]
MX?\ ORG_ ,31_P (G9_\^\/_ 'Y3_P")H_X1.S_Y]X?^_*?_ !-'_")V?_/O
M#_WY3_XFC_A$[/\ Y]X?^_*?_$T?\(G9_P#/O#_WY3_XFC_A$[/_ )]X?^_*
M?_$T?\(G9_\ /O#_ -^4_P#B:/\ A$[/_GWA_P"_*?\ Q-'_  B=G_S[P_\
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MG9_\^\/_ 'Y3_P")H_X1.S_Y]X?^_*?_ !-'_")V?_/O#_WY3_XFC_A$[/\
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M[/\ Y]X?^_*?_$T?\(G9_P#/O#_WY3_XFC_A$[/_ )]X?^_*?_$T?\(G9_\
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M\(G9_P#/O#_WY3_XFC_A$[/_ )]X?^_*?_$T?\(G9_\ /O#_ -^4_P#B:/\
MA$[/_GWA_P"_*?\ Q-'_  B=G_S[P_\ ?E/_ (FC_A$[/_GWA_[\I_\ $T?\
M(G9_\^\/_?E/_B:/^$3L_P#GWA_[\I_\31_PB=G_ ,^\/_?E/_B:/^$3L_\
MGWA_[\I_\37-?$?P];6EA-+%#$CCR\,D:*PS(H."!GI7=T44444444444444
M444444444444444450UC[@_WA_(T:/\ </\ O'^0J_111111115'7+)K^WFM
MTP&EB=03TRRD#.,\<U2M?$442B/RIH]F5V?9I2%"G: #&KH1@<;6(QBF:!&]
MQ--?-$85F2$*'VB1M@<EV5<[3\X4 DMA>0.!2ZG_ *QOP_D*V+7[B_[H_E4M
M%%%9-S_Q^0_]>]Q_Z';UK444444444444444444444444444444444444444
M44444444445DW/\ Q^0_]>]Q_P"AV]:U%%%%%%%%%%9/BS_CSN?^O>;_ - :
MCPG_ ,>=M_U[P_\ H"UK44444444444444444444444444444445DVW_ !^3
M?]>]O_Z'<5K4444444444444444444444444444444444444444444444444
M5DVW_'Y-_P!>]O\ ^AW%:U%%%%%%%%%%<I\4O^0=/_VS_P#1J5U=%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%4-8^X/]X?R-&C_</^\?Y"K]%%%%%%%%%%%86I
M_P"L;\/Y"MBU^XO^Z/Y5+11163<_\?D/_7O<?^AV]:U%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%9-S_ ,?D/_7O<?\ H=O6M1111111
M11163XL_X\[G_KWF_P#0&H\)_P#'G;?]>\/_ * M:U%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%9-M_P ?DW_7O;_^AW%:U%%%%%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%9-M_Q^3?\ 7O;_ /H=Q6M11111111117*?%+_D
M'3_]L_\ T:E=711111111111111111111111111111115#6/N#_>'\C1H_W#
M_O'^0J_111111111116%J?\ K&_#^0K8M?N+_NC^52T445DW/_'Y#_U[W'_H
M=O6M111111111111111111111111111111111111111111111111163<_P#'
MY#_U[W'_ *';UK44444444445D^+/^/.Y_Z]YO\ T!J/"?\ QYVW_7O#_P"@
M+6M111111111111111111111111111111163;?\ 'Y-_U[V__H=Q6M111111
M111111111111111111111111111111111111111111163;?\?DW_ %[V_P#Z
M'<5K44444444445RGQ2_Y!T__;/_ -&I75T4444444444444444444444444
M4444450UC[@_WA_(T:/]P_[Q_D*OT44444444445A:G_ *QOP_D*V+7[B_[H
M_E4M%%%9-S_Q^0_]>]Q_Z';UK44444444444444444444444444444444444
M444444444444445DW/\ Q^0_]>]Q_P"AV]:U%%%%%%%%%%9/BS_CSN?^O>;_
M - :CPG_ ,>=M_U[P_\ H"UK44444444444444444444444444444445DVW_
M !^3?]>]O_Z'<5K444444444444444444444444444444444444444444444
M44445DVW_'Y-_P!>]O\ ^AW%:U%%%%%%%%%%<I\4O^0=/_VS_P#1J5U=%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%4-8^X/]X?R-&C_</^\?Y"K]%%%%%%%%%%
M%86I_P"L;\/Y"MBU^XO^Z/Y5+11163<_\?D/_7O<?^AV]:U%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%%9-S_ ,?D/_7O<?\ H=O6M111
M111111163XL_X\[G_KWF_P#0&H\)_P#'G;?]>\/_ * M:U%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%9-M_P ?DW_7O;_^AW%:U%%%%%%%%%%%%%%%%%%%%%%%
M%%%%%%%%%%%%%%%%%%%%%%%%%%9-M_Q^3?\ 7O;_ /H=Q6M11111111117*?
M%+_D'3_]L_\ T:E=711111111111111111111111111111115#6/N#_>'\C1
MH_W#_O'^0J_111111111116%J?\ K&_#^0K8M?N+_NC^52T445DW/_'Y#_U[
MW'_H=O6M111111111111111111111111111111111111111111111111163<
M_P#'Y#_U[W'_ *';UK44444444445D^+/^/.Y_Z]YO\ T!J/"?\ QYVW_7O#
M_P"@+6M111111111111111111111111111111163;?\ 'Y-_U[V__H=Q6M11
M1111111111111111111111111111111111111111111111163;?\?DW_ %[V
M_P#Z'<5K44444444445RGQ2_Y!T__;/_ -&I75T444444444444444444444
M44444444450UC[@_WA_(T:/]P_[Q_D*OT44444444445A:G_ *QOP_D*V+7[
MB_[H_E4M%%%<EX[\-7>L-"]E*(FC$@8[W0D/L(&4!X^7G/M7+_\ " :S_P _
MG_DQ/_\ $T?\(!K/_/Y_Y,3_ /Q-'_" :S_S^?\ DQ/_ /$T?\(!K/\ S^?^
M3$__ ,31_P (!K/_ #^?^3$__P 31_P@&L_\_G_DQ/\ _$T?\(!K/_/Y_P"3
M$_\ \31_P@&L_P#/Y_Y,3_\ Q-'_  @&L_\ /Y_Y,3__ !-'_" :S_S^?^3$
M_P#\31_P@&L_\_G_ ),3_P#Q-'_" :S_ ,_G_DQ/_P#$T?\ " :S_P _G_DQ
M/_\ $T?\(!K/_/Y_Y,3_ /Q-'_" :S_S^?\ DQ/_ /$T?\(!K/\ S^?^3$__
M ,31_P (!K/_ #^?^3$__P 31_P@&L_\_G_DQ/\ _$T?\(!K/_/Y_P"3$_\
M\31_P@&L_P#/Y_Y,3_\ Q-'_  @&L_\ /Y_Y,3__ !-'_" :S_S^?^3$_P#\
M31_P@&L_\_G_ ),3_P#Q-'_" :S_ ,_G_DQ/_P#$T?\ " :S_P _G_DQ/_\
M$T?\(!K/_/Y_Y,3_ /Q-'_" :S_S^?\ DQ/_ /$T?\(!K/\ S^?^3$__ ,31
M_P (!K/_ #^?^3$__P 31_P@&L_\_G_DQ/\ _$T?\(!K/_/Y_P"3$_\ \31_
MP@&L_P#/Y_Y,3_\ Q-'_  @&L_\ /Y_Y,3__ !-'_" :S_S^?^3$_P#\31_P
M@&L_\_G_ ),3_P#Q-'_" :S_ ,_G_DQ/_P#$T?\ " :S_P _G_DQ/_\ $T?\
M(!K/_/Y_Y,3_ /Q-'_" :S_S^?\ DQ/_ /$T?\(!K/\ S^?^3$__ ,31_P (
M!K/_ #^?^3$__P 31_P@&L_\_G_DQ/\ _$T?\(!K/_/Y_P"3$_\ \31_P@&L
M_P#/Y_Y,3_\ Q-'_  @&L_\ /Y_Y,3__ !-'_" :S_S^?^3$_P#\31_P@&L_
M\_G_ ),3_P#Q-'_" :S_ ,_G_DQ/_P#$T?\ " :S_P _G_DQ/_\ $T?\(!K/
M_/Y_Y,3_ /Q-,/P[U<L'-V-P! /GS9 ."1G;T.!GZ#TI_P#P@&L_\_G_ ),3
M_P#Q-'_" :S_ ,_G_DQ/_P#$T?\ " :S_P _G_DQ/_\ $T?\(!K/_/Y_Y,3_
M /Q-'_" :S_S^?\ DQ/_ /$T?\(!K/\ S^?^3$__ ,31_P (!K/_ #^?^3$_
M_P 31_P@&L_\_G_DQ/\ _$T?\(!K/_/Y_P"3$_\ \31_P@&L_P#/Y_Y,3_\
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M_P 31_P@&L_\_G_DQ/\ _$T?\(!K/_/Y_P"3$_\ \31_P@&L_P#/Y_Y,3_\
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M :S_ ,_G_DQ/_P#$T?\ " :S_P _G_DQ/_\ $T?\(!K/_/Y_Y,3_ /Q-'_"
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M /$T?\(!K/\ S^?^3$__ ,31_P (!K/_ #^?^3$__P 31_P@&L_\_G_DQ/\
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M6/[4MXW;<9/*C+EHV0%F7)()5589S]W(Z=B*L7.OP6L OW;$!56W;6/#XVG
M&><CM]:KW/BZVMI6M&<F92H**CN_S*7&%522-HR2,@=\9%,_X32S\C[?YJ^3
MNV[L-G=_=VXW9[XQG'S=.:L:;XC@U&1K>-CYL8!9'1XW /0[753CD?3(SU%:
M=8\5W)=W;QJQ$-NBAE"?>DD!."[#HB;3A<<N,GM6Q7)>$_%PDL[>>[<M-.9
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MYHSAXX9&4X!P50D'!XZUSEY=WOA@+<W$RW%L742DQ")XU8[0Z["=PR>1@G@
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M1#]QTX .XY! )VD?,17,Z#&?";V<ETS"&2U:/+ A8Y9)!,0X/"Y!"YZG;D@
M9'1Z#<+J-[/=P9\CRHT+>7A)75G^=7_B"#Y,C@_0*2SP[_R$=0_[=?\ T4:T
M-$M56XO)@/G::-2<GHD$148Z<%C^?TKAXH6E\.X4$G!. ,\+<DD_0 $GT'->
MAZ5K\&K9^SR*^U58[>P?.W/H?E.5/([@9%9_C[3'U.QF@B&7*@@<DG8P<@
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MY.3GUJ:VTZ*U9GC15:0Y<JH4L>3DD#D\GKZFJ^H6CQ+)+:+$+B3;\T@(5MI
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A44444444444444444444444444444444444444445__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>flexpharmapcpage2.jpg
<TEXT>
begin 644 flexpharmapcpage2.jpg
M_]C_X  02D9)1@ ! @$ R #(  #_X@Q824-#7U!23T9)3$4  0$   Q(3&EN
M;P(0  !M;G1R4D="(%A96B 'S@ "  D !@ Q  !A8W-P35-&5     !)14,@
M<U)'0@                  ]M8  0    #3+4A0("
M                                             !%C<')T   !4
M #-D97-C   !A    &QW='!T   !\    !1B:W!T   "!    !1R6%E:   "
M&    !1G6%E:   "+    !1B6%E:   "0    !1D;6YD   "5    '!D;61D
M   "Q    (AV=65D   #3    (9V:65W   #U    "1L=6UI   #^    !1M
M96%S   $#    "1T96-H   $,     QR5%)#   $/   " QG5%)#   $/
M" QB5%)#   $/   " QT97AT     $-O<'ER:6=H=" H8RD@,3DY."!(97=L
M971T+5!A8VMA<F0@0V]M<&%N>0  9&5S8P         2<U)'0B!)14,V,3DV
M-BTR+C$              !)S4D="($E%0S8Q.38V+3(N,0
M                                                    6%E:(
M     /-1  $    !%LQ865H@                     %A96B        !O
MH@  ./4   .06%E:(        &*9  "WA0  &-I865H@        )*    ^$
M  "VSV1E<V,         %DE%0R!H='1P.B\O=W=W+FEE8RYC:
M    %DE%0R!H='1P.B\O=W=W+FEE8RYC:
M                                  !D97-C         "Y)14,@-C$Y
M-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M('-21T(
M     "Y)14,@-C$Y-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M
M('-21T(                             9&5S8P         L4F5F97)E
M;F-E(%9I97=I;F<@0V]N9&ET:6]N(&EN($E%0S8Q.38V+3(N,0
M    +%)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR
M+C$                                  '9I97<      !.D_@ 47RX
M$,\4  /MS  $$PL  UR>     5A96B       $P)5@!0    5Q_G;65A<P
M       !                         H\    "<VEG(     !#4E0@8W5R
M=@        0     !0 *  \ %  9 !X (P H "T ,@ W #L 0 !% $H 3P!4
M %D 7@!C &@ ;0!R '< ? "! (8 BP"0 )4 F@"? *0 J0"N +( MP"\ ,$
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M])5?E<F6-):?EPJ7=9?@F$R8N)DDF9"9_)IHFM6;0INOG!R<B9SWG62=TIY
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M]XKX&?BH^3CYQ_I7^N?[=_P'_)C]*?VZ_DO^W/]M____[@ .061O8F4 9
M   !_]L 0P ," @;"ALB$1<D*B0<&R D*R@H("0I)24Q+R4I+BHK*SDK*BXO
M-#4U-30O.SL[.SL[.SL[.SL[.SL[.SL[.SL[_]L 0P$-"PL0#A ;%!LD,B@A
M*#([-#(R,CL[.SL[.SL[.SL[.SL[.SL[0$! 0$ [0$! 0$! 0$! 0$! 0$!
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MQ\C)RM+3U-76U]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_:  P#   !$0(1 #\
M]5HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M13(IEE&5((R1D'/*D@CZ@@@^AXJ*RU&*_7?"ZNH."48,,]<9!//- %BBBB@
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MR?\ A++/_GXA_P"_R?\ Q5:%K=I=J)8F5T.<,A#*<'!P1QUH FHHHH ****
M"BBB@ HHK/NO$-M:,8I9HD<8RKR(K#(R,@G/2@#0HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **ANKM+13+*RH@QEG(51DX&2>.M9_\ PEEG_P _$/\
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MX<?\?FI?]?'_ +/-0!%'X[U"]GN;.UMTD:"1E5LE54*Y7YMS ,6 X *]"<$
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MNEM+G3YI#A(YF9C@G 5XB3@<]*A\9ZI'JMQI=S VZ-[AL'!&<2Q \$ ]0>U
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MXX91()O*'EA!YP50J[NC\AN&SDYQFG^ /^0->?\ ;Q_Z(6C_ )ES_/\ S]4
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M6 A<$L.#%NP6))&[/.<'MQBG^"M?@TV_OH9FVO/=;8QM8Y/F2#&0"!RPZXH
MT)_&U_JDLBZ7 DD$+;"[D89AG)4^8H(],9.,$XW #5TWQQ_:5I<7:IY<]LLN
MZ)SDAD4D9'RG!QCD*<AAVS7GOAZ.#13-97MU<6TL4IX@9UC88 # !"<G&<D#
M*E<9YQT6A0VAL]1GM&F??'*':?\ B*HY#!@HSG<2<_-TR!D9 +'AKQAJFN>5
M*EO'Y!<+(_(XW?,RAG!P%XZ-\P//\(L>!/$IGL)KM8$5HY' CMHRH8A$(^5=
MQR2<$XX')X%:'PM_Y!T'_;3_ -&O7'^"-2ETS1[FXMQF1)FQ\N[ *Q!FQ_L@
MD\\#&3D9H V]2\5ZIIL U*6&$0;E)C)<3*K-@9).,]!P"03R@P0*_P 6KU;_
M $Z"X3(666-@#UPT3D9QGGFN<UQK6\T_[7-<M/>2;2JNY_=LSYD58A]T8!!)
M&TX!7&0*UO'W_(&L_P#MW_\ 1#4 =5XM\8/ILT.G6RHUQ<=#*Q5%!; )Z;MV
M&  ;.0, D@$LM8U&UG2VNX$=)>DEL6VIC.=V_P##N.,[=S?*,_XB6VGW<L$%
M]OC=\[94 50!_"SL",9/H=O4[58D\OHTLOAR]MK.TNA=12D!D3+(JLWS':&9
M00,MD'(P2P"GY@#UV[D:)&>-=[A257(7<0.%R>!D\9[5Y1X2\S4KVZ,]HLY:
M=1(97C;R1N<8&X'< ./EQPH'I7KM>?\ PX_X_-2_Z^/_ &>:@!EQ\0;O59Y+
M;2X%D6$D,[L"IYP""&50"0<?,2PY &#6QX'\<?\ "0[X)4\JXAQN4GKV8A3A
MAAA@@YVY'))KDO ?BB+P@9]+OLHR2LP?:S*>%7& N[! #*<8(/;C.AX N6U[
M4+K5T4K"R",;NI/R8Z#&<)EAGC<!SUH !XZU&^N+BSM((Y#!*P#'( 569?F)
M< L<#&".C?*?X>X\Z?[-YFU?M/DYV?P^9LSMSNZ;N/O=._>N/^''_'YJ7_7Q
M_P"SS5Z!0!Y%X'U+4'O;@K&K%YXQ<EFSL 9AA<OT4;@,;N !];4]_-9ZS=FV
MB,LS0*J+D!0=D1W,21A1CUY.%R,Y#_!6OP:;?WT,S;7GNML8VL<GS)!C(! Y
M8=<5H:-_R'KK_KW7^4% %WP7XTGU.>73KR(1SQ M\H(7 *@@@LW/S @@D,#V
MP":4_C:_U261=+@22"%MA=R,,PSDJ?,4$>F,G&"<;@ :-_R'KK_KW7^4%<EX
M>C@T4S65[=7%M+%*>(&=8V&  P 0G)QG) RI7&>< 'I_A'Q4OB&-F*&.6)RK
MQL<LI'3L#@].0.0P[9K;FF6%2[D!5!)).  .223T KC?AM#:'[1/:-,^^0!V
MG_B*Y(8,%&<[B3GYNF0,C-CXI:P=-L7"Y#3$1@@ _>R6SGL4##(YR1]0 ><W
MJ2:K'<^(T(#1W<9C+<.%3@#: 4)&Z/KG[K<_WO:-*U--4B2ZB.4D4$=,C/4'
M!(R#P1G@@BO.K;P/J]K ;!)X1 59=O7A\[ADQ9YR>_TK5^%%TT4<^F2'+V<S
M+D ;<,3P#P3\RL>1T(^@ ,K2?B'J>KPO+;VR.8V^9QNVXVYVA"P+-W^5CP0-
MN2">CT/QLVK:?+J(4++ DF0>4+QINR.<[3D<9R.1DXR<SX*?\><G_7PW_H$=
M97@#_D#7G_;Q_P"B%H EC^(>IW-K]NBMD\M-V]SN*D ]53<& 7^(Y8<$Y&"*
MZ._\;,=,.L0* V%PLG(!\P1L/E(R.N#QV) Z5F>&O^0"W_7O=?SDK,BA:7P[
MA02<$X SPMR23]  2?0<T =7J_BB6RTP:HH4RF*%L$'9F0H#QD''S''-%[XG
MN([2WG@A,L]RB':H;8I= =Q." H8CAF7(S\W!-</K?CFUN])2P1F\_RX4*[2
M,&,KDD],';Q@D\C('.-/Q'KT^F6.GQQ.8HIHHUEE"%BH\M!QZ'!8\88[?E(P
M: -5O%E[H]U!:WZ1&.Y.U6M]W#%@.=YZ#(SP.#D$D%:KZS_R'K7_ *]V_E/7
M.:W;6EO?6(M93/*9T,LC2F5C^\0)EA\N0 1@8. ,]B>CUG_D/6O_ %[M_*>@
M#T"O"IHVL[J[U6/<6L[Y2P#!04>20,">O)"KQGACD$=/=:\JT+2_[5;6+8+N
M9Y#M&<98/,4YR/X@.IQZ\4 6OBA&VJSK9?-Y<%K-<.0P )"L$RIZX90.YPYQ
MCDU;\*^(4\/Z-'=R#.WS JY +,97P!G\SU( )P<5A>$+87MI?:D0 ?LGD+\Q
M)_=6X#G& ,-A2.I&"/<LN],>^T"%HQGR9&D8<D[0\JDC /3=D]  "<\4 ;8\
M<ZEI:B[O[51;G;DQG#KN(P2I=B..,,%^8@$@\':\6^,FT_R;>R59KBYYC (*
M[>N\X(.".AR%P"Q.%P>'O]1TRXA/F7E[(&"DQ%R3U!P=R;,J>?O8XX)XJWXS
MTM-,N+*Y9Y8[58%A\R/<LR[0V"?E&TD,,C&X@.-N1B@#H]&\:74,\=CJ<*Q/
M/GRW1AL)'1?O,,D^C9R5&WG-<?9:KJC:E*ZQ(UT(0K1LWR*GR'Y?WF.N#@,>
M6)QZ:%B=.O[NW5;F[N)%DW)O)=5*X;G<@(!QR5Z 98J!FI6U^#1-;N9KEMB&
M%%!VLW)6$XPH)Z T =!IFK^;JUQ9^7$-D(/F*F)6XBX9\\CYNF.P]*RH_'>H
M7L]S9VMNDC02,JMDJJA7*_-N8!BP' !7H3@@$"71O^0]=?\ 7NO\H*/AQ_Q^
M:E_U\?\ L\U &GX'\;-K<<OVE1%+;']Y_"@!W<_,<J1M(8'IC.><#)L_'][>
MEK^.V!T]"Q+$A9=B#YF&7 )'7 !'!3=D$U5\)V37\NL6Z8#2NZ@GIEC,!G&>
M.:/!7CJ#1[-;&3=]JB,BB(H^YG+LRJ"%;!).WG!!SQC&0#I?AYXHE\26[7$P
M4,LI4! 0,!5/<MS\U:'A>YN[B(M?QK'+O( 0@C;@8/#/SG/?MTKE_@I_QYR?
M]?#?^@1UV&B:_!K:&:V;>@8J3M9>0 <88 ]"* +5U:)=J8I55T.,JX#*<'(R
M#QUKBM>\/6T5_8Q+#$$D^T[E$:!6VQ@C(Q@X/3/2N[KE/$7_ "$=/_[>O_10
MH MZ]I,.GV=UY$:1[K>7/EHJYPC8S@#.,FN?TCQK):6D,L5L\EM##$LDH8*0
M54"3:A&6"]VX&0W( W5U7BS_ (\[G_KWF_\ 0&K*_P"8-_W#_P#VA0!H:UXK
MCTVW6]4-)YVP1*@.YVD&4 XR,CGD9]B< YH\;RV,B)J%N;>.4E5D\U9$#=@Q
M4#:#ZD_H"1SFO6^VWTR[D,J010@22P'#IYD484YY(!(P3@\<=2 9=2T:SN5$
M'VVYN3(RJ(HKE)68YS]TC "XW%F( QG.<4 >EUYI<VLL>HWNHVP9Y;7[/^Z!
MXD1XL.O'.0 &7KR/NL<5Z77*>'?^0CJ'_;K_ .BC0!7^(6H1ZCI4MQ"P:-Q&
M01_UU3\B.A!Y!X/-:OB3Q4ND,EO&AFN9B-D2G!([L3@[5&#R?0]@Q'%?$.%O
M#\$UHH)M;LH8@H^6)U=6=>>BO@LH!P"" H&370:S>KHVIQWD^5@EMO)$G\ ?
MS"^&/\(QW/'X!B "WI_C-Q.MG?0&V>4?NB9%D1SG!7<H #=,#OGL2H;"\-ZK
M=G4+HFUP9&MA*/.3]T F V<?/D?-@=,8ZU=\3:Q%K<]I9VC"9TN8YG,9#(J1
MD@DL#@'G@=?Q*@RZ-J,5KJ=\DCJK2&U"!F"ECY>, $\GD=/44 6+7Q?;V,5S
M<NBQ+#=2QD)@M(ZX^8 !<LWOGIDM@$BNWCJXLE2XO+-H;=BH:02"0INZ%D"A
M@,X!S@CI@M@'G9E9(IKE59EMM:>60)@L$3&X@$C.,_AU. "1V5YXX@,:M:,M
MQ-(5"1(X#G=R<\$H%7))8 #&#B@!^O\ BEK"5+*WA:>X=2^P,$54&1N+D$#)
M& /U!*@LT/Q<;N9K&ZB-O<@;E1G#AUQG*N  2.<@>AZX;;R^K6:0ZE/]JGFM
MDN%C,3Q2".-_+0*P9N1D'H#C_P >7.AHNEVS7D3Q7%Q=/"KMN,J2Q1AU*_,V
M!@MV523QDC:,T =W7E5Q+!875Y:WD'VFXF9GBV?O796'RQCJT95><@ [1D<*
MF[TK5O,\F3R/];Y;[.GWMIV_>XZXZ\>M>?V,^GW=@8I)%M[E<&1GP+D3Q$L7
M^8[V.XG&#G#%1M.0 #L/!>FRZ99PV]P<R(IS\V[ +$JN?]D$#C@8P,C%2^+/
M^/.Y_P"O>;_T!JY#X>>(Y=3G)O9'69X5\J)E\N-TZF51T9B03D <9VY7A.O\
M6?\ 'G<_]>\W_H#4 9OACPQ:36EN[P1%F@B))B0DDH"221R369X8MHK'5+B"
MS_U!A!E"C*+,'P%!QQP6.T' .X?PX4\/?#BPN[:":2'+R0QLQ\R09+("3@-C
MK76Z/HL.CQ^1;H$3).!DY)ZDDDDGZGH .@% &!X<\;RZTJW!MS';8??,\JA5
MV;CP" 67@ MP <C^$DPKXZN+U7N+.S::W4L%D,@C+[>I5"I8C.0,9)Z8#9 K
M^#K5KO1/)C&7DAN%49 R6:0 9/'6K?A?QE:06D:2R+&]O&(Y$E.V0-$H##8>
M3TXP"3TQNR  6+CQW']GCU*%0]N7596+;7BW$#)0*VXC/(!ST(RIR+MUXG43
MPV4(\QYE\PL"=BQ<_O-P# Y(PHZ$]67(SS6A:H-.LKF]EB9EN[J1XHF WR";
M:$7;SG=SD8/R@D!AC+_A_ _A^0Z;=*1+,B2)(Q7Y@D:*T.<G)BY  )^7+848
MR =/;Z[YEW)I[KM9(TD0[L[U/#' 'R[6XP3D]0,46^N_:;N2Q1<K!&C.^[&&
M?E4VD<Y7YMP)'8\UB^.;C^Q9+?6 &*PLT<H0<F.0<$MZ(PR%/!8CD'FKO@.R
M:&V^T/CS+MVG8+]T&7! &>0 N.#GG/)% %CQIY_V.;[)N\[:-NS[V-PW8]]N
M<8YS]WG%<UH6HZ',HB185PN<3H PR<D&20$$@GH&/MP*ZCQ5JLNDP_:HE#+&
MZF48+-Y><.5 (^8=>3@ $FL]]:TK6 )Y'MW., S; X )XQ( P&<XX]QUH RM
M2TA] L;D6A,]M,C%$+J!"CQN7=7).]>A"CGODDDFQX=\3OIUC')<P,B+';I%
ML=)'F+ *-J<$'&#M)SC/H:R=#51::DULK+8M&_D;L\D1,LK#<2Q!*C&?IP0P
M%YO%JV&FP&W=2P2WCD=?WGD!TP9&1<\C& #C+8'/0@%VX\;7.F[9;VT:* L
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MF(6- IWLY) 3O@Y!!/(X^7=P#5'C>6QD1-0MS;QRDJLGFK(@;L&*@;0?4G]
M2.'M[?;9:==R&5((FN1)+ <.GF2$*<\D D8)P>..I .UJ6C6=RH@^VW-R9&5
M1%%<I*S'.?ND8 7&XLQ &,YSB@#IM;\9_P!FW(T]8FDD>$/&%/+,7*A.F%
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M9(/'-7J** *-EH=O8-OABC1B,$HBJ<=<9 ''%366G16"[(45%)R0BA1GIG
MYXJQ10!1ET.WED^T-%&9<@[RBE\KC!W8SD8&/2KU%% %&RT.WL&WPQ1HQ&"4
M15..N,@#CBKU%% %>VTZ*U9GC15:0Y<JH4L>3DD#D\GKZFF7VDPZACSXTDVY
MQYB*V,XSC(.,X%6Z* (;JT2[4Q2JKH<95P&4X.1D'CK3;+3HK!=D**BDY(10
MHSTS@ <\58HH \WO;35HI<FWM[EHC\D[H@<@'<I^^NTC/0 8/0G[QV_A_P"%
MYM'6:XNB#/=.&<*00.I[ #=N9LXRO3%=;10!1ET.WED^T-%&9<@[RBE\KC!W
M8SD8&/2@Z';D.#%'B4@N-B_.0<@MQ\QSSSGGFKU% #(85A4(@ 50  !@ #@
M = *K_V3#YGVKRT\W^_L7?TV_>QGIQUZ<5;JKJ6I1Z9&;B8[47&3@GJ0!P 3
MU-.,7)I)7; 2WTF&V1H(XT6-\[E5%"G(P<J!@Y'!]J/[)A\O[+Y:>5_<V+LZ
M[ONXQUYZ=>:MT4@*\NG12Q_9V13%@#85!3"XP-N,8&!CTK/U^UN(X -/*I)$
M5(0J-C*HQY7;:#V(QTQE0<C8HH \GN?#VJ:I&UB+:WMHY2I=HPBYV990=K.<
M9Z8&<]P,UZAIUDMA$ENF2L2*H)ZX4 #.,<\58HH KWNG17Z[)D5U!R ZAAGI
MG!!YYJ$:';@(!%'B(DH-B_(2<DKQ\ISSQCGFKU% %>YTZ*Z97D16:,Y0LH8J
M>#D$C@\#IZ"G75HEVIBE570XRK@,IP<C(/'6IJ* *]EIT5@NR%%12<D(H49Z
M9P .>*==6B7:F*55=#C*N RG!R,@\=:FHH 9#"L*A$ "J   ,  <  #H!45S
MIT5TRO(BLT9RA90Q4\'()'!X'3T%6** (;JT2[4Q2JKH<95P&4X.1D'CK3X8
M5A4(@ 50  !@ #@  = *?10!1BT.WBD^T+%&)<D[PBA\MG)W8SDY.?6A-#MT
MC-N(HQ$QR4"*$)XY*XP3P/R%7J* *EQI,-RBP21HT:8VJR*5&!@84C P.![4
M^]TZ*_79,BNH.0'4,,],X(//-6** *(T.W 0"*/$1)0;%^0DY)7CY3GGC'/-
M/;2879I3&A>1=KL47<RD ;2<9(P!P>.*MT4 5[+3HK!=D**BDY(10HSTS@ <
M\46VG16K,\:*K2'+E5"ECR<D@<GD]?4U8HH J6^DPVR-!'&BQOG<JHH4Y&#E
M0,'(X/M3XM.BBC^SJBB+!&P* F&SD;<8P<G/K5BB@#G-:LI='BW:5;Q>:[J'
M&U4!4!N>&3)!QCGN>*J_#_PO-HZS7%T09[IPSA2"!U/8 ;MS-G&5Z8KK:* "
MH;JT2[4Q2JKH<95P&4X.1D'CK4U% %>RTZ*P79"BHI.2$4*,],X '/%":=$D
MAN BB5A@N% <CC@MC)' _(58HH *KVVG16K,\:*K2'+E5"ECR<D@<GD]?4U8
MHH *KIIT22&X"*)6&"X4!R.."V,D<#\A5BB@!DT*S*4< JP(((R"#P00>H-5
M['28=/SY$:1[L9\M%7.,XS@#.,FK=% %=-.B20W 11*PP7"@.1QP6QDC@?D*
M'TZ)Y!<%%,JC <J"X'/ ;&0.3^9JQ10!YU;:!J/B"[@NM05(H[5@RJC#)/WL
MC!D[JH;)''W><FO1:** (;JT2[4Q2JKH<95P&4X.1D'CK45QI,-RBP21HT:8
MVJR*5&!@84C P.![5;HH KW.G173*\B*S1G*%E#%3P<@D<'@=/04R^TF'4,>
M?&DFW./,16QG&<9!QG JW10!47284991&@>-=J,$7<J@$;0<9 P3P..:9+H=
MO+)]H:*,RY!WE%+Y7&#NQG(P,>E7J* *E]I,.H8\^-)-N<>8BMC.,XR#C.!4
MOV1-GD;5\O;MVX&W;C&W;TQCC'3%344 0VMHEHHBB5409PJ *HR<G ''6FV6
MG16"[(45%)R0BA1GIG  YXJQ10!GV_AZVMMWEPQ+O4JVV-!E3U4X'(/<=*<^
MAV[QBW,49B4Y"%%* \\A<8!Y/YFKU% $-U:)=J8I55T.,JX#*<'(R#QUJ*QT
MF'3\^1&D>[&?+15SC.,X SC)JW10 57MM.BM69XT56D.7*J%+'DY) Y/)Z^I
MJQ10!4OM)AU#'GQI)MSCS$5L9QG&0<9P*L0PK"H1  J@  #  '   Z 4^B@"
MO;:=%:LSQHJM(<N54*6/)R2!R>3U]35BBB@"C+H=O+)]H:*,RY!WE%+Y7&#N
MQG(P,>E3)IT22&X"*)6&"X4!R.."V,D<#\A5BB@"NFG1)(;@(HE88+A0'(XX
M+8R1P/R%,OM)AU#'GQI)MSCS$5L9QG&0<9P*MT4 ,AA6%0B !5   &  .  !
MT J*YTZ*Z97D16:,Y0LH8J>#D$C@\#IZ"K%% !5=-.B20W 11*PP7"@.1QP6
MQDC@?D*L44 5[+3HK!=D**BDY(10HSTS@ <\4RWTF&V1H(XT6-\[E5%"G(P<
MJ!@Y'!]JMT4 5XM.BBC^SJBB+!&P* F&SD;<8P<G/K3K6T2T411*J(,X5 %4
M9.3@#CK4U% &?'X>MHE:)88@DF-RB- K;3D9&,'!Z9Z58ETZ*6/[.R*8L ;"
MH*87&!MQC P,>E6** ,__A'K;9Y'DQ>7NW;?+3;NQC=MQC..,]<58?3HGD%P
M44RJ,!RH+@<\!L9 Y/YFK%% !5>VTZ*U9GC15:0Y<JH4L>3DD#D\GKZFK%%
M%2WTF&V1H(XT6-\[E5%"G(P<J!@Y'!]JEM;1+11%$JH@SA4 51DY. ..M344
M 48M#MXI/M"Q1B7).\(H?+9R=V,Y.3GUJW-"LRE' *L""",@@\$$'J#3Z* *
MECI,.GY\B-(]V,^6BKG&<9P!G&33+W0[>_;?-%&[ 8!=%8XZXR0>.:O44 5T
MTZ))#<!%$K#!<* Y''!;&2.!^0HMM.BM69XT56D.7*J%+'DY) Y/)Z^IJQ10
M!1;2EB64VX6*64'+JBYW'.&(XW$$YYZ\^M<!-#K".9!:V[3 %1<!8_,.%V;P
M2XY(]5 QP5QQ7IM% '.> _"[>&[;[.Y!D9V9BIRN3@#&0IQM4=>^>U;=EIT5
M@NR%%12<D(H49Z9P .>*L44 %0R6B2LLK*I>/.UB 67<,'!ZC(ZXZU-10 R:
M%9E*. 58$$$9!!X((/4&F?9$V>1M7R]NW;@;=N,;=O3&.,=,5-10!#]D39Y&
MU?+V[=N!MVXQMV],8XQTQ5>RT.WL&WPQ1HQ&"415..N,@#CBKU% !4,=HD3-
M*JJ'DQN8 !FVC R>IP.F>E344 0W5HEVIBE570XRK@,IP<C(/'6BZM$NU,4J
MJZ'&5<!E.#D9!XZU-10!4L=)AT_/D1I'NQGRT5<XSC. ,XR:+C28;EUGDC1I
M$QM9D4L,'(PQ&1@\CWJW10!#;VB6V[RU5=[%FV@#+'JQQU)[GK5>RT.WL&WP
MQ1HQ&"415..N,@#CBKU% %>]TZ*_79,BNH.0'4,,],X(//-%EIT5@NR%%12<
MD(H49Z9P .>*L44 %49=#MY9/M#11F7(.\HI?*XP=V,Y&!CTJ]10!#]D3?Y^
MU?,V[=V!NVYSMW=<9YQTS3YH5F4HX!5@001D$'@@@]0:?10 R&%85"( %4
M 8  X  '0"GT44 0VMHEHHBB5409PJ *HR<G ''6JMUX>MKMC++#$[G&6>-&
M8X&!DD9Z5H44 5[G3HKIE>1%9HSE"RABIX.02.#P.GH*+G3HKIE>1%9HSE"R
MABIX.02.#P.GH*L44 <OXQL+C6=NFI&/LTI0RS%P"H5MQ55Y.[Y1@X(YP1W'
M4444 %9DWABTF8N\$19B228D))/)))')-:=% !5&VT.WM59(XHU608<*BJ&'
M(P0!R.3U]35ZB@"C;:';VJLD<4:K(,.%15##D8( Y')Z^IHN=#M[I522*-EC
M&$#(K!1P, $<#@=/05>HH J7VDPZACSXTDVYQYB*V,XSC(.,X%2VMHEHHBB5
M409PJ *HR<G ''6IJ* (;6T2T411*J(,X5 %49.3@#CK1:VB6BB*)51!G"H
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M/C23;G'F(K8SC.,@XS@5+:VB6BB*)51!G"H JC)R< <=:FHH **** "BBB@
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MS:EE;R4;;&9N(L$X.#SNZFLG5]$6^M9(-/L'C*X=GN$(EP"/ECW,S$G&2 <
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M>VDU3K1E)024X\C5MKZ^JMK=ZI];DO5?(N:UJEQH,2V[3I)<7$A"22JL*(H
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M8G!!Y7"YZ<<\'FK/_"$?]/5W_P!__P#[&NFHI_VCB+6YM/1?Y!R(YG_A"/\
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MW_W_ /\ [&C_ (0C_IZN_P#O_P#_ &-=-11]?K_S?@O\@Y4<S_PA'_3U=_\
M?_\ ^QKIJ**RJUZE6W,[V&DD%%%%9#"BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M.<]^W2L_Q1J&IV\H6PACDBV DN0#NR<CF1.,8[?C0!U%%>?_ -LZ]_SZP_\
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M=@A+#)4$[2?WPY(]A]* .XHKS_\ MG7O^?6'_OH?_'Z/[9U[_GUA_P"^A_\
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M &SKW_/K#_WT/_C]']LZ]_SZP_\ ?0_^/T >@45Y_P#VSKW_ #ZP_P#?0_\
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M -]#_P"/T >@445Y_P#VSKW_ #ZP_P#?0_\ C] 'H%%>?_VSKW_/K#_WT/\
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ME_\ B* .KHKE/^%I:=_SV_\ (<O_ ,11_P +2T[_ )[?^0Y?_B* .KHKE/\
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M_B* .KHKE/\ A:6G?\]O_(<O_P 11_PM+3O^>W_D.7_XB@#JZ*Y3_A:6G?\
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M\+2T[_GM_P"0Y?\ XB@#JZ*Y3_A:6G?\]O\ R'+_ /$4?\+2T[_GM_Y#E_\
MB* .KHKE/^%I:=_SV_\ (<O_ ,11_P +2T[_ )[?^0Y?_B* .KHKE/\ A:6G
M?\]O_(<O_P 11_PM+3O^>W_D.7_XB@#JZ*Y3_A:6G?\ /;_R'+_\11_PM+3O
M^>W_ )#E_P#B* .KHKE/^%I:=_SV_P#(<O\ \11_PM+3O^>W_D.7_P"(H ZN
MBN4_X6EIW_/;_P AR_\ Q%'_  M+3O\ GM_Y#E_^(H ZNBN4_P"%I:=_SV_\
MAR__ !%'_"TM._Y[?^0Y?_B* .KHKE/^%I:=_P ]O_(<O_Q%'_"TM._Y[?\
MD.7_ .(H ZNBN4_X6EIW_/;_ ,AR_P#Q%'_"TM._Y[?^0Y?_ (B@#JZ*Y3_A
M:6G?\]O_ "'+_P#$4?\ "TM._P">W_D.7_XB@#JZ*Y3_ (6EIW_/;_R'+_\
M$4?\+2T[_GM_Y#E_^(H ZNBN4_X6EIW_ #V_\AR__$4?\+2T[_GM_P"0Y?\
MXB@#JZ*Y3_A:6G?\]O\ R'+_ /$4?\+2T[_GM_Y#E_\ B* .KHKE/^%I:=_S
MV_\ (<O_ ,11_P +2T[_ )[?^0Y?_B* .KHKE/\ A:6G?\]O_(<O_P 11_PM
M+3O^>W_D.7_XB@#JZ*Y3_A:6G?\ /;_R'+_\11_PM+3O^>W_ )#E_P#B* .K
MHKE/^%I:=_SV_P#(<O\ \11_PM+3O^>W_D.7_P"(H ZNBN4_X6EIW_/;_P A
MR_\ Q%'_  M+3O\ GM_Y#E_^(H ZNBN4_P"%I:=_SV_\AR__ !%:>A^+K77&
M9+:0.R#)&&4XZ9PP&1ZXZ9&>HH V**** "BBB@ HHHH **** "BBB@ HHHH
M**** /+/B]XQDMV_LN$@!D!E*GYOFS^[_P!D8Y/=@0.!G=RO@_X<3^(U\_(C
MAR1O8$DXS]U>,@'@DD#KC)!%,^*7_(1G_P"V?_HI*]J\)_\ 'G;?]>\/_H"T
M <!_PHS_ *>?_(/_ -LH_P"%&?\ 3S_Y!_\ ME>JT4 >5?\ "C/^GG_R#_\
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M!Y5_PHS_ *>?_(/_ -LH_P"%&?\ 3S_Y!_\ ME>JT4 >5?\ "C/^GG_R#_\
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M!Y5_PHS_ *>?_(/_ -LH_P"%&?\ 3S_Y!_\ ME>JT4 >5?\ "C/^GG_R#_\
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M!Y5_PHS_ *>?_(/_ -LH_P"%&?\ 3S_Y!_\ ME>JT4 >5?\ "C/^GG_R#_\
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M!Y5_PHS_ *>?_(/_ -LH_P"%&?\ 3S_Y!_\ ME>JT4 >5?\ "C/^GG_R#_\
M;*/^%&?]//\ Y!_^V5ZK10!Y5_PHS_IY_P#(/_VRC_A1G_3S_P"0?_ME>JT4
M >5?\*,_Z>?_ "#_ /;*/^%&?]//_D'_ .V5ZK10!Y5_PHS_ *>?_(/_ -LH
M_P"%&?\ 3S_Y!_\ ME>JT4 >5?\ "C/^GG_R#_\ ;*/^%&?]//\ Y!_^V5ZK
M10!Y5_PHS_IY_P#(/_VRC_A1G_3S_P"0?_ME>JT4 >5?\*,_Z>?_ "#_ /;*
M/^%&?]//_D'_ .V5ZK10!Y5_PHS_ *>?_(/_ -LH_P"%&?\ 3S_Y!_\ ME>J
MT4 >5?\ "C/^GG_R#_\ ;*/^%&?]//\ Y!_^V5ZK10!Y5_PHS_IY_P#(/_VR
MC_A1G_3S_P"0?_ME>JT4 >5?\*,_Z>?_ "#_ /;*/^%&?]//_D'_ .V5ZK10
M!Y5_PHS_ *>?_(/_ -LH_P"%&?\ 3S_Y!_\ ME>JT4 >5?\ "C/^GG_R#_\
M;*/^%&?]//\ Y!_^V5ZK10!Y5_PHS_IY_P#(/_VRC_A1G_3S_P"0?_ME>JT4
M >5?\*,_Z>?_ "#_ /;*/^%&?]//_D'_ .V5ZK10!Y5_PHS_ *>?_(/_ -LH
M_P"%&?\ 3S_Y!_\ ME>JT4 >5?\ "C/^GG_R#_\ ;*/^%&?]//\ Y!_^V5ZK
M10!Y5_PHS_IY_P#(/_VRC_A1G_3S_P"0?_ME>JT4 >5?\*,_Z>?_ "#_ /;*
M/^%&?]//_D'_ .V5ZK10!Y5_PHS_ *>?_(/_ -LH_P"%&?\ 3S_Y!_\ ME>J
MT4 >5?\ "C/^GG_R#_\ ;*/^%&?]//\ Y!_^V5ZK10!Y5_PHS_IY_P#(/_VR
MC_A1G_3S_P"0?_ME>JT4 >5?\*,_Z>?_ "#_ /;*/^%&?]//_D'_ .V5ZK10
M!Y5_PHS_ *>?_(/_ -LH_P"%&?\ 3S_Y!_\ ME>JT4 >5?\ "C/^GG_R#_\
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M!Y5_PHS_ *>?_(/_ -LH_P"%&?\ 3S_Y!_\ ME>JT4 >5?\ "C/^GG_R#_\
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M!Y5_PHS_ *>?_(/_ -LH_P"%&?\ 3S_Y!_\ ME>JT4 >5?\ "C/^GG_R#_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 5Y_\ &O\ X\X_^OA?_0)*] KS_P"-?_'G
M'_U\+_Z!)0 ?!3_CSD_Z^&_] CKT"O/_ (*?\><G_7PW_H$=>@4 %%%% !11
M10 4444 %%%% !1110 4444 ?/\ \4O^0C/_ -L__125[5X3_P"/.V_Z]X?_
M $!:\5^*7_(1G_[9_P#HI*]J\)_\>=M_U[P_^@+0!K4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MSD_Z^&_] CKT"@ HHHH **** "BBB@ HHHH **** "BBB@#Y_P#BE_R$9_\
MMG_Z*2O:O"?_ !YVW_7O#_Z M>*_%+_D(S_]L_\ T4E>U>$_^/.V_P"O>'_T
M!: -:BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M:II<>JQM;3KNC?&1DC."".00>H'>F6&BPV$(LXT A 8;#EAAB2P.XG(.3UH
MXC_A,;;^Q]F]?,^R^5Y>Y/,W;?*SMW9QGYO7;SCM7/\ AVU:ZT.[1!DB8MU
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M1G_[9_\ HI*]J\)_\>=M_P!>\/\ Z M &M1110 4444 %%%% !1110 4444
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M[(C,$'5BH)"C /)Z=#]* +%%>-:3\/;OQ9ON[Z5XW#;0)8V+$?>.%)0*N6X
MXSD8&.;OP\\1SZ3+<V-RQDBM(I&X)8CR"%(0MCY2.@.!P,8YR >L45XIHOAB
M?XB-+J%Q+LVL%7";EZ9* ;P5"@CUSG.2<FMOX<^+I+!;C3[O<?L4;N,8+!8C
MATSNP<'&WMU&<!10!ZA17@7CGQ5<^(5CGD0QVS%O+7.063 =LX&XC=@'  Y
MYW9]J\2ZP-'MI;LXS&A*Y!(+'A 0.<%B!V^HZT :=%>&0^&SXBB&H7E[&DTH
M<HDS#H&8#JPVJ7#8"J0!T]!Z1\/8KZVB:#4 VY6RCO(KL0W53M)/RD9R3_%@
M<"@#JZ*YKXA7UQ:VA%FKM+(P3,0)90<DM@ GH-N>,$@@Y KSR;X87$-L=6>8
MB=4,Q4JP8$?.<N3N#@<_=^]QG^*@#VBBO/\ P7XX9-->^O"S_9Y-F5 +D?(
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M 'H6G^'(+*W73PH:%1C;( ^>=Q)!X)+<], ] .*Q?B'IRPZ9-# @"J$(6-<
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M*F>4DH<,5((P21QC./>CPQXF:WU*]-S,WD0B<X=V*+B90,+D\\X  SS@=<4
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M +I#(QX)X#@$X .<9QWH VZ**Q-9\:6>C-Y4\JJ_]T!G8< \A 2,@C&<9[4
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M,DD  %PH))/ ')]*X_QA\1C#>Q6T,NVWBD3SR%(;*R_.I)&2 %_AZY(.X<4
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M3]0WO:1+#/U=2!NPV,[3_P \\\8& #CY5R,PW_AK5H97DMKQ623'^N4 C&0
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M"!DD@'+_ !*T^/PM<VVH6:B-V+$JORI^[V_PKC 8,0P! (]R2;'C[_D,V?\
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M)?A#I[:E<"Y=OELH]J 8!S*7..G(^9SUSDCMQ0!Z[IUDMA$ENF2L2*H)ZX4
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M5Y_\%/\ CSD_Z^&_] CKT"@ HHHH **** "BBB@ HHHH **** "BBB@#Y_\
MBE_R$9_^V?\ Z*2O:O"?_'G;?]>\/_H"UXK\4O\ D(S_ /;/_P!%)7M7A/\
MX\[;_KWA_P#0%H UJ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH *Y_PIX*A\,>9Y#.WF[<^85/W<XQA5_O&N@HH **** "BBB@
MHHHH Y_Q7X*A\3^7Y[.OE;L>65'WL9SE6_NBM#0M"BT.(6T PJ]2?O,>[$]R
M?_K#   T** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH Y_Q7X*A\3^7Y[.OE;L>65'WL9SE6_NBM#0M"BT.(6T PJ]2?O,
M>[$]R?\ ZPP  -"B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ KS_P"-?_'G'_U\+_Z!)7H%>?\
MQK_X\X_^OA?_ $"2@ ^"G_'G)_U\-_Z!'7H%>?\ P4_X\Y/^OAO_ $".O0*
M"BBB@ HHHH **** "BBB@ HHHH **** /G_XI?\ (1G_ .V?_HI*]J\)_P#'
MG;?]>\/_ * M>*_%+_D(S_\ ;/\ ]%)7M7A/_CSMO^O>'_T!: -:BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH *\_P#C7_QYQ_\ 7PO_ *!)7H%>
M?_&O_CSC_P"OA?\ T"2@ ^"G_'G)_P!?#?\ H$=>@5Y_\%/^/.3_ *^&_P#0
M(Z] H **** "BBB@ HHHH **** "BBB@ HHHH ^?_BE_R$9_^V?_ **2O:O"
M?_'G;?\ 7O#_ .@+7BOQ2_Y",_\ VS_]%)7M7A/_ (\[;_KWA_\ 0%H UJ**
M* "BBB@ HHHH **** "BBB@ HHK)UW4;FSV_9K?S]V[=^]6+;C&/O YSD].F
M/>@#6HKBO^$VO?.^Q?8?WOE^9M^TQ_=W;<YVXZ\8SGVJU>>+KG3K::]N;7R_
M*\O:OGJ^_>VT\JIV[<@\CF@#JZ*** "BBB@ HHHH **R?[=_TS^S=O\ R[^;
MOW?[>S;MQ^.<_A6M0 4444 %%%% !1163_;O^F?V;M_Y=_-W[O\ ;V;=N/QS
MG\* -:BBB@ HHK)T#7?[7\[Y=OD7$D7WLYV8^;H,9STYQZT :U%%9.G:[]LN
M;BRVX^S>5\V[.[S5+=,#&,8ZG/M0!K4444 %%%9/]N^9=_8(UW;(]\K[N$SP
MBX .6;K@E?EY&>E &M11535;I[2)YHD\QT4D)D@MCD@$*QSCH,<G XZT 6Z*
MJ:5J::I$EU$<I(H(Z9&>H."1D'@C/!!%6Z "BLGPMKO]O6R7NW9YF[Y=V[&U
MBO7 ],]*UJ "BBB@ HHHH **J:M??V?#)<XW>5&[XSC.U2<9P<9QZ4:3??VA
M#'<XV^;&CXSG&Y0<9P,XSZ4 6Z*** "BBB@ HHHH **** "BBB@ HHJI;W$D
MDDD;Q[8TV;'W@[\C+?*.5VGCGKU% %NBBB@ HK,\.:XNN0+>(I57+X!ZX5V4
M$X[G&<<XZ9/6F?V[YEW]@C7=LCWRONX3/"+@ Y9NN"5^7D9Z4 :U%%5-5NGM
M(GFB3S'120F2"V.2 0K'..@QR<#CK0!;HJII6IIJD2741RDB@CID9Z@X)&0>
M",\$$5;H ***R?"VN_V];)>[=GF;OEW;L;6*]<#TSTH UJ**R=?UW^R/)^7=
MY]Q'%][&-^?FZ'.,=.,^M &M1110 4444 %%<_XU\5_\(Q"MSL\S=($QNV]5
M8YSAO[OI6QIUZM_$EPF0LJ*P!ZX8 C.,\\T 6**Y=_'*C41HPC)..7+8P?+,
MF N#D8QSD<YXXYZB@ HHKG-=\9+82BR@C:XN2 ?+CX"@D#+MSM'.>A[9P"#0
M!T=%<E+XTGTX>;?6C0PY ,B2I-M+$ %E7!"^_/.  21750S+,H=""K $$'((
M/(((Z@T /HHK)U'7?L=S;V6W/VGS?FW8V^4H;I@YSG'48]Z -:BBB@ HHHH
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M6H **R=1UW['<V]EMS]I\WYMV-OE*&Z8.<YQU&/>M:@ HHHH **** "BBB@
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MDCE5?8_"HC$D!SSD]5P"I."":MXTB\11MINGYEFG1E)*,L:*<*S,6VD#:3C
M;YL#'(!I>(-$&A26UW+%]IMX;7R)1Y0<J(P660*6P,GJ3PH!&<L* &7FJIX;
M"W5O?&X0.OFQ2S),[(3C,>,$,N<XR >I.%P=#7K>?4M36R2:2*$VF]Q&Y4\2
M, 5X(#;MN3P=N1GL:\>KZ9J+K;V-K%/*W;R%C10",L[,F0,'C"MD\=2,ZO\
MS&?^X?\ ^UZ ,7QKX8\@6:^?<-FZBCRTN3\S.WF=/]8,X5NP &*[K2]/_L^-
M8-[R;<_-*VYSDD\M@9QG ]L5SOQ&E%O';7#9\N&]@=R 3M4;LL< \<@?4@=3
M71:7JD>JQK<P-NC?.#@C."0>" >H/:@#E?&VH?V?>V$^QY-OVGY8EW.<QJ.%
MR,XSD^V:M?\ "??].=Y_X#__ &5'B+_D(Z?_ -O7_HH5U= '#^#M1:_O-0G2
M-D9A;82<>6V1&P ;&[ ..N#P<X[52O+)+(,^HZE*)QMW)!*(PN0H $2@D^N0
MHR.2!R:T+/S/M>J^1_K?+M]G3[WDMM^]QUQUX]:Q/#_B#2],@BC:'-Y'M4IY
M&Z?S0V#AF'7=R!N! P  1MH T-!\:/;Z;/>.WG&VD:.-RI!<?*(V8$@\EQGG
M..N6R3H6G@^YN$6XGN[A;DJ"0K*(E;' \H#:0. PSA\$\9K'T?1Y-=M+^Q?$
M,\EV[E&.[;N*.N<?PMM(# 8(Y /2M6Q^)T&T1W*R1W0"@P^4^]G*@X4<\,3A
M=Q!Z9XYH PK'3WO+#4/-=DDCNKIV\ABJLRQ_,IR"3&2>AY(Q6QI&FMI>EO<)
M+*S2608!Y,B,B(D;, ;1S^@]*I:%(TMAJ;R+L<S7A9<AMI,8RN1P<'C/>MK_
M )@W_</_ /:% &?J'B22VM;&!95BENHT+3S8955(U9R2QP68D 9R#D\@X-4M
M0F31XVNK/43)+&,^7<7"3(ZCDH%ZACC@CGL",Y#]3TMI;73;U8O/6WCC$D7E
MB0LDL:!F"DC)7' P>2">%-"^(])N@J6MLDT\G"Q+;JK9()^9F4* ,?,06QUY
M )H TM1O5O[W2[A,A94N& /7#0J1G&>>:;$)_%<]POFRPVMM)Y:B$JCM(GWR
M6^8X&>!P""IX*FI=7C\J^TQ-JKM6Y&U/NKB%>!PO Z#@<=A52#5AX,GGCNMW
MV>YF,R2K&Q56DW;D8C/(V#:%!)'S' .  12Z7+IFHV,+RM+%_I)C:4YE!,7S
MJS<!AG!4]1D@\ 5Z!7G\OB!=;U&QDA5O('VD+(P*ASY7S;5(!PO R>IR!]W)
M[6WU2.YDDMD;,D&S>,$8WC*\D8.1Z$^] %NN$T6VG\8JU])/-#"TCB!(&6([
M =NYB-Q))'0G@@D<,,=W7G_AOQ G@Z,Z;?EH_*D<1.8WVR(3NW KO&06Y'8$
M#KF@#5\.7\]E=RZ3<.T@6-9(9&"[C'PA#$'D@\9(RQ#,>"!6/H6D3Z_+=M+<
MSI%%=RI&(92I&#\P.5/R@;=HS@?-P,\Z?APOK-]+JNUE@$*PPED*F121(7Y.
M<9^Z< $$=""*E\ ?\OG_ &$+C_V6@#JZ\_N=876YYXYKS[-!!(8U1)$AE9DX
M9RQR=N20 .#@$@%>?0*\T=+?PY=7"ZC K0SS&2.=H Z@R LR%OF(P1A0!GJQ
M !% &GH.M?8+M+!;D74$Z/L)=9)4=!N(9UQE6&<$Y/ 4  $FE+$^JV>H^9+*
M/(NKLKM<C*HG$9SG]WSRO K5\-7UIJ4^^PMD\N+.ZX\M8@"5&%3Y=S$Y(;.W
M ]<C-+1X6FM-41 2S7-Z  ,DDH   .I- #M-TC[#I,LOF2OYUCG;(^Y4_<DX
M08&T<].> /2F^&?",U_:PRSW<ZDQ)L6W<1HJ;04! 7YFQU8\]N<9+M-U^#4M
M)EAA;<\%CMD&UA@^21C) !Y4],UTOA/_ (\[;_KWA_\ 0%H Y5_&,]K9R*SK
M]H2\:U69PJIG=GS6 P% 7/\ >Y )R":9-#'$IFAU4_:<$CS+B(P%CU_=<@*>
M<#G;P1G%9\VDR:A;7;0J)'M]5EE$97<'V8!4C(R,$G').-H&35[_ (2?1\8^
MS+YV[;Y'V5?-W;MNW&-N?;=GMUXH M:]XF?4-&.H1EHY&6/)0E2&$JH^""2
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M4[Q!XM<PV@B=;=[T!C))M9(T"!VY; +<@+D8//W3@UN^+/\ CSN?^O>;_P!
M:N0U/2VEM=-O5B\];>.,21>6)"R2QH&8*2,E<<#!Y()X4T ,U"9-'C:ZL]1,
MDL8SY=Q<),CJ.2@7J&..".>P(SD:'B'5)[^;3S9R&/[4DS?/DC!C5@60'#,H
M)*@Y&[';-4E\1Z3=!4M;9)IY.%B6W56R03\S,H4 8^8@MCKR 36KJ\?E7VF)
MM5=JW(VI]U<0KP.%X'0<#CL* ,SQ#I=SX;,,EI=2NT\H@VW3^:F90=K]."I&
M>AS],AG^)M*G\-P'5$NII)8F0LLK9A?<P5AY8P%&6R "=HX'.&&KX^_Y<_\
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MXKJM)OO[0ACN<;?-C1\9SC<H.,X&<9]*J>+/^/.Y_P"O>;_T!J/"?_'G;?\
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M('- %ZBL_5];32O*\P,?/F2)=H!PSYP3DCCCGJ?:M"@ HHHH **** "BBB@
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MR>0<9QSBK=% &3X8T3^QH%@)W2'+2-G):1N78M@$\\ GG &:UJ** "BBL_\
MMM/M/]GX;S/)\W.!MV[]F,YSG/MC'>@#0HHK/T#6TUN!+R(,$DW8#@!OE8J<
MX)'4>M &A1110 4444 %%%% !16?H&MIK<"7D08))NP' #?*Q4YP2.H]:T*
M"BBB@ HHHH **** "BJ-YK$=I+%:MGS+@N$ ']Q2S$GL!P/7)'&,D-O=;2TG
MALV#;[GS-I &T>6NXYYSTZ8!_"@#0HHHH **** "BJEQJ'D21P;';S=_S*N4
M7:,_,V>,]%]35N@ HHHH **** "BBJ.J:Q'I@0R9_>RI&H SEG.!] .23Z#C
M)P" 7J*S]7UM-*\KS Q\^9(EV@'#/G!.2...>I]JT* "BBB@ HHHH **** "
MBJ-KK$=S-+:)DO (R_' \P$J,]S@9/;D<YR!>H **** "BBB@ HHHH ****
M"BBB@ K/M+%TGFN7*[76)$"@Y"Q[B2Q)ZEG;H,  =R<:%% !1110 445#=W2
MVB--(<)&I9C@G 49)P.>E $U%5].O5OXDN$R%E16 /7# $9QGGFK% !1110
M4444 %%5]1O5L(GN'R5B1F('7"@DXSCGBC3KU;^)+A,A945@#UPP!&<9YYH
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M8ATW59U%PUQ''(0#Y A#1@C^ R;B^#_$1G!)VD@"JFJ>,)GTR6\3$=U XCD
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M@1R6S0NQX$;M(9L,1N7&6V@YP<,W % &QJ&H7OA79<7,RW%NTBK(3#Y;1@Y
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MK(<_(2N"H(&<DX/<84E0"[ID6H6$RPS.MQ X8M+M6)T(' V@X93CC SDDD@
M9?HVJ27-[>6SMF.#[/L& ,;XR6Y R<GU)]JX^PT^'0[FUBTRZ:7S)CYD/FJZ
M%=OSR'9M4%5' .2QQC.T@[MGJ,6D:E>?:76/STMWC+L%#*BE&Y)P"&XP<$]0
M,<T :>LZI);7MG;(V(Y_M&\8!SLC!7DC(P?0CWKGXH[JXU&^AM66/=]F+RL
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MET)2K[!$ZF-0Q&%RI7'3ODGG  +O#O\ R$=0_P"W7_T4:/$7_(1T_P#[>O\
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MC/DW!?:K#&6&> "I/ ?</8;@& -W0Q>VTK6]T5EB"96=0$8MGE&C!///!'&
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MN<Y& ,G(.,Z&C:C%:ZG?)(ZJTAM0@9@I8^7C !/)Y'3U%6/#O_(1U#_MU_\
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MG.,=>,9S[5;H *ANK1+M3%*JNAQE7 93@Y&0>.M357M-0CO"XC8-Y3E&QV8
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M;=O3&.,=,55U+7X-->*&9MKSMMC&UCDY QD @<L.N*T* &0PK"H1  J@  #
M '   Z 4RWM$MMWEJJ[V+-M &6/5CCJ3W/6L"[^(]A:.T,DV'C8JP\N0X*G!
M&0N.M.T_XAV&H2+!',"[G"@HZY/8990,GMSR>!S0!L6.DPZ?GR(TCW8SY:*N
M<9QG &<9-6)H5F4HX!5@001D$'@@@]0:KZIJD>E1M<SMMC3&3@G&2 . ">I'
M:GZ?J$>HQK<0L&C<9!'^>".A!Y!X/- $-EH=O8-OABC1B,$HBJ<=<9 ''%/_
M +)A\O[+Y:>5_<V+LZ[ONXQUYZ=>:KZCXDM].ECM97"RS$!%P23D[1T!P">
M3@'GT-:= !4-K:):*(HE5$&<*@"J,G)P!QUJK#K\$T[V"MF>-=S+M;@';SG&
M#]X=#WK0H S[?P];6V[RX8EWJ5;;&@RIZJ<#D'N.E7885A4(@ 50  !@ #@
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M@JB?,_!.0< E\;2QZ9SVK6HH X3^W5F?S)-,E^UAL!O)1EW*<(?/('' ^?&
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M_P#CSC_Z^%_] DKT"O/_ (U_\><?_7PO_H$E !\%/^/.3_KX;_T".O0*\_\
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M88[B*1005WI&=V"">.?PZ9.,G/L_#\>LVL=_?W<KI(J-(OFK';YR/D*@ #!
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M_P"/.V_Z]X?_ $!:\ZT&Y&GP:5>R<1))<HS9  ,S,JDY(XX))[ 'V! .HO\
MQ!J&@(;N]2!X%*AOL[.'7<P&[$G##M@8))'( )JWXD\62:=+:QVZ"9;H2X"<
MEMJJ4VMG:%);+,00%R>U6/'NIII]C.TA^_&T:CC):0%0!DC.,Y/? )QQ6(;5
MK2XTB&08>.&96&0<%8%!&1QUH L7_B#4- 0W=ZD#P*5#?9V<.NY@-V).&';
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MBIUN^O%MQN\K3W@)RN/,<EE4<_4'.,$$''&>@\&:K%/80RJZ[8H45R3@*8T
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M ) *_P#7O:_SCKL-=T9=7B,#<-U1QG<CC[KC!!!4\\$9Z=": ,3Q%_R$=/\
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M23S=H9,,6PGR AAC)7)QC/2@#LZY+_A(+W5Y)4L$B6.WE:-GN&8[F7&=JQ]
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M\*0S EBN?EPN!P/F8<]C#XEFN+F&WTR8J)[R7;)Y!8#RD):0JS="$P"&SG)
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M !YR?]?#?^@1UZ!7G_P4_P"/.3_KX;_T".O0* "BBB@ HHHH **** "BBB@
MHHHH **** /G_P"*7_(1G_[9_P#HI*]J\)_\>=M_U[P_^@+7BOQ2_P"0C/\
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MFL>!K/6)/M$\0:0@ D,ZYQTSM89/;)YQ@= *WJ* *FF:5%I:"&!%1!V48R<
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M6?J3AG5BO3@@@ $5MT44 <U_PK?3]_G>0N[=NQN?;G.?N;MN/]G&,<8Q6J-
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MD9VK@>W)K6HHH Y_4_ -CJ;F:6%2YZE2R9))))"%022>2>3ZUI1:+#%!]A5
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MS0SZPZ$AE@B((.""+=R"".A%,\*?VE]DA^S?8_*\M=O^MS[[MO&[.=V/XLT
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MN1ZRAEBW?*Q5E=2K*P +(0>XSSC(SWK"^%4*IIT1  +&0D@8R?,89/J< #Z
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M_P"/.V_Z]X?_ $!:Y#0HVBL-321M[B:\#-@+N(C&6P.!D\X[5U_A/_CSMO\
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MMV>=MVX^7&.,8Z8XQ0!U&GZA'J,:W$+!HW&01_G@CH0>0>#S7.?%+_D'3_\
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M.3TR#@G!K(^%4*IIT1  +&0D@8R?,89/J< #Z "N9\5S-$=7*D@XLAD''#
MCZ$$@^HXH ZC_A8T#?O$BN'@_P">RP,8L#[S9.#A>=WR]CC-='I^H1ZC&MQ"
MP:-QD$?YX(Z$'D'@\UR]I_:VQ?*^P^7M&W9YVW;CY<8XQCICC%:'@K1)M'B>
M*X*9:9W58BWEJKX.U0P&T YP!QSZYH T-;T"#6T$-RN] P8#<R\@$9RI!Z$U
MQ^O^!+"Q"0PVZM<3L5C5II N0"S.WSYVH!DXR3P!R0:] KE/#?\ Q,KV[OST
MB86T>>& C^:08'!#.003D_0<4 ;NBZ/'H\*6D.=D8P,G).2223ZDDGL/0 <5
M>HHH P?%%G<:@8K6!FCC=R9I8V"NJJ,A1GG+GC(Z8Y!!(K"U[P!;:3"]]9!H
M)[=6D5U9F^XI)4AV((8<']<C(/<33+"I=R J@DDG  ')))Z 5R5QCQQM1-PL
M$8,S_,AF9?X ."(U/WF(R6&%P5W4 1:QJLNJQ6-LCM%)?;7=HSMPB1B20*W)
M!.1MZYQACC.8=?\  \.BP27NG[H)X5W[ED<@JGS,K!BP((&<8P2!GC-:'B7]
MW?Z?*W"!KA2QX7<\8"KGIEB.!U/:M/QC,L5E<EB /(D&2<<LI 'U)( ]3Q0!
M4U7Q+-Y,,EE TKW*;ESA40; P+MG /(P,C=R V<9Q_A_#/#=WR7;*\X^S;F3
MA3\C8Q\J]!@=!74>&(6AM+='!#+!$"",$$( 00>A%8_AW_D(ZA_VZ_\ HHT
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MBPZY&37>W=Q]F1I<,VQ2=J#+' S@#N3V'K7->'?^0CJ'_;K_ .BC75T <%X
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M7-A)<3W1B_TAD8+ 7V!@"';:P&"W!)Y)/7M72T %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %>?\ QK_X\X_^OA?_ $"2O0*\_P#C7_QY
MQ_\ 7PO_ *!)0 ?!3_CSD_Z^&_\ 0(Z] KS_ ."G_'G)_P!?#?\ H$=>@4 %
M%%% !1110 4444 %%%% !1110 4444 ?/_Q2_P"0C/\ ]L__ $4E>U>$_P#C
MSMO^O>'_ - 6O%?BE_R$9_\ MG_Z*2O:O"?_ !YVW_7O#_Z M &M1110 444
M4 %%%% !1110 4444 %9/B7P^NNQ>2S,C*P>-T)#(ZYVL,$9QGI^1!P1K44
M<?/X&GU/Y+Z[>:+:PV(BPC)QACM)#;2,@$=0.V0;LGA-IH+6V:09LY8GW!,;
MA"" N-QP2,9.3SSCG Z.B@"CK6CQZQ"]I-G9(,'!P1@@@@^H(!]/4$<5SO\
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M4;8TR.R* !VSD@ ' 9KGA<WTJWL$K0W*)L#J ZE2<[61N&'7'3D@G.!C>HH
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M>#D?-E3GID8]_:MNBB@#S3P%X<GDLHI[2X: R;_,!C656*R,JL Y^4X&#CJ
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M_P 7^&I-?5(DF\I%;<RF,2*Y!!7() (!'W3D'N.!53_A'=1_Y_\ _P E8O\
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M4-'BOH&LF4")DVX4 8&,# P0"O!7C@@5Y[:W376GZ6[G)%]"O0#A'D11QZ
M?SYH 9K?B2"QMX;>"\G87$Z.\CES*(<LC[6* @!DZ#GKP0>>CT%K93;-'=W$
MOFM.8A*[$2;5"N&R@X3;E0<<DD9S4OC[_ES_ .PA;_\ LU'B+_D(Z?\ ]O7_
M **% &WK.OP:*OF7,BH#TSRQY .%&2<9&< XZGBF:'XDM]=5GMG#A#AN"I&>
MG# '!['&#@^AK%TF%;S5+N60!FMD@2(D?=61&9L>Y)//7!(!P<4[Q5I\-B[Z
MFC^5=K;S[0K*/,V1D_,A!W[, _@-V0!@ MZGX^L=,<PRS*''4*&?!!(()0,
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M_P IMWE2-&W!&&7&X<@9QGJ./>N:^*-L%M/MJ\2VLD;QL "0=ZKCD'CG..Y
MSTQ4L?\ Q*]48'[E_""">29(."HQT'EG)W=3T/:@#H)-4CCE6T+?O74L% ).
MT=6. 0HSP"V 3P,FL+P=J+.MX\SDK%>W !=N%1=IQDGA1^0IGA7_ (FUQ<:J
MW3<8(<<KY<9R6## 8._.<'&,!B*Q]/T-M<M=1LT8*SW\V">F59& ..QQC/..
MN#TH Z"+XB:?))Y G7=DC)#!.,Y^<@)CC@YP>V<BL_Q_XN32&@@$A1C/"\@
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M_P 2K3)8X/E5(TC ZX4LL9'.?X21GKWSGF@"Q+\1-/CD\@SKNR!D!BG.,?.
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M.C$&9B?FQTS&N"O]UCSEOX;7Q$\3QPNFDRLT4<Z[I90"2(\GY5"Y.7*[22"
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MPQ0QB^@5 &\R8$X)^=?EVG!XX.0,CC) .]OM:AL'2*5PK2ARN<XQ&NYR6Q@
M#GDBLW3/'UCJ;B&*92YZ!@R9)(  +A022> .3Z5F>,=/CU"_T^&90R$W)*GH
M=J*PR.XR!QT/0\5-\585?3I20"5,9!(S@^8HR/0X)'T)% '1:?JD>H;_ "FW
M>5(T;<$89<;AR!G&>HX]Z)-4CCE6T+?O74L% ).T=6. 0HSP"V 3P,FN?C_X
ME>J,#]R_A!!/),D'!48Z#RSD[NIZ'M1X5_XFUQ<:JW3<8(<<KY<9R6## 8._
M.<'&,!B* .KKG]3\?6.F.899E#CJ%#/@@D$$H& ((Y!Y'I705PEEJKPB0Z39
M^8A9P9GE0;W5F^;+,6E7)R&+<Y(&,4 =;H^M0ZQ'Y]NX=,D9&1@CJ"" 0?J.
MF#T(K-U/Q]8Z8YAEF4..H4,^""002@8 @CD'D>E<OHLL^G/JLLGEK.D4;_N0
M?+W>5(P8!AR3U.>K9KJ/ 6F)I]C L8^_&LC'C):0!B3@#.,X'?  SQ0!F66I
MBXN-2WRL(%B@*LCD[%:%F9TQG!_BR!R<'FNETZXC2W24.6B$2D22'DJ%!WL3
MCDCDDX]ZX6+3X]/;6885"H($(4=!N@D8X'89)XZ#H.*EUU#<:;86A)"7+V<;
MXQG:R9X)!P<@'/MZ9% '01?$33Y)/($Z[LD9(8)QG/SD!,<<'.#VSD5L:AJD
M>G[/-;;YLBQKP3EFSM' .,XZGCWIFH:/%?0-9,H$3)MPH P,8&!@@%>"O'!
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MBB..WDVKC(!52P//?/.>N><YYKC(YY7GL5C@%SY.G12(A=8]K,0IDRPY(V@
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MPH'' ]34_"\M[8PZ7E0 (%F.3]R/!;8<'YLJ,;AC&<UU%% #(85A4(@ 50
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M:KHCW=W:WBE=EMYVX$G<?,0*,<8Z]<D?C1XST1];M)+.(J'DV8+DA?E=6.<
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 5Y_\:_\ CSC_ .OA?_0)*] K
MS_XU_P#'G'_U\+_Z!)0 ?!3_ (\Y/^OAO_0(Z] KS_X*?\><G_7PW_H$=>@4
M %%%% !1110 4444 %%%% !1110 4444 ?/_ ,4O^0C/_P!L_P#T4E>U>$_^
M/.V_Z]X?_0%KQ7XI?\A&?_MG_P"BDKVKPG_QYVW_ %[P_P#H"T :U%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 5Y_\ &O\ X\X_^OA?_0)*] KS
M_P"-?_'G'_U\+_Z!)0 ?!3_CSD_Z^&_] CKT"O/_ (*?\><G_7PW_H$=>@4
M%%%% !1110 4444 %%%% !1110 4444 ?/\ \4O^0C/_ -L__125[5X3_P"/
M.V_Z]X?_ $!:\5^*7_(1G_[9_P#HI*]J\)_\>=M_U[P_^@+0!K4444 %%%%
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MNZQXAMFD@=-T<C?.X0,WR B-5V;1CJ2V,E@ 0 :W?A=XPF\0QR)<8+PE?G
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M^\8!L>859&'(^8D$+MY % 'JM%>>2_%E([%+O:#<R%D"#=L#IC<Q)Q\N&5L
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M]3TH^*_BFYT'R/LS[/,\W=\JMG;LQ]X'U/2@#T"BO+/%WB#5]"*WTC1K#(X
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M_7O#_P"@+0!K4444 %%%% !1110 4444 %%%% !1110!Y5X^_P"0S9_]N_\
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MP\#>'DEL((KN%2\?F?+-&"R[I&/1QD9&/KQ76S0K,I1P"K @@C((/!!!Z@T
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M=\=1H%AIZPWLMB\S.MK.A\T#;M*Y# A !DC@$AL _+Q7IM[H=O?MOFBC=@,
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M'K;9Y'DQ>7NW;?+3;NQC=MQC..,]<5:^R)L\C:OE[=NW V[<8V[>F,<8Z8H
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M'48'/85%:^'K:T82Q0Q(XSADC16&1@X(&>E:% '!?%VR=88M1BR)+24$'Y<
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M'6FQ:=%%']G5%$6"-@4!,-G(VXQ@Y.?6@#R?PEICZGHMU!$,N9B0.23L$3D
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MM]O67;Q(BL"J_>'."&!.0,*X!W?=.37H%5[W3HK]=DR*Z@Y =0PSTS@@\\T
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MZ>TM[=9X_)VK$GEJVYFSN^<9P 2.1^.: /1;758KMWAC=6>+&\*<[22P )'
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M"S6L18C.48[&(/8@$J<CL,?,>V9X9\<ZGXAQY,,6P2!9)"&V@''13(I)49)
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MC!PSCDD#@Y7C(PV0 =W17)>-O&S:*T=E;J'NIRNU6X0!FV@DY&22, 9&.I(
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M[O#I=]$J2'(&P$8*J6.<LV00,@@^G4'( /0**X+4/'MSJ,[6VD1+,(A\[O\
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M^8@!CG'4#"GD\9&,YXJIJ'BFVT^9+*5]LLNW:NUCG<Q5>0"!DC')KR#[;?\
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MR6"[T_[5+=O/<R;2(FD^57+Y;$0^[M7<H)^4@Y4#*BO3;+P-9V4<EO'$!'.
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M0?*B.UG*X(^8$$GY1DY+''1CP9?!>C-HUG#:R??526Z<%V+E>"0<$XSGG&:
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MK&[7QAJT,X50EO;QN1O+<@;P 0!RDD@!!_NG/]VO5:XKX5>&'T6W:29=LL[
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M8ZD8..7^'VF/#IM_=,,)+"X7.<GRXWR>F,9;&0>H([5WLOP[T^23SS N[(.
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M)QDXR3CH.*S_ /A +#S/M'D)N],'9TQ_J\[.G^SUYZ\T <5\#/\ EZ_[8_\
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MF+Y5<[B,-C@9)! %6]8U=/&VFSBS#;@!E71@<HP?:" P9B%X"D]5SC-;&I^
M;'4W,TL*ESU*EDR2222$*@DD\D\GUK8T_3X].C6WA4+&@P /\\D]23R3R>:
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M@7=DG!+%.<Y^0DICG@8P.V,"@#S?X<?\>>I?]>__ +)-75_!3_CSD_Z^&_\
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MS&'9!@'+*<=<94C(],],G'4TR7P9:2O%,8_GME18SO?Y1&<H,;L'!]<Y[YH
M\_TJZ7POK,YNSM6XW[7P=F)7#J23CC@J3R V<G )#?B5J$?BFYMM/LV$CJ6!
M9?F3]YM_B7.0H4EB 0![@@>FZSH$&M+Y=S&K@=,\,.03AA@C.!G!&>AXJ'1/
M"MKHF3;1JA.<MRS8..-S$G' XSC/.,T <!X^_P"0S9_]N_\ Z/:CXY_\NO\
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M4 %%%% !1110 4444 %>?_&O_CSC_P"OA?\ T"2O0*\_^-?_ !YQ_P#7PO\
MZ!)0 ?!3_CSD_P"OAO\ T".O0*\_^"G_ !YR?]?#?^@1UZ!0 4444 %%%% !
M1110 4444 %%%% !1110!\__ !2_Y",__;/_ -%)7M7A/_CSMO\ KWA_] 6O
M%?BE_P A&?\ [9_^BDKVKPG_ ,>=M_U[P_\ H"T :U%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 5Y_\:_\ CSC_ .OA?_0)*] KS_XU_P#'G'_U
M\+_Z!)0 ?!3_ (\Y/^OAO_0(Z] KS_X*?\><G_7PW_H$=>@4 %%%% !1110
M4444 %%%% !1110 4444 ?/_ ,4O^0C/_P!L_P#T4E>U>$_^/.V_Z]X?_0%K
MQ7XI?\A&?_MG_P"BDKVKPG_QYVW_ %[P_P#H"T :U%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 5Y_\ &O\ X\X_^OA?_0)*] KS_P"-?_'G'_U\
M+_Z!)0 ?!3_CSD_Z^&_] CKT"O/_ (*?\><G_7PW_H$=>@4 %%%% !1110 4
M444 %%%% !1110 4444 ?/\ \4O^0C/_ -L__125[5X3_P"/.V_Z]X?_ $!:
M\5^*7_(1G_[9_P#HI*]J\)_\>=M_U[P_^@+0!K4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !7G_ ,:_^/./_KX7_P! DKT"O/\ XU_\><?_ %\+
M_P"@24 'P4_X\Y/^OAO_ $".O0*\_P#@I_QYR?\ 7PW_ *!'7H% !1110 44
M44 %%%% !1110 4444 %%%% 'S_\4O\ D(S_ /;/_P!%)7M7A/\ X\[;_KWA
M_P#0%KQ7XI?\A&?_ +9_^BDKVKPG_P >=M_U[P_^@+0!K4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !7G_QK_X\X_\ KX7_ - DKT"O/_C7_P >
M<?\ U\+_ .@24 'P4_X\Y/\ KX;_ - CKT"O/_@I_P ><G_7PW_H$=>@4 %%
M%% !1110 4444 %%%% !1110 4444 ?/_P 4O^0C/_VS_P#125[5X3_X\[;_
M *]X?_0%KQ7XI?\ (1G_ .V?_HI*]J\)_P#'G;?]>\/_ * M &M1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %>?_&O_ (\X_P#KX7_T"2O0*\_^
M-?\ QYQ_]?"_^@24 'P4_P"/.3_KX;_T".O0*\_^"G_'G)_U\-_Z!'7H% !1
M110 4444 %%%% !1110 4444 %%%% 'S_P#%+_D(S_\ ;/\ ]%)7M7A/_CSM
MO^O>'_T!:\5^*7_(1G_[9_\ HI*]J\)_\>=M_P!>\/\ Z M &M1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %>?_ !K_ ././_KX7_T"2O0*\_\
MC7_QYQ_]?"_^@24 'P4_X\Y/^OAO_0(Z] KS_P""G_'G)_U\-_Z!'7H% !11
M10 4444 %%%% !1110 4444 %%%% 'S_ /%+_D(S_P#;/_T4E>U>$_\ CSMO
M^O>'_P! 6O%?BE_R$9_^V?\ Z*2O:O"?_'G;?]>\/_H"T :U%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 5Y_P#&O_CSC_Z^%_\ 0)*] KS_ .-?
M_'G'_P!?"_\ H$E !\%/^/.3_KX;_P! CKT"O/\ X*?\><G_ %\-_P"@1UZ!
M0 4444 %%%% !1110 4444 %%%% !1110!\__%+_ )",_P#VS_\ 125[5X3_
M ./.V_Z]X?\ T!:\5^*7_(1G_P"V?_HI*]J\)_\ 'G;?]>\/_H"T :U%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 5Y_\:_^/./_ *^%_P#0)*]
MKS_XU_\ 'G'_ -?"_P#H$E !\%/^/.3_ *^&_P#0(Z] KS_X*?\ 'G)_U\-_
MZ!'7H% !1110 4444 %%%% !1110 4444 %%%% 'S_\ %+_D(S_]L_\ T4E>
MU>$_^/.V_P"O>'_T!:\5^*7_ "$9_P#MG_Z*2O:O"?\ QYVW_7O#_P"@+0!K
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7G_QK_P"/./\ Z^%_
M] DKT"O/_C7_ ,><?_7PO_H$E !\%/\ CSD_Z^&_] CKT"O/_@I_QYR?]?#?
M^@1UZ!0 4444 %%%% !1110 4444 %%%% !1110!\_\ Q2_Y",__ &S_ /12
M5[5X3_X\[;_KWA_] 6O%?BE_R$9_^V?_ **2O:O"?_'G;?\ 7O#_ .@+0!K4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %>?\ QK_X\X_^OA?_ $"2
MO0*\_P#C7_QYQ_\ 7PO_ *!)0 ?!3_CSD_Z^&_\ 0(Z] KS_ ."G_'G)_P!?
M#?\ H$=>@4 %%%% !1110 4444 %%%% !1110 4444 ?/_Q2_P"0C/\ ]L__
M $4E>U>$_P#CSMO^O>'_ - 6O%?BE_R$9_\ MG_Z*2O:O"?_ !YVW_7O#_Z
MM &M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>?_&O_CSC_P"O
MA?\ T"2O0*\_^-?_ !YQ_P#7PO\ Z!)0 ?!3_CSD_P"OAO\ T".O0*\_^"G_
M !YR?]?#?^@1UZ!0 4444 %%%% !1110 4444 %%%5]1O5L(GN'R5B1F('7"
M@DXSCGB@"Q16?J>L"Q9(0CR22[MJQ@9P@&YB695 &0.3R2 ,T[3=66^+( 5D
MB(#QL5WKN&Y<[2PP1R""1VZ@@ 'AOQ2_Y",__;/_ -%)7M7A/_CSMO\ KWA_
M] 6O%?BE_P A&?\ [9_^BDKVKPG_ ,>=M_U[P_\ H"T :U%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M/_H"T :U%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5Y_P#&O_CS
MC_Z^%_\ 0)*] KS_ .-?_'G'_P!?"_\ H$E !\%/^/.3_KX;_P! CKT"O/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !7G_QK_P"/./\ Z^%_] DK
MT"O/_C7_ ,><?_7PO_H$E !\%/\ CSD_Z^&_] CKT"O/_@I_QYR?]?#?^@1U
MZ!0 4444 %%%% !1110 4444 %5]1O5L(GN'R5B1F('7"@DXSCGBK%5]1LEO
MXGMWR%E1E)'7# @XSGGF@#"?Q;)9.D%S;LLDZ@Q+"XE+$$;T.0@4H"&))V8R
M=W'.KI=Q/<%GFC6).-B[]\G!;);;\HR-I 4MCG)]*DWAQYBCM<S$QMN7BWX)
M5DS_ *GGAB.?7UK0L;)[;.^5Y,XQY@C&,9Z>6B=??/3C'- 'A7Q2_P"0C/\
M]L__ $4E>U>$_P#CSMO^O>'_ - 6O%?BE_R$9_\ MG_Z*2O:O"?_ !YVW_7O
M#_Z M &M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>?_&O_CSC
M_P"OA?\ T"2O0*\_^-?_ !YQ_P#7PO\ Z!)0 ?!3_CSD_P"OAO\ T".O0*\_
M^"G_ !YR?]?#?^@1UZ!0 4444 %%%% !1110 4444 %%%% !1110!\__ !2_
MY",__;/_ -%)7M7A/_CSMO\ KWA_] 6O%?BE_P A&?\ [9_^BDKVKPG_ ,>=
MM_U[P_\ H"T :U%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5Y_\
M:_\ CSC_ .OA?_0)*] KS_XU_P#'G'_U\+_Z!)0 ?!3_ (\Y/^OAO_0(Z] K
MS_X*?\><G_7PW_H$=>@4 %%%% !1110 4444 %%%% !116?XANFM+:>:,X>.
M&1E. <%4)!P>.M &A17/C2;G2MTT$KSYWL8K@K\Q.,;) H\O&#A<%.<87[P-
M UU=7GE>,MM6&'*-D,C[YPZLO\+# !]<#J,&@#Q_XI?\A&?_ +9_^BDKVKPG
M_P >=M_U[P_^@+7BOQ2_Y",__;/_ -%)7M7A/_CSMO\ KWA_] 6@#6HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M&1G&?6@#"L-0CL96FN+46I<O^^(B*D94_/(A.QF)Z,<$C 8GBMJ*Y5KB2(*
MRQ1,7[D,TH"].B[21S_$>!WRKWQSIX;[-)-&WF#! ^="&^7#, 4 ]=Q&!R>*
M?X6T5+(O-#-YL$BHL0R&"+&7.P2 G< 7(&>5 "Y.* /'_BE_R$9_^V?_ **2
MO:O"?_'G;?\ 7O#_ .@+7BOQ2_Y",_\ VS_]%)7M7A/_ (\[;_KWA_\ 0%H
MUJ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MFN@\.V*HINA,;AY@H:7*E3Y>0 H3Y54$L<#)R3DDT >+_%+_ )",_P#VS_\
M125[5X3_ ./.V_Z]X?\ T!:\5^*7_(1G_P"V?_HI*]J\)_\ 'G;?]>\/_H"T
M :U%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5Y_\:_^/./_ *^%
M_P#0)*] KS_XU_\ 'G'_ -?"_P#H$E !\%/^/.3_ *^&_P#0(Z] KS_X*?\
M'G)_U\-_Z!'7H% !1110 4444 %%%% !1110 51URR:_MYK=,!I8G4$],LI
MSC/'-7J* ,2U\111*(_*FCV979]FE(4*=H ,:NA&!QM8C&*9H$;W$TU\T1A6
M9(0H?:)&V!R795SM/SA0"2V%Y X%;U% 'S_\4O\ D(S_ /;/_P!%)7M7A/\
MX\[;_KWA_P#0%KQ7XI?\A&?_ +9_^BDKVKPG_P >=M_U[P_^@+0!K4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !7G_QK_X\X_\ KX7_ - DKT"O
M/_C7_P ><?\ U\+_ .@24 'P4_X\Y/\ KX;_ - CKT"O/_@I_P ><G_7PW_H
M$=>@4 %%%% !1110 4444 %%%% !1110 4444 ?/_P 4O^0C/_VS_P#125[5
MX3_X\[;_ *]X?_0%KQ7XI?\ (1G_ .V?_HI*]J\)_P#'G;?]>\/_ * M &M1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!SGCGQ>OAF#S0 TKG
M:BD]\9+$9SM7OCN0,C.1PMCX=UK75%X;@QB0*5!F9,J5!#!8@5 (^ASG([FU
M\<H6*VS@':#*"<< G80,^IP<?0^E>FVETMVBS1G*2*&4X(R&&0<'GI0!P7PZ
M\2WDDTFF7RL6B ^<J25('"LR@@A@"RL3S@\MN&.MUOQ5:Z)@7,BH3C"\LV#G
MG:H)QP><8SQG-5;'QS:WET^FJS>:C%1E3M8J"6 /^S@YSC/\.:X+X:Z?'XIN
M;G4+Q1(ZE2%;YD_>;OX6SD*% 4$D >X! !Z;HVOP:TOF6TBN!UQPPY(&5.",
MX.,@9ZCBJ\WBZUAG-B\@$R@D@A@  GF$EB-H 7GK7GFJVJ^%]9@%H-JW&S<F
M3LQ*Y1@ ,<<!@.0&Q@8  ;?Z?'J'B PS*&0E25/0[;<,,CN,@<=#T/% '?Z/
MXYL]8D^SP2AI""0"KKG'7&Y1D]\#G&3T!KC?&'Q&,-[%;0R[;>*1//(4ALK+
M\ZDD9( 7^'KD@[AQ6?XNTJ+3=8M%@145VMV(087/FE<@#@<*.F/7J33_ !YI
MT2:O:H$4+*82X"C#%IF#%ACDGOGKWH W?&FM0:C';W,=Z]M&_F[3&DIW[2H.
M0I4C:1W'.>*ZK7?%-MH.W[2^SS-VWY6;.W&?N@^HZUYU\:;1+1;6*)51!Y^%
M0!5&3&3@#CK4WQS_ .77_MM_[3H [6Z\?6-I*;5YE$BL%(PVT'T+ ;1COD\<
MYQ@UH:WK\&B()KEMB%@H.UFY()QA03T!KSSXL^&K;3+2)X(E1EE5,J,$J48\
MG^(_*.6R>O/)RWQ]_P @:S_[=_\ T0U 'HMSK\%K +]VQ 55MVUCP^-IP!GG
M([?6I=+U2/58UN8&W1OG!P1G!(/! /4'M7%>)?\ D K_ ->]K_..N<OM0DL]
M!MQ&Q7S971L=U+2DKGT.!GU'!X)% '??\+(T_?Y/GKNW;<[7VYSC[^W;C_:S
MC'.<5OW5VEHIEE9408RSD*HR<#)/'6O&(9?.LQ:II;$M$ )PK%BQ&1(&$>2"
M><;L8^7[M9_B*\NDL+:SN59 DLH D5E8A%38?FYP/,91C P ,<4 =[XO\?VU
M]93?8Y\2KY>,%HWYD7.W(4G@'.,X'7K6W\.+M[NPAEE9G<^9EG)9CB1@,D\]
M*Y_XA^#K:PTXM$BJ\'E8<*@=N1&=S!03D-D],M@^U;7PM_Y!T'_;3_T:] '2
MW5VEHIEE9408RSD*HR<#)/'6N=A^)NG2L$$XRQ &4D4<^I*@ >Y.!WJ7Q^ML
MUHXO'98LC_5MAV8'(4#HQ..A! ^\<8W#SWQ-;B\L3/#8I! FQDF9AYK+N"+\
MJC=EL@DN64C)R3M:@#U+5?$EOI42W4S@1.0%8 N#N!88V \$#.>E9]Y\0["R
M*B28 NBN $=OE<97.%."1S@X."#CD5YOK/\ R ;7_KX;^<];&O\ AJV@T5+A
M8E$HB@?>!\^YRN[+=2#N/!R!Q@<# !Z;]K39Y^Y?+V[MV1MVXSNW=,8YSTQ7
M*ZSX_LYX;B&"=?-6&7:067Y@I VN0 3G&-I)/45Q6IW30Z!;HIP))BK<#D!Y
M7Q[<J#QZ>E=!_P (=;?V/OV+YGV7S?,VIYF[;YN-VW.,_+Z[>,]Z +OPBU&6
M_M'>9V=A.P!=BQQL0XR2>.:Z#Q7XB30+=KAR V&$8(8@OM)53M[''L/<5R_P
M4_X\Y/\ KX;_ - CKI?&EHES9S^8JMLAE9=P!PP1L,,]".QZT <O\,O'(U(&
MWNI2UU+*Q4%3]U8UZ;5V ?*3CCG)ZGGJ-9\:6>C-Y4\JJ_\ = 9V' /(0$C(
M(QG&>U<+\,T2TT^XU 1H9X&F*,R@L-L*G&[KCKD CJ?6G?";PY!JD4M]<J)9
M6E9?WH#CHK$X;/S$MR3D^F,G(!Z1IFJQ:H@F@=70]U.<' .".H.",@X([BK=
M>3^&XAX=UI]/M\B&0$%6)./W7FCOU4\ G)VDCJ<UZQ0!Y5X;\5FTU*\%W.P@
MC\_:LDA*@K*,!5)ZXS@ 9QP!7?Z)XJM=;R+:17(SE>5; QSM8 XY'.,9XSFO
M,O"FCQ:IK%R)E#+&]PP5@&4GS-G((.0-V?J :F\16*Z%K5L;8!!*82555"C>
MQB8  8 *CZY).>F #T77/%UKH;*ES($9QD##,<=,X4' ],]<''0U:T?6H=8C
M\^W<.F2,C(P1U!! (/U'3!Z$5XEX6UE[B6:[FM&OI'VY)!8+G/\ "$<<X '
MP%PO&171^!Q<P:DTJ6LEO;7 8,C+)L7"[@<D* =PXXP Q4"@#UBN?U/Q]8Z8
MYAEF4..H4,^""002@8 @CD'D>E=!7BB:!/X+D<RVJ7=N<G>4W85 3G.&\O[W
MS;@0<<$@;J /6]&U^#6E\RVD5P.N.&') RIP1G!QD#/4<5S7PWE23SMEX]W_
M *O/F+(NS[W3S"<[O;TY[4?#O5-/U#>]I$L,_5U(&[#8SM/_ #SSQ@8 ./E7
M(SQ_PMNFM+;4)HSAXX593@'!5)2#@\=: /1[WQS964OV:291)G! R0#G;AF
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M<?[6<8YSBN!OM0DL]!MQ&Q7S971L=U+2DKGT.!GU'!X)%589?.LQ:II;$M$
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M^O>'_P! 6@#6HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MM7".",CCA=H '/)HT'X;W&FZ@-1DE21-TC,<%')D1@3L *CYF_O=/RKT6B@
MKBO%?@![Z<:G92^5<KC[V=K$84'/./EX(P0PP"!DD]K10!P6C_#V>>Y74M3F
M$LL9&U4R%^7!0YPN #D[0H!/))R0;'B?P5-JM_;ZA&R".#RMP8L&.R0N< *1
MT/'(YKM:* .*^)'@J;Q/Y/D,B^5YF?,+#[VW&,*W]TUVM%% '%>)_!4VJW]O
MJ$;((X/*W!BP8[)"YP I'0\<CFM_Q/X>3Q! UI(<;L%6P"58=",_D>A()&1F
MM:B@#S>+PCK-G']DANH_)4%5SD/MYQSY;,IQTPQV] >!7<:%I\FGQ"&:5IG'
M\;*%..@&!STZDDDG))[#0HH \TT?X6RV5ZMPS(;6*9Y$C#R%ES]PX(QD$)GG
MG;R375^,_!Z>)XA"S;'1LJX4,1V(QP<$=@1R ><8KH** /.AX7UJ91;O=H(_
ME!9"?, !'(81JQ/'=ANZ$\FK'CCP%<Z_';HLJN\(DWO+\FXOMY"HA '!X[#'
M).37>T4 5]0@>XC9(W,;D?*X56P>QVL""/4>G0@\CS^;PCK)C:T%U&\+!U_>
M9+E6SG),;,"0?[QQT!X%>D44 <UHO@6+3[)M+<[UEW[VQ@DMT8!BP!4!<>X!
MZUSEEX+U;15^S6=U'Y(.5WKSSUX*28&<\!L=^I->D44 8GA/1Y]+B\NYG:9^
M.HX7N0&/S-R3RQZ8 "XYMZ[I\FH1&&&5H7/\:J&..A&#STZ$$$'!!['0HH \
MTN?!FKZC&+.XN8C =H;C<V%(.<^6"2,9Y89/4\UI^(_A\UU80Z7;,H,+JQ+E
M@#\K[CP'()9LXZ#IZ5W%% '):QX"76+*"QD8++;I& ZKNP54*PYP2IQZCD*3
MTQ7.7?P[U+4;<6<]Q$4AV>4@7Y?E!7EPBL,*>.&SWQUKU"B@#C[/P'YNFKI-
MP5WKN(=!N"L79E(W 'H<'H2"0",YK'B\(ZS9Q_9(;J/R5!5<Y#[><<^6S*<=
M,,=O0'@5Z110!GZ%I\FGQ"&:5IG'\;*%..@&!STZDDDG))[#0HHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH *\_^-?_ !YQ_P#7PO\ Z!)7H%>?
M_&O_ (\X_P#KX7_T"2@ ^"G_ !YR?]?#?^@1UZ!7G_P4_P"/.3_KX;_T".O0
M* "BBB@ HHHH **** "BBB@ HHHH **** /G_P"*7_(1G_[9_P#HI*]J\)_\
M>=M_U[P_^@+7BOQ2_P"0C/\ ]L__ $4E>U>$_P#CSMO^O>'_ - 6@#6HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M(G>?\^\W_?E__B:/^$3O/^?>;_OR_P#\37TK10!\U?\ ")WG_/O-_P!^7_\
MB:/^$3O/^?>;_OR__P 37TK10!\U?\(G>?\ /O-_WY?_ .)H_P"$3O/^?>;_
M +\O_P#$U]*T4 ?-7_")WG_/O-_WY?\ ^)H_X1.\_P"?>;_OR_\ \37TK10!
M\U?\(G>?\^\W_?E__B:/^$3O/^?>;_OR_P#\37TK10!\U?\ ")WG_/O-_P!^
M7_\ B:/^$3O/^?>;_OR__P 37TK10!\U?\(G>?\ /O-_WY?_ .)H_P"$3O/^
M?>;_ +\O_P#$U]*T4 ?-7_")WG_/O-_WY?\ ^)H_X1.\_P"?>;_OR_\ \37T
MK10!\U?\(G>?\^\W_?E__B:/^$3O/^?>;_OR_P#\37TK10!\U?\ ")WG_/O-
M_P!^7_\ B:/^$3O/^?>;_OR__P 37TK10!\U?\(G>?\ /O-_WY?_ .)H_P"$
M3O/^?>;_ +\O_P#$U]*T4 ?-7_")WG_/O-_WY?\ ^)H_X1.\_P"?>;_OR_\
M\37TK10!\U?\(G>?\^\W_?E__B:/^$3O/^?>;_OR_P#\37TK10!\U?\ ")WG
M_/O-_P!^7_\ B:/^$3O/^?>;_OR__P 37TK10!\U?\(G>?\ /O-_WY?_ .)H
M_P"$3O/^?>;_ +\O_P#$U]*T4 ?-7_")WG_/O-_WY?\ ^)H_X1.\_P"?>;_O
MR_\ \37TK10!\U?\(G>?\^\W_?E__B:/^$3O/^?>;_OR_P#\37TK10!\U?\
M")WG_/O-_P!^7_\ B:/^$3O/^?>;_OR__P 37TK10!\U?\(G>?\ /O-_WY?_
M .)H_P"$3O/^?>;_ +\O_P#$U]*T4 ?-7_")WG_/O-_WY?\ ^)H_X1.\_P"?
M>;_OR_\ \37TK10!\U?\(G>?\^\W_?E__B:/^$3O/^?>;_OR_P#\37TK10!\
MU?\ ")WG_/O-_P!^7_\ B:/^$3O/^?>;_OR__P 37TK10!\U?\(G>?\ /O-_
MWY?_ .)H_P"$3O/^?>;_ +\O_P#$U]*T4 ?-7_")WG_/O-_WY?\ ^)H_X1.\
M_P"?>;_OR_\ \37TK10!\U?\(G>?\^\W_?E__B:/^$3O/^?>;_OR_P#\37TK
M10!\U?\ ")WG_/O-_P!^7_\ B:/^$3O/^?>;_OR__P 37TK10!\U?\(G>?\
M/O-_WY?_ .)H_P"$3O/^?>;_ +\O_P#$U]*T4 ?-7_")WG_/O-_WY?\ ^)H_
MX1.\_P"?>;_OR_\ \37TK10!\U?\(G>?\^\W_?E__B:/^$3O/^?>;_OR_P#\
M37TK10!\U?\ ")WG_/O-_P!^7_\ B:/^$3O/^?>;_OR__P 37TK10!\U?\(G
M>?\ /O-_WY?_ .)H_P"$3O/^?>;_ +\O_P#$U]*T4 ?-7_")WG_/O-_WY?\
M^)H_X1.\_P"?>;_OR_\ \37TK10!\U?\(G>?\^\W_?E__B:/^$3O/^?>;_OR
M_P#\37TK10!\U?\ ")WG_/O-_P!^7_\ B:/^$3O/^?>;_OR__P 37TK10!\U
M?\(G>?\ /O-_WY?_ .)H_P"$3O/^?>;_ +\O_P#$U]*T4 ?-7_")WG_/O-_W
MY?\ ^)H_X1.\_P"?>;_OR_\ \37TK10!\U?\(G>?\^\W_?E__B:/^$3O/^?>
M;_OR_P#\37TK10!\U?\ ")WG_/O-_P!^7_\ B:/^$3O/^?>;_OR__P 37TK1
M0!\U?\(G>?\ /O-_WY?_ .)H_P"$3O/^?>;_ +\O_P#$U]*T4 ?-7_")WG_/
MO-_WY?\ ^)H_X1.\_P"?>;_OR_\ \37TK10!\U?\(G>?\^\W_?E__B:/^$3O
M/^?>;_OR_P#\37TK10!\U?\ ")WG_/O-_P!^7_\ B:/^$3O/^?>;_OR__P 3
M7TK10!\U?\(G>?\ /O-_WY?_ .)H_P"$3O/^?>;_ +\O_P#$U]*T4 ?-7_")
MWG_/O-_WY?\ ^)H_X1.\_P"?>;_OR_\ \37TK10!\U?\(G>?\^\W_?E__B:/
M^$3O/^?>;_OR_P#\37TK10!\U?\ ")WG_/O-_P!^7_\ B:/^$3O/^?>;_OR_
M_P 37TK10!\U?\(G>?\ /O-_WY?_ .)H_P"$3O/^?>;_ +\O_P#$U]*T4 ?-
M7_")WG_/O-_WY?\ ^)H_X1.\_P"?>;_OR_\ \37TK10!\U?\(G>?\^\W_?E_
M_B:/^$3O/^?>;_OR_P#\37TK10!\U?\ ")WG_/O-_P!^7_\ B:/^$3O/^?>;
M_OR__P 37TK10!\U?\(G>?\ /O-_WY?_ .)H_P"$3O/^?>;_ +\O_P#$U]*T
M4 ?-7_")WG_/O-_WY?\ ^)H_X1.\_P"?>;_OR_\ \37TK10!\U?\(G>?\^\W
M_?E__B:/^$3O/^?>;_OR_P#\37TK10!\U?\ ")WG_/O-_P!^7_\ B:/^$3O/
M^?>;_OR__P 37TK10!\U?\(G>?\ /O-_WY?_ .)H_P"$3O/^?>;_ +\O_P#$
MU]*T4 ?-7_")WG_/O-_WY?\ ^)H_X1.\_P"?>;_OR_\ \37TK10!\U?\(G>?
M\^\W_?E__B:/^$3O/^?>;_OR_P#\37TK10!\U?\ ")WG_/O-_P!^7_\ B:/^
M$3O/^?>;_OR__P 37TK10!\U?\(G>?\ /O-_WY?_ .)H_P"$3O/^?>;_ +\O
M_P#$U]*T4 ?-7_")WG_/O-_WY?\ ^)H_X1.\_P"?>;_OR_\ \37TK10!\U?\
M(G>?\^\W_?E__B:/^$3O/^?>;_OR_P#\37TK10!\U?\ ")WG_/O-_P!^7_\
MB:/^$3O/^?>;_OR__P 37TK10!\U?\(G>?\ /O-_WY?_ .)H_P"$3O/^?>;_
M +\O_P#$U]*T4 ?-7_")WG_/O-_WY?\ ^)H_X1.\_P"?>;_OR_\ \37TK10!
M\U?\(G>?\^\W_?E__B:/^$3O/^?>;_OR_P#\37TK10!\U?\ ")WG_/O-_P!^
M7_\ B:/^$3O/^?>;_OR__P 37TK10!\U?\(G>?\ /O-_WY?_ .)H_P"$3O/^
M?>;_ +\O_P#$U]*T4 ?-7_")WG_/O-_WY?\ ^)H_X1.\_P"?>;_OR_\ \37T
MK10!\U?\(G>?\^\W_?E__B:/^$3O/^?>;_OR_P#\37TK10!\U?\ ")WG_/O-
M_P!^7_\ B:/^$3O/^?>;_OR__P 37TK10!\U?\(G>?\ /O-_WY?_ .)H_P"$
M3O/^?>;_ +\O_P#$U]*T4 ?-7_")WG_/O-_WY?\ ^)H_X1.\_P"?>;_OR_\
M\37TK10!\VP^#KV5@@MY<L0!F-E'/J2  /<G [UT_A[X/W-VY^U_N8UQT*NS
M<\@;20..YZ''!YQ[710!#:6JVB+#&,)&H51DG 48 R>>E3444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
? 4444 %%%% !1110 4444 %%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
